
<html lang="en"     class="pb-page"  data-request-id="32cd8f1a-cb25-48e3-b74a-423edd000766"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2018.61.issue-3;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01420;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties" /></meta><meta name="dc.Creator" content="Eric J.  Miller" /></meta><meta name="dc.Creator" content="Edgars  Jecs" /></meta><meta name="dc.Creator" content="Valarie M.  Truax" /></meta><meta name="dc.Creator" content="Brooke M.  Katzman" /></meta><meta name="dc.Creator" content="Yesim A.  Tahirovic" /></meta><meta name="dc.Creator" content="Robert J.  Wilson" /></meta><meta name="dc.Creator" content="Katie M.  Kuo" /></meta><meta name="dc.Creator" content="Michelle B.  Kim" /></meta><meta name="dc.Creator" content="Huy H.  Nguyen" /></meta><meta name="dc.Creator" content="Manohar T.  Saindane" /></meta><meta name="dc.Creator" content="Huanyu  Zhao" /></meta><meta name="dc.Creator" content="Tao  Wang" /></meta><meta name="dc.Creator" content="Chi S.  Sum" /></meta><meta name="dc.Creator" content="Mary E.  Cvijic" /></meta><meta name="dc.Creator" content="Gretchen M.  Schroeder" /></meta><meta name="dc.Creator" content="Lawrence J.  Wilson" /></meta><meta name="dc.Creator" content="Dennis C.  Liotta" /></meta><meta name="dc.Description" content="CXCR4 is a seven-transmembrane receptor expressed by hematopoietic stem cells and progeny, as well as by ≥48 different cancers types. CXCL12, the only chemokine ligand of CXCR4, is secreted within ..." /></meta><meta name="Description" content="CXCR4 is a seven-transmembrane receptor expressed by hematopoietic stem cells and progeny, as well as by ≥48 different cancers types. CXCL12, the only chemokine ligand of CXCR4, is secreted within ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 30, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01420" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01420" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01420" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01420" /></link>
        
    
    

<title>Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01420" /></meta><meta property="og:title" content="Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0017.jpeg" /></meta><meta property="og:description" content="CXCR4 is a seven-transmembrane receptor expressed by hematopoietic stem cells and progeny, as well as by ≥48 different cancers types. CXCL12, the only chemokine ligand of CXCR4, is secreted within the tumor microenvironment, providing sanctuary for CXCR4+ tumor cells from immune surveillance and chemotherapeutic elimination by (1) stimulating prosurvival signaling and (2) recruiting CXCR4+ immunosuppressive leukocytes. Additionally, distant CXCL12-rich niches attract and support CXCR4+ metastatic growths. Accordingly, CXCR4 antagonists can potentially obstruct CXCR4-mediated prosurvival signaling, recondition the CXCR4+ leukocyte infiltrate from immunosuppressive to immunoreactive, and inhibit CXCR4+ cancer cell metastasis. Current small molecule CXCR4 antagonists suffer from poor oral bioavailability and off-target liabilities. Herein, we report a series of novel tetrahydroisoquinoline-containing CXCR4 antagonists designed to improve intestinal absorption and off-target profiles. Structure–activity relationships regarding CXCR4 potency, intestinal permeability, metabolic stability, and cytochrome P450 inhibition are presented." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01420"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01420">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01420&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01420&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01420&amp;href=/doi/10.1021/acs.jmedchem.7b01420" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 946-979</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01411" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01409" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+J.++Miller">Eric J. Miller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-3659-0105" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edgars++Jecs">Edgars Jecs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valarie+M.++Truax">Valarie M. Truax</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brooke+M.++Katzman">Brooke M. Katzman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yesim+A.++Tahirovic">Yesim A. Tahirovic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Wilson">Robert J. Wilson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-8344-5325" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Katie+M.++Kuo">Katie M. Kuo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+B.++Kim">Michelle B. Kim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huy+H.++Nguyen">Huy H. Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manohar+T.++Saindane">Manohar T. Saindane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huanyu++Zhao">Huanyu Zhao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tao++Wang">Tao Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chi+S.++Sum">Chi S. Sum</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+E.++Cvijic">Mary E. Cvijic</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gretchen+M.++Schroeder">Gretchen M. Schroeder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+J.++Wilson">Lawrence J. Wilson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+C.++Liotta">Dennis C. Liotta</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7736-7113" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Bristol-Myers Squibb Research & Development, Princeton, New Jersey 08543, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 404-727-6602. E-mail: <a href="/cdn-cgi/l/email-protection#c1a5ada8aeb5b5a081a4acaeb3b8efa4a5b4"><span class="__cf_email__" data-cfemail="fa9e9693958e8e9bba9f97958883d49f9e8f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01420&amp;href=/doi/10.1021%2Facs.jmedchem.7b01420" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 946–979</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 19, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 September 2017</li><li><span class="item_label"><b>Published</b> online</span>30 January 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 February 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01420" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01420</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D946%26pageCount%3D34%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEric%2BJ.%2BMiller%252C%2BEdgars%2BJecs%252C%2BValarie%2BM.%2BTruax%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D3%26contentID%3Dacs.jmedchem.7b01420%26title%3DDiscovery%2Bof%2BTetrahydroisoquinoline-Containing%2BCXCR4%2BAntagonists%2Bwith%2BImproved%2Bin%2BVitro%2BADMET%2BProperties%26numPages%3D34%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D979%26publicationDate%3DFebruary%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01420"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1697</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">14</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01420" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Tetrahydroisoquinoline-Containing CXCR4 Antagonists with Improved in Vitro ADMET Properties&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;J. Miller&quot;},{&quot;first_name&quot;:&quot;Edgars&quot;,&quot;last_name&quot;:&quot;Jecs&quot;},{&quot;first_name&quot;:&quot;Valarie&quot;,&quot;last_name&quot;:&quot;M. Truax&quot;},{&quot;first_name&quot;:&quot;Brooke&quot;,&quot;last_name&quot;:&quot;M. Katzman&quot;},{&quot;first_name&quot;:&quot;Yesim&quot;,&quot;last_name&quot;:&quot;A. Tahirovic&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Wilson&quot;},{&quot;first_name&quot;:&quot;Katie&quot;,&quot;last_name&quot;:&quot;M. Kuo&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;B. Kim&quot;},{&quot;first_name&quot;:&quot;Huy&quot;,&quot;last_name&quot;:&quot;H. Nguyen&quot;},{&quot;first_name&quot;:&quot;Manohar&quot;,&quot;last_name&quot;:&quot;T. Saindane&quot;},{&quot;first_name&quot;:&quot;Huanyu&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Tao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Chi&quot;,&quot;last_name&quot;:&quot;S. Sum&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;E. Cvijic&quot;},{&quot;first_name&quot;:&quot;Gretchen&quot;,&quot;last_name&quot;:&quot;M. Schroeder&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;J. Wilson&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;C. Liotta&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;946-979&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01420&quot;},&quot;abstract&quot;:&quot;CXCR4 is a seven-transmembrane receptor expressed by hematopoietic stem cells and progeny, as well as by ≥48 different cancers types. CXCL12, the only chemokine ligand of CXCR4, is secreted within the tumor microenvironment, providing sanctuary for CXCR4+ tumor cells from immune surveillance and chemotherapeutic elimination by (1) stimulating prosurvival signaling and (2) recruiting CXCR4+ immunosuppressive leukocytes. Additionally, distant CXCL12-rich niches attract and support CXCR4+ metastatic growths. Accordingly, CXCR4 antagonists can potentially obstruct CXCR4-mediated prosurvival signaling, recondition the CXCR4+ leukocyte infiltrate from immunosuppressive to immunoreactive, and inhibit CXCR4+ cancer cell metastasis. Current small molecule CXCR4 antagonists suffer from poor oral bioavailability and off-target liabilities. Herein, we report a series of novel tetrahydroisoquinoline-containing CXCR4 antagonists designed to improve intestinal absorption and off-target profiles. Structure–activity relations&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01420&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01420" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01420&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01420" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01420&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01420" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01420&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01420&amp;href=/doi/10.1021/acs.jmedchem.7b01420" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01420" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01420" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01420%26sid%3Dliteratum%253Aachs%26pmid%3D29350534%26genre%3Darticle%26aulast%3DMiller%26date%3D2018%26atitle%3DDiscovery%2Bof%2BTetrahydroisoquinoline-Containing%2BCXCR4%2BAntagonists%2Bwith%2BImproved%2Bin%2BVitro%2BADMET%2BProperties%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D3%26spage%3D946%26epage%3D979%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291235" title="Column chromatography">Column chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291251" title="Sodium">Sodium</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=291304" title="Organic reactions">Organic reactions</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/jmcmar.2018.61.issue-3/20180208/jmcmar.2018.61.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">CXCR4 is a seven-transmembrane receptor expressed by hematopoietic stem cells and progeny, as well as by ≥48 different cancers types. CXCL12, the only chemokine ligand of CXCR4, is secreted within the tumor microenvironment, providing sanctuary for CXCR4<sup>+</sup> tumor cells from immune surveillance and chemotherapeutic elimination by (1) stimulating prosurvival signaling and (2) recruiting CXCR4<sup>+</sup> immunosuppressive leukocytes. Additionally, distant CXCL12-rich niches attract and support CXCR4<sup>+</sup> metastatic growths. Accordingly, CXCR4 antagonists can potentially obstruct CXCR4-mediated prosurvival signaling, recondition the CXCR4<sup>+</sup> leukocyte infiltrate from immunosuppressive to immunoreactive, and inhibit CXCR4<sup>+</sup> cancer cell metastasis. Current small molecule CXCR4 antagonists suffer from poor oral bioavailability and off-target liabilities. Herein, we report a series of novel tetrahydroisoquinoline-containing CXCR4 antagonists designed to improve intestinal absorption and off-target profiles. Structure–activity relationships regarding CXCR4 potency, intestinal permeability, metabolic stability, and cytochrome P450 inhibition are presented.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chemokines are small, soluble cytokines that bind to and signal through seven-transmembrane chemokine receptors.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> These interactions facilitate the directional migration of chemokine receptor-expressing leukocytes along concentration gradients of chemokine ligands, and they also promote the migratory aptitude and proliferation of these cells via prochemotactic and prosurvival gene transcription. Although most chemokine receptors interact with numerous chemokine ligands, several others bind only to one, such as the CXC type 4 receptor (CXCR4), which interacts solely with the CXC type 12 ligand (CXCL12, also known as stromal cell-derived factor 1, or SDF-1).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Extracellular CXCL12 binding to CXCR4 causes a conformational change that translates to the intracellular portions of the receptor, which associate with heterotrimeric G proteins.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This causes dissociation of the Gα subunit from the Gβγ heterodimer. CXCR4 predominantly signals through G proteins that contain Gα<sub>i/o</sub> subunits, which are ubiquitously expressed, or Gα<sub>15</sub> subunits,<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> which are primarily expressed by cells of hematopoietic origin. Once released from Gβγ, Gα<sub>i/o</sub> proteins inhibit adenylyl cyclase (AC) and stimulate phosphoinositide 3-kinase (PI3K). Alternatively, Gα<sub>15</sub> proteins activate phospholipase C (PLC), leading to the release of intracellular Ca<sup>2+</sup> ions, which is commonly measured to quantify CXCR4 activity in vitro. Through these signaling cascades, binding of CXCL12 to CXCR4 facilitates many cellular activities comprising chemotaxis, hematopoiesis, transcription, survival, and proliferation.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">CXCR4 is the only functional chemokine receptor expressed on hematopoietic stem cells<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (HSCs). As the CXCR4/CXCL12 axis is essential for HSC colonization of fetal bone marrow during development,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> CXCL12 or CXCR4 knockout mice are embryonic lethal, exhibiting defects in hematopoiesis, vascularization, and vital organ development.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> In adults, high levels of CXCL12 are secreted by stromal cells residing in the bone marrow, liver, lungs, and lymph nodes, as well as by pathogenic, damaged, and hypoxic tissue. In contrast, CXCR4 is predominantly expressed by HSCs and their lineages, including T and B lymphocytes, natural killer cells, macrophages, and neutrophils, as well as by injured or hypoxic tissue.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These expression profiles result in chemoattraction of CXCR4<sup>+</sup> leukocytes and progenitors to CXCL12-rich niches where they become sequestered as a result of integrin-mediated adhesion to stromal cell layers. CXCL12 also encourages CXCR4<sup>+</sup> leukocyte motility by stimulating cytoskeletal rearrangements, F-actin bundle organization, and leading edge formation CXCL12 further activates integrins and upregulates matrix metalloproteinases (MMPs), thereby facilitating attachment to and penetration through proximal circulatory vessel endothelia.</div><div class="NLM_p">Although CXCR4 has received much attention from the drug discovery and development communities as the co-receptor for T-tropic HIV entry,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> the CXCR4/CXCL12 axis is also integrally involved in the progression of many types of cancer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> CXCR4 overexpression relative to normal tissue has been detected in ≥48 different types of solid and hematological cancers.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Although oncogenic mutations provide the host immune system with various tumor-specific antigens, intratumoral CXCL12 instigates CXCR4<sup>+</sup> cancer cell adhesion to and migration beneath tumor-associated stroma in an integrin-dependent manner. CXCL12 also induces CXCR4-mediated transcription of growth factors, angiogenic factors, and immunosuppressive cytokines. These events promote tumor progression, evasion of immune surveillance, and resistance to chemotherapy.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Privileged CXCL12-rich stromal niches within the tumor microenvironment additionally provide a prosurvival sanctuary for quiescent CXCR4<sup>+</sup> cancer cell subpopulations that persist after radiation therapy and/or chemotherapy, increasing the likelihood of relapse.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Accordingly, high intratumoral levels of CXCR4<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and CXCL12<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> are independent indicators of poor clinical prognosis for patients suffering from various types of cancer.</div><div class="NLM_p">Tumor cells additionally evade immune surveillance and chemotherapeutic elimination by hijacking CXCR4/CXCL12-mediated leukocyte trafficking to chemotactically recruit CXCR4<sup>+</sup> leukocytes and progenitors, many of which are immunosuppressive rather than immunoreactive.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although various leukocyte subsets gain access to the tumor microenvironment, many of these cells are immunosuppressive rather than immunoreactive. For example, intratumoral CXCL12 both repels cluster of differentiation 8 (CD8)-expressing effector T lymphocytes and recruits immunosuppressive forkhead box P3 (FoxP3)-expressing regulatory T lymphocytes, which facilitate both immune evasion and chemotherapeutic resistance.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Accordingly, low ratios of CD8<sup>+</sup> cytotoxic T lymphocytes to FoxP3<sup>+</sup> regulatory T lymphocytes correlate with poor clinical prognosis, while high ratios are associated with increased survival. CXCL12 also recruits CXCR4<sup>+</sup> proangiogenic cells, which support tumor vascularization, growth, and invasion.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><div class="NLM_p">CXCR4<sup>+</sup> cancer cells further hijack the normal physiological functions of the CXCR4/CXCL12 axis to gain entry to distant CXCL12-rich tissues, where they find environments that cultivate the formation of new metastases.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Stromal cell secretion of CXCL12 recruits CXCR4<sup>+</sup> tumor cells to, for example, the bone marrow microenvironment, which provides a prosurvival sanctuary for these cancer cells to evade immune recognition and chemotherapeutic elimination. This migration of CXCR4<sup>+</sup> cancer cells from the primary tumor to CXCL12-rich metastatic sites occurs via a mechanism equal but opposite to normal CXCR4<sup>+</sup> leukocyte trafficking.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Once the primary tumor is sufficiently vascularized, CXCR4<sup>+</sup> cancer cells can enter circulation, chemotactically migrate toward distant stromal origins of CXCL12 secretion (typically the bone marrow, liver, lungs, and lymph nodes), and penetrate deep into the target organ where they engraft into prosurvival stromal compartments. Ultimately, stromal cell secretion of CXCL12 is essential for (1) prosurvival signaling within the primary CXCR4<sup>+</sup> tumor microenvironment, (2) recruitment of CXCR4<sup>+</sup> immunosuppressive leukocytes and proangiogenic cells to intratumoral stromal niches, and (3) CXCR4<sup>+</sup> cancer cell metastasis to distant CXCL12-rich tissues.</div><div class="NLM_p">In principle therefore, small molecule CXCR4 antagonists can inhibit cancer progression via several mechanisms of action (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> CXCR4 blockade can disrupt tumor–stromal interactions that confer resistance to the host immune system and to anticancer agents by obstructing autocrine and paracrine survival signaling mechanisms.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> CXCR4 antagonists can also combat cancer progression through inhibition of CXCR4<sup>+</sup> immunosuppressive leukocyte migration,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> thereby reconditioning the tumor microenvironment in an immunomodulatory manner that induces a higher susceptibility to immune elimination. Furthermore, inhibition of CXCR4<sup>+</sup> provasculogenic and proangiogenic progenitor trafficking from bone marrow stromal niches to the tumor microenvironment can prevent tumor cell access to systemic and lymphatic vasculature.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Moreover, CXCR4 antagonists have the potential to inhibit cancer metastasis to distant CXCL12-rich tissues, blocking one of the predominant factors that contributes to poor patient prognosis across many cancer types.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Finally, since metastatic CXCR4<sup>+</sup> tumor cells commonly find sanctuary in bone marrow compartments where they evade chemotherapeutic elimination, CXCR4 antagonists can disrupt local tumor–stromal interactions, mobilizing tumor cells into circulation where they are accessible to cytotoxic drugs.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Each of these mechanisms of action has been highlighted in various preclinical models of cancer by AMD3100<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (Mozobil, Plerixafor, <a class="ref internalNav" href="#fig2" aria-label="Figure 02">Figure 02</a>), a potent<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and selective<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> CXCR4 antagonist that is FDA-approved for autologous HSC mobilization and transplantation for non-Hodgkin’s lymphoma and multiple myeloma. Some particularly notable preclinical antitumor effects of AMD3100 include delayed development of malignant ascites and an increased overall survival window as a single agent in immunocompetent murine models of ovarian cancer.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> These results were attributed to reduced vessel density, increased apoptosis and necrosis, and 6-fold higher CD8<sup>+</sup>:FoxP3<sup>+</sup> T lymphocyte ratios in the tumor microenvironment, enhancing susceptibility to the host immune system. Another example involved an immunocompetent model of hepatocellular carcinoma (HCC) and combination therapy with an antibody against immune checkpoint programmed cell death protein 1 (PD-1).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> HCC standard of care sorafenib causes rapid clinical resistance, which begins with the induction of hypoxia. Hypoxia, in turn, upregulates CXCR4, CXCL12, and immune checkpoint programmed death ligand 1 (PD-L1), all of which promote immunosuppression and chemotherapeutic evasion. AMD3100 in combination with sorafenib or with sorafenib and anti-PD-1 decreased both tumor volume and the number of metastatic growths relative to sorafenib alone or sorafenib and anti-PD-1 combination. In particular, the triple combination paradigm substantially improved both the CD8<sup>+</sup> cytotoxic T lymphocyte infiltrate and intratumoral apoptotic activity, emphasizing the clinical potential of combination with immune checkpoint inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potential CXCR4 mechanisms of action against cancer progression. Reproduced from  <cite>European Journal of Cancer</cite> (<a href="https://www.sciencedirect.com/science/journal/09598049" class="extLink">https://www.sciencedirect.com/science/journal/09598049</a>), Vol. <em>49</em>, <contrib-group>Domanska, U. M.; Kruizinga, R. C.; Nagengast, W. B.; Timmer-Bosscha, H.; Huls, G.; de Vries, E. G. E.; Walenkamp, A. M. E.</contrib-group>, A Review on CXCR4/CXCL12 Axis in Oncology: No Place to Hide, pp 219–230, Copyright <span class="NLM_year">2013</span>,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Non-peptide small molecule CXCR4 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Despite these preclinical triumphs, the utility of AMD3100 in clinical oncology as an antitumor agent is somewhat limited due to dose-limiting cardiotoxicity and lack of oral bioavailability.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> A second generation CXCR4 antagonist AMD11070 (<a class="ref internalNav" href="#fig2" aria-label="Figure 02">Figure 02</a>) with no cyclams was developed as an orally bioavailable anti-HIV treatment,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> but potent inhibition of cytochrome P450 (CYP450) isoforms 2D6 and 3A4<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and signs of hepatotoxicity in long-term animal studies<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> ultimately prevented clinical continuation. Various AMD11070 analogs have since been described with particular focus on tetrahydroquinoline modifications,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> side chain alterations,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and benzimidazole substitutions,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> culminating in the discovery of advanced leads such as GSK812397.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Alternative scaffolds of small molecule CXCR4 antagonists include isothioureas,<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> the most characteristic of which is IT1t, cyclic peptides,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and other chemotypes.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In contrast, our research group focused on modifying the benzimidazole motif of AMD11070, replacing it with N-substituted piperazines<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> or with tetrahydroisoquinolines.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> These efforts led to the discovery of TIQ-15, a highly potent (IC<sub>50</sub> = 6.25 nM) and selective (<10% inhibition of all other chemokine receptors at 10 μM) small molecule CXCR4 antagonist that exhibits robust metabolic stability in human liver microsomes (<i>t</i><sub>1/2</sub> = 1.0 h), strong plasma stability in rats (<i>t</i><sub>1/2</sub> = 6.0 h), and rapid mobilization of leukocytes that correlated with plasma drug concentrations in mice. Despite this impressive activity profile, TIQ-15 potently inhibits CYP450 subtype 2D6 (IC<sub>50</sub> = 0.320 nM), limiting its utility in combination treatment paradigms, which are commonly employed in clinical oncology. TIQ-15 is also rapidly metabolized in mouse liver microsomes (only 17% remaining after 10 min), hindering the evaluation of antitumor efficacy after oral dosing regimens in preclinical mouse models of cancer. Furthermore, despite moderate oral bioavailability in rats, systemic exposure of TIQ-15 after oral administration undoubtedly remains limited by the presence of multiple basic amines. Herein, we describe the design, synthesis, and pharmacological evaluation of TIQ-15 analogs with enhanced CYP450 2D6:CXCR4 IC<sub>50</sub> ratios, improved passive membrane permeability, and elevated mouse liver microsomal stability.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To surmount the indicated shortcomings of TIQ-15, a series of conformationally restricted TIQ-15 derivatives with decreased basicity and/or increased lipophilicity were designed (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). While improving basicity and lipophilicity parameters was expected to increase intestinal permeability, rigidifying the butylamine side chain was anticipated to maximize CXCR4 specificity and to limit CYP450 2D6 inhibition and mouse metabolism. These design principles led to the conception of TIQ-15 analogs bearing benzylic amine (<b>1</b>), allylic amine (<b>2</b>), or <i>gem</i>-dimethylbutylamine (<b>3</b>–<b>5</b>) side chains, as well as carbocyclic or heterocyclic amine functionalization. Synthesis of these compounds was envisioned to be conducted in a modular fashion, quite similar to the previously described preparation of TIQ-15 analogs,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> which utilized butylamine <b>6</b> as a common synthetic intermediate (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design principles of TIQ-15 analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Arylmethyl Functionalization of the Butylamine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) C<sub>5</sub>H<sub>5</sub>NCHO or PhCHO, Na(OAc)<sub>3</sub>BH, DCM, rt, 24 h, 26–68% yield; (b) TFA, DCM, rt, 24 h, 67–88% yield; (c) C<sub>5</sub>H<sub>5</sub>NCHO, Na(OAc)<sub>3</sub>BH, DCM, rt, 5 h; (d) BOC<sub>2</sub>O, DMAP, DIPEA, DCM, rt, 6 h, 78–79% yield over 2 steps; (e) TFA, DCM, rt, 24 h, 14–24% yield; (f) PhCHO, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 44% yield; (g) TFA, DCM, rt, 24 h, 20% yield.</p></p></figure><div class="NLM_p">Sodium triacetoxyborohydride (STAB)-mediated reductive aminations involving amine <b>6</b> and benzaldehyde or 2-, 3-, or 4-pyridinecarboxaldehydes were anticipated to deliver the monosubstituted analogs after BOC group removal. In contrast, the corresponding bis(pyridylmethyl) (<b>7a</b>–<b>c</b>) and dibenzyl (<b>7d</b>) analogs predominated over the desired monosubstituted derivatives, even when only 0.95 equiv of aldehyde was added, indicating that the monosubstituted products retained comparable reactivity to the unsubstituted starting material. Although the disubstituted compounds were undesired byproducts, they were still considered useful probes to investigate the CXCR4 binding pocket that interacts with the butylamine side chain of TIQ-15. While STAB-mediated reductive amination of butylamine <b>6</b> and pyridinecarboxaldehydes favored disubstituted over monosubstituted products, column chromatography provided ample quantities of pure disubstituted products for biological evaluation, as well as smaller quantities of difficult to separate mixtures (∼2:1) of mono- to bis(pyridylmethyl) congeners. This permitted selective masking of the only remaining nucleophilic amines via DMAP-catalyzed BOC protection, which enabled chromatographic purification of the desired monopyridylmethyl BOC-protected amines. BOC protecting groups were subsequently removed using TFA, which cleanly provided the desired monopyridylmethyl TIQ-15 analogs <b>8a</b>–<b>c</b>.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> While this BOC protection strategy delivered the desired compounds in the face of unexpected overreactivity during STAB-mediated reductive amination, this was clearly a problem that needed to be addressed for future analogs. A particularly attractive option was to first preform the imine intermediate and subsequently add a reducing agent.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Accordingly, butylamine <b>6</b> was stirred with benzaldehyde and titanium isopropoxide to ensure complete imine formation, followed by addition of sodium borohydride to rapidly reduce both the imine and any remaining benzaldehyde to prevent overreactivity. This protocol facilitated isolation of the desired monobenzyl product, which was then subjected to BOC deprotection conditions, generating the desired monobenzyl TIQ-15 analog <b>9</b>. This titanium isopropoxide/sodium borohydride procedure was additionally applied toward the syntheses of carbocyclic and heterocyclic TIQ-15 derivatives (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Butylamine <b>6</b> underwent titanium isopropoxide/sodium borohydride-mediated reductive amination with aldehydes <b>10a</b>–<b>f</b>, producing the corresponding monosubstituted products without detection of any undesired disubstituted byproducts. These intermediates were then treated with TFA to remove the BOC protecting groups, delivering the desired monosubstituted TIQ-15 analogs <b>11a</b>–<b>f</b>. Finally, reductive amination between butylamine <b>6</b> and ketones <b>12a</b>–<b>g</b> did not require the titanium isopropoxide/sodium borohydride protocol but was rather afforded using STAB with acetic acid as an additive, generating the intermediate monosubstituted products. Typical BOC deprotection was carried out to yield the resulting monosubstituted TIQ-15 analogs <b>13a</b>–<b>g</b>, thereby furnishing this series of substituted-butylamine derivatives of TIQ-15.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Saturated Cyclic Functionalization of the Butylamine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 27–62% yield; (b) TFA, DCM, rt, 24 h, 42–98% yield; (c) <b>12</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 40–55% yield; (d) TFA, DCM, rt, 24 h, 19–98% yield.</p></p></figure><div class="NLM_p">Secondary amine <b>14</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> was used as the common starting material for the syntheses of benzylic and allylic amine side chain analogs. First, secondary amine <b>14</b> underwent STAB-mediated reductive amination with 2-cyanobenzaldehyde to produce the corresponding nitrile <b>15</b> in 64% yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>a). The nitrile was subsequently reduced using nickel(II) chloride hexahydrate and sodium borohydride, and the forming amine was trapped in situ with BOC<sub>2</sub>O.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> The resulting intermediate was deprotected using TFA to deliver the desired <i>ortho</i>-benzylic amine side chain analog <b>16</b> in 62% yield. Alternatively, the <i>meta</i>- and <i>para</i>-benzylic amine side chain derivatives <b>19a</b> and <b>19b</b> were prepared using a different approach (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>b). Commercially available carboxylic acids <b>17a</b> and <b>17b</b> were reduced to the corresponding alcohols <b>18a</b> and <b>18b</b><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> using borane-dimethyl sulfide complex, followed by Dess–Martin oxidation<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> of the resulting alcohols to the analogous aldehydes. With the <i>meta</i>- and <i>para</i>-substituted benzaldehyde derivatives in hand, each of them was subjected to STAB-mediated reductive amination with secondary amine <b>14</b> using an acetic acid additive to yield the desired bis-BOC-protected intermediates. BOC group removal using TFA generated <i>meta</i>- and <i>para</i>-benzylic amine congeners <b>19a</b> and <b>19b</b>, respectively. To prepare the <i>cis</i>-allylic and <i>trans</i>-allylic amine side chain analogs of TIQ-15, secondary amine <b>14</b> was reacted with <i>cis</i>-allylic chloride <b>20</b><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> or <i>trans</i>-allylic bromide <b>22</b><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> in S<sub>N</sub>2 fashion under Finkelstein-like conditions<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> to generate the corresponding tertiary amines (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The BOC protecting groups of the resulting <i>cis</i>-allylic amine were removed using TFA to deliver derivative <b>21</b> in 59% yield. Alternatively, the amines of the <i>trans</i>-allylic intermediate were differentially protected as phthalimide and BOC. Accordingly, the phthalimide group was removed using aqueous hydrazine, generating allylic amine <b>23</b>, followed by BOC group deprotection using TFA to afford <i>trans</i>-allylic amine analog <b>24</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzylic Amine Side Chain Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-cyanobenzaldehyde, Na(OAc)<sub>3</sub>BH, DCM, rt, 4 h, 64% yield; (b) NiCl<sub>2</sub>-(H<sub>2</sub>O)<sub>6</sub>, NaBH<sub>4</sub>, BOC<sub>2</sub>O, NH(CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>, MeOH, 0 °C to rt, 96 h, 26% yield; (c) TFA, DCM, rt, 24 h, 62% yield; (d) BH<sub>3</sub>-Me<sub>2</sub>S, DCM, rt, 24 h, 49–74% yield; (e) Dess–Martin periodinane, DCM, rt, 2.5 h; (f) <b>14</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 51–55% yield over 2 steps; (g) TFA, DCM, rt, 24 h, 49–65% yield.</p></p></figure><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Allylic Amine Side Chain Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>20</b>, KI, DIPEA, MeCN, 50 °C, 72 h, 69% yield; (b) TFA, DCM, rt, 24 h, 59% yield; (c) <b>22</b>, KI, DIPEA, 50 °C, 24 h, 51% yield; (d) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 24 h, 76% yield; (e) TFA, DCM, rt, 24 h, 25% yield.</p></p></figure><div class="NLM_p">To prepare the 2,2-dimethylbutyl side chain analog, lactone <b>25</b> preliminarily underwent trimethylaluminum-mediated ring opening with 1-octanethiol<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>a), followed by Mitsunobu reaction<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> of the resulting alcohol with nucleophilic phthalimide to yield desired intermediate <b>26</b>. Fukuyama reduction<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> of the thioester to the corresponding aldehyde proceeded cleanly, and subsequent STAB-mediated reductive amination with amine <b>27</b> generated anticipated secondary amine <b>28</b> in high yield. Ensuing reductive amination with aldehyde <b>29</b> using titanium isopropoxide and STAB furnished the differentially protected scaffold of the 2,2-dimethylbutyl side chain analog. Phthalimide deprotection with aqueous hydrazine, followed by TFA-mediated BOC group removal, yielded derivative <b>30</b>. To prepare the 3,3-dimethylbutyl side chain analog, the least sterically encumbered alcohol of 2,2-dimethylbutane-1,4-diol was selectively silyl protected in 67% isolated yield<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>b). The remaining alcohol was subjected to Mitsunobu reaction<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> using phthalimide as a nucleophile, which was followed by silyl group removal using aqueous hydrochloric acid to generate desired intermediate <b>32</b>. Sulfur trioxide–pyridine complex was subsequently employed in a Parikh–Doering oxidation<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> to deliver the corresponding aldehyde, which was then subjected to reductive amination involving secondary amine <b>14</b> and STAB, followed by aqueous hydrazine-mediated phthalimide deprotection to yield the desired primary amine <b>33</b>. Finally, analog <b>34</b> was afforded via removal of the BOC protecting group with TFA. Reduction of nitropentanoate <b>35</b> via Raney nickel-catalyzed hydrogenolysis generated the corresponding amine in situ, which spontaneously cyclized onto the ester to deliver the related pyrrolidinone<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>c). BOC protection of this γ-lactam furnished desired intermediate <b>36</b>. DIBALH-mediated amide reduction to corresponding hemiaminal proceeded cleanly in 71% isolated yield. Subsequent STAB-mediated reductive amination with secondary amine <b>14</b> delivered the resulting bis-BOC protected scaffold, which was finally deprotected with TFA to yield the desired 4,4-dimethylbutylamine <b>37</b>.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>gem</i>-Dimethylbutylamine Side Chain Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HSC<sub>8</sub>H<sub>17</sub>, Me<sub>3</sub>Al, DCM, 0 °C to rt, 12 h, 66% yield; (b) PPh<sub>3</sub>, DIAD, phthalimide, THF, rt, 2.5 h, 93% yield; (c) PdCl<sub>2</sub>, Et<sub>3</sub>SiH, Et<sub>3</sub>N, DCM, rt, 20 min, 86% yield; (d) <b>27</b>, Na(OAc)<sub>3</sub>BH, DCE, rt, 1 h, 99% yield; (e) <b>29</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, Na(OAc)<sub>3</sub>BH, DCM, rt, 12 h, 56% yield; (f) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 12 h; (g) TFA, DCM, rt, 24 h, 85% over 2 steps; (h) TBSCl, imidazole, DMF, 0 °C to rt, 1 h, 67% yield; (i) PPh<sub>3</sub>, DIAD, phthalimide, THF, rt, 36 h; (j) HCl (aq), THF, rt, 2 h, 84% yield over 2 steps; (k) SO<sub>3</sub>-C<sub>5</sub>H<sub>5</sub>N, Et<sub>3</sub>N, DCM, DMSO, 0 °C, 3 h, 77% yield; (l) <b>14</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCE, rt, 12 h, 81% yield; (m) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 24 h; (n) TFA, DCM, rt, 24 h, 91% yield over 2 steps; (o) Raney Ni, H<sub>2</sub>, EtOH, rt, 18 h, 88% yield; (p) BOC<sub>2</sub>O, DMAP, Et<sub>3</sub>N, DCM, 18 h, 40 °C, 82% yield; (q) DIBALH, Et<sub>2</sub>O, −78 °C to rt, 6 h, 71% yield; (r) <b>14</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 60 h, 30% yield; (s) TFA, DCM, rt, 24 h, 36% yield.</p></p></figure><div class="NLM_p">Each of these final compounds was evaluated in vitro for CXCR4 inhibition using a fluorometric Ca<sup>2+</sup> flux assay,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> for intestinal permeability via parallel artificial membrane permeability assay<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> (PAMPA), for CYP450 isoform inhibition using a fluorescence-based assay,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and for metabolic stability via human and mouse liver microsome assays using liquid chromatography–tandem mass spectrometry (LC–MS/MS) quantification.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Muscarinic acetylcholine receptors (mAChR) were considered surrogates for off-target activity due to previously observed CXCR4 antagonist promiscuity at these receptors (unpublished data), and inhibition was measured using fluorometric Ca<sup>2+</sup> flux assays. <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> includes the results obtained for the mono- and bis(arylmethyl) substituted analogs. Among this initial series of TIQ-15 derivatives, mono-3-pyridylmethyl (<b>8b</b>, IC<sub>50</sub> = 15.3 ± 5.00 nM), mono-4-pyridylmethyl (<b>8c</b>, IC<sub>50</sub> = 22.7 nM), and monobenzyl (<b>9</b>, IC<sub>50</sub> = 20.1 ± 10.5 nM) analogs demonstrated the most potent inhibition of CXCR4, while bis(pyridylmethyl) analogs were much less potent (471 ± 190 nM ≤ IC<sub>50</sub> ≤ 832 ± 522 nM), and dibenzyl congener <b>7d</b> was completely inactive. None of these compounds strongly inhibited mAChR activity (IC<sub>50</sub> > 10 μM) except for the monobenzyl analog, which still proved relatively inactive (<b>9</b>, IC<sub>50</sub> ≈ 3.43 μM). Although the monosubstituted derivatives poorly permeated artificial intestinal membranes, disubstituted amines were substantially more permeable, likely due to increased lipophilicity and decreased amine basicity. None of the monoarylmethyl derivatizations of the TIQ-15 butylamine improved the CYP450 profile, each potently inhibiting the 2D6 isoform with IC<sub>50</sub> values in the nanomolar range and picking up micromolar activity against the 3A4 isoform. Perhaps not surprisingly, the disubstituted analogs not only retained potent 2D6 and modest 3A4 inhibition but also introduced antagonist activity at several other CYP450 isoforms (unpublished data) and suffered from extremely rapid metabolism by both human and mouse liver microsomes. Although monobenzyl congener <b>9</b> demonstrated reasonable metabolic stability for both species relative to TIQ-15, the other monosubstituted analogs were metabolized much more rapidly. Despite suboptimal PAMPA, CYP450, and metabolic properties, monopyridylmethyl functionalization produced the most interesting and attractive activity profiles relative to other compounds within this series, marking them for further investigation with alternative side chains.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Activity Profiles of Mono- and Bis(arylmethyl)-Substituted Butylamines<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0014.gif" alt="" id="GRAPHIC-d7e1295-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">CXCR4 Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" align="center">mAChR Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" colspan="2" align="center">PAMPA (nm/s)<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">CYP450 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="2" align="center">metabolic stability (% remaining)<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pH 7.4</th><th class="colsep0 rowsep0" align="center">pH 5.5</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIQ-15</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.25 ± 2.05</td><td class="colsep0 rowsep0" align="left">>30.0</td><td class="colsep0 rowsep0" align="left">0<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6.00<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.320</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">77.0</td><td class="colsep0 rowsep0" align="left">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">2-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">2-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">664 ± 123</td><td class="colsep0 rowsep0" align="left">12.9</td><td class="colsep0 rowsep0" align="left">294 ± 128</td><td class="colsep0 rowsep0" align="left">48.0 ± 7.00</td><td class="colsep0 rowsep0" align="left">1.16</td><td class="colsep0 rowsep0" align="left">6.01</td><td class="colsep0 rowsep0" align="left">0.548</td><td class="colsep0 rowsep0" align="left">0.374</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">3-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">3-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">471 ± 190</td><td class="colsep0 rowsep0" align="left">∼11.5</td><td class="colsep0 rowsep0" align="left">435 ± 14.0</td><td class="colsep0 rowsep0" align="left">91.0 ± 23.0</td><td class="colsep0 rowsep0" align="left">0.348</td><td class="colsep0 rowsep0" align="left">1.29</td><td class="colsep0 rowsep0" align="left">0.432</td><td class="colsep0 rowsep0" align="left">1.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">4-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">4-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">832 ± 522</td><td class="colsep0 rowsep0" align="left">11.4</td><td class="colsep0 rowsep0" align="left">774 ± 303</td><td class="colsep0 rowsep0" align="left">180 ± 7.00</td><td class="colsep0 rowsep0" align="left">0.120</td><td class="colsep0 rowsep0" align="left">0.622</td><td class="colsep0 rowsep0" align="left">0.521</td><td class="colsep0 rowsep0" align="left">1.55</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">>16700<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">39.0 ± 51.0</td><td class="colsep0 rowsep0" align="left">0.494</td><td class="colsep0 rowsep0" align="left">2.24</td><td class="colsep0 rowsep0" align="left">4.84</td><td class="colsep0 rowsep0" align="left">0.298</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">89.5 ± 24.8</td><td class="colsep0 rowsep0" align="left">>30.0</td><td class="colsep0 rowsep0" align="left">109<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">58.0<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.350</td><td class="colsep0 rowsep0" align="left">4.50</td><td class="colsep0 rowsep0" align="left">26.0</td><td class="colsep0 rowsep0" align="left">8.60</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">15.3 ± 5.00</td><td class="colsep0 rowsep0" align="left">∼19.9</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.217</td><td class="colsep0 rowsep0" align="left">8.45</td><td class="colsep0 rowsep0" align="left">21.4</td><td class="colsep0 rowsep0" align="left">10.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">22.7<a class="ref internalNav" href="#t1fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">6.50 ± 5.00</td><td class="colsep0 rowsep0" align="left">0.145</td><td class="colsep0 rowsep0" align="left">4.50</td><td class="colsep0 rowsep0" align="left">1.92</td><td class="colsep0 rowsep0" align="left">6.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">benzyl</td><td class="colsep0 rowsep0" align="left">20.1 ± 10.5</td><td class="colsep0 rowsep0" align="left">∼3.43</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.141</td><td class="colsep0 rowsep0" align="left">6.15</td><td class="colsep0 rowsep0" align="left">71.7</td><td class="colsep0 rowsep0" align="left">31.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">ND = not determined. Reported error represents standard deviation.</p></div><div class="footnote" id="t1fn1"><sup>b</sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="t1fn2"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p">Activity profiles of final compounds containing saturated carbocyclic and heterocyclic substituted butylamines are outlined in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. All TIQ-15 analogs in this second series demonstrated poor passive permeability, as well as virtual inactivity at mAChR. In contrast, each of these congeners potently inhibited CXCR4 activity (IC<sub>50</sub> < 100 nM) except for cyclohexylmethyl (<b>11a</b>, IC<sub>50</sub> = 158 ± 22.8 nM) and difluorocyclohexylmethyl (<b>11b</b>, IC<sub>50</sub> = 168 ± 83.1 nM) derivatives. Notably, difluorocyclohexyl analog <b>13b</b> and sulfonyl analog <b>11f</b> were the only compounds with comparable CXCR4 potency (IC<sub>50</sub> = 3.71 ± 0.620 nM and 17.0 ± 13.4 nM, respectively) to TIQ-15 (IC<sub>50</sub> = 6.25 ± 2.05 nM). All other derivatives among this series exhibited relatively similar CXCR4 antagonist activity (29.4 ± 16.5 nM ≤ IC<sub>50</sub> ≤ 77.6 nM). Attractively, none of these congeners inhibited CYP450 1A4, 2C19, 2C8, or 2C9 isoforms (unpublished data), nor did any of them substantially inhibit the 3A4 isoform (IC<sub>50</sub> values of >10 μM), except for cyclohexylmethyl analog <b>11a</b> (IC<sub>50</sub> = 2.78 μM). Although each of the compounds retained antagonist activity against the 2D6 isoform, piperidinyl (<b>13d</b>), piperidinylmethyl (<b>11d</b>), and tetrahydropyranylmethyl (<b>11c</b>) modifications in particular limited this activity (2.53 μM ≤ IC<sub>50</sub> ≤ 2.72 μM). Furthermore, none of these compounds demonstrated metabolic liabilities on the order of the arylmethyl analogs. Rather, metabolic stability was considerably improved across the board, perhaps with the exception of sulfonyl analog <b>13f</b>, which was metabolized relatively extensively. While piperidinyl and piperidinylmethyl derivatives <b>13d</b> and <b>11d</b> were particularly resistant to human microsomal metabolism, tetrahydropyranyl (<b>13c</b>), tetrahydropyranylmethyl (<b>11c</b>), and dimethylcyclohexyl (<b>13g</b>) congeners were the least susceptible to mouse microsomal metabolism relative to the rest of the compounds in this series. Although piperidinyl and piperidinylmethyl functionalization of the butylamine resulted in reasonably attractive activity profiles, each of these modifications introduces an additional basic amine, which would likely make robust oral bioavailability extremely difficult to achieve. Accordingly, these compounds represent important data points but were not marked for further investigation. In contrast, difluorocyclohexyl (<b>13b</b>, most potent against CXCR4), dimethylcyclohexyl (<b>13g</b>, good mouse metabolic stability), tetrahydropyranyl (<b>13c</b>, good mouse metabolic stability), and tetrahydropyranylmethyl (<b>11c</b>, good mouse metabolic stability and most optimal 2D6 activity) modifications warranted further exploration with alternative side chains due to relatively attractive full activity profiles with particular emphasis on the indicated properties.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Activity Profiles of Saturated Carbocyclic and Heterocyclic Substituted Butylamines<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0015.gif" alt="" id="GRAPHIC-d7e1736-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">CXCR4 Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" align="center">mAChR Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" colspan="2" align="center">PAMPA (nm/s)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">CYP450 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="2" align="center">metabolic stability (% remaining)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center"><i>n</i></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pH 7.4</th><th class="colsep0 rowsep0" align="center">pH 5.5</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIQ-15</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">6.25 ± 2.05</td><td class="colsep0 rowsep0" align="left">>30.0</td><td class="colsep0 rowsep0" align="left">0<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6.00<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.320</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">77.0</td><td class="colsep0 rowsep0" align="left">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">158 ± 22.8</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">9.00 ± 13.0</td><td class="colsep0 rowsep0" align="left">21.0 ± 7.00</td><td class="colsep0 rowsep0" align="left">0.354</td><td class="colsep0 rowsep0" align="left">2.78</td><td class="colsep0 rowsep0" align="left">50.0</td><td class="colsep0 rowsep0" align="left">41.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">CF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">168 ± 83.1</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.538</td><td class="colsep0 rowsep0" align="left">19.2</td><td class="colsep0 rowsep0" align="left">49.2</td><td class="colsep0 rowsep0" align="left">37.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">52.9 ± 45.0</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">6.00 ± 8.00</td><td class="colsep0 rowsep0" align="left">2.72</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">57.6</td><td class="colsep0 rowsep0" align="left">48.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">36.5<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">2.53</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">84.6</td><td class="colsep0 rowsep0" align="left">37.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11e</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">69.6 ± 2.78</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.629</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">49.4</td><td class="colsep0 rowsep0" align="left">2.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11f</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">17.0 ± 13.4</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">1.17</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">74.0</td><td class="colsep0 rowsep0" align="left">39.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">75.2 ± 53.9</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">14.5 ± 11.0</td><td class="colsep0 rowsep0" align="left">0.524</td><td class="colsep0 rowsep0" align="left">11.7</td><td class="colsep0 rowsep0" align="left">46.1</td><td class="colsep0 rowsep0" align="left">43.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">CF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">3.71 ± 0.620</td><td class="colsep0 rowsep0" align="left">∼28.2</td><td class="colsep0 rowsep0" align="left">32.0 ± 9.00</td><td class="colsep0 rowsep0" align="left">17.0 ± 9.00</td><td class="colsep0 rowsep0" align="left">0.189</td><td class="colsep0 rowsep0" align="left">11.3</td><td class="colsep0 rowsep0" align="left">57.2</td><td class="colsep0 rowsep0" align="left">34.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">29.4 ± 16.5</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.657</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">53.0</td><td class="colsep0 rowsep0" align="left">55.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">63.4 ± 48.7</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">19.0 ± 26.0</td><td class="colsep0 rowsep0" align="left">2.61</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">38.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">54.7 ± 1.93</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">2.00 ± 3.00</td><td class="colsep0 rowsep0" align="left">46.0 ± 17.0</td><td class="colsep0 rowsep0" align="left">0.434</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">39.9</td><td class="colsep0 rowsep0" align="left">23.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13f</b></td><td class="colsep0 rowsep0" align="left">SO<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">45.5 ± 28.8</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.853</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">11.7</td><td class="colsep0 rowsep0" align="left">17.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13g</b></td><td class="colsep0 rowsep0" align="left">C(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">77.6<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">∼19.9</td><td class="colsep0 rowsep0" align="left">3.00 ± 4.00</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.090</td><td class="colsep0 rowsep0" align="left">12.9</td><td class="colsep0 rowsep0" align="left">30.1</td><td class="colsep0 rowsep0" align="left">50.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">ND = not determined. Reported error represents standard deviation.</p></div><div class="footnote" id="t2fn1"><sup>b</sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="t2fn2"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p">Activity profiles of the TIQ-15 side chain analogs are presented in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>. This series of compounds retained moderately potent CXCR4 antagonist activity (50.8 ± 37.1 nM ≤ IC<sub>50</sub> ≤ 129 ± 109 nM) with the exceptions of 2,2-dimethylbutyl analog <b>30</b> (IC<sub>50</sub> > 33.3 μM) and the <i>meta</i>-benzylic amine <b>19a</b> (IC<sub>50</sub> = 292 ± 82.9 nM), which were particularly weak inhibitors, as well as <i>cis</i>-allylic amine <b>21</b> and 4,4-dimethylbutyl derivative <b>37</b>, which were particularly potent (IC<sub>50</sub> = 9.26 nM and 24.6 ± 8.46 nM, respectively). All of these congeners, except for <i>cis</i>-allylic amine <b>21</b> (IC<sub>50</sub> = 0.605 ± 0.287 nM) and <i>ortho</i>-benzylic amine <b>16</b> (IC<sub>50</sub> = 1.20 μM), were virtually inactive at mAChR (IC<sub>50</sub> ≥ 16.7 μM). Notably, intestinal permeability was dramatically improved across the board, with the interesting exception of 4,4-dimethylbutyl congener <b>37</b>, which marked only a marginal improvement over TIQ-15 passive membrane diffusion. Although potent inhibition of the CYP450 2D6 isoform was demonstrated by all of the compounds within this series, only analogs containing benzylic amine side chains inhibited other CYP450 isoforms (unpublished data). Inhibition of the 3A4 isoform was variable across the series, but only <i>meta</i>-benzylic amine <b>19a</b> (IC<sub>50</sub> = 4.63 μM) exhibited <5 μM antagonist activity. Furthermore, each of the compounds among this series showed robust human metabolic stability, the most susceptible of which was <i>ortho</i>-benzylic amine <b>16</b> (50.5% remaining after 10 min). In stark contrast, mouse microsomal stability was particularly poor (<10% remaining after 10 min) for the <i>cis</i>-allylic amine (<b>21</b>), <i>ortho</i>-benzylic amine (<b>16</b>), 4,4-dimethylbutyl (<b>37</b>), and 2,2-dimethylbutyl (<b>30</b>) side chain derivatives. Although <i>trans</i>-allylic amine <b>24</b> was only modestly more stable in mouse liver microsomes than these compounds, 3,3-dimethylbutyl congener <b>34</b> and the <i>meta</i>- and <i>para</i>-benzylic amines <b>19a</b> and <b>19b</b> were quite stable in comparison. Ultimately, the <i>para</i>-benzylic amine (<b>19b</b>), <i>trans</i>-allylic amine (<b>24</b>), and 3,3-dimethylbutylamine (<b>34</b>) side chains elicited more attractive full activity profiles than <i>cis</i>-allylic amine <b>21</b>, as well as the other <i>gem</i>-dimethylbutyl and benzylic amine side chain analogs, marking these three particular side chains to be incorporated in subsequent series of TIQ-15 analogs.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Activity Profiles of TIQ-15 Amine Side Chain Analogs<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">CXCR4 Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" align="center">mAChR Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" colspan="2" align="center">PAMPA (nm/s)<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">CYP450 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="2" align="center">metabolic stability (% remaining)<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">amine side chain</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pH 7.4</th><th class="colsep0 rowsep0" align="center">pH 5.5</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIQ-15</td><td class="colsep0 rowsep0" align="left">butyl</td><td class="colsep0 rowsep0" align="left">6.25 ± 2.05</td><td class="colsep0 rowsep0" align="left">>30.0</td><td class="colsep0 rowsep0" align="left">0<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6.00<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.320</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">77.0</td><td class="colsep0 rowsep0" align="left">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left"><i>ortho</i>-benzylic</td><td class="colsep0 rowsep0" align="left">50.8 ± 37.1</td><td class="colsep0 rowsep0" align="left">1.20</td><td class="colsep0 rowsep0" align="left">214 ± 1.00</td><td class="colsep0 rowsep0" align="left">184 ± 41.5</td><td class="colsep0 rowsep0" align="left">0.318</td><td class="colsep0 rowsep0" align="left">15.2</td><td class="colsep0 rowsep0" align="left">50.5</td><td class="colsep0 rowsep0" align="left">1.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="left"><i>meta</i>-benzylic</td><td class="colsep0 rowsep0" align="left">292 ± 82.9</td><td class="colsep0 rowsep0" align="left">∼25.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">4.63</td><td class="colsep0 rowsep0" align="left">97.3</td><td class="colsep0 rowsep0" align="left">89.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">115 ± 85.9</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">301 ± 22.5</td><td class="colsep0 rowsep0" align="left">337 ± 61.0</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">7.44</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">94.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left"><i>cis</i>-allylic</td><td class="colsep0 rowsep0" align="left">9.26<a class="ref internalNav" href="#t3fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.605 ± 0.287<a class="ref internalNav" href="#t3fn1" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">569 ± 129</td><td class="colsep0 rowsep0" align="left">39.0 ± 5.00</td><td class="colsep0 rowsep0" align="left">0.333</td><td class="colsep0 rowsep0" align="left">12.7</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">4.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">129 ± 109</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">829 ± 100</td><td class="colsep0 rowsep0" align="left">264 ± 27.0</td><td class="colsep0 rowsep0" align="left">0.510</td><td class="colsep0 rowsep0" align="left">9.29</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">2,2-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">>33,300</td><td class="colsep0 rowsep0" align="left">>33.3</td><td class="colsep0 rowsep0" align="left">255 ± 106</td><td class="colsep0 rowsep0" align="left">268 ± 95.0</td><td class="colsep0 rowsep0" align="left">0.197</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">76.1</td><td class="colsep0 rowsep0" align="left">5.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">3,3-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">69.0 ± 54.4</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">405 ± 144</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.498</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">88.7</td><td class="colsep0 rowsep0" align="left">51.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">4,4-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">24.6 ± 8.46</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">20.0 ± 28.0</td><td class="colsep0 rowsep0" align="left">0.345</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">73.5</td><td class="colsep0 rowsep0" align="left">3.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">ND = not determined. Reported error represents standard deviation.</p></div><div class="footnote" id="t3fn1"><sup>b</sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="t3fn2"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p">At this point, three arylmethyl substitutions (2-, 3-, and 4-monopyridylmethyl), four saturated carbocyclic and heterocyclic modifications (difluorocyclohexyl, dimethylcyclohexyl, tetrahydropyranyl, and tetrahydropyranylmethyl), and three side chains (<i>para</i>-benzylic amine, <i>trans</i>-allylic amine, and 3,3-dimethylbutylamine) were selected as the subject of second generation investigation. Accordingly, amine <b>38</b> and phthalimide <b>39</b> underwent phthalimide transfer reaction<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>), which was followed by Dess–Martin oxidation<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> of the remaining benzylic alcohol to corresponding aldehyde <b>40</b>. Subsequent reductive amination with secondary amine <b>14</b> and STAB furnished the differentially protected scaffold of the <i>para</i>-benzylic amine side chain analog of TIQ-15. Subsequent phthalimide protecting group removal using aqueous hydrazine delivered corresponding primary amine <b>41</b>, which was primed for selective functionalization of the benzylic amine. Amine <b>41</b> and aldehyde <b>10c</b> were then subjected to reductive amination using titanium isopropoxide and sodium borohydride to yield the corresponding monoadduct, which was subsequently deprotected with TFA to deliver the desired tetrahydropyranylmethyl benzylic amine <b>42</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Alternatively, amine <b>41</b> underwent STAB-mediated reductive amination with difluorocyclohexanone <b>12b</b>, tetrahydropyranone <b>12c</b>, and dimethylcyclohexanone <b>12g</b>, followed by TFA-mediated BOC deprotection to furnish the corresponding substituted benzylic amines <b>43b</b>, <b>43c</b>, and <b>43g</b>. Benzylic amine <b>41</b> and 2-, 3-, and 4-pyridinecarboxaldehydes were also subjected to titanium isopropoxide and sodium borohydride reductive amination conditions to generate solely the corresponding monoadducts, which were then deprotected using TFA to afford the desired bis(arylmethyl) amines <b>44a</b>–<b>c</b>. In parallel, second generation substituted <i>trans</i>-allylic amines (<a class="ref internalNav" href="#sch8" aria-label="Scheme 8">Scheme 8</a>) and substituted 3,3-dimethylbutylamines (<a class="ref internalNav" href="#sch9" aria-label="Scheme 9">Scheme 9</a>) were prepared in similar fashion. All final compounds were pharmacologically evaluated according to the previously described assay paradigm, and activity profiles of these second generation TIQ-15 analogs are presented in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of the <i>para</i>-Benzylic Amine Side Chain Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>39</b>, Et<sub>3</sub>N, THF, rt, 24 h; (b) Dess–Martin periodinane, DCM, rt, 3 h; (c) <b>14</b>, Na(OAc)<sub>3</sub>BH, DCM, rt, 24 h, 65% yield over 3 steps; (d) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 24 h, 55% yield.</p></p></figure><figure id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Functionalization of the <i>para</i>-Benzylic Amine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10c</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 37% yield; (b) TFA, DCM, rt, 24 h, 88% yield; (c) <b>12b</b>, <b>12c</b>, or <b>12g</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 59–84% yield; (d) TFA, DCM, rt, 24 h, 71–87% yield; (e) C<sub>5</sub>H<sub>5</sub>NCHO, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 61–65% yield; (f) TFA, DCM, rt, 24 h, 70–92% yield.</p></p></figure><figure id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Functionalization of the <i>trans</i>-Allylic Amine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10c</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 40% yield; (b) TFA, DCM, rt, 24 h, 75% yield; (c) <b>12b</b>, <b>12c</b>, or <b>12g</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 51–63% yield; (d) TFA, DCM, rt, 24 h, 19–98% yield; (e) C<sub>5</sub>H<sub>5</sub>NCHO, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 54–63% yield; (f) TFA, DCM, rt, 24 h, 70–92% yield.</p></p></figure><figure id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Functionalization of the 3,3-Dimethylbutylamine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10c</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 73% yield; (b) TFA, DCM, rt, 24 h, 74% yield; (c) <b>12b</b>, <b>12c</b>, or <b>12g</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 54–60% yield; (d) TFA, DCM, rt, 24 h, 96–98% yield.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Activity profiles of second generation TIQ-15 analogs<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0016.gif" alt="" id="GRAPHIC-d7e2988-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">CXCR4 Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" align="center">mAChR Ca<sup>2+</sup> flux</th><th class="rowsep1 colsep0" colspan="2" align="center">PAMPA (nm/s)<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></th><th class="rowsep1 colsep0" colspan="2" align="center">CYP450 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="2" align="center">metabolic stability (% remaining)<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">amine side chain</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">pH 7.4</th><th class="colsep0 rowsep0" align="center">pH 5.5</th><th class="colsep0 rowsep0" align="center">2D6</th><th class="colsep0 rowsep0" align="center">3A4</th><th class="colsep0 rowsep0" align="center">human</th><th class="colsep0 rowsep0" align="center">mouse</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIQ-15</td><td class="colsep0 rowsep0" align="left">butyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.25 ± 2.05</td><td class="colsep0 rowsep0" align="left">>30.0</td><td class="colsep0 rowsep0" align="left">0<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">6.00<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.320</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">77.0</td><td class="colsep0 rowsep0" align="left">17.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">4-tetrahydropyranylmethyl</td><td class="colsep0 rowsep0" align="left">183 ± 156</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">9.00 ± 4.00</td><td class="colsep0 rowsep0" align="left">0.403</td><td class="colsep0 rowsep0" align="left">0.994</td><td class="colsep0 rowsep0" align="left">2.71</td><td class="colsep0 rowsep0" align="left">45.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43b</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">4,4-difluorocyclohexyl</td><td class="colsep0 rowsep0" align="left">143 ± 35.7</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">5.00 ± 3.50</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.577</td><td class="colsep0 rowsep0" align="left">0.200</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">30.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43c</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">4-tetrahydropyranyl</td><td class="colsep0 rowsep0" align="left">90.3 ± 46.0</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">92.0 ± 7.00</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.507</td><td class="colsep0 rowsep0" align="left">0.442</td><td class="colsep0 rowsep0" align="left">20.4</td><td class="colsep0 rowsep0" align="left">34.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43g</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">4,4-dimethylcyclohexyl</td><td class="colsep0 rowsep0" align="left">661 ± 428</td><td class="colsep0 rowsep0" align="left">∼8.76</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">∼0</td><td class="colsep0 rowsep0" align="left">0.258</td><td class="colsep0 rowsep0" align="left">0.334</td><td class="colsep0 rowsep0" align="left">14.9</td><td class="colsep0 rowsep0" align="left">23.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44a</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">2-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">286 ± 263</td><td class="colsep0 rowsep0" align="left">6.94</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">16.0 ± 5.00</td><td class="colsep0 rowsep0" align="left">0.377</td><td class="colsep0 rowsep0" align="left">0.109</td><td class="colsep0 rowsep0" align="left">1.77</td><td class="colsep0 rowsep0" align="left">11.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44b</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">3-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">60.5 ± 33.2</td><td class="colsep0 rowsep0" align="left">∼21.4</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0.355</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">1.02</td><td class="colsep0 rowsep0" align="left">0.423</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44c</b></td><td class="colsep0 rowsep0" align="left"><i>para</i>-benzylic</td><td class="colsep0 rowsep0" align="left">4-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">134 ± 65.0</td><td class="colsep0 rowsep0" align="left">∼12.2</td><td class="colsep0 rowsep0" align="left">385 ± 233</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.084</td><td class="colsep0 rowsep0" align="left">0.059</td><td class="colsep0 rowsep0" align="left">0.882</td><td class="colsep0 rowsep0" align="left">4.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">4-tetrahydropyranylmethyl</td><td class="colsep0 rowsep0" align="left">24.2 ± 13.7</td><td class="colsep0 rowsep0" align="left">∼19.9</td><td class="colsep0 rowsep0" align="left">122 ± 29.0</td><td class="colsep0 rowsep0" align="left">33.5 ± 11.0</td><td class="colsep0 rowsep0" align="left">3.32</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">74.5</td><td class="colsep0 rowsep0" align="left">32.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46b</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">4,4-difluorocyclohexyl</td><td class="colsep0 rowsep0" align="left">82.1 ± 74.8</td><td class="colsep0 rowsep0" align="left">∼6.98</td><td class="colsep0 rowsep0" align="left">49.0 ± 6.00</td><td class="colsep0 rowsep0" align="left">9.00 ± 6.00</td><td class="colsep0 rowsep0" align="left">1.45</td><td class="colsep0 rowsep0" align="left">0.839</td><td class="colsep0 rowsep0" align="left">31.7</td><td class="colsep0 rowsep0" align="left">2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46c</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">4-tetrahydropyranyl</td><td class="colsep0 rowsep0" align="left">15.5<a class="ref internalNav" href="#t4fn2" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">∼5.61</td><td class="colsep0 rowsep0" align="left">434 ± 86.5</td><td class="colsep0 rowsep0" align="left">105 ± 18.0</td><td class="colsep0 rowsep0" align="left">2.61</td><td class="colsep0 rowsep0" align="left">7.73</td><td class="colsep0 rowsep0" align="left">69.9</td><td class="colsep0 rowsep0" align="left">10.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46g</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">4,4-dimethylcyclohexyl</td><td class="colsep0 rowsep0" align="left">64.6 ± 49.5</td><td class="colsep0 rowsep0" align="left">2.45</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.660</td><td class="colsep0 rowsep0" align="left">0.990</td><td class="colsep0 rowsep0" align="left">42.0</td><td class="colsep0 rowsep0" align="left">7.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47a</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">2-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">58.3 ± 38.3</td><td class="colsep0 rowsep0" align="left">∼22.0</td><td class="colsep0 rowsep0" align="left">50.0 ± 15.0</td><td class="colsep0 rowsep0" align="left">18.0 ± 2.00</td><td class="colsep0 rowsep0" align="left">0.709</td><td class="colsep0 rowsep0" align="left">1.56</td><td class="colsep0 rowsep0" align="left">31.2</td><td class="colsep0 rowsep0" align="left">2.98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47b</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">3-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">92.8 ± 74.2</td><td class="colsep0 rowsep0" align="left">∼35.1</td><td class="colsep0 rowsep0" align="left">244 ± 125</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.453</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.84</td><td class="colsep0 rowsep0" align="left">0.953</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47c</b></td><td class="colsep0 rowsep0" align="left"><i>trans</i>-allylic</td><td class="colsep0 rowsep0" align="left">4-pyridylmethyl</td><td class="colsep0 rowsep0" align="left">40.7 ± 18.0</td><td class="colsep0 rowsep0" align="left">>16.7</td><td class="colsep0 rowsep0" align="left">212 ± 46.0</td><td class="colsep0 rowsep0" align="left">78.0 ± 22.0</td><td class="colsep0 rowsep0" align="left">0.254</td><td class="colsep0 rowsep0" align="left">0.350</td><td class="colsep0 rowsep0" align="left">1.51</td><td class="colsep0 rowsep0" align="left">2.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">3,3-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">4-tetrahydropyranylmethyl</td><td class="colsep0 rowsep0" align="left">43.8 ± 23.3</td><td class="colsep0 rowsep0" align="left">∼13.0</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">62.0 ± 20.0</td><td class="colsep0 rowsep0" align="left">1.75</td><td class="colsep0 rowsep0" align="left">>20.0</td><td class="colsep0 rowsep0" align="left">46.1</td><td class="colsep0 rowsep0" align="left">60.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49b</b></td><td class="colsep0 rowsep0" align="left">3,3-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">4,4-difluorocyclohexyl</td><td class="colsep0 rowsep0" align="left">168 ± 54.8</td><td class="colsep0 rowsep0" align="left">∼18.8</td><td class="colsep0 rowsep0" align="left">22.0 ± 3.00</td><td class="colsep0 rowsep0" align="left">17.5 ± 5.00</td><td class="colsep0 rowsep0" align="left">2.04</td><td class="colsep0 rowsep0" align="left">5.58</td><td class="colsep0 rowsep0" align="left">16.1</td><td class="colsep0 rowsep0" align="left">16.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49c</b></td><td class="colsep0 rowsep0" align="left">3,3-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">4-tetrahydropyranyl</td><td class="colsep0 rowsep0" align="left">36.3 ± 13.4</td><td class="colsep0 rowsep0" align="left">∼11.5</td><td class="colsep0 rowsep0" align="left">57.0 ± 18.0</td><td class="colsep0 rowsep0" align="left">57.0 ± 16.3</td><td class="colsep0 rowsep0" align="left">6.21</td><td class="colsep0 rowsep0" align="left">17.7</td><td class="colsep0 rowsep0" align="left">21.8</td><td class="colsep0 rowsep0" align="left">49.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49g</b></td><td class="colsep0 rowsep0" align="left">3,3-dimethylbutyl</td><td class="colsep0 rowsep0" align="left">4,4-dimethylcyclohexyl</td><td class="colsep0 rowsep0" align="left">541 ± 24.5</td><td class="colsep0 rowsep0" align="left">∼18.8</td><td class="colsep0 rowsep0" align="left">28.0 ± 9.00</td><td class="colsep0 rowsep0" align="left">11.0 ± 5.50</td><td class="colsep0 rowsep0" align="left">2.22</td><td class="colsep0 rowsep0" align="left">7.83</td><td class="colsep0 rowsep0" align="left">23.9</td><td class="colsep0 rowsep0" align="left">51.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">ND = not determined. Reported error represents standard deviation.</p></div><div class="footnote" id="t4fn1"><sup>b</sup><p class="last"><i>n</i> = 2.</p></div><div class="footnote" id="t4fn2"><sup>c</sup><p class="last"><i>n</i> = 1.</p></div></div></div><div class="NLM_p last">While compounds <b>43g</b>, <b>44a</b>, and <b>49g</b> demonstrated poor CXCR4 potency (IC<sub>50</sub> > 250 nM), <i>trans</i>-allylic tetrahydropyranyl amine <b>46c</b> (IC<sub>50</sub> = 15.5 nM), <i>trans</i>-allylic tetrahydropyranylmethyl amine <b>45</b> (IC<sub>50</sub> = 24.2 ± 13.7 nM), and 3,3-dimethylbutyl tetrahydropyranyl amine <b>49c</b> (IC<sub>50</sub> = 36.3 ± 13.4 nM) retained reasonably good on-target potency (IC<sub>50</sub> < 40 nM) relative to the first generation analogs. Additionally, all compounds except for <b>46b</b>, <b>46g</b>, <b>46c</b>, <b>43g</b>, and <b>44a</b> (2.45 μM ≤ IC<sub>50</sub> ≤ ∼8.76 μM) exhibited minimal off-target activity at mAChR (IC<sub>50</sub> > 10 μM). Although <i>trans</i>-allylic and <i>para</i>-benzylic pyridylmethyl amines expectedly demonstrated improved predicted intestinal permeability where measured, <i>trans</i>-allylic tetrahydropyranyl and tetrahydropyranylmethyl amines <b>46c</b> and <b>45</b> performed better than expected in the PAMPA assay. These two analogs (IC<sub>50</sub> = 2.61 μM and 3.32 μM, respectively), as well as 3,3-dimethylbutyl tetrahydropyranyl derivative <b>49c</b> (IC<sub>50</sub> = 6.21 μM), further exhibited substantially diminished inhibitory activity at the CYP450 2D6 isoform. Each of these three compounds also proved inactive at the other CYP450 isoforms examined except for the 3A4 isoform, whose activity was only modestly affected by congeners <b>46c</b> (IC<sub>50</sub> = 7.73 μM) and <b>49c</b> (IC<sub>50</sub> = 17.7 μM). Finally, while analog <b>49c</b> was poorly stable in human liver microsomes (21.8% remaining after 10 min), the mouse liver microsomal stability was quite robust (49.8% remaining after 10 min) relative to the first generation compounds. Although compounds <b>46c</b> and <b>45</b> retained comparably good human liver microsomal stability (69.9% and 74.5% remaining after 10 min, respectively), persistence in mouse liver microsomes was more limited (10.0% and 32.3% remaining after 10 min, respectively). Ultimately, derivatives <b>45</b>, <b>46c</b>, and <b>49c</b> demonstrated the most attractive full activity profiles among all of the compounds, with <b>45</b> and <b>49c</b> offering weakened CYP450 2D6 inhibition, improved PAMPA permeability, and elevated mouse liver microsomal stability as compared to TIQ-15.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07178" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07178" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Of all of the analogs prepared, difluorocyclohexyl amine <b>13b</b> (IC<sub>50</sub> = 3.71 ± 0.620 nM) and <i>cis</i>-allylic amine <b>21</b> (IC<sub>50</sub> = 9.26 nM) exhibited the most comparable CXCR4 potency to TIQ-15 (IC<sub>50</sub> = 6.25 ± 2.05 nM). While 3-pyridylmethyl (<b>8b</b>, IC<sub>50</sub> = 15.3 ± 5.00 nM), 4-pyridylmethyl (<b>8c</b>, IC<sub>50</sub> = 22.7 nM), benzyl (<b>9</b>, IC<sub>50</sub> = 20.1 ± 10.5 nM), piperidinylmethyl (<b>11d</b>, IC<sub>50</sub> = 36.5 nM), sulfonyl (<b>11f</b>, IC<sub>50</sub> = 17.0 ± 13.4 nM), tetrahydropyranyl (<b>13c</b>, IC<sub>50</sub> = 29.4 ± 16.5 nM), and 4,4-dimethylbutyl (<b>37</b>, IC<sub>50</sub> = 24.6 ± 8.46 nM) analogs were the only other first generation compounds to demonstrate <40 nM CXCR4 antagonist activity, only three of the second generation derivatives, 3,3-dimethylbutyl tetrahydropyranyl (<b>49c</b>, IC<sub>50</sub> = 36.3 ± 13.4 nM), <i>trans</i>-allylic tetrahydropyranyl (<b>46c</b>, IC<sub>50</sub> = 15.5 nM), and <i>trans</i>-allylic tetrahydropyranylmethyl (<b>45</b>, IC<sub>50</sub> = 24.2 ± 13.7 nM) congeners, achieved this level of potency. Overall, several conclusions can be drawn regarding the intermolecular interactions between CXCR4 and these types of TIQ-15 analogs. First, CXCR4 is unlikely to favorably accommodate two bulky butylamine substituents, as exhibited by disubstituted analogs <b>7a</b>–<b>d</b> (471 ± 190 nM ≤ IC<sub>50</sub> ≤ 16 700 nM). In contrast, there is clearly room for single substitution of the butylamine, as all but two of the monofunctionalized butylamines explored herein maintained <100 nM CXCR4 antagonist activity. While most of the monoarylmethyl derivatives retained good on-target potency (15.3 ± 5.00 nM ≤ IC<sub>50</sub> ≤ 22.7 nM), 2-pyridylmethyl analog <b>8a</b> (IC<sub>50</sub> = 89.5 ± 24.8 nM) exhibited relatively poor activity, potentially due to intramolecular hydrogen bonding between the protonated butylamine and the pyridine nitrogen lone pair. Additionally, the series of heterocyclic compounds containing the methylene spacer potentially benefit from hydrogen bond accepting capacity at the 4-position, as cyclohexylmethyl analog <b>11a</b> (IC<sub>50</sub> = 158 ± 22.8 nM) and 4,4-difluorocyclohexylmethyl analog <b>11b</b> (IC<sub>50</sub> = 168 ± 83.1 nM) were substantially less potent than the others, which are reasonable hydrogen bond acceptors (17.0 ± 13.4 nM ≤ IC<sub>50</sub> ≤ 69.6 ± 2.78 nM). Furthermore, all saturated carbocyclic and heterocyclic functionalized compounds without a methylene spacer exhibited equipotent activity, with the exception of difluorocyclohexyl analog <b>13b</b> (IC<sub>50</sub> = 3.71 ± 0.620 nM), which is the most potent compound reported herein. As heteroatom alteration among this series had little effect on CXCR4 activity, this impressive potency is likely due to subtle conformational effects<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> and/or dipolar interactions<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> imposed by the difluoromethylene unit. Unfortunately, this remarkable activity did not translate to second generation analogs containing this motif. It can also be concluded that the range of CXCR4 potency varies much more between side chain analogs than between monomodified butylamine analogs, indicating the relative importance of side chain conformation. The equipotent activity of TIQ-15 (IC<sub>50</sub> = 6.25 ± 2.05 nM) and <i>cis</i>-allylic amine <b>21</b> (IC<sub>50</sub> = 9.26 nM) suggests that the <i>cis</i> configuration favorably reinforces the on-target conformation of the TIQ-15 butylamine side chain. Consistent with this assertion is the significantly less potent <i>trans</i>-allylic amine <b>24</b> (IC<sub>50</sub> = 129 ± 109 nM), as well as the enhanced potency of <i>ortho</i>-benzylic amine <b>16</b> (IC<sub>50</sub> = 50.8 ± 37.1 nM), as compared to <i>meta</i>-benzylic (<b>19a</b>, IC<sub>50</sub> = 292 ± 82.9 nM) and <i>para</i>-benzylic (<b>19b</b>, IC<sub>50</sub> = 115 ± 85.9 nM) amines. Moreover, <i>gem</i>-dimethyl functionalization was tolerated at positions γ and Δ to the central tertiary amine, as highlighted by compounds <b>34</b> (IC<sub>50</sub> = 69.0 ± 54.4 nM) and <b>37</b> (IC<sub>50</sub> = 24.6 ± 8.46 nM), respectively, but this moiety completely abrogated activity when installed at the β position (<b>30</b>), suggesting a detrimental steric clash with CXCR4. This steric limitation is also highlighted by the <i>para</i>-benzylic amine series (60.5 ± 33.2 nM ≤ IC<sub>50</sub> ≤ 661 nM), as well as by 3,3-dimethylbutyl dimethylcyclohexyl amine <b>49g</b> (IC<sub>50</sub> = 541 ± 24.5 nM). Despite the relatively poor potency of <i>trans</i>-allylic amine <b>24</b> (IC<sub>50</sub> = 129 ± 109 nM) and 3,3-dimethylbutylamine <b>34</b> (IC<sub>50</sub> = 69.0 ± 54.4 nM), second generation <i>trans</i>-allylic tetrahydropyranyl (<b>46c</b>, IC<sub>50</sub> = 15.5 nM), <i>trans</i>-allylic tetrahydropyranylmethyl (<b>45</b>, IC<sub>50</sub> = 24.2 ± 13.7 nM), and 3,3-dimethylbutyl tetrahydropyranyl (<b>49c</b>, IC<sub>50</sub> = 36.3 ± 13.4 nM) analogs achieved comparatively potent CXCR4 antagonist activity. Interestingly, a series of AMD11070 side chain analogs<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> containing benzimidazoles instead of tetrahydroisoquinolines described similar potency trends between <i>trans</i>-allylic, <i>cis</i>-allylic, <i>ortho</i>-benzylic, <i>meta</i>-benzylic, and <i>para</i>-benzylic amine side chains, suggesting that these AMD11070 analogs and the corresponding TIQ-15 derivatives adopt analogous binding modes in the same CXCR4 binding pocket.</div><div class="NLM_p">As one of the desirable characteristics of TIQ-15 analogs is oral bioavailability, promising compounds must demonstrate facile intestinal permeability, as estimated using PAMPA, and robust metabolic stability, as measured in human and mouse liver microsomes. The hypothesis that decreasing amine basicity and increasing lipophilicity would improve PAMPA values relative to TIQ-15 was upheld by the compounds described herein. Notably, however, reducing amine basicity had a much more profound effect on PAMPA results than did increasing lipophilicity. This is demonstrated by the dramatic permeability enhancement of <i>cis</i>- and <i>trans</i>-allylic amines <b>21</b> and <b>24</b>, respectively, juxtaposed to the modest improvement achieved by cyclohexyl and cyclohexylmethyl analogs <b>13a</b> and <b>11a</b>, respectively. Consistent with this are the generally elevated PAMPA values of allylic and benzylic amines as compared to the butylamines presented in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>. Two exceptions are 3-pyridylmethyl and 4-pyridylmethyl analogs <b>8b</b> and <b>8c</b>, respectively, which exhibited negligible PAMPA permeability. Interestingly, the 2-pyridylmethyl congener <b>8a</b> proved substantially more permeable, again perhaps suggesting intramolecular hydrogen bonding, which can partially mask the polarity of a protonated amine. Although second generation analogs generally did not perform as robustly as parent <i>trans</i>-allylic amine <b>24</b>, 3,3-dimethylbutyl (<b>34</b>), <i>para</i>-benzylic (<b>19b</b>), <i>trans</i>-allylic tetrahydropyranyl (<b>46c</b>), <i>trans</i>-allylic tetrahydropyranylmethyl (<b>45</b>), and 3,3-dimethylbutyl tetrahydropyranyl (<b>49c</b>) amines demonstrated substantially improved PAMPA permeability as compared to TIQ-15. As for metabolic stability, installation of additional pyridines introduced new metabolic liabilities, ultimately leading to low human and mouse metabolic stability. The series of TIQ-15 analogs monosubstituted with saturated carbocycles and heterocycles generally exhibited moderate metabolic stability in both human and mouse liver microsomes, with piperidinyl (<b>13d</b>, 100% remaining after 10 min) and piperidinylmethyl (<b>11d</b>, 84.6% remaining after 10 min) analogs demonstrating particularly robust human microsomal stability and with tetrahydropyranyl (<b>13c</b>, 55.8% remaining after 10 min), tetrahydropyranylmethyl (<b>11c</b>, 48.5% remaining after 10 min), and dimethylcyclohexyl (<b>13g</b>, 50.0% remaining after 10 min) amines exhibiting particularly attractive mouse metabolic stability. Interestingly, first generation side chain analogs presented in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a> demonstrated robust human microsomal stability (50.5–100% remaining after 10 min) but poor mouse microsomal stability (1.29–10.7% remaining after 10 min), with the exceptions of 3,3-dimethylbutylamine <b>34</b> (51.2% remaining after 10 min), <i>meta</i>-benzylic amine <b>19a</b> (89.2% remaining after 10 min), and <i>para</i>-benzylic amine <b>19b</b> (94.2% remaining after 10 min). Despite the high metabolic stability of <b>19b</b>, second generation analogs of this compound suffered from substantially increased metabolic lability, resulting in suboptimal metabolic profiles across this series. The only second generation compounds with reasonable metabolic profiles across both species include <i>trans</i>-allylic tetrahydropyranylmethyl amine <b>45</b>, as well as 3,3-dimethylbutyl dimethylcyclohexyl (<b>49g</b>), tetrahydropyranyl (<b>49c</b>), and tetrahydropyranylmethyl (<b>48</b>) amines.</div><div class="NLM_p">Another requirement of effective TIQ-15 analogs is limited off-target activity and wide therapeutic window, with an emphasis on clean CYP450 profiles to enable potential utility in combination therapy. Although mAChR antagonist activity was measured as an estimation of compound promiscuity, only <i>cis</i>-allylic amine <b>21</b> (IC<sub>50</sub> = 0.605 ± 0.287 μM), <i>ortho</i>-benzylic amine <b>16</b> (IC<sub>50</sub> = 1.20 μM), and <i>trans</i>-allylic dimethylcyclohexyl amine <b>46g</b> (IC<sub>50</sub> = 2.45 μM) exhibited antagonist potency of <5 μM, whereas only four other compounds demonstrated 5–10 μM mAChR antagonist activity. In contrast, CYP450 2D6 and 3A4 isoforms are much more significant off-target liabilities, especially for antitumor therapies, which commonly involve several different clinical agents in the fight against cancer progression. As clinical candidate AMD11070 and lead compound TIQ-15 potently inhibit the 2D6 isoform, thereby limiting their potential use in combination therapy regimens, it was essential to dial down this activity. Unfortunately, little information could be extracted from the first generation compounds in this regard except that adding another basic amine reduced activity at 2D6, as demonstrated by piperidinyl (IC<sub>50</sub> = 2.61 μM) and piperidinylmethyl (IC<sub>50</sub> = 2.53 μM) analogs <b>13d</b> and <b>11d</b>, respectively. Of course, incorporation of an additional basic amine would virtually eliminate all hope of achieving passive intestinal permeability, and therefore, these motifs were not pursued further. Although tetrahydropyranylmethyl analog <b>11c</b> (IC<sub>50</sub> = 2.72 μM) was the only other first generation compound to limit 2D6 potency to >2 μM, five second-generation analogs, namely, <i>trans</i>-allylic tetrahydropyranyl (<b>46c</b>, IC<sub>50</sub> = 2.61 μM) and tetrahydropyranylmethyl (<b>45</b>, IC<sub>50</sub> = 3.32 μM) amines and 3,3-dimethylbutyl difluorocyclohexyl (<b>49b</b>, IC<sub>50</sub> = 2.04 μM), dimethylcyclohexyl (<b>49g</b>, IC<sub>50</sub> = 2.22 μM), and tetrahydropyranyl (<b>49c</b>, IC<sub>50</sub> = 6.21 μM) congeners, achieved this substantial reduction in CYP450 inhibition. Each of these five second-generation compounds notably inhibited the 2D6 isoform less potently than AMD11070 (IC<sub>50</sub> = 1.60 μM, unpublished data), and none of them demonstrated antagonist activity at the other CYP450 isoforms of <5 μM. Overall, <i>trans</i>-allylic tetrahydropyranyl (<b>46c</b>, IC<sub>50</sub>(2D6):IC<sub>50</sub>(CXCR4) = 168), <i>trans</i>-allylic tetrahydropyranylmethyl (<b>45</b>, IC<sub>50</sub> 2D6:IC<sub>50</sub> CXCR4 = 138), and 3,3-dimethylbutyl tetrahydropyranyl (<b>49c</b>, IC<sub>50</sub>(2D6):IC<sub>50</sub>(CXCR4) = 171) amines achieved significantly improved 2D6:CXCR4 indexes, as compared to TIQ-15 (IC<sub>50</sub>(2D6):IC<sub>50</sub>(CXCR4) = 51).</div><div class="NLM_p">Ultimately, these three compounds exhibited the most attractive full activity profiles, demonstrating enhanced predicted intestinal permeability and elevated 2D6:CXCR4 indexes, therefore representing marked advancements over TIQ-15 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). These improvements endow <i>trans</i>-allylic tetrahydropyranylmethyl amine <b>45</b> (mouse CXCR4 IC<sub>50</sub> = 5.47 ± 1.52 nM, <i>n</i> = 6) and 3,3-dimethylbutyl tetrahydropyranyl amine <b>49c</b> (mouse CXCR4 IC<sub>50</sub> = 20.0 ± 6.01 nM, <i>n</i> = 4) as more appropriate candidates for efficacy studies in preclinical mouse models of cancer than TIQ-15, whereas <i>trans</i>-allylic tetrahydropyranylmethyl amine <b>45</b> and <i>trans</i>-allylic tetrahydropyranyl amine <b>46c</b> (mouse CXCR4 IC<sub>50</sub> = 9.24 ± 0.45 nM, <i>n</i> = 6) are more suitable clinical candidates than TIQ-15. The discovery of these compounds enables the evaluation of tetrahydroisoquinoline-containing CXCR4 antagonist antitumor efficacy as single agent immunomodulatory chemotherapeutics in immunocompetent mouse models<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and/or in combination with clinically approved cancer drugs, such as immune checkpoint inhibitors anti-PD-1 or anti-PD-L1.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> As CXCR4<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and CXCL12<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> are independent clinical indicators of poor prognosis, these CXCR4 inhibitors have the potential to directly benefit cancer patients with high CXCR4 and/or CXCL12 expression in the primary tumor microenvironment or at secondary metastatic sites. Highlighted not only by the overexpression of CXCR4 in ≥48 types of cancer<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> but also by the upregulation of CXCR4 and CXCL12 in response to tumor hypoxia, a great number of cancer patients could benefit from CXCR4 antagonists. As precision medicine emerges into the clinic, it should be emphasized that the cellular and molecular content of tumor microenvironments varies widely between different tissue types, different stages of tumorigenesis, and different patient populations. Preliminary evaluation of intratumoral expression profiles prior to treatment will enable more targeted therapeutic options and will specifically facilitate administration of CXCR4 antagonists only to patients with the proper genotype and/or phenotype. Given an appropriate CXCR4 and CXCL12 expression profile, tetrahydroisoquinoline-containing CXCR4 antagonists have the potential to inhibit intratumoral prosurvival signaling, to challenge the initiation of distant metastases, and to improve the leukocyte infiltrate by increasing the ratio of CD8<sup>+</sup> cytotoxic T lymphocytes to FoxP3<sup>+</sup> regulatory T lymphocytes, thereby sensitizing tumor cells to the host immune system and improving overall clinical outcome.</div><figure id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity profile summary of TIQ-15 analogs with improved ADMET properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56550" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56550" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemical Methods</h3><div class="NLM_p last">Automated flash column chromatography was performed using a Teledyne ISCO CombiFlash Companion system with silica gel-packed columns (SiliCycle Inc.). Analytical thin-layer chromatography (TLC, commercially available from Sigma) was carried out on aluminum-supported silica gel plates (thickness: 200 μm) with fluorescent indicator (F-254). Visualization of compounds on TLC plates was accomplished UV light (254 nm) and/or with phosphomolybdic acid, ninhydrin, or ceric ammonium molybdate. Optical rotation was measured using a PerkinElmer 341 polarimeter. NMR spectra (<sup>1</sup>H, <sup>19</sup>F, and <sup>13</sup>C) were obtained using a Varian INOVA 600 MHz spectrometer, a Varian INOVA 500 MHz spectrometer, a Varian INOVA 400 MHz spectrometer, or a Varian VNMR 400 MHz spectrometer. NMR samples were prepared and processed in deuterated chloroform (CDCl<sub>3</sub>) or deuterated methanol (CD<sub>3</sub>OD) using the residual solvent peak (CDCl<sub>3</sub>, <sup>1</sup>H = 7.27 ppm, <sup>13</sup>C = 77.23 ppm; CD<sub>3</sub>OD, <sup>13</sup>C = 49.2 ppm) as an internal reference or using trifluoroacetic acid (TFA) as external reference (TFA, <sup>19</sup>F = −76.55 ppm), unless otherwise specified. NMR data are reported to include chemical shifts (δ) reported in ppm, multiplicities indicated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), br (broad), or app (apparent), coupling constants (<i>J</i>) reported in Hz, and integration normalized to 1 atom (H, C, or F). High resolution mass spectrometry (HRMS) was performed by the Emory University Mass Spectrometry Center, directed by Dr. Fred Strobel. Liquid chromatography–mass spectrometry (LC–MS) was performed on an Agilent 1200 HPLC equipped with a 6120 quadrupole mass spectrometer (ESI-API), eluting at a rate of 1.00 mL/min with mixtures of HPLC grade MeOH and H<sub>2</sub>O or MeCN and H<sub>2</sub>O (all spiked with 0.1% formic acid) through an analytical, reverse-phase Agilent C18 XDB eclipse column (50 mm × 4.6 mm, 3.5 μm). LC–MS samples were prepared in a solution of 75:25 MeOH/H<sub>2</sub>O (spiked with 0.1% formic acid), and ultraviolet activity was monitored at 254 nm. Normal phase analytical chiral HPLC was performed on an Agilent 1100 series HPLC equipped with a G1315B diode array detector using mixtures of HPLC grade hexanes/<i>i</i>PrOH and a Daicel ChiralPak AD-H column (150 mm × 4.6 mm, 5 μm). Reverse phase HPLC was performed on the same instrument using mixtures of HPLC grade MeCN/H<sub>2</sub>O and a Daicel ChiralCel OD-RH column (150 mm × 4.6 mm, 5 μm). X-ray crystallography was performed by the Emory University X-ray Crystallography Center, directed by Dr. John Bacsa. Final compound purity was assessed using <sup>1</sup>H NMR and LC–MS. All final compounds were determined to be ≥95% pure except for compounds <b>21</b> and <b>49g</b>, which were determined to be 90–95% pure, as indicated below.</div></div><div id="sec4-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Reductive Amination Protocol A</h3><div class="NLM_p last">A solution of amine (1.00 equiv) in DCM (0.10 M) was added to a flask with a stir bar. The aldehyde (2.00 equiv) was subsequently added, and the resulting mixture was allowed to stir for 10 min at room temperature under Ar. Added sodium triacetoxyborohydride (3.00 equiv), and the resulting reaction mixture was allowed to stir at room temperature under Ar overnight. The next day, LC–MS indicated almost complete conversion of starting material. The reaction mixture was diluted with DCM and quenched with saturated aqueous sodium bicarbonate. The resulting aqueous layer was extracted 3 times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div></div><div id="sec4-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Deprotection Protocol</h3><div class="NLM_p">BOC-protected amine (1.00 equiv) was added to a flask with a stir bar. Diluted with DCM (0.10 M), and the resulting solution was stirred under Ar and room temperature for 5 min. Added 2,2,2-trifluoroacetic acid (32.0 equiv), and the resulting reaction mixture was allowed to stir at room temperature under Ar overnight. Once TLC indicated complete conversion of starting material, the reaction mixture was quenched with 1 M aqueous sodium hydroxide until the pH reached 13–14. The resulting aqueous layer was extracted 3 times with DCM, and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div><div id="sec4-3-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <i>N</i>1,<i>N</i>1-Bis(pyridin-2-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>7a</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol A using amine <b>6</b> and 2-pyridinecarboxaldehyde. Purified via column chromatography, eluting with 40:1:1 DCM/MeOH/Et<sub>3</sub>N to yield a yellow oil (87 mg, 0.134 mmol, 26% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.52 (d, <i>J</i> = 4.5 Hz, 2H), 8.31–8.35 (m, 1H), 7.63 (dt, <i>J</i> = 1.0 Hz, <i>J</i> = 7.5 Hz, 2H), 7.53–7.54 (m, 2H), 7.23–7.24 (m, 1H), 7.13 (t, <i>J</i> = 6.0 Hz, 2H), 7.06–7.10 (m, 2H), 6.94–7.01 (m, 3H), 4.62–4.66 (m, 1.5H), 4.34 (br s, 0.5H), 4.13 (d, <i>J</i> = 17.0 Hz, 1H), 3.88 (br s, 1H), 3.79 (s, 4H), 2.74–3.08 (m, 3H), 2.61–2.63 (m, 6H), 2.31 (m, 1H), 1.91–1.99 (m, 2H), 1.58–1.70 (m, 3H) 1.43–1.51 (m, 10H), 1.26–1.35 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 647.40620 (M + H); calcd for C<sub>40</sub>H<sub>50</sub>O<sub>2</sub>N<sub>6</sub> + H = 647.40680. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 647.3 (M + H), 324.2 (M/2 + H), <i>t</i> = 0.939 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 647.4 (M + H), 324.2 (M/2 + H), <i>t</i> = 3.917 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography, eluting with 40:1:1 DCM/MeOH/Et<sub>3</sub>N to yield a yellow oil (59 mg, 0.108 mmol, 80% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.47 (m, 2H), 8.36 (d, <i>J</i> = 3.6 Hz, 1H), 7.60 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.8 Hz, 2H), 7.48 (d, <i>J</i> = 7.8 Hz, 2H), 7.36 (d, <i>J</i> = 7.8 Hz, 1H), 7.15–7.16 (m, 2H), 7.05–7.11 (m, 5H), 4.10–4.31 (m, 3H), 3.76 (s, 4H), 2.64–3.09 (m, 9H), 2.46 (app t, <i>J</i> = 7.2 Hz, 3H), 2.04–2.06 (m, 1H), 1.93–1.95 (m, 1H), 1.79–1.85 (m, 1H), 1.69–1.75 (m, 1H), 1.47 (m, 2H), 1.31–1.38 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 160.1, 158.7, 149.0 (2C), 146.5 (2C), 137.2, 136.5 (2C), 134.2, 133.6, 129.2, 126.7, 126.6, 126.2, 123.0, 122.9 (2C), 122.0 (2C), 121.8, 62.4, 60.6 (2C), 56.9, 54.4, 53.2, 52.5, 46.8, 29.8, 29.4, 28.4, 27.4, 24.8, 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 547.35399 (M + H); calcd for C<sub>35</sub>H<sub>42</sub>N<sub>6</sub> + H = 547.35437. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 547.3 (M + H), 274.2 (M/2 + H), <i>t</i> = 0.786 min; 25–95% MeOH in H<sub>2</sub>O, 8 min,, <i>m</i>/<i>z</i> = 547.2 (M + H), 274.2 (M/2 + H), <i>t</i> = 5.464 min.</div></div></div><div id="sec4-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Reductive Amination Protocol B</h3><div class="NLM_p">A solution of amine (1.00 equiv) in DCM (0.10 M) was added to a flask with a stir bar. The aldehyde (1.00 equiv) was subsequently added in dropwise fashion, and the resulting mixture was allowed to stir for 30 min at room temperature under Ar. Added sodium triacetoxyborohydride (3.00 equiv), and the resulting reaction mixture was allowed to stir at room temperature overnight. In the morning, TLC indicated complete conversion of starting material. The reaction mixture was diluted with DCM and quenched with saturated aqueous sodium bicarbonate. The resulting aqueous layer was extracted 3 times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div><div id="sec4-4-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>1,<i>N</i>1-Bis(pyridin-3-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>7b</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol B using amine <b>6</b> and 3-pyridinecarboxyaldehyde. Purified via column chromatography, eluting with 9:1 DCM to MeOH to yield a clear oil (222 mg, 0.343 mmol, 64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.54 (d, <i>J</i> = 0.8 Hz, 2H), 8.49 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 1.2 Hz, 2H), 8.34–8.35 (m, 1H), 7.67 (d, <i>J</i> = 7.2 Hz, 1H), 7.22–7.26 (m, 3H), 7.04–7.12 (m, 2H), 6.95–7.02 (m, 3H), 4.61–4.68 (m, 1.5H), 4.36 (br s, 0.5H), 4.14 (d, <i>J</i> = 17.2 Hz, 1H), 3.84 (br s, 1H), 3.55 (s, 4H), 2.90–3.09 (m, 2H), 2.53–2.67 (m, 5H), 2.34–2.37 (m, 3H), 2.00 (br s, 1H), 1.91 (br s, 1H), 1.80 (br s, 1H), 1.64–1.69 (m 2H), 1.47 (m, 10H), 1.26–1.35 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 190.6, 158.0, 154.9, 149.9 (2C), 148.3 (2C), 146.6, 136.2 (2C), 134.8, 133.9, 133.0, 132.9, 129.2, 128.9, 126.2, 125.9, 125.8, 123.2 (2C), 121.2, 79.4, 61.3, 61.0, 55.5 (2C), 54.9, 54.2, 51.3, 49.4, 47.7, 43.2, 30.4, 29.0, 28.5 (3C), 24.6, 21.2. HRMS (NSI) <i>m</i>/<i>z</i> = 647.40704 (M + H); calcd for C<sub>40</sub>H<sub>50</sub>O<sub>2</sub>N<sub>6</sub> + H = 647.40680. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 647.4 (M + H), 324.2 (M/2 + H), <i>t</i> = 1.426 min; 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 647.4 (M + H), 324.2 (M/2 + H), <i>t</i> = 5.730 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography, eluting with 45:3:1 DCM/MeOH/NH<sub>4</sub>OH to yield a slightly yellow oil (166 mg, 0.304 mmol, 88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.55 (d, <i>J</i> = 2.0 Hz, 2H), 8.47 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.8 Hz, 2H), 8.42 (dd, <i>J</i> = 1.4 Hz, <i>J</i> = 4.6 Hz, 1H), 7.66 (dt, <i>J</i> = 1.9 Hz, <i>J</i> = 7.7 Hz, 2H), 7.31 (dd, <i>J</i> = 7.6 Hz, <i>J</i> = 1.2 Hz, 1H), 7.20 (ddd, <i>J</i> = 0.7 Hz, <i>J</i> = 4.9 Hz, <i>J</i> = 7.7 Hz, 2H), 7.07–7.11 (m, 2H), 6.99–7.05 (m, 3H), 4.01–4.04 (m, 2H), 3.86 (d, <i>J</i> = 15.2 Hz, 1H), 3.56 (s, 4H), 2.91–3.02 (m, 2H), 2.51–2.79 (m, 6H), 2.41–2.44 (m, 4H), 1.92–2.04 (m, 2H), 1.80–1.89 (m, 1H), 1.66–1.73 (m, 1H), 1.40–1.61 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 150.2 (2C), 148.6 (2C), 146.8, 136.6, 136.4 (2C), 135.5, 134.9 (2C), 134.7, 134.0, 129.2, 126.5, 126.0, 125.6, 123.4 (2C), 121.4, 61.4, 57.8, 55.7 (2C), 54.2, 53.7, 52.5, 48.7, 33.8, 29.5, 29.1, 27.5, 24.9, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 547.35477 (M + H); calcd for C<sub>35</sub>H<sub>42</sub>N<sub>6</sub> + H = 547.35437. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 547.3 (M + H), 274.2 (M/2 + H), <i>t</i> = 0.969 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 547.2 (M + H), 274.2 (M/2 + H), <i>t</i> = 5.530 min.</div></div><div id="sec4-4-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>1,<i>N</i>1-Bis(pyridin-4-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>7c</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol B using amine <b>6</b> and 4-pyridinecarboxaldehyde. Purified via column chromatography, eluting with 10:1 DCM to MeOH to yield a yellow oil (236 mg, 0.538 mmol, 68% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.54 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 1.5 Hz, 4H), 8.53 (d, <i>J</i> = 5.4 Hz, 4H), 8.35 (d, <i>J</i> = 16.2 Hz, 1H), 7.29 (br s, 4H), 7.24–7.25 (m, 1H), 7.06–7.11 (m, 2H), 6.96–7.02 (m, 3H), 4.62–4.69 (m, 1.5H), 4.38 (br s, 0.5H), 4.14 (d, <i>J</i> = 16.8 Hz, 1H), 3.85 (br s, 1H), 3.55 (s, 4H), 3.01–3.08 (m, 1H), 2.91–2.94 (m, 1H), 2.50–2.61 (m, 5H), 2.35–2.36 (m, 3H), 1.91–1.99 (m, 2H), 1.61–1.66 (m, 2H), 1.47–1.49 (m, 11H), 1.33 (br s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 191.4, 158.1, 155.0, 151.2, 149.7 (4C), 148.9, 146.7, 136.3, 134.0, 129.3, 126.3 (2C), 125.9, 123.5 (4C), 122.1, 121.3, 79.5, 61.3, 57.5 (2C), 54.9, 54.4, 54.1, 51.4, 49.4, 47.9, 43.4, 30.5, 29.1, 28.6 (3C), 24.8, 21.4. HRMS (NSI) <i>m</i>/<i>z</i> = 647.40702 (M + H); calcd for C<sub>40</sub>H<sub>50</sub>O<sub>2</sub>N<sub>6</sub> + H = 647.40680. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 647.4 (M + H), 324.2 (M/2 + H), <i>t</i> = 1.000 min; 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 647.3 (M + H), 324.2 (M/2 + H), <i>t</i> = 5.223 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography, eluting with 45:3:1 DCM/MeOH/NH<sub>4</sub>OH to yield a white foam (38 mg, 0.070 mmol, 78% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.50 (m, 4H), 8.37 (d, <i>J</i> = 6.0 Hz, 1H), 7.32 (d, <i>J</i> = 9.5 Hz, 1H), 7.26 (d, <i>J</i> = 10.0 Hz, 4H), 7.09–7.11 (m, 2H), 7.00–7.04 (m, 3H), 4.05–4.14 (m, 2H), 3.93–4.08 (m, 1H), 3.53 (s, 4H), 2.97–3.00 (m, 1H), 2.88–2.92 (m, 1H), 2.81 (br s, 1H), 2.69–2.75 (m, 1H), 2.62–2.66 (m, 4H), 2.48–2.53 (m, 1H), 2.38–2.41 (m, 2H), 2.00–2.03 (m, 1H), 1.92–1.95 (m, 1H), 1.78–1.86 (m, 1H), 1.64–1.70 (m, 1H), 1.38–1.55 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 150.0 (4C), 148.8 (2C), 146.6, 137.0, 134.2, 134.0, 129.3 (2C), 126.6 (2C), 126.0, 123.6 (4C), 121.7, 62.1, 57.7 (2C), 57.2, 54.1, 53.1, 52.8, 47.4, 32.7, 29.5, 28.6, 27.3, 24.9, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 547.35464 (M + H); calcd for C<sub>35</sub>H<sub>42</sub>N<sub>6</sub> + H = 547.35437. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 547.3 (M + H), 274.2 (M/2 + H), <i>t</i> = 1.038 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 547.3 (M + H), 274.2 (M/2 + H), <i>t</i> = 5.477 min.</div></div><div id="sec4-4-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>1,<i>N</i>1-Dibenzyl-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>7d</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol A using amine <b>6</b> and benzaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (235 mg, 0.364 mmol, 68% yield): 0–5 min, 0% MeOH in DCM; 5–15 min, 0–5% MeOH in DCM; 15–25 min, 5% MeOH in DCM; 25–30 min, 5–25% MeOH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 16.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 4H), 7.30 (t, <i>J</i> = 7.5 Hz, 4H), 7.21–7.25 (m, 3H), 7.06–7.11 (m, 2H), 6.96–7.02 (m, 3H), 4.64–4.67 (m, 1.5H), 4.36 (br s, 0.5H), 4.14 (d, <i>J</i> = 17.0 Hz, 1H), 3.82–3.92 (m, 1H), 3.54 (s, 4H), 2.90–3.10 (m, 2H), 2.50–2.81 (m, 5H), 2.32–2.37 (m, 3H), 1.91–2.00 (m, 2H), 1.62–1.73 (m, 2H), 1.48–1.50 (m, 11H), 1.27–1.35 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 645.41632 (M + H); calcd for C<sub>42</sub>H<sub>52</sub>O<sub>2</sub>N<sub>4</sub> + H = 645.41630. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 645.4 (M + H), 323.2 (M/2 + H), <i>t</i> = 1.072 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 645.3 (M + H), 323.2 (M/2 + H), <i>t</i> = 4.371 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a yellow oil (133 mg, 0.244 mmol, 67% yield): 0–5 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH; 5–25 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH; 25–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 4.5 Hz, 1H), 7.37 (d, <i>J</i> = 7.5 Hz, 4H), 7.26–7.32 (m, 5H), 7.19–7.22 (m, 2H), 7.08–7.10 (m, 2H), 7.00–7.04 (m, 3H), 4.00–4.04 (m, 2H), 3.89 (d, <i>J</i> = 14.0 Hz, 1H), 3.59 (d, <i>J</i> = 13.5 Hz, 2H), 3.51 (d, <i>J</i> = 14.0 Hz, 2H), 3.04–3.09 (m, 1H), 2.88 (dd, <i>J</i> = 13.0 Hz, <i>J</i> = 2.5 Hz, 1H), 2.63–2.78 (m, 4H), 2.53–2.59 (m, 2H), 2.36–2.44 (m, 3H), 2.26–2.31 (app t, <i>J</i> = 11.8 Hz, 1H), 2.00–2.04 (m, 1H), 1.94–1.97 (m, 1H), 1.82–1.89 (m, 1H), 1.64–1.73 (m, 1H), 1.47–1.62 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.0, 146.8, 140.1 (2C), 136.5, 135.9, 134.9, 134.0, 129.2, 128.9 (4C), 128.2 (4C), 126.8 (2C), 126.6, 126.0, 125.5, 121.4, 61.4, 58.5 (2C), 57.9, 54.5, 53.5, 52.4, 48.9, 34.0, 29.6, 29.5, 27.6, 24.9, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 545.36387 (M + H); calcd for C<sub>37</sub>H<sub>44</sub>N<sub>4</sub> + H = 545.36387. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 545.3 (M + H), 273.2 (M/2 + H), <i>t</i> = 0.815 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 545.2 (M + H), 273.2 (M/2 + H), <i>t</i> = 6.726 min.</div></div></div><div id="sec4-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> General Reductive Amination Protocol C</h3><div class="NLM_p">A solution of amine (1.00 equiv) in DCM (0.10 M) was added to a flask with a stir bar. Added a solution of aldehyde (0.95 equiv) in DCM (0.10 M), and the resulting mixture was allowed to stir under Ar at room temperature for 30 min. After this time, sodium triacetoxyborohydride (3.00 equiv) was added, and the resulting mixture was allowed to stir at room temperature under Ar. After 5 h, TLC indicated almost complete conversion of starting material. The reaction mixture was diluted with DCM and quenched with saturated aqueous sodium bicarbonate. The resulting aqueous layer was extracted 3 times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography to yield a 2:1 mixture of desired product to double addition product. A solution of this mixture (1.00 equiv of monoadduct, 0.50 equiv of disubstituted adduct) in DCM (0.30 M) was added to a flask with a stir bar. Added <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (1.20 equiv), and the resulting solution was stirred under Ar at room temperature. Added a solution of di-<i>tert</i>-butyl dicarbonate (1.05 equiv) in DCM (0.20 M), and the resulting reaction mixture was stirred vigorously under Ar at room temperature. After 1 week, TLC indicated mostly starting material. Added 4-dimethylaminopyridine (0.20 equiv), and the resulting reaction mixture was allowed to stir under Ar at room temperature. After 6 h, LC–MS indicated complete conversion of the monosubstituted starting material to the desired BOC-protected derivative. The reaction mixture was poured over saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted 3 times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div><div id="sec4-5-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>1-(Pyridin-3-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>8b</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol C using amine <b>6</b> and 3-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 12 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (70 mg, 0.107 mmol, 78% yield): 0–5 min, 0% MeOH in DCM; 5–15 min, 0–10% MeOH in DCM; 15–20 min, 10% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.49–8.54 (m, 2H), 8.36 (d, <i>J</i> = 17.4 Hz, 1H), 7.55–7.66 (m, 1H), 7.22–7.25 (m, 2H), 7.07–7.10 (m, 2H), 6.96–7.02 (m, 3H), 4.60–4.68 (m, 2H), 4.36–4.42 (m, 2H), 4.14 (d, <i>J</i> = 15.0 Hz, 1H), 3.84–3.89 (m, 1H), 2.94–3.18 (m, 4H), 2.37–2.71 (m, 6H), 1.93–2.00 (m, 2H), 1.59–1.69 (m, 2H), 1.44–1.50 (m, 20H), 1.32–1.36 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 656.41693 (M + H); calcd for C<sub>39</sub>H<sub>53</sub>O<sub>4</sub>N<sub>5</sub> + H = 656.41703. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 656.4 (M + H), 328.8 (M/2 + H), <i>t</i> = 3.020 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 656.4 (M + H), 328.6 (M/2 + H), <i>t</i> = 4.528 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g, 25 mL/min), eluting with the following gradient to yield a white oil (19 mg, 0.042 mmol, 24% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–15 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 15–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.55 (d, <i>J</i> = 2.0 Hz, 1H), 8.48 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.42 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 1.5 Hz, 1H), 7.66 (dt, <i>J</i> = 1.9 Hz, <i>J</i> = 7.7 Hz, 1H), 7.32 (d, <i>J</i> = 7.0 Hz, 1H), 7.23 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 7.5 Hz, 1H), 7.06–7.10 (m, 2H), 6.99–7.04 (m, 3H), 4.06–4.08 (m, 1H), 4.04 (d, <i>J</i> = 15.0 Hz, 1H), 3.89 (d, <i>J</i> = 15.0 Hz, 1H), 3.79 (s, 2H), 3.01–3.04 (m, 1H), 2.97 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.5 Hz, 1H), 2.71–2.79 (m, 2H), 2.67 (m, 1H), 2.58–2.64 (m, 5H), 2.34–2.45 (m, 3H), 2.04–2.09 (m, 1H), 1.96–1.99 (m, 1H), 1.87–1.99 (m, 1H), 1.67–1.74 (m, 1H), 1.50–1.58 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 149.9, 148.6, 146.9, 136.7, 136.0, 136.0, 135.7, 134.8, 134.1, 129.3, 126.6, 126.1, 125.7, 123.6, 121.6, 61.5, 58.0, 54.5, 52.5, 51.6, 49.6, 48.9, 34.0, 29.6, 29.3, 28.0, 27.8, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 456.31169 (M + H); calcd for C<sub>29</sub>H<sub>37</sub>N<sub>5</sub> + H = 456.31217. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 456.2 (M + H), 228.6 (M/2 + H), <i>t</i> = 0.734 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 456.2 (M + H), 228.2 (M/2 + H), <i>t</i> = 6.236 min.</div></div><div id="sec4-5-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>1-(Pyridin-4-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>8c</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol C using amine <b>6</b> and 4-pyridinecarboxaldehyde. Purified via column chromatography, eluting with 10:1 DCM/MeOH. The resulting material was dissolved in diethyl ether, decanted away from a small amount of white residue, and evaporated under reduced pressure to yield a yellow oil (72 mg, 0.110 mmol, 79% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.55 (br s, 2H), 8.34–8.36 (m, 1H), 7.25 (br s, 1H), 7.08–7.13 (m, 4H), 6.97–7.01 (m, 3H), 4.59–4.69 (m, 2H), 4.38–4.43 (m, 2H), 4.14–4.16 (m, 1H), 3.84 (br s, 1H), 2.91–3.23 (m, 4H), 2.60–2.71 (m, 5H), 2.39 (br s, 1H), 1.93–2.01 (m, 2H), 1.60–1.68 (m, 2H), 1.37–1.50 (m, 22H). HRMS (NSI) <i>m</i>/<i>z</i> = 656.41672 (M + H); calcd for C<sub>39</sub>H<sub>53</sub>O<sub>4</sub>N<sub>5</sub> + H = 656.41703. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 656.4 (M + H), 328.8 (M/2 + H), <i>t</i> = 4.496 min; 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 656.4 (M + H), 328.8 (M/2 + H), <i>t</i> = 2.137 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography, eluting with 4:1 DCM/MeOH, followed by 40:1:1 DCM/MeOH/Et<sub>3</sub>N. The resulting material was dissolved in diethyl ether, decanted away from a small amount remaining residue, and evaporated under reduced pressure to yield a yellow oil (11 mg, 0.024 mmol, 14% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 4.0 Hz, 2H), 8.44 (d, <i>J</i> = 2.4 Hz, 1H), 7.32 (d, <i>J</i> = 6.0 Hz, 1H), 7.24 (d, <i>J</i> = 4.0 Hz, 2H), 7.06–7.10 (m, 2H), 6.99–7.05 (m, 3H), 4.05–4.09 (m, 1H), 4.03 (d, <i>J</i> = 10.0 Hz, 1H), 3.89 (d, <i>J</i> = 10.0 Hz, 1H), 3.80 (s, 2H), 3.02–3.08 (m, 1H), 2.97 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz, 1H), 2.57–2.80 (m, 7H), 2.32–2.45 (m, 3H), 2.04–2.10 (m, 2H), 1.94–2.01 (m, 1H), 1.84–1.91 (m, 1H), 1.65–1.75 (m, 1H), 1.50–1.62 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 149.8 (2C), 149.7, 146.8, 136.6, 135.6, 134.7, 134.0, 129.2, 126.5, 126.0, 125.6, 123.1 (2C), 121.5, 61.6, 57.9, 54.3, 52.8, 52.4, 49.5, 48.7, 33.8, 29.5, 28.8, 27.9, 27.6, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 456.31165 (M + H); calcd for C<sub>29</sub>H<sub>37</sub>N<sub>5</sub> + H = 456.31217. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 456.2 (M + H), 228.6 (M/2 + H), <i>t</i> = 0.910 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 456.2 (M + H), 228.6 (M/2 + H), <i>t</i> = 4.689 min.</div></div></div><div id="sec4-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Reductive Amination Protocol D</h3><div class="NLM_p">A solution of amine (1.00 equiv) in DCM (0.30 M) was added to a flask with a stir bar. Added a solution of aldehyde (1.00 equiv) in DCM (0.30 M), and the resulting mixture was stirred under Ar at room temperature for 10 min. Added titanium isopropoxide (1.50 equiv) in dropwise fashion, and the resulting mixture was stirred under Ar at room temperature for 2 h. After this time, sodium borohydride (3.00 equiv) and MeOH (0.90 M) were added, and the resulting reaction mixture was stirred under Ar at room temperature. After 2 h, TLC indicated almost complete conversion of starting material. The reaction was quenched with 1 M aqueous sodium hydroxide. The organic layer was separated, and MeOH from the aqueous layer was evaporated under reduced pressure. The resulting aqueous layer was extracted twice with DCM, and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div><div id="sec4-6-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>1-Benzyl-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>9</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>6</b> and benzaldehyde. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (121 mg, 0.218 mmol, 44% yield): 0–5 min, 0% MeOH in DCM; 5–20 min, 0–10% MeOH in DCM; 20–30 min, 10% MeOH in DCM; 30–35 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 17.0 Hz, 1H), 7.34 (d, <i>J</i> = 5.0 Hz, 4H), 7.24–7.30 (m, 2H), 7.06–7.11 (m, 2H), 6.97–7.02 (m, 3H), 4.64–4.68 (m, 1.5H), 4.38 (br s, 0.5H), 4.15 (d, <i>J</i> = 17.0 Hz, 1H), 3.87–3.93 (m, 1H), 3.79 (s, 2H), 2.92–3.11 (m, 2H), 2.67–2.72 (m, 2H), 2.59–2.62 (m, 5H), 2.41 (app p, <i>J</i> = 6.9 Hz, 1H), 2.02 (br s, 1H), 1.93 (br s, 2H), 1.71–1.74 (m, 1H), 1.58–1.62 (m, 1H), 1.50 (m, 11H), 1.34–1.44 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 555.36929 (M + H); calcd for C<sub>35</sub>H<sub>46</sub>O<sub>2</sub>N<sub>4</sub> + H = 555.36935. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 555.2 (M + H), 278.2 (M/2 + H), <i>t</i> = 1.003 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 555.2 (M + H), 278.2 (M/2 + H), <i>t</i> = 4.157 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g, 25 mL/min), eluting with the following gradient to yield a clear oil (20 mg, 0.044 mmol, 20% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–15 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 15–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 1.3 Hz, <i>J</i> = 4.8 Hz, 1H), 7.29–7.36 (m, 5H), 7.24 (m, 1H), 7.07–7.11 (m, 2H), 6.99–7.05 (m, 3H), 4.07–4.09 (m, 1H), 4.36 (d, <i>J</i> = 15.0 Hz, 1H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 3.79 (s, 2H), 3.04–3.08 (m, 1H), 2.97 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.3 Hz, 1H), 2.72–2.80 (m, 2H), 2.68 (m, 1H), 2.58–2.65 (m, 5H), 2.42 (dd, <i>J</i> = 11.3 Hz, <i>J</i> = 15.8 Hz, 1H), 2.35 (dd, <i>J</i> = 10.8 Hz, <i>J</i> = 13.0 Hz, 1H), 2.05–2.09 (m, 1H), 1.95–2.01 (m, 1H), 1.85–1.93 (m, 1H), 1.66–1.75 (m, 1H), 1.49–1.58 (m, 5H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 159.0, 146.9, 140.7, 136.6, 135.9, 134.9, 134.1, 129.3, 128.6 (2C), 128.3 (2C), 127.1, 126.6, 126.1, 125.6, 121.5, 61.5, 58.0, 54.6, 54.3, 52.6, 49.7, 48.9, 34.0, 29.7, 29.5, 28.1, 27.9, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 455.31707 (M + H); calcd for C<sub>30</sub>H<sub>38</sub>N<sub>4</sub> + H = 455.31692. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 455.2 (M + H), 228.2 (M/2 + H), <i>t</i> = 0.891 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 455.2 (M + H), 228.2 (M/2 + H), <i>t</i> = 7.333 min.</div></div><div id="sec4-6-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>1-(Cyclohexylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>11a</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol D using amine <b>6</b> and aldehyde <b>10a</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (82 mg, 0.146 mmol, 27% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 21.6 Hz, 1H), 7.24 (d, <i>J</i> = 7.2 Hz, 1H), 7.07–7.11 (m, 2H), 6.96–7.03 (m, 3H), 4.63–4.67 (m, 1.5H), 4.38 (br s, 0.5H), 4.13 (d, <i>J</i> = 18.0 Hz, 1H), 3.86–3.92 (m, 1H), 2.92–3.10 (m, 2H), 2.69 (m, 2H), 2.52–2.62 (m, 5H), 2.40–2.42 (m, 3H), 2.02 (m, 1H), 1.93 (m, 1H), 1.70–1.75 (m, 4H), 1.60–1.67 (m, 2H), 1.50 (s, 9H), 1.34–1.46 (m, 5H), 1.20–1.28 (m, 2H), 1.12–1.19 (m, 1H), 0.89 (ddd, <i>J</i> = 2.4 Hz, <i>J</i> = 12.2 Hz, <i>J</i> = 24.6 Hz, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 561.41620 (M + H); calcd for C<sub>35</sub>H<sub>52</sub>N<sub>4</sub>O<sub>2</sub> + H = 561.41630. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 561.8 (M + H), 281.5 (M/2 + H), <i>t</i> = 0.831 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 561.8 (M + H), 281.5 (M/2 + H), <i>t</i> = 4.605 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a clear oil (28 mg, 0.061 mmol, 42% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 4.0 Hz, 1H), 7.31 (d, <i>J</i> = 7.5 Hz, 1H), 7.06–7.09 (m, 2H), 7.00–7.04 (m, 3H), 4.03–4.09 (m, 2H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 3.04–3.09 (m, 1H), 2.96 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.5 Hz, 1H), 2.73–2.80 (m, 2H), 2.67 (m, 1H), 2.61–2.64 (m, 2H), 2.57–2.59 (m, 3H), 2.39–2.47 (m, 3H), 2.34 (dd, <i>J</i> = 10.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.06–2.10 (m, 1H), 1.94–2.00 (m, 1H), 1.86–1.93 (m, 1H), 1.56–1.74 (m, 6H), 1.40–1.56 (m, 6H), 1.10–1.28 (m, 3H), 0.85–0.93 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.8, 136.5, 135.8, 134.8, 134.0, 129.2, 126.5, 125.9, 125.5, 121.4, 61.4, 57.9, 57.0, 54.5, 52.4, 50.3, 48.8, 38.0, 33.9, 31.6 (2C), 29.6, 29.2, 28.0, 27.8, 26.8, 26.2 (2C), 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 461.36405 (M + H); calcd for C<sub>30</sub>H<sub>44</sub>N<sub>4</sub> + H = 461.36387. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 461.4 (M + H), 231.4 (M/2 + H), <i>t</i> = 5.589 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 461.5 (M + H), 231.4 (M/2 + H), <i>t</i> = 7.668 min.</div></div><div id="sec4-6-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>1-((4,4-Difluorocyclohexyl)methyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>11b</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol D using amine <b>6</b> and aldehyde <b>10b</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (198 mg, 0.332 mmol, 62% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 23.4 Hz, 1H), 7.25 (d, <i>J</i> = 6.0 Hz, 1H), 7.07–7.12 (m, 2H), 6.98–7.03 (m, 3H), 4.63–4.69 (m, 1.5H), 4.39 (br s, 0.5H), 4.14 (d, <i>J</i> = 17.4 Hz, 1H), 3.89 (m, 1H), 3.02–3.09 (m, 1H), 2.93–2.95 (m, 1H), 2.69 (m, 2H), 2.54–2.62 (m, 5H), 2.48 (d, <i>J</i> = 7.2 Hz, 2H), 2.39–2.44 (m, 1H), 2.06–2.11 (m, 2H), 2.02 (m, 1H), 1.93 (m, 1H), 1.82 (d, <i>J</i> = 13.8 Hz, 2H), 1.69–1.76 (m, 3H), 1.59–1.68 (m, 2H), 1.50 (m, 10H), 1.40–1.47 (m, 4H), 1.23–1.30 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 597.39766 (M + H); calcd for C<sub>35</sub>H<sub>50</sub>N<sub>4</sub>O<sub>2</sub>F<sub>2</sub> + H = 597.39746. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 598.0 (M + H), 299.6 (M/2 + H), <i>t</i> = 1.002 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 598.0 (M + H), 299.6 (M/2 + H), <i>t</i> = 4.373 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a clear oil (161 mg, 0.324 mmol, 98% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.32 (dt, <i>J</i> = 0.7 Hz, <i>J</i> = 7.5 Hz, 1H), 7.06–7.10 (m, 2H), 6.99–7.06 (m, 3H), 4.02–4.09 (m, 2H), 3.91 (d, <i>J</i> = 15.0 Hz, 1H), 3.04–3.09 (m, 1H), 2.97 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.71–2.80 (m, 2H), 2.68 (m, 1H), 2.58–2.65 (m, 5H), 2.49 (d, <i>J</i> = 6.5 Hz, 2H), 2.41 (dd, <i>J</i> = 11.3 Hz, <i>J</i> = 15.8 Hz, 1H), 2.35 (dd, <i>J</i> = 10.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.05–2.11 (m, 3H), 1.95–2.01 (m, 1H), 1.86–1.94 (m, 1H), 1.80–1.83 (m, 2H), 1.62–1.76 (m, 3H), 1.45–1.60 (m, 5H), 1.25 (ddd, <i>J</i> = 3.3 Hz, <i>J</i> = 12.8 Hz, <i>J</i> = 25.0 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 146.8, 136.6, 135.7, 134.7, 134.0, 129.1, 126.5, 125.9, 125.5, 123.8 (t, <i>J</i> = 238.8 Hz), 121.4, 61.4, 57.9, 55.3, 54.4, 52.4, 50.3, 48.8, 36.3, 33.9, 33.4 (dd, <i>J</i> = 22.5 Hz, <i>J</i> = 25.0 Hz, 2C), 29.5, 29.0, 28.0, 27.7, 27.4, 27.3, 22.0. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>, TFA standard) δ −91.3 (d, <i>J</i> = 234.2 Hz), −102.0 (app dt, <i>J</i> = 33.2 Hz, <i>J</i> = 233.1 Hz). HRMS (NSI) <i>m</i>/<i>z</i> = 497.34518 (M + H); calcd for C<sub>30</sub>H<sub>42</sub>N<sub>4</sub>F<sub>2</sub> + H = 497.34503. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 497.6 (M + H), 249.4 (M/2 + H), <i>t</i> = 0.887 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 497.8 (M + H), 249.4 (M/2 + H), <i>t</i> = 7.390 min.</div></div><div id="sec4-6-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>1-((Tetrahydro-2<i>H</i>-pyran-4-yl)methyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>11c</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol D using amine <b>6</b> and aldehyde <b>10c</b>. Purified via column chromatography (CombiFlash, 12 g, 25 mL/min), eluting with the following gradient to yield a clear oil (170 mg, 0.302 mmol, 61% yield): 0–5 min, 0% MeOH in DCM; 5–20 min, 0–10% MeOH in DCM; 20–30 min (10% MeOH in DCM); 30–35 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 16.5 Hz, 1H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.07–7.12 (m, 2H), 6.97–7.02 (m, 3H), 4.62–4.68 (m, 1.5H), 4.38 (br s, 0.5H), 4.14 (d, <i>J</i> = 17.0 Hz, 1H), 3.97 (dd, <i>J</i> = 3.8 Hz, <i>J</i> = 11.3 Hz, 2H), 3.88–3.89 (m, 1H), 3.38 (dt, <i>J</i> = 11.8, <i>J</i> = 1.5 Hz, 2H), 3.01–3.09 (m, 1H), 2.92–2.95 (m, 1H), 2.67–2.69 (m, 2H), 2.55–2.62 (m, 5H), 2.49 (d, <i>J</i> = 6.5 Hz, 2H), 2.38–2.44 (m, 1H), 1.92–2.02 (m, 2H), 1.72 (m, 2H), 1.62–1.65 (m, 4H), 1.50 (s, 9H), 1.37–1.46 (m, 4H), 1.29 (ddd, <i>J</i> = 4.1 Hz, <i>J</i> = 12.4 Hz, <i>J</i> = 24.5 Hz, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 563.39569 (M + H); calcd for C<sub>34</sub>H<sub>50</sub>O<sub>3</sub>N<sub>4</sub> + H = 563.39557. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 563.3 (M + H), 282.2 (M/2 + H), <i>t</i> = 0.865 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 563.4 (M + H), 282.2 (M/2 + H), <i>t</i> = 4.023 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (76 mg, 0.164 mmol, 54% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–15 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 15–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 1.0 Hz, 1H), 7.32 (dd, <i>J</i> = 0.5 Hz, <i>J</i> = 7.5 Hz, 1H), 7.06–7.10 (m, 2H), 6.99–7.05 (m, 3H), 4.07–4.09 (m, 1H), 4.04 (d, <i>J</i> = 15.0 Hz, 1H), 3.96 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 11.0 Hz, 2H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 3.38 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 11.8 Hz, 2H), 3.04 (m, 1H), 2.97 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.71–2.80 (m, 2H), 2.68 (m, 1H), 2.58–2.65 (m, 5H), 2.49 (d, <i>J</i> = 7.0 Hz, 2H), 2.42 (dd, <i>J</i> = 11.3 Hz, <i>J</i> = 16.0 Hz, 1H), 2.36 (dd, <i>J</i> = 10.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.05–2.10 (m, 1H), 1.96–2.00 (m, 1H), 1.88–1.93 (m, 1H), 1.65–1.75 (m, 2H), 1.61–1.64 (m, 2H), 1.47–1.59 (m, 4H), 1.28 (ddd, <i>J</i> = 4.5 Hz, <i>J</i> = 12.3 Hz, <i>J</i> = 24.8 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.8, 136.6, 135.7, 134.8, 134.1, 129.2, 126.5, 126.0, 125.6, 121.5, 68.0 (2C), 61.5, 57.9, 56.4, 54.5, 52.5, 50.3, 48.9, 35.5, 33.9, 31.5 (2C), 29.6, 29.2, 28.1, 27.8, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 463.34319 (M + H); calcd for C<sub>29</sub>H<sub>42</sub>ON<sub>4</sub> + H = 463.34314. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 463.2 (M + H), 232.2 (M/2 + H), <i>t</i> = 0.734 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 463.2 (M + H), 232.2 (M/2 + H), <i>t</i> = 6.799 min.</div></div><div id="sec4-6-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>1-(Piperidin-4-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>11d</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol D using amine <b>6</b> and aldehyde <b>10d</b>. Purified via column chromatography (CombiFlash, 24 g, 30 mL/min), eluting with the following gradient to yield a white foam (177 mg, 0.267 mmol, 53% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 17.5 Hz, 1H), 7.25 (d, <i>J</i> = 7.0 Hz, 1H), 7.07–7.12 (m, 2H), 6.97–7.02 (m, 3H), 4.62–4.69 (m, 1.5H), 4.38 (br s, 0.5H), 4.08–4.16 (m, 3H), 3.89 (br s, 1H), 3.02–3.10 (m, 1H), 2.92–2.95 (m, 1H), 2.69 (m, 3H), 2.59–2.63 (m, 4H), 2.53 (br s, 2H), 2.47 (d, <i>J</i> = 6.5 Hz, 2H), 2.41 (app p, <i>J</i> = 6.8 Hz, 1H), 2.01–2.05 (m, 1H), 1.93 (br s, 1H), 1.68–1.70 (m, 4H), 1.58–1.70 (m, 2H), 1.50 (s, 9H), 1.33–1.46 (m, 13H), 1.10 (ddd, <i>J</i> = 4.1 Hz, <i>J</i> = 12.4 Hz, <i>J</i> = 24.5 Hz, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 662.46344 (M + H); calcd for C<sub>39</sub>H<sub>59</sub>O<sub>4</sub>N<sub>5</sub> + H = 662.46398. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 662.4 (M + H), 562.4 (M + H – BOC), 303.8 ((M – BOC)/2 + Na), <i>t</i> = 1.135 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 662.4 (M + H), 562.4 (M + H – BOC), 303.8 ((M – BOC)/2 + Na), <i>t</i> = 4.329 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 80:20:3 DCM/MeOH/NH<sub>4</sub>OH to yield a yellow foam (123 mg, 0.267 mmol, 74% yield. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 3.5 Hz, 1H), 7.33 (d, <i>J</i> = 7.5 Hz, 1H), 7.07–7.11 (m, 2H), 7.01–7.06 (m, 3H), 4.06–4.11 (m, 2H), 3.92 (d, <i>J</i> = 15.0 Hz, 1H), 3.25–3.41 (br s, 3H), 3.13 (app d, <i>J</i> = 12.5 Hz, 2H), 2.95–3.04 (m, 3H), 2.73–2.80 (m, 2H), 2.54–2.68 (m, 7H), 2.42–2.51 (m, 3H), 2.08–2.10 (m, 1H), 1.96–1.99 (m, 1H), 1.85–1.93 (m, 1H), 1.67–1.77 (m, 3H), 1.49–1.66 (m, 4H), 1.18–1.25 (m, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 146.8, 136.7, 135.3, 134.6, 134.1, 129.2, 126.5, 126.1, 125.6, 121.5, 61.6, 57.8, 56.0, 54.3, 52.5, 52.2, 50.1, 48.6, 45.7, 35.9, 33.7, 30.6, 30.5, 29.5, 28.8, 27.7 (2C), 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 462.35969 (M + H); calcd for C<sub>29</sub>H<sub>43</sub>N<sub>5</sub> + H = 462.35912. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 462.4 (M + H), 231.8 (M/2 + H), <i>t</i> = 0.738 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 462.4 (M + H), 231.8 (M/2 + H), <i>t</i> = 0.623 min.</div></div><div id="sec4-6-6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>1-((Tetrahydro-2<i>H</i>-thiopyran-4-yl)methyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>11e</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol D using amine <b>6</b> and aldehyde <b>10e</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (179 mg, 0.309 mmol, 58% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 22.8 Hz, 1H), 7.24 (d, <i>J</i> = 6.0 Hz, 1H), 7.07–7.11 (m, 2H), 6.97–7.02 (m, 3H), 4.62–4.68 (m, 1.5H), 4.38 (br s, 0.5H), 4.13 (d, <i>J</i> = 16.8 Hz, 1H), 3.88 (m, 1H), 3.01–3.09 (m, 1H), 2.92–2.94 (m, 1H), 2.66–2.70 (m, 4H), 2.58–2.61 (m, 5H), 2.52 (m, 2H), 2.44 (d, <i>J</i> = 6.6 Hz, 2H), 2.38–2.43 (m, 1H), 2.04–2.06 (m, 3H), 1.92 (m, 1H), 1.73 (m, 1H), 1.59–1.64 (m, 1H), 1.50 (s, 9H), 1.43–1.46 (m, 5H), 1.35 (ddd, <i>J</i> = 2.6 Hz, <i>J</i> = 12.2 Hz, <i>J</i> = 24.5 Hz, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 579.37342 (M + H); calcd for C<sub>34</sub>H<sub>50</sub>N<sub>4</sub>O<sub>2</sub>S + H = 579.37272. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min,<i>m</i>/<i>z</i> = 579.6 (M + H), 290.4 (M/2 + H), <i>t</i> = 0.852 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 579.6 (M + H), 290.4 (M/2 + H), <i>t</i> = 4.044 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a clear oil (127 mg, 0.265 mmol, 86% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.32 (dd, <i>J</i> = 0.5 Hz, <i>J</i> = 7.5 Hz, 1H), 7.06–7.10 (m, 2H), 7.00–7.05 (m, 3H), 4.02–4.09 (m, 2H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 3.03–3.08 (m, 1H), 2.96 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.71–2.80 (m, 3H), 2.67–2.70 (m, 2H), 2.63–2.64 (m, 1H), 2.56–2.62 (m, 6H), 2.45 (d, <i>J</i> = 7.0 Hz, 1H), 2.41 (dd, <i>J</i> = 11.8 Hz, <i>J</i> = 16.3 Hz, 1H), 2.34 (dd, <i>J</i> = 10.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.02–2.10 (m, 3H), 1.95–2.00 (m, 1H), 1.86–1.93 (m, 1H), 1.66–1.74 (m, 1H), 1.43–1.59 (m, 6H), 1.34 (ddd, <i>J</i> = 3.5 Hz, <i>J</i> = 11.8 Hz, <i>J</i> = 24.8 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 146.7, 136.5, 135.6, 134.7, 134.0, 129.1, 126.5, 125.9, 125.5, 121.4, 61.4, 57.9, 56.6, 54.4, 52.4, 50.2, 48.7, 37.7, 33.8, 32.5 (2C), 29.5, 29.0, 28.6 (2C), 27.9, 27.7, 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 479.32040 (M + H); calcd for C<sub>29</sub>H<sub>42</sub>N<sub>4</sub>S + H = 479.32029. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 479.6 (M + H), 240.4 (M/2 + H), <i>t</i> = 0.900 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 479.6 (M + H), 240.4 (M/2 + H), <i>t</i> = 7.311 min.</div></div><div id="sec4-6-7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 4-(((4-((((<i>R</i>)-1,2,3,4-Tetrahydroisoquinolin-3-yl)methyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)butyl)amino)methyl)tetrahydro-2<i>H</i>-thiopyran 1,1-dioxide (<b>11f</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol D using amine <b>6</b> and aldehyde <b>10f</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (100 mg, 0.164 mmol, 33% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 18.0 Hz, 1H), 7.25 (m, 1H), 7.08–7.13 (m, 2H), 6.98–7.06 (m, 3H), 4.59–4.71 (m, 1.5H), 4.39 (br s, 0.5H), 4.14 (d, <i>J</i> = 17.0 Hz, 1H), 3.89 (dd, <i>J</i> = 6.0 Hz, <i>J</i> = 9.0 Hz, 1H), 3.05–3.08 (m, 3H), 2.92–2.99 (m, 3H), 2.53–2.73 (m, 9H), 2.40–2.42 (m, 1H), 2.17–2.20 (m, 2H), 2.01–2.05 (m, 1H), 1.92–1.94 (m, 1H), 1.80–1.88 (m, 2H), 1.71–1.75 (m, 1H), 1.56–1.67 (m, 2H), 1.50 (s, 9H), 1.37–1.44 (m, 5H). HRMS (NSI) <i>m</i>/<i>z</i> = 611.36295 (M + H); calcd for C<sub>34</sub>H<sub>50</sub>N<sub>4</sub>O<sub>4</sub>S + H = 611.36255. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 611.2 (M + H), 511.3 (M – BOC + H), 306.2 (M/2 + H), <i>t</i> = 0.875 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 611.3 (M + H), 511.2 (M – BOC + H), 306.2 (M/2 + H), <i>t</i> = 3.982 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a white foam (77 mg, 0.164 mmol, 92% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.33 (dt, <i>J</i> = 0.8 Hz, <i>J</i> = 7.7 Hz, 1H), 7.07–7.11 (m, 2H), 7.00–7.06 (m, 3H), 4.02–4.09 (m, 2H), 3.89 (d, <i>J</i> = 15.0 Hz, 1H), 3.01–3.07 (m, 3H), 2.90–3.00 (m, 3H), 2.71–2.80 (m, 2H), 2.69–2.71 (m, 1H), 2.58–2.66 (m, 5H), 2.53 (d, <i>J</i> = 7.0 Hz, 2H), 2.41 (dd, <i>J</i> = 11.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.35 (dd, <i>J</i> = 10.8 Hz, <i>J</i> = 12.8 Hz, 1H), 2.15–2.19 (m, 2H), 2.05–2.10 (m, 1H), 1.96–2.01 (m, 1H), 1.79–1.94 (m, 3H), 1.66–1.75 (m, 2H), 1.46–1.65 (m, 5H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.8, 136.7, 135.7, 134.8, 134.1, 129.2, 126.5, 126.1, 125.6, 121.5, 61.6, 57.9, 54.5, 54.4, 52.5, 51.0 (2C), 50.2, 48.8, 36.1, 33.9, 29.6, 28.9, 28.4 (2C), 28.0, 27.7, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 511.31035 (M + H); calcd for C<sub>29</sub>H<sub>42</sub>N<sub>4</sub>O<sub>2</sub>S + H = 511.31012. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 511.2 (M + H), 256.2 (M/2 + H), <i>t</i> = 0.732 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 511.2 (M + H), 256.2 (M/2 + H), <i>t</i> = 6.176 min.</div></div></div><div id="sec4-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Reductive Amination Protocol E</h3><div class="NLM_p">A solution of amine (1.00 equiv) in DCM (0.12 M) was added to a flask with a stir bar. Added a solution (0.54 M) of ketone (1.00 equiv) in DCM, and the resulting reaction mixture was stirred at room temperature under Ar for 5 min. Added acetic acid (0.031 mL, 0.538 mmol, 1.00 equiv), and the resulting mixture was stirred at room temperature under Ar for 2.5 h. Added sodium triacetoxyborohydride (0.342 g, 1.61 mmol, 3.00 equiv), and the resulting reaction mixture was stirred under Ar at room temperature overnight. Once LC–MS indicated disappearance of starting material, the reaction mixture was diluted with DCM and washed once with 1 M aqueous sodium hydroxide. The resulting aqueous layer was extracted three times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div><div id="sec4-7-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>1-Cyclohexyl-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>13a</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol E using amine <b>6</b> and ketone <b>12a</b>. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (162 mg, 0.296 mmol, 55% yield): 0–5 min, 0% MeOH in DCM; 5–15 min, 0–10% MeOH in DCM; 15–25 min, 10% MeOH in DCM; 25–30 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 23.4 Hz, 1H), 7.25 (d, <i>J</i> = 7.2 Hz, 1H), 6.97–7.12 (m, 5H), 4.63–4.68 (m, 1.5H), 4.38 (br s, 0.5H), 4.14 (d, <i>J</i> = 16.8 Hz, 1H), 3.86–3.92 (m, 1H), 3.02–3.11 (m, 1H), 2.92–2.94 (m, 1H), 2.68–2.72 (m, 2H), 2.57–2.62 (m, 5H), 2.40 (br s, 2H), 2.02 (br s, 1H), 1.93–1.95 (m, 1H), 1.87 (d, <i>J</i> = 11.4 Hz, 2H), 1.72–1.74 (m, 4H), 1.61–1.63 (m, 2H), 1.50 (s, 9H), 1.36–1.43 (m, 4H), 1.25 (ddt, <i>J</i> = 25.5 Hz, <i>J</i> = 12.8 Hz, <i>J</i> = 3.2 Hz, 2H), 1.16 (ddt, <i>J</i> = 24.9 Hz, <i>J</i> = 12.3 Hz, <i>J</i> = 3.4 Hz, 1H), 1.00–1.09 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 547.40106 (M + H); calcd for C<sub>34</sub>H<sub>50</sub>O<sub>2</sub>N<sub>4</sub> + H = 547.40065. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 547.4 (M + H), 274.2 (M/2 + H), <i>t</i> = 0.826 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 547.4 (M + H), 274.2 (M/2 + H), <i>t</i> = 4.049 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (130 mg, 0.291 mmol, 98% yield): 0–5 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 5–15 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 15–25 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 5.0 Hz, 1H), 7.32 (d, <i>J</i> = 12.5 Hz, 1H), 7.06–7.09 (m, 2H), 7.00–7.05 (m, 3H), 4.07–4.09 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 10.0 Hz, 1H), 4.05 (d, <i>J</i> = 15.0 Hz, 1H), 3.91 (d, <i>J</i> = 15.0 Hz, 1H), 3.03–3.08 (app p, <i>J</i> = 6.1 Hz, 1H), 2.96–2.99 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 13.3 Hz, 1H), 2.73–2.80 (m, 2H), 2.58–2.67 (m, 6H), 2.33–2.44 (m, 3H), 2.07–2.09 (m, 1H), 1.96–1.99 (m, 1H), 1.88–1.90 (m, 3H), 1.70–1.74 (m, 3H), 1.46–1.60 (m, 5H), 1.02–1.28 (m, 6H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.7, 136.4, 135.7, 134.7, 133.9, 129.0, 126.4, 125.8, 125.4, 121.3, 61.3, 57.8, 56.9, 54.4, 52.3, 48.7, 46.9, 33.8, 33.5, 33.5, 29.4, 29.2, 28.2, 27.8, 26.2, 25.1 (2C), 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 447.34800 (M + H); calcd for C<sub>29</sub>H<sub>42</sub>N<sub>4</sub> + H = 447.34822. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 447.2 (M + H), 224.2 (M/2 + H), <i>t</i> = 0.859 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 447.2 (M + H), 224.2 (M/2 + H), <i>t</i> = 5.457 min.</div></div><div id="sec4-7-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>1-(4,4-Difluorocyclohexyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>13b</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl (<i>R</i>)-3-(((4-aminobutyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>6</b>, 0.180 g, 0.387 mmol, 1.00 equiv), 4,4-difluorocyclohexanone (<b>12b</b>, 0.073 g, 0.542 mmol, 1.40 equiv), and acetic acid (0.022 mL, 0.387 mmol, 1.00 equiv) were added to a dry 15 mL flask and diluted with DCE (3.87 mL). Sodium triacetoxyborohydride (0.197 g, 0.930 mmol, 2.40 equiv) was then added, and the resulting reaction mixture was stirred at room temperature for 2 h. After this time, LC–MS indicated complete conversion of starting material to desired product. The reaction mixture was diluted with saturated aqueous sodium bicarbonate until the aqueous layer remained basic. The aqueous layer was then extracted with DCM (2 × 30 mL), and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography, eluting with 95:5:0.5 DCM/MeOH/NH<sub>4</sub>OH to yield the desired product (0.120 g, 0.206 mmol, 53% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 23.4 Hz, 1H), 7.24 (m, 1H), 7.07–7.11 (m, 2H), 6.96–7.02 (m, 3H), 4.60–4.68 (m, 1.5H), 4.38 (br s, 0.5H), 4.14 (d, <i>J</i> = 16.8 Hz, 1H), 3.89 (m, 1H), 3.01–3.09 (m, 1H), 2.92–2.94 (m, 1H), 2.59–2.68 (m, 8H), 2.39–2.43 (m, 1H), 2.05–2.12 (m, 2H), 2.02 (br s, 1H), 1.92 (br s, 1H), 1.86–1.88 (m, 2H), 1.69–1.80 (m, 3H), 1.60–1.63 (m, 1H), 1.49 (s, 9H), 1.39–1.47 (m, 6H). HRMS (APCI) <i>m</i>/<i>z</i> = 583.38181 (M + H); calcd for C<sub>34</sub>H<sub>48</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> + H = 583.38181. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography, eluting with 98:2:0.5 DCM/MeOH/NH<sub>4</sub>OH, followed by 95:5:0.5 DCM/MeOH/NH<sub>4</sub>OH, followed by 90:10:0.5 DCM/MeOH/NH<sub>4</sub>OH to yield the desired product (0.045 g, 0.093 mmol, 45% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 3.6 Hz, 1H), 7.33 (d, <i>J</i> = 7.8 Hz, 1H), 7.08–7.11 (m, 2H), 7.01–7.06 (m, 3H), 4.06–4.09 (m, 2H), 3.91 (d, <i>J</i> = 15.0 Hz, 1H), 2.98–3.02 (m, 2H), 2.74–2.79 (m, 2H), 2.57–2.68 (m, 7H), 2.41–2.49 (m, 3H), 2.08–2.12 (m, 3H), 1.97–1.99 (m, 1H), 1.87–1.93 (m, 3H), 1.70–1.79 (m, 3H), 1.43–1.57 (m, 6H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 136.8, 135.3, 134.7, 134.2, 129.3, 126.7, 126.2, 125.8, 123.6 (t, <i>J</i> = 239.6 Hz), 121.7, 61.8, 57.8, 54.5, 54.4, 52.6, 48.6, 47.6, 33.7, 32.0 (t, <i>J</i> = 24.2 Hz, 2C), 29.7, 29.1, 29.0 (2C), 28.4, 27.9, 22.2. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>, TFA standard) δ −96.0 (app d, <i>J</i> = 233.5 Hz), −100.4 (app d, <i>J</i> = 232.0 Hz). HRMS (ESI) <i>m</i>/<i>z</i> = 483.32994 (M + H); calcd for C<sub>29</sub>H<sub>40</sub>N<sub>4</sub>F<sub>2</sub> + H = 483.32938. LC–MS (ESI-API) 85% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 483.2 (M + H), 242.2 (M/2 + H), <i>t</i> = 0.519 min; 85% MeCN in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 483.2 (M + H), 242.2 (M/2 + H), <i>t</i> = 0.560 min.</div></div><div id="sec4-7-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>1-(Tetrahydro-2<i>H</i>-pyran-4-yl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>13c</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol E using amine <b>6</b> and ketone <b>12c</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (118 mg, 0.215 mmol, 40% yield): 0–5 min, 0% MeOH in DCM; 5–20 min, 0–10% MeOH in DCM; 20–25 min, 10% MeOH in DCM; 25–30 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 22.2 Hz, 1H), 7.25–7.26 (m, 1H), 7.07–7.12 (m, 2H), 6.98–7.03 (m, 3H), 4.60–4.69 (m, 1.5H), 4.38 (br s, 0.5H), 4.15 (d, <i>J</i> = 16.8 Hz, 1H), 3.98 (d, <i>J</i> = 11.4 Hz, 2H), 3.88–3.89 (m, 1H), 3.40 (t, <i>J</i> = 11.4 Hz, 2H), 3.01–3.09 (m, 1H), 2.92–2.95 (m, 1H), 2.59–2.67 (m, 8H), 2.42 (app p, <i>J</i> = 6.6 Hz, 1H), 2.02 (br s, 1H), 1.93 (br s, 1H), 1.82 (d, <i>J</i> = 10.2 Hz, 2H), 1.72–1.75 (m, 1H), 1.60–1.65 (m, 2H), 1.50 (s, 9H), 1.39–1.47 (m, 7H). HRMS (NSI) <i>m</i>/<i>z</i> = 549.37972 (M + H); calcd for C<sub>33</sub>H<sub>48</sub>O<sub>3</sub>N<sub>4</sub> + H = 549.37992. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 549.3 (M + H), 275.2 (M/2 + H), <i>t</i> = 1.098 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 549.3 (M + H), 275.2 (M/2 + H), <i>t</i> = 4.003 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (31 mg, 0.069 mmol, 32% yield): 0–2 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 2–10 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 10–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 4.2 Hz, 1H), 7.33 (d, <i>J</i> = 7.2 Hz, 1H), 7.07–7.10 (m, 2H), 7.00–7.05 (m, 3H), 4.08 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.9 Hz, 1H), 4.04 (d, <i>J</i> = 15.0 Hz, 1H), 3.97 (app d, <i>J</i> = 12.6 Hz, 2H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 3.37–3.41 (dt, <i>J</i> = 1.4 Hz, <i>J</i> = 11.7 Hz, 2H), 3.01–3.04 (m, 1H), 2.99 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.2 Hz, 1H), 2.68–2.77 (m, 2H), 2.59–2.67 (m, 7H), 2.43 (dd, <i>J</i> = 11.1 Hz, <i>J</i> = 15.9 Hz, 1H), 2.37 (dd, <i>J</i> = 9.9 Hz, <i>J</i> = 13.2 Hz, 1H), 2.35 (br s, 1H), 2.06–2.09 (m 1H), 1.96–2.00 (m, 1H), 1.89–1.93 (ddd, <i>J</i> = 2.7 Hz, <i>J</i> = 12.6 Hz, <i>J</i> = 22.8 Hz, 1H), 1.82 (dt, <i>J</i> = 12.8 Hz, <i>J</i> = 1.7 Hz, 2H), 1.67–1.74 (m, 1H), 1.47–1.59 (m, 4H), 1.39 (ddd, <i>J</i> = 3.9 Hz, <i>J</i> = 11.7 Hz, <i>J</i> = 23.7 Hz, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 136.7, 135.8, 134.8, 134.1, 129.3, 126.6, 126.1, 125.6, 121.6, 67.1 (2C), 61.5, 58.0, 54.6, 54.3, 52.5, 48.9, 46.7, 34.0, 34.0, 34.0, 29.6, 29.2, 28.4, 27.9, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 449.32727 (M + H); calcd for C<sub>28</sub>H<sub>40</sub>ON<sub>4</sub> + H = 449.32749. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 449.2 (M + H), 225.2 (M/2 + H), <i>t</i> = 0.732 min; 10–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 449.4 (M + H), 225.2 (M/2 + H), <i>t</i> = 4.521 min.</div></div><div id="sec4-7-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>1-(Piperidin-4-yl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>13d</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol E using amine <b>6</b> and ketone <b>12d</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (186 mg, 0.287 mmol, 53% yield): 0–5 min, 0% MeOH in DCM; 5–20 min, 0–10% MeOH in DCM; 20–25 min, 10% MeOH in DCM; 25–30 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 24.6 Hz, 1H), 7.24 (br s, 1H), 7.09–7.11 (m, 2H), 6.97–7.02 (m, 3H), 4.61–4.68 (m, 1.5H), 4.38 (br s, 0.5H), 4.14 (d, <i>J</i> = 17.4 Hz, 1H), 4.01–4.06 (m, 2H), 3.88 (br s, 1H), 3.02–3.09 (m, 1H), 2.92–2.94 (m, 1H), 2.78 (br s, 2H), 2.68 (br s, 2H), 2.58–2.62 (m, 6H), 2.38–2.43 (m, 1H), 2.02 (br s, 1H), 1.93 (br s, 1H), 1.82 (d, <i>J</i> = 9.6 Hz, 2H), 1.73–1.74 (m, 1H), 1.60–1.63 (m, 1H), 1.49 (s, 9H), 1.45 (s, 9H), 1.35–1.43 (m, 4H), 1.22–1.25 (m, 3H). HRMS (NSI) <i>m</i>/<i>z</i> = 648.44846 (M + H); calcd for C<sub>38</sub>H<sub>57</sub>O<sub>4</sub>N<sub>5</sub> + H = 648.44833. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 648.4 (M + H), 548.4 (M + H - BOC), 296.8 ((M – BOC)/2 + Na), 274.9 ((M – BOC)/2 + H), <i>t</i> = 0.839 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 648.4 (M + H), 548.4 (M + H - BOC), 296.8 ((M – BOC)/2 + Na), <i>t</i> = 4.231 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (97 mg, 0.217 mmol, 75% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–13 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 13–25 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH; 25–42 min, 100% 80:20:3 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 4.5 Hz, 1H), 7.33 (d, <i>J</i> = 7.5 Hz, 1H), 7.07–7.11 (m, 2H), 6.99–7.05 (m, 3H), 4.07 (m, 1H), 4.06 (d, <i>J</i> = 15.0 Hz, 1H), 3.89 (d, <i>J</i> = 15.0 Hz, 1H), 3.08–3.10 (m, 2H), 3.02 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 13.3 Hz, 1H), 2.93–2.99 (m, 1H), 2.73–2.80 (m, 2H), 2.54–2.68 (m, 10H), 2.41–2.50 (m, 3H), 2.07–2.11 (m, 1H), 1.97–1.99 (m, 1H), 1.85–1.93 (m, 3H), 1.67–1.74 (m, 1H), 1.46–1.60 (m, 4H), 1.23–1.31 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.6, 146.8, 136.7, 135.4, 134.6, 134.0, 129.1, 126.5, 126.0, 125.6, 121.5, 61.6, 57.8, 55.0, 54.2, 52.4, 48.5, 46.4, 45.1 (2C), 33.7, 33.3, 29.5, 28.5, 27.9, 27.7, 22.0 (2C). HRMS (NSI) <i>m</i>/<i>z</i> = 448.34330 (M + H); calcd for C<sub>28</sub>H<sub>41</sub>N<sub>5</sub> + H = 448.34347. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 448.2 (M + H), 224.8 (M/2 + H), <i>t</i> = 0.731 min; 10–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 448.4 (M + H), 224.6 (M/2 + H), <i>t</i> = 0.617 min.</div></div><div id="sec4-7-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>1-(Tetrahydro-2<i>H</i>-thiopyran-4-yl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>13e</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol E using amine <b>6</b> and ketone <b>12e</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (158 mg, 0.280 mmol, 52% yield): 0–2 min, 0% MeOH in DCM; 2–13 min, 0–10% MeOH in DCM; 13–23 min, 10% MeOH in DCM; 23–28 min, 10–50% MeOH in DCM; 28–33 min, 50% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.36 (d, <i>J</i> = 22.8 Hz, 1H), 7.23 (br s, 1H), 7.08–7.10 (m, 2H), 6.96–7.01 (m, 3H), 4.59–4.67 (m, 1.5H), 4.37 (br s, 0.5H), 4.13 (d, <i>J</i> = 16.8 Hz, 1H), 3.87 (br s, 1H), 3.00–3.08 (m, 1H), 2.91–2.94 (m, 1H), 2.64–2.68 (m, 5H), 2.58–2.62 (m, 6H), 2.39–2.42 (m, 2H), 2.15 (d, <i>J</i> = 10.2 Hz, 2H), 2.01 (br s, 1H), 1.92 (br s, 1H), 1.72 (br s, 1H), 1.59–1.62 (m, 1H), 1.49 (m, 11H), 1.36–1.45 (m, 5H). HRMS (NSI) <i>m</i>/<i>z</i> = 565.35685 (M + H); calcd for C<sub>33</sub>H<sub>48</sub>O<sub>2</sub>N<sub>4</sub>S + H = 565.35707. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 565.2 (M + H), 283.2 (M/2 + H), <i>t</i> = 1.147 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 565.2 (M + H), 283.2 (M/2 + H), <i>t</i> = 4.473 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (53 mg, 0.114 mmol, 41% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–10 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 10–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (d, <i>J</i> = 4.0 Hz, 1H), 7.33 (d, <i>J</i> = 8.5 Hz, 1H), 7.07–7.10 (m, 2H), 7.00–7.06 (m, 3H), 4.07–4.09 (m, 1H), 4.05 (d, <i>J</i> = 15.0 Hz, 1H), 3.91 (d, <i>J</i> = 15.5 Hz, 1H), 3.03–3.09 (m, 1H), 2.96–2.99 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.71–2.80 (m, 2H), 2.58–2.69 (m, 9H), 2.39–2.46 (m, 2H), 2.35 (dd, <i>J</i> = 10.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.15–2.18 (m, 2H), 2.05–2.10 (m, 1H), 1.95–2.01 (m, 1H), 1.69–1.75 (m, 2H), 1.44–1.60 (m, 7H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 136.6, 135.8, 134.8, 134.1, 129.2, 126.6, 126.0, 125.6, 121.5, 61.5, 58.0, 56.3, 54.6, 52.5, 48.9, 46.9, 34.8, 34.8, 34.0, 29.6, 29.3, 28.4, 27.9, 27.8 (2C), 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 465.30452 (M + H); calcd for C<sub>28</sub>H<sub>40</sub>N<sub>4</sub>S + H = 465.30464. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 465.2 (M + H), 233.2 (M/2 + H), <i>t</i> = 1.020 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 465.2 (M + H), 233.3 (M/2 + H), <i>t</i> = 5.190 min.</div></div><div id="sec4-7-6" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-((4-((((<i>R</i>)-1,2,3,4-Tetrahydroisoquinolin-3-yl)methyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)butyl)amino)tetrahydro-2<i>H</i>-thiopyran 1,1-Dioxide (<b>13f</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol E using amine <b>6</b> and ketone <b>12f</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (164 mg, 0.275 mmol, 51% yield): 0–2 min, 0% MeOH in DCM; 2–13 min, 0–10% MeOH in DCM; 13–23 min, 10% MeOH in DCM; 23–28 min, 10–50% MeOH in DCM; 28–33 min, 50% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 23.4 Hz, 1H), 7.24–7.27 (m, 1H), 7.10 (app p, <i>J</i> = 6.9 Hz, 2H), 6.99–7.03 (m, 3H), 4.62–4.71 (m, 1H), 4.58 (br s, 0.5H), 4.40 (br s, 0.5H), 4.15 (d, <i>J</i> = 16.8 Hz, 1H), 3.90 (br s, 1H), 3.30 (br s, 2H), 3.04 (br s, 1H), 2.94 (dd, <i>J</i> = 15.6 Hz, <i>J</i> = 5.4 Hz, 1H), 2.86 (br s, 3H), 2.50–2.66 (m, 7H), 2.43 (br s, 1H), 2.22 (dd, <i>J</i> = 11.1 Hz, <i>J</i> = 14.1 Hz, 2H), 2.04 (br s, 3H), 1.93 (br s, 1H), 1.71–1.73 (m, 1H), 1.60–1.66 (m, 1H), 1.50 (s, 9H), 1.37–1.53 (m, 5H). HRMS (NSI) <i>m</i>/<i>z</i> = 597.34651 (M + H); calcd for C<sub>33</sub>H<sub>48</sub>O<sub>4</sub>N<sub>4</sub>S + H = 597.34690. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 597.3 (M + H), 497.3 (M – BOC + H), 299.2 (M/2 + H), <i>t</i> = 0.887 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 597.3 (M + H), 497.3 (M – BOC + H), 299.2 (M/2 + H), <i>t</i> = 4.257 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (56 mg, 0.113 mmol, 41% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–10 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 10–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.33 (dt, <i>J</i> = 7.7 Hz, <i>J</i> = 0.9 Hz, 1H), 7.06–7.11 (m, 2H), 7.00–7.05 (m, 3H), 4.07–4.09 (m, 1H), 4.04 (d, <i>J</i> = 15.0 Hz, 1H), 3.88 (d, <i>J</i> = 14.5 Hz, 1H), 3.27–3.32 (m, 2H), 2.98–3.04 (m, 2H), 2.80–2.88 (m, 3H), 2.56–2.78 (m, 8H), 2.43 (dd, <i>J</i> = 10.3 Hz, <i>J</i> = 15.3 Hz, 1H), 2.38 (dd, <i>J</i> = 10.3 Hz, <i>J</i> = 12.8 Hz, 1H), 2.19–2.24 (m, 2H), 1.97–2.10 (m, 5H), 1.87–1.94 (m, 1H), 1.67–1.76 (m, 1H), 1.45–1.62 (m, 4H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.9, 136.7, 135.7, 134.7, 134.1, 129.2, 126.6, 126.1, 125.7, 121.6, 61.6, 57.9, 54.5, 52.5, 51.0, 48.8, 47.8 (2C), 47.3, 33.9, 29.6, 29.4, 29.4, 28.9, 28.2, 27.8, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 497.29454 (M + H); calcd for C<sub>28</sub>H<sub>40</sub>O<sub>2</sub>N<sub>4</sub>S + H = 497.29447. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 497.2 (M + H), 249.2 (M/2 + H), <i>t</i> = 0.725 min; 10–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 497.2 (M + H), 249.3 (M/2 + H), <i>t</i> = 4.274 min.</div></div><div id="sec4-7-7" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>1-(4,4-Dimethylcyclohexyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>13g</b>)</h4><div class="NLM_p last">To solution of (<i>R</i>)-<i>tert</i>-butyl 3-(((4-aminobutyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>6</b>, 0.260 g, 0.560 mmol, 1.00 equiv) in DCE (5.60 mL) was added 4,4-dimethylcyclohexanone (<b>12g</b>, 0.078 g, 0.616 mmol, 1.10 equiv). Acetic acid (0.032 mL, 0.560 mmol, 1.00 equiv) was then added, and the resulting mixture was allowed to stir for 20 min. After this time, sodium triacetoxyborohydride (0.296 g, 1.40 mmol, 2.50 equiv) was added, and the resulting reaction mixture was allowed to stir overnight. The reaction mixture was diluted with saturated aqueous sodium bicarbonate until the aqueous layer remained basic. The aqueous layer was then extracted with DCM (2 × 30 mL), and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography, eluting with 100 mL of 90:10:0.5 DCM/MeOH/NH<sub>4</sub>OH, followed by 100 mL of 85:15:0.5 DCM/MeOH/NH<sub>4</sub>OH, followed by 80:20:0.5 DCM/MeOH/NH<sub>4</sub>OH to yield the desired product (0.300 g, 0.522 mmol, 49% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.35 (d, <i>J</i> = 20.4 Hz, 1H), 7.22 (d, <i>J</i> = 6.6 Hz, 1H), 7.05–7.09 (m, 2H), 6.94–7.02 (m, 3H), 4.61–4.66 (m, 1.5H), 4.36 (br s, 0.5H), 4.12 (d, <i>J</i> = 16.8 Hz, 1H), 3.85–3.90 (m, 1H), 2.90–3.09 (m, 1H), 2.90–2.93 (m, 1H), 2.57–2.68 (m, 7H), 2.37–2.41 (m, 2H), 2.00 (br s, 1H), 1.91 (br s, 1H), 1.56–1.69 (m, 4H), 1.48 (s, 9H), 1.24–1.45 (m, 8H), 1.78 (dt, <i>J</i> = 3.0 Hz, <i>J</i> = 12.9 Hz, 2H), 0.89 (s, 6H). HRMS (ESI) <i>m</i>/<i>z</i> = 575.43097 (M + H); calcd for C<sub>36</sub>H<sub>54</sub>N<sub>4</sub>O<sub>2</sub> + H = 575.43195. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 575.4 (M + H), 287.2 (M/2 + H), <i>t</i> = 0.773 min; 50–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 575.4 (M + H), 288.2 (M/2 + H), <i>t</i> = 2.937 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography, eluting with 100 mL of 95:5:0.5 DCM/MeOH/NH<sub>3</sub> in MeOH (7.0 M), followed by 100 mL of 90:10:0.5 DCM/MeOH/NH<sub>3</sub> in MeOH (7.0 M), followed by 85:15:0.5 DCM/MeOH/NH<sub>3</sub> in MeOH (7.0 M) to yield the desired product (0.048 g, 0.101 mmol, 19% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 7.33 (dt, <i>J</i> = 0.8 Hz, <i>J</i> = 7.5 Hz, 1H), 7.07–7.10 (m, 2H), 7.00–7.07 (m, 3H), 4.07–4.09 (m, 1H), 4.05 (d, <i>J</i> = 12.5 Hz, 1H), 3.92 (d, <i>J</i> = 15.0 Hz, 1H), 3.04–3.08 (m, 1H), 2.98 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.68–2.80 (m, 3H), 2.58–2.67 (m, 5H), 2.42 (dd, <i>J</i> = 11.0 Hz, <i>J</i> = 16.0 Hz, 1H), 2.33–2.39 (m, 2H), 2.05–2.11 (m, 1H), 1.95–2.01 (m, 1H), 1.86–1.93 (m, 1H), 1.44–1.75 (m, 7H), 1.36–1.40 (m, 2H), 1.16–1.31 (m, 5H), 0.90 (s, 3H), 0.86 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 146.8, 136.6, 135.5, 134.6, 134.0, 129.1, 126.5, 126.0, 125.5, 121.5, 61.5, 57.8, 57.3, 54.3, 52.4, 48.6, 47.0, 37.9, 33.8, 32.4, 30.1, 29.8, 29.5, 29.0, 29.0, 28.9, 28.0, 27.7, 24.7, 22.0. HRMS (ESI) <i>m</i>/<i>z</i> = 475.37893 (M + H); calcd for C<sub>31</sub>H<sub>46</sub>N<sub>4</sub> + H = 475.37952. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 475.3 (M + H), 238.2 (M/2 + H), <i>t</i> = 1.158 min.</div></div><div id="sec4-7-8" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>tert</i>-Butyl (<i>R</i>)-3-(((2-Cyanobenzyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (1<b>5</b>)</h4><div class="NLM_p last">To a solution of secondary amine <b>14</b> (0.298 g, 0.757 mmol, 1.00 equiv) in DCM (6.00 mL) was added 2-cyanobenzaldehyde (0.099 g, 0.757 mmol, 1.00 equiv) immediately followed by sodium triacetoxyborohydride (0.241 g, 1.14 mmol, 1.50 equiv). The resulting reaction mixture was allowed to stir at room temperature for 4 h. The reaction was quenched with saturated aqueous sodium bicarbonate and extracted with DCM. The organic layer was washed with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to yield an off-white foam (0.360 g). The crude material was purified by column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield an off-white foam (0.246 g, 0.484 mmol, 64% yield): 0–15 min, 0–25% EtOAc in hexanes. HRMS (NSI) <i>m</i>/<i>z</i> = 509.29073 (M + H); calcd for C<sub>32</sub>H<sub>36</sub>N<sub>4</sub>O<sub>2</sub> + H = 509.29110.</div></div><div id="sec4-7-9" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>S</i>)-<i>N</i>-(2-(Aminomethyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>16</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (<i>R</i>)-3-(((2-cyanobenzyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>15</b>, 0.224 g, 0.440 mmol, 1.00 equiv) in dry MeOH (4.40 mL) chilled to 0 °C was added di-<i>tert</i>-butyl dicarbonate (0.210 mL, 0.880 mmol, 2.00 equiv) and nickel(II) chloride hexahydrate (10.5 mg, 0.044 mmol, 0.100 equiv), and the resulting mixture was stirred under Ar. Sodium borohydride (0.351 g, 9.27 mmol, 21.1 equiv) was added in portionwise fashion, and the resulting reaction mixture was slowly allowed to warm to room temperature and stir for 72 h. After this time, diethylenetriamine (0.048 mL, 0.440 mmol, 1.00 equiv) and a small volume of MeOH were added, and the resulting mixture was stirred for 24 h at room temperature before concentrating under reduced pressure. The resulting light gray oil was diluted with EtOAc and washed with saturated aqueous sodium bicarbonate twice. The organic layer was washed once with brine, dried over anhydrous sodium sulfate, and concentrated to an off-white foam (0.292 g). The crude material was purified by column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (0.069 g, 0.113 mmol, 26% yield) and starting material (0.079 g, 0.155 mmol, 35% recovered): 0–15 min, 0–25% EtOAc in hexanes. LC–MS (ESI-API) 95% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 613.3 (M + H), <i>t</i> = 1.153 min. Amine deprotection was carried out according to the general deprotection protocol, yielding a yellow oil (29.0 mg, 0.070 mmol, 62% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.51 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 4.8 Hz, 1H), 7.46 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 7.2 Hz, 1H), 7.38 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 7.4 Hz, 1H), 7.31–7.34 (m, 1H), 7.21–7.29 (m, 2H), 7.04–7.09 (m, 3H), 6.96–7.02 (m, 2H), 4.47 (d, <i>J</i> = 13.2 Hz, 1H), 3.77–4.10 (m, 6H), 3.36–3.69 (m, 3H), 2.73–2.84 (m, 2H), 2.53–2.66 (m, 3H), 2.45 (dd, <i>J</i> = 10.2 Hz, <i>J</i> = 13.4 Hz, 1H), 2.35 (dd, <i>J</i> = 11.0 Hz, <i>J</i> = 16.2 Hz, 1H), 2.11–2.15 (m, 1H), 1.93–2.03 (m, 2H), 1.57–1.69 (m, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 162.8, 149.6, 149.4, 141.0, 139.8, 137.8, 136.9, 134.0, 133.4, 131.7, 130.7, 130.1, 129.6, 128.8, 128.6, 128.4, 124.6, 60.3, 59.5, 54.5, 49.8, 44.7, 36.0, 32.3, 32.0, 24.6, 24.3. HRMS (NSI) <i>m</i>/<i>z</i> = 413.26985 (M + H); calcd for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub> + H = 413.26997. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 413.2 (M + H), 207.2 (M/2 + H), <i>t</i> = 0.836 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 413.2 (M + H), 207.2 (M/2 + H), <i>t</i> = 1.766 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 413.2 (M + H), 207.2 (M/2 + H), <i>t</i> = 4.292 min.</div></div></div><div id="sec4-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Reduction Protocol</h3><div class="NLM_p">Carboxylic acid (1.00 equiv) was added to a flame-dried flask with a stir bar. Diluted with THF (0.10 M), and the resulting solution was stirred vigorously under Ar at room temperature. Added borane–dimethyl sulfide complex (3.50 equiv) dropwise via syringe pump at a rate of 6.0 mL/h, and the resulting reaction mixture was allowed to stir overnight at room temperature under Ar. In the morning, the reaction was quenched dropwise with MeOH at room temperature, ensuring that the ensuing gas expulsion did not become too vigorous. 1 M aqueous sodium hydroxide was added, and the resulting aqueous layer was extracted 3 times with EtOAc. Combined organic layers were washed once with 1 M aqueous sodium hydroxide, washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure.</div><div id="sec4-8-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>tert</i>-Butyl (3-(Hydroxymethyl)benzyl)carbamate (<b>17a</b>)</h4><div class="NLM_p last">Synthesis was carried out according to the general reduction protocol starting with 3-(((<i>tert</i>-butoxycarbonyl)amino)methyl)benzoic acid. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a slightly yellow oil (700 mg, 2.95 mmol, 74% yield): 0–5 min, 0% MeOH in DCM; 5–10 min, 0–5% MeOH in DCM; 10–15 min, 5% MeOH in DCM; 15–20 min, 5–10% MeOH in DCM; 20–30 min, 10% MeOH in DCM; 30–35 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.32 (app t, <i>J</i> = 7.5 Hz, 1H), 7.28 (m, 1H), 7.25–7.27 (m, 1H), 7.21 (d, <i>J</i> = 7.5 Hz, 1H), 4.92 (br s, 1H), 4.67 (s, 2H), 4.31 (d, <i>J</i> = 6.0 Hz, 2H), 2.11 (br s, 1H), 1.46 (s, 9H). HRMS (NSI) <i>m</i>/<i>z</i> = 238.14399 (M + H); calcd for C<sub>13</sub>H<sub>19</sub>O<sub>3</sub>N + H = 238.14377. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 260.2 (M + Na), 196.2 (M – <i>t</i>BuO + MeOH), 164.2 (M – <i>t</i>BuO), 138.2 (M + H – BOC), <i>t</i> = 1.362 min.</div></div><div id="sec4-8-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>tert</i>-Butyl (4-(Hydroxymethyl)benzyl)carbamate (<b>17b</b>)</h4><div class="NLM_p last">Synthesis was carried out according to the general reduction protocol starting with 4-(((<i>tert</i>-butoxycarbonyl)amino)methyl)benzoic acid. Purified. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white solid (462 mg, 1.95 mmol, 49% yield): 0–5 min, 5% MeOH in DCM; 5–10 min, 5–10% MeOH in DCM; 10–20 min, 10% MeOH in DCM; 20–25 min, 10–50% MeOH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.33 (d, <i>J</i> = 8.0 Hz, 2H), 7.26–7.28 (m, 2H), 4.87 (br s, 1H), 4.68 (s, 2H), 4.31 (d, <i>J</i> = 5.5 Hz, 2H), 1.87 (br s, 1H), 1.46 (s, 9H). HRMS (NSI) <i>m</i>/<i>z</i> = 238.14408 (M + H); calcd for C<sub>13</sub>H<sub>19</sub>O<sub>3</sub>N + H = 238.14377. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 260.2 (M + Na), 164.2 (M – <i>t</i>BuO), <i>t</i> = 1.862 min.</div></div></div><div id="sec4-9" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> General Reductive Amination Protocol F</h3><div class="NLM_p">Dess–Martin periodinane (1.25 equiv) was added to a flask with a stir bar. Diluted with DCM (0.25 M), and the resulting slurry was stirred vigorously at room temperature. Added a solution of alcohol (1.00 equiv) in DCM (0.20 M) in dropwise fashion, and the resulting reaction mixture was stirred vigorously under Ar at room temperature. After 2.5 h, TLC indicated complete conversion of starting material. The reaction mixture was poured over a 1:1 mixture of saturated aqueous NaHCO<sub>3</sub> and saturated aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (55 mL per mmol alcohol). The resulting organic layer was dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. A solution of amine (1.00 equiv) in DCM (0.12 M) was added to a flask with a stir bar. Added a solution of aldehyde (1.05 equiv) in DCM (0.53 M), and the resulting mixture was stirred under Ar at room temperature for 5 min. After this time, acetic acid (1.00 equiv) was added, and the resulting mixture was stirred under Ar at room temperature for 15 min. After this time, sodium triacetoxyborohydride (3.00 equiv) was added, and the resulting reaction mixture was allowed to stir overnight at room temperature under Ar. In the morning, the reaction mixture was diluted with DCM and washed once with 1 M aqueous sodium hydroxide. The resulting aqueous layer was extracted 3 times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was taken up in DCM (40 mL per mmol amine), filtered, and evaporated under reduced pressure.</div><div id="sec4-9-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (<i>S</i>)-<i>N</i>-(3-(Aminomethyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>19a</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol F using alcohol <b>17a</b> and amine <b>14</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (298 mg, 0.486 mmol, 55% yield): 0–3 min, 0% MeOH in DCM; 3–15 min, 0–5% MeOH in DCM; 15–20 min, 5% MeOH in DCM; 20–25 min, 5–25% MeOH in DCM.<sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45 (d, <i>J</i> = 9.0 Hz, 1H), 7.25–7.29 (m, 2H), 7.17–7.24 (m, 2H), 7.14 (d, <i>J</i> = 6.0 Hz, 1H), 7.04–7.09 (m, 2H), 6.84–7.01 (m, 3H), 5.34 (br s, 0.5H), 4.96 (br s, 0.5H), 4.62 (d, <i>J</i> = 16.8 Hz, 1H), 4.49 (d, <i>J</i> = 16.8 Hz, 1H), 4.24–4.35 (m, 2H), 3.99–4.03 (m, 1H), 3.55–3.78 (m, 3H), 2.88–3.00 (m, 3H), 2.60–2.71 (m, 3H), 2.21 (br s, 1H), 1.97 (br s, 1H), 1.79–1.83 (m, 2H), 1.64–1.71 (m, 1H), 1.47–1.52 (m, 18H). HRMS (NSI) <i>m</i>/<i>z</i> = 613.37482 (M + H); calcd for C<sub>37</sub>H<sub>48</sub>O<sub>4</sub>N<sub>4</sub> + H = 613.37483. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 613.3 (M + H), <i>t</i> = 5.047 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 613.2 (M + H), <i>t</i> = 4.848 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (121 mg, 0.293 mmol, 65% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–15 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 15–25 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.47–8.49 (m, 1H), 7.23–7.39 (m, 4H), 7.14 (d, <i>J</i> = 7.5 Hz, 1H), 7.01–7.05 (m, 3H), 6.93–6.98 (m, 2H), 4.34–4.43 (m, 1H), 4.08 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 10.5 Hz, 1H), 3.94 (d, <i>J</i> = 15.0 Hz, 1H), 3.86 (d, <i>J</i> = 14.5 Hz, 1H), 3.84 (s, 2H), 3.62–3.68 (m, 1H), 2.89 (m, 1H), 2.71–2.77 (m, 1H), 2.60–2.65 (m, 2H), 2.53 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.32–2.44 (m, 2H), 2.09–2.15 (m, 2H), 1.89–1.97 (m, 3H), 1.59–1.68 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 143.3, 142.4, 136.5, 135.8, 134.7, 134.2, 129.1, 128.5, 127.2, 126.9, 126.5, 125.9, 125.5, 125.5, 121.5, 62.3, 59.5, 58.2, 52.1, 48.7, 46.7, 33.9, 29.5, 29.5, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 413.26977 (M + H); calcd for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub> + H = 413.26997. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 413.2 (M + H), 207.2 (M/2 + H), <i>t</i> = 0.885 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 413.2 (M + H), 207.2 (M/2 + H), <i>t</i> = 6.694 min.</div></div><div id="sec4-9-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (<i>S</i>)-<i>N</i>-(4-(Aminomethyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>19b</b>)</h4><div class="NLM_p last">Synthesis was carried out according to general reductive amination protocol F using alcohol <b>17b</b> and amine <b>14</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with 40:1 DCM/MeOH to yield a white foam (275 mg, 0.449 mmol, 51% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 12.5 Hz, 1H), 7.24–7.32 (m, 3H), 7.16 (br s, 2H), 7.06 (m, 2H), 6.83–7.00 (m, 3H), 4.65–4.80 (m, 2H), 4.44–4.51 (m, 1H), 4.29 (s, 2H), 3.86–4.09 (m, 2H), 3.55–3.71 (m, 2H), 2.85–3.05 (m, 2H), 2.51–2.69 (m, 4H), 2.10–2.22 (m, 1H), 1.95 (br s, 1H), 1.66–1.82 (m, 2H), 1.45–1.53 (m, 18H). HRMS (NSI) <i>m</i>/<i>z</i> = 613.37490 (M + H); calcd for C<sub>37</sub>H<sub>48</sub>O<sub>4</sub>N<sub>4</sub> + H = 613.37483. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 613.3 (M + H), <i>t</i> = 4.666 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 613.2 (M + H), <i>t</i> = 6.799 min. Synthesis was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (82 mg, 0.199 mmol, 49% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–15 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 15–25 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.51 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 2H), 7.34 (dt, <i>J</i> = 0.9 Hz, <i>J</i> = 7.8 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 2H), 7.03–7.07 (m, 3H), 6.96–7.02 (m, 2H), 4.37 (d, <i>J</i> = 14.0 Hz, 1H), 4.11 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 10.0 Hz, 1H), 3.97 (d, <i>J</i> = 15.0 Hz, 1H), 3.90 (d, <i>J</i> = 14.5 Hz, 1H), 3.84 (s, 2H), 3.68 (d, <i>J</i> = 15.0 Hz, 1H), 2.91 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 13.3 Hz, 1H), 2.74–2.80 (m, 1H), 2.64–2.70 (m, 2H), 2.55 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.36–2.46 (m, 3H), 2.11–2.16 (m, 1H), 1.91–2.00 (m, 3H), 1.62–1.88 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 141.8, 140.5, 136.5, 135.7, 134.7, 134.2, 129.1, 128.6 (2C), 127.1 (2C), 126.5, 125.9, 125.5, 121.5, 62.1, 59.2, 58.0, 52.1, 48.6, 46.4, 33.8, 29.6, 29.5, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 413.26930 (M + H); calcd for C<sub>27</sub>H<sub>32</sub>N<sub>4</sub> + H = 413.26997. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 413.3 (M + H), 207.2 (M/2 + H), <i>t</i> = 0.844 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 413.3 (M + H), 207.2 (M/2 + H), <i>t</i> = 6.354 min.</div></div><div id="sec4-9-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> (Z)-<i>N</i>1-(((<i>R</i>)-1,2,3,4-Tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>1-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>21</b>)</h4><div class="NLM_p last">To a solution of <i>tert</i>-butyl (<i>R</i>)-3-((((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>14</b>, 0.298 g, 0.757 mmol, 1.00 equiv) in MeCN (7.00 mL) were added <i>N</i>,<i>N</i>-diisopropylethylamine (0.198 mL, 1.14 mmol, 1.50 equiv) and potassium iodide (0.013 g, 0.076 mmol, 0.100 equiv), and the resulting mixture was stirred vigorously at room temperature under Ar. To the stirring mixture was added <i>tert</i>-butyl (<i>Z</i>)-(4-chlorobut-2-en-1-yl)carbamate (<b>20</b>, 0.187 g, 0.909 mmol, 1.20 equiv), and the resulting reaction mixture was warmed to 50 °C and stirred for 72 h under Ar. After this time, the reaction was quenched with saturated aqueous sodium bicarbonate. The resulting aqueous layer was extracted three times with DCM, and combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and concentrated to an off-white foam (0.430 g). The crude material was purified by column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield an off-white foam (0.293 g, 0.521 mmol, 69% yield): 0–15 min, 0–25% EtOAc in hexanes. HRMS (NSI) <i>m</i>/<i>z</i> = 563.35924 (M + H); calcd for C<sub>33</sub>H<sub>46</sub>O<sub>4</sub>N<sub>4</sub> + H = 563.35918. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 563.3 (M + H), <i>t</i> = 1.500 min. BOC group removal was carried out according to the general deprotection protocol. The crude material was purified via column chromatography, eluting with 9:1:1 DCM/MeOH/NH<sub>4</sub>OH) to yield a light brown oil (76.1 mg, 0.210 mmol, 59% yield, 90–95% purity). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (d, <i>J</i> = 4.5 Hz, 1H), 7.32 (d, <i>J</i> = 8.0 Hz, 1H), 7.11–6.99 (m, 5H), 5.60–5.73 (m, 2H), 4.10 (dd, <i>J</i> = 10.0 Hz, <i>J</i> = 6.5 Hz, 1H), 4.03 (d, <i>J</i> = 15.0 Hz, 1H), 3.82–3.90 (m, 2H), 3.42 (dd, <i>J</i> = 6.6 Hz, <i>J</i> = 14.5 Hz, 1H), 3.28–3.33 (m, 2H), 2.75–2.86 (m, 3H), 2.64–2.74 (m, 1H), 2.57 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 16.3 Hz, 1H), 2.36–2.43 (m, 2H), 2.04–2.24 (m, 4H), 1.95–2.00 (m, 1H), 1.87–1.92 (m, 1H), 1.65–1.74 (m, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 158.6, 146.9, 136.6, 135.7, 134.6, 134.1, 132.9, 130.3, 129.2, 126.5, 126.0, 125.6, 121.5, 60.6, 57.3, 51.9, 50.9, 48.6, 38.9, 33.9, 29.5, 28.5, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 363.25433 (M + H); calcd for C<sub>23</sub>H<sub>30</sub>N<sub>4</sub> + H = 363.25432. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.2 (M/2 + H), <i>t</i> = 0.588 min; 10–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.3 (M/2 + H), <i>t</i> = 0.909 min; 0–95% MeCN in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.2 (M/2 + H), <i>t</i> = 3.731 min.</div></div><div id="sec4-9-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>tert</i>-Butyl (<i>R</i>)-3-((((<i>E</i>)-4-Aminobut-2-en-1-yl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>23</b>)</h4><div class="NLM_p last">(<i>R</i>)-<i>tert</i>-Butyl 3-((((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>14</b>, 4.96 g, 12.6 mmol, 1.00 equiv) was added to a 250 mL flask equipped with a stir bar and a reflux condenser. Diluted with acetonitrile (126 mL), and the resulting solution was stirred vigorously at room temperature under Ar. Added (<i>E</i>)-2-(4-bromobut-2-en-1-yl)isoindoline-1,3-dione (<b>22</b>, 4.24 g, 15.1 mmol, 1.20 equiv), potassium iodide (0.209 g, 1.26 mmol, 0.100 equiv), and diisopropylethylamine (4.39 mL, 25.2 mmol, 2.00 equiv), warmed to 50 °C, and the resulting reaction mixture was stirred under Ar overnight. After 19 h, TLC indicated complete conversion of starting material to one major spot. The reaction mixture was washed once with brine, and the resulting aqueous layer was extracted 3 times with DCM. Combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to yield a brown oil. Purified via column chromatography (CombiFlash, 120 g column, 75 mL/min), eluting with the following gradient to yield a yellow foam (3.78 g, 6.38 mmol, 51% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.34 (br s, 1H), 7.83–7.88 (m, 2H), 7.71–7.78 (m, 2H), 7.19 (d, <i>J</i> = 7.2 Hz, 1H), 7.07–7.08 (m, 2H), 6.98–7.03 (m, 2H), 6.92 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 7.8 Hz, 1H), 5.75–5.76 (m, 1H), 5.57 (dt, <i>J</i> = 6.0 Hz, <i>J</i> = 15.6 Hz, 1H), 4.61–4.67 (m, 1.5H), 4.40 (br s, 0.5H), 4.18 (d, <i>J</i> = 6.0 Hz, 2H), 4.06–4.10 (m, 1H), 3.91 (m, 1H), 3.33–3.40 (m, 1H), 3.14–3.15 (m, 1H), 2.89–3.00 (m, 2H), 2.60–2.67 (m, 2H), 2.44–2.57 (m, 2H), 1.91–1.98 (m, 2H), 1.57–1.71 (m, 2H), 1.47 (s, 9H). LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 593.2 (M + H), <i>t</i> = 0.709 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 593.2 (M + H), <i>t</i> = 2.762 min. The purified product (3.76 g, 6.34 mmol, 1.00 equiv) was added to a 500 mL flask with a stir bar. The starting material was diluted with MeOH (63.4 mL), and the resulting solution was stirred vigorously at room temperature under Ar. Added a solution of hydrazine (6.78 mL, 50.7 mmol, 8.00 equiv) in water (24% by wt) in dropwise fashion via syringe pump at a rate of 6 mL/h, and the resulting reaction mixture was stirred vigorously at room temperature under Ar overnight. After 23 h, the reaction mixture was partitioned between DCM and 1 M aqueous sodium hydroxide. The resulting aqueous layer was extracted 3 times with DCM, and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to yield a white foam (2.64 g). The crude material was purified via column chromatography (CombiFlash, 80 g column, 50 mL/min), eluting with the following gradient to yield a white foam (2.23 g, 4.81 mmol, 76% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–40 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J</i> = 17.5 Hz, 1H), 7.25 (d, <i>J</i> = 6.5 Hz, 1H), 7.06–7.11 (m, 2H), 6.98–7.03 (m, 3H), 5.55–5.64 (m, 2H), 4.68 (dd, <i>J</i> = 17.8 Hz, <i>J</i> = 26.8 Hz, 1.5H), 4.47 (br s, 0.5H), 4.10 (app t, <i>J</i> = 15.3 Hz, 1H), 3.98 (dd, <i>J</i> = 6.0 Hz, <i>J</i> = 8.5 Hz, 1H), 3.27–3.35 (m, 1H), 3.18 (d, <i>J</i> = 4.5 Hz, 2H), 3.09 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 14.0 Hz, 1H), 2.92–3.03 (m, 2H), 2.63–2.72 (m, 2H), 2.51–2.59 (m, 2H), 1.92–2.02 (m, 2H), 1.74 (dd, <i>J</i> = 10.5 Hz, <i>J</i> = 21.0 Hz, 1H), 1.58–1.66 (m, 1H), 1.50 (s, 9H), 1.26–1.42 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 463.30612 (M + H); calcd for C<sub>28</sub>H<sub>38</sub>N<sub>4</sub>O<sub>2</sub> + H = 463.30675. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 463.2 (M + H), <i>t</i> = 0.558 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 463.2 (M + H), 363.2 (M – BOC + H), 232.2 (M/2 + H), <i>t</i> = 0.719 min.</div></div><div id="sec4-9-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> (<i>E</i>)-<i>N</i>1-(((<i>R</i>)-1,2,3,4-Tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>1-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>24</b>)</h4><div class="NLM_p last">The BOC protecting group of amine <b>23</b> was removed according to the general deprotection protocol. The crude material was purified via column chromatography (CombiFlash), eluting with following gradient to yield the desired product (0.013 g, 0.036 mmol, 25% yield): 0–3 min, 0% 80:20:3 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–8 min, 10% 80:20:3 DCM/MeOH/NH<sub>4</sub>OH in DCM; 8–17 min, 50% 80:20:3 DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (500 Hz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 4.5 Hz, 1H), 7.32 (dd, <i>J</i> = 0.5 Hz, <i>J</i> = 7.5 Hz, 1H), 6.99–7.10 (m, 5H), 5.65–5.77 (m, 2H), 4.09–4.14 (m, 1H), 4.02 (d, <i>J</i> = 15.0 Hz, 1H), 3.83 (d, <i>J</i> = 15.0 Hz, 1H), 3.60 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 13.8 Hz, 1H), 3.22–3.33 (m, 3H), 2.90 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.68–2.84 (m, 3H), 2.59–2.65 (m, 2H), 2.41–2.47 (m, 4H), 2.04–2.09 (m, 1H), 1.87–2.01 (m, 2H), 1.66–1.74 (m, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 158.8, 147.0, 136.7, 135.6, 134.8, 134.1, 133.2, 129.9, 129.3, 126.6, 126.1, 125.7, 121.6, 61.4, 57.2, 56.3, 52.2, 48.6, 43.9, 33.8, 29.6, 28.1, 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 363.25441 (M + H); calcd for C<sub>23</sub>H<sub>30</sub>N<sub>4</sub> + H = 363.25432. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.3 (M/2 + H), <i>t</i> = 0.645 min; 50–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.3 (M/2 + H), <i>t</i> = 0.617 min; 25–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.2 (M/2 + H), <i>t</i> = 0.525 min; 10–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 363.2 (M + H), 182.2 (M/2 + H), <i>t</i> = 0.868 min.</div></div><div id="sec4-9-6" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>S</i>-Octyl 4-(1,3-Dioxoisoindolin-2-yl)-2,2-dimethylbutanethioate (<b>26</b>)</h4><div class="NLM_p last">A 250 mL flask equipped with a stir bar was set under Ar atmosphere and charged with a solution of trimethylaluminum (2.0 M in hexanes, 19.7 mL, 39.4 mmol, 3.00 equiv). The solution was cooled to 0 °C, and 1-octanethiol (6.84 mL, 39.4 mmol, 3.00 equiv) was added dropwise. After stirring at room temperature for 20 min, a solution of 3,3-dimethyldihydrofuran-2(3<i>H</i>)-one (<b>25</b>, 1.50 g, 13.1 mmol, 1.00 equiv) in DCM (30.6 mL) was added dropwise, and the resulting reaction mixture was stirred at room temperature for 12 h. After this time, the reaction was quenched by addition of diethyl ether (77.0 mL) and 1 N aqueous HCl (116 mL). The resulting aqueous layer was extracted three times with diethyl ether, and combined organic layers were washed once with 1 N aqueous HCl, washed once with saturated aqueous sodium bicarbonate, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 5–25% EtOAc in hexanes to afford a clear liquid (2.26 g, 8.68 mmol, 66% yield). A portion of the purified alcohol (0.429 g, 1.65 mmol, 1.00 equiv), phthalimide (0.279 g, 1.89 mmol, 1.15 equiv), triphenylphosphine (0.475 g, 1.81 mmol, 1.10 equiv), and THF (8.20 mL) were added to a 50 mL Schlenk tube equipped with a stir bar. Then DIAD (0.368 mL, 1.89 mmol, 1.15 equiv) was added, and the resulting reaction mixture was stirred for 30 min at room temperature. After this time, the reaction was quenched by addition of water. The resulting aqueous layer was extracted three times with diethyl ether, and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography, eluting with a gradient of 10–20% EtOAc in hexanes to yield the desired product as a clear oil (0.549 g, 1.41 mmol, 86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 3.1 Hz, 2H), 7.67 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.0 Hz, 2H), 3.63–3.68 (m, 2H), 2.70 (t, <i>J</i> = 7.4 Hz, 2H), 1.92–1.97 (m, 2H), 1.45 (p, <i>J</i> = 7.5 Hz, 2H), 1.28 (s, 6H), 1.18–1.34 (m, 10H), 0.83 (t, <i>J</i> = 6.8 Hz, 3H). LC–MS (ESI-API) 95% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 412.0 (M + Na), <i>t</i> = 1.407 min.</div></div><div id="sec4-9-7" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (<i>S</i>)-2-(3,3-Dimethyl-4-((5,6,7,8-tetrahydroquinolin-8-yl)amino)butyl)isoindoline-1,3-dione (<b>28</b>)</h4><div class="NLM_p last">A 20 mL vial equipped with a stir bar was charged with the thioester <b>26</b> (0.594 g, 1.53 mmol, 1.00 equiv), palladium(II) chloride (0.027 g, 0.152 mmol, 0.100 equiv), triethylamine (0.043 mL, 0.305 mmol, 0.200 equiv), and DCM (3.05 mL). Then triethylsilane (0.731 mL, 4.57 mmol, 3.00 equiv) was added in dropwise fashion, turning the reaction mixture into a black suspension. After stirring at room temperature for 20 min, the reaction was quenched by addition of 10% aqueous citric acid, and the resulting mixture was filtered through a plug of Celite. The aqueous layer was extracted twice with DCM, and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 10–30% EtOAc in hexanes to afford the desired product as a clear oil (0.321 g, 1.31 mmol, 86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.47 (s, 1H), 7.84 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 3.1 Hz, 2H), 7.71 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.0 Hz, 2H), 3.61–3.70 (m, 2H), 1.84–1.93 (m, 2H), 1.16 (s, 6H). LC–MS (ESI-API) 95% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 246.0 (M + H), <i>t</i> = 0.580 min. The purified material (0.321 g, 1.31 mmol, 1.00 equiv) was transferred to a 20 mL vial equipped with a stir bar, and (<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-amine (<b>27</b>, 0.291 g, 1.96 mmol, 1.50 equiv), sodium triacetoxyborohydride (0.444 g, 2.09 mmol, 1.60 equiv), and DCE (8.72 mL) were added. The resulting reaction mixture was stirred at room temperature for 1 h. After this time, the reaction was quenched with saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted three time with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with EtOAc to afford the desired product as a white solid (0.492 g, 1.30 mmol, 100% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 4.7 Hz, 1H), 7.82 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.0 Hz, 2H), 7.68 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.0 Hz, 2H), 7.35 (d, <i>J</i> = 7.7 Hz, 1H), 7.05 (dd, <i>J</i> = 7.6 Hz, <i>J</i> = 4.7 Hz, 2H), 3.69–3.75 (m, 3H), 2.81 (dt, <i>J</i> = 13.6 Hz, <i>J</i> = 6.6 Hz, 1H), 2.72 (dt, <i>J</i> = 16.8 Hz, <i>J</i> = 5.6 Hz, 1H), 2.61 (d, <i>J</i> = 11.3 Hz, 1H), 2.55 (d, <i>J</i> = 11.4 Hz, 1H), 1.98–2.14 (m, 2H), 1.62–1.82 (m, 4H), 1.04 (s, 3H), 1.03 (s, 3H). LC–MS (ESI-API) 95% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 378.2 (M/2 + H), <i>t</i> = 0.469 min.</div></div><div id="sec4-9-8" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2,2-Dimethyl-<i>N</i>1-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>1-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>30</b>)</h4><div class="NLM_p last">A 50 mL Schlenk tube equipped with a stir bar was charged with amine <b>28</b> (0.223 g, 0.591 mmol, 1.00 equiv), aldehyde <b>29</b> (0.170 g, 0.650 mmol, 1.10 equiv), and DCM (5.91 mL). Then titanium isopropoxide (0.190 mL, 0.650 mmol, 1.10 equiv) was added, and the resulting mixture was stirred at room temperature for 1 h. After this time, sodium triacetoxyborohydride (0.250 g, 1.18 mmol, 2.00 equiv) was added, and the resulting reaction mixture was stirred at room temperature for 12 h. After this time, the reaction was quenched by addition of saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted three times with DCM. Combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 0–40% EtOAc in hexanes to afford the desired product as a slightly yellow powder (0.207 g, 0.332 mmol, 56% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (br s, 0.7H), 8.33 (br s, 0.3H), 7.82 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.0 Hz, 2H), 7.70 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.1 Hz, 2H), 7.10–7.21 (m, 1H), 6.92–7.08 (m, 4H), 6.88 (dd, <i>J</i> = 7.7 Hz, <i>J</i> = 4.6 Hz, 1H), 4.71 (br s, 0.3H), 4.71 (d, <i>J</i> = 16.8 Hz, 0.7H), 4.67 (d, <i>J</i> = 16.8 Hz, 0.3H), 4.44 (br s, 0.7H), 4.27 (d, <i>J</i> = 17.4 Hz, 0.3H), 4.15 (d, <i>J</i> = 17.2 Hz, 0.7H), 4.05 (br s, 0.3H), 3.94 (br s, 0.7H), 3.54–3.69 (m, 2H), 3.30 (d, <i>J</i> = 16.1 Hz, 0.7H), 3.15 (d, <i>J</i> = 16.2 Hz, 0.3H), 2.82–3.02 (m, 2H), 2.08–2.68 (m, 7H), 1.87–1.94 (m, 1H), 1.31–1.80 (m, 3H), 1.49 (s, 6.3H), 1.46 (s, 2.7H), 0.98 (s, 2.1H), 0.91 (s, 2.1H), 0.87 (s, 0.9H), 0.84 (s, 0.9H). LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 623.2 (M + H), <i>t</i> = 0.946 min. The purified material (0.129 g, 0.207 mmol, 1.00 equiv) was added to a 20 mL vial equipped with a stir bar and diluted with MeOH (1.04 mL). Then a solution of hydrazine (0.217 mL, 1.66 mmol, 8.00 equiv) in water (24% by wt) was added, and the resulting reaction mixture was stirred at room temperature for 12 h. After this time, the reaction was quenched by addition of saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted three times with DCM. Combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was carried forward without further purification. The remaining BOC group was removed according to the general deprotection protocol. The crude material was purified via silica gel column eluting with a gradient of 0–60% 70:30:3 DCM/MeOH/NH<sub>4</sub>OH in DCM to afford the desired product as a slightly yellow powder (0.069 g, 0.176 mmol, 85% yield over 2 steps). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.44 (d, <i>J</i> = 4.8 Hz, 1H), 7.31 (d, <i>J</i> = 7.8 Hz, 1H), 7.04–7.08 (m, 3H), 7.00–7.01 (m, 2H), 4.00–4.05 (m, 2H), 3.80 (d, <i>J</i> = 15.0 Hz, 1H), 3.55 (d, <i>J</i> = 13.8 Hz, 1H), 2.85 (d, <i>J</i> = 12.6 Hz, 1H), 2.73–2.78 (m, 3H), 2.60–2.67 (m, 2H), 2.50 (dd, <i>J</i> = 15.9 Hz, <i>J</i> = 3.3 Hz, 1H), 2.45 (d, <i>J</i> = 14.4 Hz, 1H), 2.35 (dd, <i>J</i> = 15.9 Hz, <i>J</i> = 11.7 Hz, 1H), 2.21–2.23 (m, 1H), 2.15 (app t, <i>J</i> = 12.0 Hz, 1H), 1.90–1.99 (m, 3H), 1.67–1.73 (m, 3H), 1.43–1.56 (m, 2H), 0.98 (s, 3H), 0.96 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.9, 146.4, 136.3, 135.5, 134.6, 133.6, 128.9, 126.4, 125.7, 125.3, 121.3, 68.9, 64.3, 59.6, 52.1, 48.4, 44.7, 37.8, 35.4, 33.6, 29.9, 29.5, 25.8, 25.3, 22.5. HRMS (NSI) <i>m</i>/<i>z</i> = 393.30915 (M + H); calcd for C<sub>25</sub>H<sub>36</sub>N<sub>4</sub> + H = 393.30127. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 393.2 (M + H), 197.2 (M/2 + H), <i>t</i> = 0.855 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 393.2 (M + H), 197.2 (M/2 + H), <i>t</i> = 0.790 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 393.2 (M + H), 197.2 (M/2 + H), <i>t</i> = 3.284 min.</div></div><div id="sec4-9-9" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 2-(4-Hydroxy-2,2-dimethylbutyl)isoindoline-1,3-dione (<b>32</b>)</h4><div class="NLM_p last">A 100 mL flask equipped with a stir bar was charged with 2,2-dimethylbutane-1,4-diol (<b>31</b>, 1.43 g, 12.1 mmol, 1.00 equiv), imidazole (1.24 g, 18.2 mmol, 1.50 equiv), and DMF (30.0 mL). Then TBSCl (1.82 g, 12.1 mmol, 1.00 equiv) was added at 0 °C, and the resulting reaction mixture was stirred at room temperature for 1 h. After this time, the reaction was quenched by addition of saturated aqueous ammonium chloride, and the resulting aqueous layer was extracted three times with diethyl ether. Combined organic layers were washed once with brine, dried over anhydrous magnesium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 10–30% EtOAc in hexanes to afford the desired product as a clear oil (1.88 g, 8.08 mmol, 67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.70 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 4.0 Hz, 2H), 3.59 (t, <i>J</i> = 7.0 Hz, 1H), 3.28 (d, <i>J</i> = 7.0 Hz, 2H), 1.50 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 4.0 Hz, 2H), 0.91 (s, 9H), 0.90 (s, 6H), 0.09 (s, 6H). A 100 mL flask equipped with a stir bar was charged with the purified alcohol (1.88 g, 8.08 mmol, 1.00 equiv), phthalimide (1.43 g, 9.79 mmol, 1.20 equiv), triphenylphosphine (2.44 g, 9.30 mmol, 1.15 equiv), and THF (40.4 mL). Then DIAD (1.90 mL, 9.79 mmol, 1.21 equiv) was added, and the resulting reaction mixture was stirred at room temperature for 24 h. After this time, phthalimide (0.715 g, 4.86 mmol, 0.600 equiv), triphenylphosphine (1.22 g, 4.65 mmol, 0.580 equiv), and DIAD (0.950 mL, 4.90 mmol, 0.605 equiv) were added, and stirring was continued at room temperature for 12 h. After this time, the reaction was quenched by addition of water, and the resulting aqueous layer was extracted twice with DCM. Combined organic layers were washed once with water, washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was filtered through a silica gel plug, eluting with 10% EtOAc in hexanes to afford the desired product as a clear oil (3.03 g), which was carried forward without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.85 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 3.1 Hz, 2H), 7.72 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 3.1 Hz, 2H), 3.77 (t, <i>J</i> = 7.0 Hz, 2H), 3.55 (s, 2H), 1.57 (t, <i>J</i> = 7.0 Hz, 2H), 0.97 (s, 6H), 0.89 (s, 9H), 0.06 (s, 6H). A 25 mL flask equipped with a stir bar was charged with the crude material (2.92 g, 8.08 mmol, 1.00 equiv), 2 M aqueous HCl (8.08 mL, 16.2 mmol, 2.00 equiv), and THF (16.0 mL), and the resulting reaction mixture was stirred at room temperature for 2 h. After this time, the reaction was quenched by addition of saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted three times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 10–40% EtOAc in hexanes to afford the desired product as a white solid (1.67 g, 6.75 mmol, 84% yield over 2 steps). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.72–7.77 (m, 2H), 7.61–7.67 (m, 2H), 3.74 (t, <i>J</i> = 7.1 Hz, 2H), 3.51 (s, 2H), 2.77 (s, 1H), 1.49 (t, <i>J</i> = 7.1 Hz, 2H), 0.91 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 169.0 (2C), 133.8 (2C), 131.7 (2C), 123.0 (2C), 59.2, 48.0, 42.0, 35.4, 25.8 (2C). LC–MS (ESI-API) 95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 248.0 (M + H), <i>t</i> = 0.562 min.</div></div><div id="sec4-9-10" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>tert</i>-Butyl (<i>R</i>)-3-(((4-Amino-3,3-dimethylbutyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>33</b>)</h4><div class="NLM_p last">A 50 mL Schlenk flask equipped with a stir bar was charged with the alcohol <b>32</b> (0.438 g, 1.77 mmol, 1.00 equiv), triethylamine (1.31 mL, 9.39 mmol, 5.30 equiv), and DCM (5.40 mL). After the mixture was cooled to 0 °C, a solution of sulfur trioxide–pyridine complex (1.13 g, 7.08 mmol, 4.00 equiv) in DMSO (5.40 mL) was added dropwise, and the resulting reaction mixture was stirred at 0<sup>°</sup>C for 3 h. After this time, the reaction mixture was quenched by addition of saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted three times with diethyl ether. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 0–50% EtOAc in hexanes to afford the desired product as a white solid (0.334 g, 1.36 mmol, 77% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.82 (t, <i>J</i> = 2.4 Hz, 1H), 7.78 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 3.0 Hz, 2H), 7.68 (dd, <i>J</i> = 5.4 Hz, <i>J</i> = 3.1 Hz, 2H), 3.58 (s, 2H), 2.31 (d, <i>J</i> = 2.5 Hz, 2H), 1.07 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 201.9, 168.7 (2C), 134.0 (2C), 131.7 (2C), 123.2 (2C), 52.6, 47.7, 35.8, 25.9 (2C). LC–MS (ESI-API) 95% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 268.0 (M + Na), <i>t</i> = 0.572 min. To a 20 mL vial equipped with a stir bar were added the purified aldehyde (0.270 g, 1.10 mmol, 1.20 equiv), amine <b>14</b> (0.361 g, 0.917 mmol, 1.00 equiv), acetic acid (0.074 mL, 1.28 mmol, 1.40 equiv), sodium triacetoxyborohydride (0.253 g, 1.19 mmol, 1.30 equiv), and DCE (9.17 mL). After stirring at room temperature for 12 h, the reaction was quenched by addition of saturated aqueous sodium bicarbonate, and the resulting aqueous layer was extracted three times with diethyl ether. Combined organic layers were washed once with saturated aqueous sodium bicarbonate, washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude product was purified via silica gel column, eluting with a gradient of 0–40% EtOAc in hexanes to afford the desired product as a clear oil (0.463 g, 0.743 mmol, 81% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.34 (br s, 1H), 7.83–7.89 (m, 2H), 7.71–7.75 (m, 2H), 7.21 (d, <i>J</i> = 9.0 Hz, 1H), 7.04–7.09 (m, 3H), 6.96–6.98 (m, 1H), 6.93 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 7.5 Hz, 1H), 4.66 (d, <i>J</i> = 16.5 Hz, 1.5H), 4.42 (br s, 0.5H), 4.08 (d, <i>J</i> = 17.0 Hz, 1H), 3.82–3.96 (m, 1H), 3.42 (s, 2H), 2.93–3.14 (m, 2H), 2.73–2.79 (m, 1.5H), 2.58–2.69 (m, 4H), 2.49 (app t, <i>J</i> = 11.0 Hz, 0.5H), 1.94–1.98 (m, 2H), 1.73–1.79 (m, 1H), 1.62–1.68 (m, 1H), 1.44–1.54 (m, 10H), 1.25–1.37 (m, 1H), 1.01 (s, 0.5H), 0.86 (s, 3H), 0.81 (s, 2.5H). HRMS (NSI) <i>m</i>/<i>z</i> = 623.36086 (M + H); calcd for C<sub>38</sub>H<sub>46</sub>N<sub>4</sub>O<sub>4</sub> + H = 623.35918. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 623.3 (M + H), <i>t</i> = 1.176 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 623.4 (M + H), <i>t</i> = 4.922 min. A 20 mL vial equipped with a stir bar was charged with a solution of purified amine (0.177 g, 0.284 mmol, 1.00 equiv) in MeOH (1.42 mL). Then a solution of hydrazine (0.301 mL, 2.27 mmol, 8.00 equiv) in water (24% by wt) was added, and the resulting reaction mixture was stirred at room temperature for 24 h. After this time, the reaction was quenched by addition of saturated aqueous sodium carbonate, and the resulting aqueous layer was extracted three times with DCM. Combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was carried forward without further purification. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 10.2 Hz, 1H), 7.26 (d, <i>J</i> = 7.2 Hz, 1H), 7.08–7.11 (m, 2H), 7.04–7.06 (m, 1H), 6.98 (m, 2H), 4.62–4.68 (m, 1.5H), 4.39 (br s, 0.5H), 4.07–4.13 (m, 1H), 3.92 (m, 1H), 2.89–3.12 (m, 2H), 2.71 (m, 1H), 2.56–2.66 (m, 4H), 2.42–2.46 (m, 2H), 2.32–2.38 (m, 2H), 1.96–2.03 (m, 2H), 1.74 (m, 1H), 1.61–1.63 (m, 2H), 1.50 (s, 9H), 1.21–1.42 (m, 2H), 0.85 (s, 1H), 0.77 (s, 5H). HRMS (NSI) <i>m</i>/<i>z</i> = 493.35435 (M + H); calcd for C<sub>30</sub>H<sub>44</sub>N<sub>4</sub>O<sub>2</sub> + H = 493.35370. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 493.2 (M + H), 247.2 (M/2 + H), <i>t</i> = 0.519 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 493.2 (M + H), 393.2 (M – BOC + H), 247.2 (M/2 + H), <i>t</i> = 0.921 min.</div></div><div id="sec4-9-11" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 3,3-Dimethyl-<i>N</i>1-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>1-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>34</b>)</h4><div class="NLM_p last">The BOC protecting group of amine <b>33</b> was removed according to the general deprotection protocol. The crude material was purified via silica gel column, eluting with a gradient of 0–20% MeOH in DCM with 1% NH<sub>4</sub>OH to afford the desired product as a slightly yellow solid (0.102 g, 0.260 mmol, 91% yield). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.45 (d, <i>J</i> = 4.7 Hz, 1H), 7.32 (d, <i>J</i> = 7.7 Hz, 1H), 6.99–7.10 (m, 5H), 4.07 (dd, <i>J</i> = 9.9 Hz, <i>J</i> = 6.3 Hz, 1H), 4.03 (d, <i>J</i> = 15.1 Hz, 1H), 3.87 (d, <i>J</i> = 15.1 Hz, 1H), 2.99 (dt, <i>J</i> = 11.6 Hz, <i>J</i> = 5.8 Hz, 1H), 2.94 (dd, <i>J</i> = 13.1 Hz, <i>J</i> = 3.2 Hz, 1H), 2.57–2.80 (m, 5H), 2.39–2.46 (m, 3H), 2.35 (dd, <i>J</i> = 13.2 Hz, <i>J</i> = 10.1 Hz, 1H), 2.03–2.10 (m, 1H), 1.94–2.02 (m, 1H), 1.84–1.94 (m, 1H), 1.67–1.75 (m, 1H), 1.60 (ddd, <i>J</i> = 13.4 Hz, <i>J</i> = 11.4 Hz, <i>J</i> = 4.9 Hz, 1H), 1.37 (ddd, <i>J</i> = 13.3 Hz, <i>J</i> = 11.1 Hz, <i>J</i> = 5.0 Hz, 1H), 0.84 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.5, 146.6, 136.2, 135.6, 134.6, 133.7, 128.9, 126.2, 125.6, 125.2, 121.2, 61.0, 57.8, 52.7, 52.1, 49.6, 48.6, 38.8, 34.0, 33.7, 29.2, 28.7, 24.9, 24.7, 21.7. HRMS (NSI) <i>m</i>/<i>z</i> = 393.30074 (M + H); calcd for C<sub>25</sub>H<sub>36</sub>N<sub>4</sub> + H = 393.30127. LC–MS (ESI-API) 65% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 393.2 (M + H), 197.2 (M/2 + H), <i>t</i> = 0.875 min; 75–95% MeOH in H<sub>2</sub>O, 3 min, <i>m</i>/<i>z</i> = 393.2 (M + H), 197.2 (M/2 + H), <i>t</i> = 0.773 min; 55% MeOH in H<sub>2</sub>O isocratic, 3 min, <i>m</i>/<i>z</i> = 393.2 (M + H), 197.2 (M/2 + H), <i>t</i> = 0.890 min.</div></div><div id="sec4-9-12" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl 2,2-Dimethyl-5-oxopyrrolidine-1-carboxylate (<b>36</b>)</h4><div class="NLM_p last">To a solution of methyl 4-methyl-4-nitropentanoate (<b>35</b>, 15.0 g, 86.0 mmol, 1.00 equiv) in EtOH (100 mL) was added a catalytic amount of Raney nickel. The resulting heterogeneous mixture was stirred vigorously, degassed using weak vacuum, and subsequently flushed with Ar. This degas cycle was repeated twice. Weak vacuum was applied to the flask once more, and the flask was finally flushed with hydrogen gas (40 psi). The resulting reaction mixture was shaken vigorously at room temperature for 18 h using a Parr hydrogenator. After this time, the reaction mixture was filtered over a plug of Celite, and the resulting mother liquor was stirred at reflux for an additional 18 h. After this time, solvent was evaporated under reduced pressure to yield the desired product (8.50 g, 75.0 mmol, 88% yield). To a solution of the crude material (4.00 g, 35.3 mmol, 1.00 equiv) in DCM (70.7 mL) were added di-<i>tert</i>-butyl dicarbonate (12.3 g, 56.4 mmol, 2.90 equiv), triethylamine (0.493 mL, 3.53 mmol, 0.100 equiv), and 4-dimethylaminopyridine (0.432 g, 3.53 mmol, 0.100 equiv). The resulting reaction mixture was warmed to reflux and stirred for 18 h. After this time, the reaction mixture was quenched with saturated aqueous ammonium chloride. The resulting organic layer was washed with saturated aqueous ammonium chloride (2 × 70 mL), and combined aqueous layers were extracted with DCM (3 × 50 mL). Combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography, eluting with 10% EtOAc in hexanes, followed by 20% EtOAc in hexanes, followed by DCM to yield the desired product as a yellow crystalline solid (6.15 g, 28.8 mmol, 82% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.47 (t, <i>J</i> = 7.8 Hz, 2H), 1.84 (t, <i>J</i> = 8.2 Hz, 2H), 1.53 (s, 9H), 1.45 (s, 6H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 174.6, 150.3, 82.7, 62.1, 34.3, 30.8, 28.1 (3C), 26.9 (2C). HRMS (ESI) <i>m</i>/<i>z</i> = 236.12545 (M + Na); calcd for C<sub>11</sub>H<sub>19</sub>O<sub>3</sub>N + Na = 236.12571. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 236.2 (M + Na), 449.2 (2 M + Na), <i>t</i> = 2.511 min.</div></div><div id="sec4-9-13" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-Methyl-<i>N</i>1-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>1-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)pentane-1,4-diamine (<b>37</b>)</h4><div class="NLM_p last">A solution of lactam <b>36</b> (3.10 g, 14.5 mmol, 1.00 equiv) in dry diethyl ether (29.1 mL) was cooled to −78 °C and stirred under Ar. A solution of diisobutylaluminum hydride (17.4 mL, 17.4 mmol, 1.2 equiv) in toluene (1.0 M) was slowly added, and the resulting reaction mixture was stirred at −78 °C under Ar for 4 h. Then the reaction mixture was slowly allowed to warm to room temperature and stirred for another 2 h. After this time, the reaction was quenched with water at 0 °C, and the resulting aqueous layer was extracted with EtOAc (4 × 40 mL). Combined organic layers were washed with water (3 × 100 mL), washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography, eluting with 10% EtOAc in hexanes, followed by DCM to yield the desired product as a white solid (2.23 g, 10.4 mmol, 71% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.36–5.47 (m, 1H), 3.72 (s, 0.7H), 2.89 (s, 0.3H), 1.91–2.12 (m, 2H), 1.70–1.82 (m, 2H), 1.43–1.50 (m, 12H), 1.29 (s, 0.9H), 1.25 (s, 2.1H). The purified material (1.09 g, 5.08 mmol, 2.00 equiv) and acetic acid (0.335 mL, 5.84 mmol, 2.3 equiv) were added to a solution of secondary amine <b>14</b> (1.00 g, 2.54 mmol, 1.00 equiv) in DCM (25.4 mL), and the resulting mixture was stirred at room temperature for 2 h. Then sodium triacetoxyborohydride (1.08 g, 5.08 mmol, 2.00 equiv) was added, and the resulting reaction mixture was stirred at room temperature for 58 h. After this time, the reaction mixture was quenched with 1 M aqueous potassium carbonate, the resulting organic layer was washed with 1 M aqueous potassium carbonate (3 × 70 mL), and combined aqueous layers were extracted with DCM (2 × 30 mL). Combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure. The crude material was purified via column chromatography, eluting with DCM, followed by 1% MeOH in DCM to yield the desired product as a yellow oil (0.450 g, 0.759 mmol, 30% yield). BOC group removal was carried out according to the general deprotection protocol. The crude material was purified via column chromatography, eluting with 90:10 DCM/MeOH, followed by 80:20:2 DCM/MeOH/NH<sub>4</sub>OH to yield the desired product as a viscous yellow oil (0.094 g, 0.240 mmol, 36% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.49 (d, <i>J</i> = 3.2 Hz, 1H), 7.33 (d, <i>J</i> = 7.2 Hz, 1H), 6.99–7.09 (m, 5H), 3.77–4.08 (m, 4H), 2.93–2.99 (m, 2H), 2.41–2.80 (m, 8H), 2.09–2.12 (m, 1H), 1.84–2.01 (m, 2H), 1.69–1.72 (m, 1H), 1.25–1.56 (m, 5H), 1.17 (s, 3H), 1.16 (s, 3H). HRMS (ESI) <i>m</i>/<i>z</i> = 393.30118 (M + H); calcd for C<sub>25</sub>H<sub>36</sub>N<sub>4</sub> + H = 393.30127. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 393.4 (M + H), 376.2 (M – NH<sub>3</sub> + H), 197.3 (M/2 + H), <i>t</i> = 1.350 min; 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 393.3 (M + H), 376.4 (M – NH<sub>3</sub> + H), 197.3 (M/2 + H), <i>t</i> = 1.277 min.</div></div><div id="sec4-9-14" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 4-((1,3-Dioxoisoindolin-2-yl)methyl)benzaldehyde (<b>40</b>)</h4><div class="NLM_p last">(4-(Aminomethylphenyl)methanol (<b>38</b>, 5.00 g, 36.4 mmol, 1.00 equiv) was added to a 500 mL flask with a stir bar. Diluted with THF (121 mL), added triethylamine (5.08 mL, 36.4 mmol, 1.00 equiv) and ethyl 1,3-dioxoisoindoline-2-carboxylate (<b>39</b>, 7.99 g, 36.4 mmol, 1.00 equiv), and the resulting reaction mixture was stirred vigorously at room temperature under Ar overnight. After 17 h, TLC indicated complete conversion of starting material to one major spot. Solvent was evaporated under reduced pressure to yield a yellow paste, which was carried forward without further purification. Dess–Martin periodinane (17.0 g, 40.1 mmol, 1.10 equiv) was added to a 500 mL flask with a stir bar. The white solid was diluted with DCM (121 mL), and the resulting slurry was stirred vigorously at room temperature. Added a solution of the crude alcohol (9.74 g, 36.4 mmol, 1.00 equiv) in DCM (121 mL) in dropwise fashion via addition funnel, and the resulting reaction mixture was stirred vigorously at room temperature under Ar. After 3 h, TLC indicated complete consumption of starting material. The reaction mixture was poured over 750 mL of a 1:1 mixture of saturated aqueous sodium bicarbonate and saturated aqueous sodium thiosulfate. The resulting organic layer was washed once with 150 mL of a 1:1 mixture of saturated aqueous sodium bicarbonate and saturated aqueous sodium thiosulfate, washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to yield an orange oil. Half of the crude material was immediately carried forward without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.99 (s, 1H), 7.84–7.89 (m, 4H), 7.71–7.76 (m, 2H), 7.58 (d, <i>J</i> = 8.0 Hz, 2H), 4.93 (s, 2H).</div></div><div id="sec4-9-15" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl (<i>R</i>)-3-(((4-(Aminomethyl)benzyl)((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)amino)methyl)-3,4-dihydroisoquinoline-2(1<i>H</i>)-carboxylate (<b>41</b>)</h4><div class="NLM_p last">Sodium triacetoxyborohydride (11.1 g, 52.1 mmol, 3.00 equiv) was added to a 500 mL flask with a stir bar. Diluted with DCM (87.0 mL), and the resulting slurry was stirred vigorously at room temperature under Ar. Added a solution of secondary amine <b>14</b> (6.84 g, 17.4 mmol, 1.00 equiv) in DCM (43.4 mL), followed by a solution of aldehyde <b>40</b> (4.84 g, 18.3 mmol, 1.05 equiv) in DCM (43.4 mL), and the resulting reaction mixture was stirred vigorously at room temperature under Ar overnight. After 15 h, TLC indicated complete consumption of starting material. The reaction mixture was diluted with DCM and washed three times with 1 M aqueous sodium hydroxide. The resulting aqueous layer was extracted twice with DCM. Combined organic layers were washed once with brine, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to yield a yellow foam (11.0 g). The crude material was purified via column chromatography (CombiFlash, 120 g column, 75 mL/min), eluting with the following gradient to yield a white foam (7.30 g, 11.4 mmol, 65% yield): 0–3 min, 0% MeOH in DCM; 3–8 min, 0–1% MeOH in DCM; 8–13 min, 1% MeOH in DCM; 13–23 min, 1–2% MeOH in DCM; 23–30 min, 2% MeOH in DCM; 30–40 min, 2–20% MeOH in DCM. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.40 (d, <i>J</i> = 14.4 Hz, 1H), 7.85–7.87 (m, 2H), 7.72 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 5.4 Hz, 2H), 7.29–7.30 (m, 3H), 7.19–7.26 (m, 2H), 7.03 (app t, <i>J</i> = 6.6 Hz, 1.5H), 6.93–6.97 (m, 3H), 6.74 (d, <i>J</i> = 6.6 Hz, 0.5H), 4.83–4.88 (m, 2H), 4.61–4.76 (m, 1H), 4.36–4.39 (m, 1H), 4.01–4.10 (m, 1H), 3.85–3.88 (m, 1H), 3.60 (app t, <i>J</i> = 16.2 Hz, 1H), 3.50 (d, <i>J</i> = 14.4 Hz, 0.5H), 3.36 (d, <i>J</i> = 17.4 Hz, 0.5H), 2.89–3.09 (m, 2H), 2.80 (d, <i>J</i> = 16.2 Hz, 0.5H), 2.62–2.66 (m, 3H), 2.48 (dd, <i>J</i> = 9.6 Hz, <i>J</i> = 12.0 Hz, 0.5H), 2.25–2.27 (m, 0.5H), 2.08 (m, 0.5H), 1.93–1.95 (m, 1H), 1.75 (dd, <i>J</i> = 11.7 Hz, <i>J</i> = 23.1 Hz, 1H), 1.59–1.69 (m, 1H), 1.48 (s, 4.5H), 1.42 (s, 4.5H). HRMS (NSI) <i>m</i>/<i>z</i> = 643.32782 (M + H); calcd for C<sub>40</sub>H<sub>42</sub>N<sub>4</sub>O<sub>4</sub> + H = 643.32788. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 643.2 (M + H), <i>t</i> = 1.137 min; 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 643.2 (M + H), <i>t</i> = 3.216 min. The purified material (0.769 g, 1.20 mmol, 1.00 equiv) was added to a 50 mL flask with a stir bar. Diluted with MeOH (12.0 mL), added a small volume of DCM to coerce all of the starting material into solution, and the resulting solution was stirred vigorously at room temperature under Ar. Added a solution of hydrazine (1.29 mL, 9.57 mmol, 8.00 equiv) in water (24% by wt) in dropwise fashion via syringe pump at a rate of 4 mL/h, and the resulting reaction mixture was stirred vigorously at room temperature under Ar overnight. After 17 h, TLC indicated almost complete conversion of starting material to one major product spot. The reaction mixture was partitioned between DCM and 1 M aqueous sodium hydroxide. The resulting aqueous layer was extracted 3 times with DCM, and combined organic layers were dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to yield a yellow foam (617 mg). The crude material was purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (474 mg, 0.925 mmol, 77% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 10.0 Hz, 1H), 7.29–7.34 (m, 2H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.19–7.20 (m, 2H), 7.04–7.09 (m, 2H), 6.82–7.00 (m, 3H), 4.65–4.78 (m, 1H), 4.45–4.52 (m, 1H), 3.89–4.10 (m, 2H), 3.85 (s, 2H), 3.57–3.81 (m, 2H), 2.86–3.05 (m, 2H), 2.52–2.75 (m, 3H), 2.10–2.24 (m, 1H), 1.94–1.95 (m, 1H), 1.79 (app p, <i>J</i> = 11.0 Hz, 1H), 1.42–1.66 (m, 12H). HRMS (NSI) <i>m</i>/<i>z</i> = 513.32201 (M + H); calcd for C<sub>32</sub>H<sub>40</sub>N<sub>4</sub>O<sub>2</sub> + H = 513.32240. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 513.2 (M + H), 457.2 (M – tBu + H), 413.2 (M – BOC + H), 257.1 (M/2 + H), <i>t</i> = 0.854 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 513.2 (M + H), 457.2 (M – <i>t</i>Bu + H), 413.2 (M – BOC + H), 257.1 (M/2 + H), <i>t</i> = 4.136 min.</div></div><div id="sec4-9-16" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> (<i>S</i>)-<i>N</i>-(4-((((Tetrahydro-2<i>H</i>-pyran-4-yl)methyl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>42</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>41</b> and aldehyde <b>10c</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (110 mg, 0.180 mmol, 37% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 10.0 Hz, 1H), 7.29–7.32 (m, 2H), 7.24 (d, <i>J</i> = 7.0 Hz, 1H), 7.19 (br s, 2H), 7.04–7.07 (m, 2H), 6.81–7.00 (m, 3H), 4.65–4.78 (m, 1H), 4.45–4.50 (m, 1H), 3.89–4.09 (m, 4H), 3.57–3.81 (m, 4H), 3.40 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 11.8 Hz, 2H), 2.85–3.03 (m, 3H), 2.57–2.75 (m, 3H), 2.54 (d, <i>J</i> = 7.0 Hz, 2H), 2.10–2.24 (m, 1H), 1.93–1.95 (m, 1H), 1.71–1.78 (m, 2H), 1.66–1.67 (m, 3H), 1.46–1.58 (m, 10H), 1.26–1.36 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 611.39646 (M + H); calcd for C<sub>38</sub>H<sub>50</sub>N<sub>4</sub>O<sub>3</sub> + H = 611.39557. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 611.2 (M + H), 306.2 (M/2 + H), <i>t</i> = 1.126 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 611.2 (M + H), 306.2 (M/2 + H), <i>t</i> = 4.534 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (81.0 mg, 0.159 mmol, 88% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 4.0 Hz, 1H), 7.42 (d, <i>J</i> = 7.5 Hz, 2H), 7.33 (d, <i>J</i> = 7.5 Hz, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 2H), 7.04–7.08 (m, 3H), 6.95–7.01 (m, 2H), 4.38 (d, <i>J</i> = 14.0 Hz, 1H), 4.11 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 9.5 Hz, 1H), 3.90–3.98 (m, 4H), 3.76 (s, 2H), 3.67 (d, <i>J</i> = 15.0 Hz, 1H), 3.38 (dt, <i>J</i> = 1.3 Hz, <i>J</i> = 11.8 Hz, 2H), 2.90 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 13.3 Hz, 1H), 2.73–2.80 (m, 1H), 2.63–2.68 (m, 2H), 2.55 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.51 (d, <i>J</i> = 7.0 Hz, 2H), 2.35–2.48 (m, 2H), 2.12–2.16 (m, 1H), 1.91–1.99 (m, 3H), 1.66–1.76 (m, 2H), 1.62–1.65 (m, 2H), 1.25–1.33 (m, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.0, 146.9, 140.8, 139.0, 136.6, 135.7, 134.7, 134.2, 129.2, 128.5 (2C), 128.1 (2C), 126.5, 126.0, 125.5, 121.5, 68.0 (2C), 62.4, 59.4, 58.1, 55.7, 54.0, 52.1, 48.7, 35.6, 33.9, 31.5 (2C), 29.7, 29.6, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 511.34459 (M + H); calcd for C<sub>33</sub>H<sub>42</sub>N<sub>4</sub>O + H = 511.34314. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 511.2 (M + H), 256.2 (M/2 + H), <i>t</i> = 0.722 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 511.2 (M + H), 256.2 (M/2 + H), <i>t</i> = 3.070 min.</div></div><div id="sec4-9-17" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-<i>N</i>-(4-(((4,4-Difluorocyclohexyl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>43b</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>41</b> and ketone <b>12b</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (238 mg, 0.377 mmol, 84% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 9.5 Hz, 1H), 7.30–7.32 (m, 2H), 7.24 (d, <i>J</i> = 7.5 Hz, 1H), 7.19 (m, 2H), 7.04–7.07 (m, 2H), 6.82–7.00 (m, 3H), 4.65–4.77 (m, 1H), 4.45–4.52 (m, 1H), 3.90–4.08 (m, 2H), 3.59–3.82 (m, 4H), 2.87–3.03 (m, 2H), 2.53–2.75 (m, 4H), 2.10–2.24 (m, 3H), 1.90–1.94 (m, 3H), 1.71–1.87 (m, 4H), 1.64–1.66 (m, 1H), 1.46–1.60 (m, 12H). HRMS (NSI) <i>m</i>/<i>z</i> = 631.38184 (M + H); calcd for C<sub>38</sub>H<sub>48</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> + H = 631.38181. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 631.2 (M + H), 316.2 (M/2 + H), <i>t</i> = 1.620 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 631.2 (M + H), 316.2 (M/2 + H), <i>t</i> = 4.864 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (147 mg, 0.277 mmol, 73% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.51 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 5.0 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 2H), 7.33 (dt, <i>J</i> = 0.8 Hz, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 2H), 7.04–7.08 (m, 3H), 6.95–7.02 (m, 2H), 4.39 (d, <i>J</i> = 14.5 Hz, 1H), 4.10 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 10.3 Hz, 1H), 3.94 (dd, <i>J</i> = 14.8 Hz, <i>J</i> = 24.8 Hz, 2H), 3.78 (s, 2H), 3.68 (d, <i>J</i> = 15.0 Hz, 1H), 2.90 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.74–2.80 (m, 2H), 2.63–2.70 (m, 3H), 2.55 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.35–2.45 (m, 2H), 2.07–2.16 (m, 3H), 1.88–1.99 (m, 4H), 1.65–1.80 (m, 4H), 1.50–1.58 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 140.9, 138.9, 136.5, 135.7, 134.7, 134.2, 129.1, 128.6 (2C), 128.0 (2C), 126.5, 125.9, 125.5, 123.5 (t, <i>J</i> = 239.4 Hz), 121.5, 62.3, 59.4, 58.0, 53.2, 52.1, 51.2, 48.7, 33.9, 31.5 (t, <i>J</i> = 23.8 Hz, 2C), 29.6, 29.5, 28.8 (t, <i>J</i> = 4.4 Hz, 2C), 22.2. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>, TFA standard) δ −95.7 (app d, <i>J</i> = 236.9 Hz), −98.6 (app d, <i>J</i> = 229.4 Hz). HRMS (NSI) <i>m</i>/<i>z</i> = 531.32872 (M + H); calcd for C<sub>33</sub>H<sub>40</sub>F<sub>2</sub>N<sub>4</sub> + H = 531.32938. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 531.2 (M + H), 266.2 (M/2 + H), <i>t</i> = 1.124 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 531.2 (M + H), 266.2 (M/2 + H), <i>t</i> = 3.512 min.</div></div><div id="sec4-9-18" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> (<i>S</i>)-<i>N</i>-(4-(((Tetrahydro-2<i>H</i>-pyran-4-yl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>43c</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>41</b> and ketone <b>12c</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (220 mg, 0.369 mmol, 76% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 9.0 Hz, 1H), 7.29–7.32 (m, 2H), 7.24 (d, <i>J</i> = 7.5 Hz, 1H), 7.20 (br s, 2H), 7.04–7.07 (m, 2H), 6.83–7.00 (m, 3H), 4.66–4.77 (m, 1H), 4.45–4.52 (m, 1H), 3.90–4.08 (m, 4H), 3.59–3.85 (m, 4H), 3.41 (dt, <i>J</i> = 2.0 Hz, <i>J</i> = 11.8 Hz, 2H), 2.86–3.03 (m, 3H), 2.53–2.78 (m, 4H), 2.11–2.22 (m, 1H), 1.93 (m, 1H), 1.87 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 12.5 Hz, 2H), 1.78 (app p, <i>J</i> = 10.3 Hz, 1H), 1.64–1.65 (m, 1H), 1.43–1.58 (m, 12H). HRMS (NSI) <i>m</i>/<i>z</i> = 597.38109 (M + H); calcd for C<sub>37</sub>H<sub>48</sub>N<sub>4</sub>O<sub>3</sub> + H = 597.37992. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 6 min, <i>m</i>/<i>z</i> = 597.2 (M + H), 299.2 (M/2 + H), <i>t</i> = 0.906 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 597.2 (M + H), 299.2 (M/2 + H), <i>t</i> = 4.219 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (159 mg, 0.320 mmol, 87% yield). 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.51 (d, <i>J</i> = 3.5 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 2H), 7.33 (dd, <i>J</i> = 0.5 Hz, <i>J</i> = 7.5 Hz, 1H), 7.26 (d, <i>J</i> = 7.0 Hz, 2H), 7.04–7.07 (m, 3H), 6.95–7.01 (m, 2H), 4.39 (d, <i>J</i> = 14.0 Hz, 1H), 4.10 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 10.0 Hz, 1H), 3.90–3.98 (m, 4H), 3.81 (s, 2H), 3.68 (d, <i>J</i> = 15.0 Hz, 1H), 3.70 (dt, <i>J</i> = 2.0 Hz, <i>J</i> = 11.8 Hz, 2H), 2.90 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 8.3 Hz, 1H), 2.64–2.80 (m, 5H), 2.55 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.35–2.45 (m, 2H), 2.11–2.15 (m, 1H), 1.91–1.99 (m, 2H), 1.83–1.86 (m, 2H), 1.62–1.70 (m, 1H), 1.26–1.49 (m, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 140.7, 138.9, 136.5, 135.7, 134.7, 134.1, 129.1, 128.5 (2C), 128.0 (2C), 126.4, 125.9, 125.5, 121.4, 66.8 (2C), 62.2, 59.3, 58.0, 53.2, 52.1, 50.3, 48.7, 33.9, 33.8, 33.8, 29.6, 29.5, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 497.32792 (M + H); calcd for C<sub>32</sub>H<sub>40</sub>N<sub>4</sub>O + H = 497.32749. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 497.2(M + H), 249.2 (M/2 + H), <i>t</i> = 0.631 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 497.2 (M + H), 249.2 (M/2 + H), <i>t</i> = 2.688 min.</div></div><div id="sec4-9-19" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> (<i>S</i>)-<i>N</i>-(4-(((4,4-Dimethylcyclohexyl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>43g</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>41</b> and ketone <b>12g</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (166 mg, 0.267 mmol, 59% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.43 (d, <i>J</i> = 9.0 Hz, 1H), 7.23–7.31 (m, 3H), 7.19 (br s, 2H), 7.05–7.07 (m, 2H), 6.82–7.00 (m, 3H), 4.65–4.79 (m, 1H), 4.44–4.51 (m, 1H), 4.00–4.11 (m, 1H), 3.89–3.92 (m, 1H), 3.79 (s, 2H), 3.56–3.75 (m, 2H), 3.02–3.05 (m, 1H), 2.71–2.99 (m, 2H), 2.52–2.74 (m, 3H), 2.46 (m, 1H), 2.10–2.24 (m, 1H), 1.94–1.95 (m, 1H), 1.63–1.77 (m, 5H), 1.46–1.58 (m, 9H), 1.32–1.43 (m, 4H), 1.18–1.24 (m, 2H), 0.92 (s, 3H), 0.91 (s, 3H). HRMS (NSI) <i>m</i>/<i>z</i> = 623.43140 (M + H); calcd for C<sub>40</sub>H<sub>54</sub>N<sub>4</sub>O<sub>2</sub> + H = 623.43195. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 623.3 (M + H), 312.2 (M/2 + H), <i>t</i> = 2.592 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 623.2 (M + H), 312.2 (M/2 + H), <i>t</i> = 5.806 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a white foam (99.0 mg, 0.189 mmol, 71% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.51 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 5.0 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 2H), 7.33 (dt, <i>J</i> = 0.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 2H), 7.04–7.08 (m, 3H), 6.95–7.02 (m, 2H), 4.40 (d, <i>J</i> = 14.0 Hz, 1H), 4.10 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 10.0 Hz, 1H), 3.94 (dd, <i>J</i> = 14.3 Hz, <i>J</i> = 26.3 Hz, 2H), 3.79 (s, 2H), 3.69 (d, <i>J</i> = 15.0 Hz, 1H), 2.89 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 13.3 Hz, 1H), 2.63–2.79 (m, 4H), 2.55 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.35–2.47 (m, 3H), 2.10–2.15 (m, 1H), 1.90–1.99 (m, 2H), 1.70–1.75 (m, 2H), 1.61–1.69 (m, 1H), 1.37–1.40 (m, 2H), 1.27–1.34 (m, 3H), 1.19 (dt, <i>J</i> = 3.5 Hz, <i>J</i> = 12.8 Hz, 2H), 0.91 (s, 3H), 0.90 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.0, 146.9, 140.6, 139.4, 136.5, 135.8, 134.8, 134.2 129.2, 128.5 (2C), 128.1 (2C), 126.5, 125.9, 125.5, 121.5, 62.2, 59.4, 58.0, 56.5, 52.1, 51.1, 48.7, 37.9, 33.9, 32.3, 30.3, 29.8, 29.5, 29.4, 25.0, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 523.37923 (M + H); calcd for C<sub>35</sub>H<sub>46</sub>N<sub>4</sub> + H = 523.37952. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 523.2 (M + H), 262.2 (M/2 + H), <i>t</i> = 3.052 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 523.2 (M + H), 262.2 (M/2 + H), <i>t</i> = 4.873 min.</div></div><div id="sec4-9-20" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> (<i>S</i>)-<i>N</i>-(4-(((Pyridin-2-ylmethyl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>44a</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>41</b> and 2-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a yellow foam (181 mg, 0.300 mmol, 62% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.58 (d, <i>J</i> = 5.0 Hz, 1H), 8.43 (d, <i>J</i> = 10.0 Hz, 1H), 7.65 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.9 Hz, 1H), 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.29–7.31 (m, 2H), 7.25 (m, 3H), 7.17 (dd, <i>J</i> = 4.5 Hz, <i>J</i> = 7.5 Hz, 1H), 7.04–7.06 (m, 2H), 6.79–7.00 (m, 3H), 4.65–4.79 (m, 1H), 4.44–4.50 (m, 1H), 3.99–4.11 (m, 1H), 3.95 (s, 2H), 3.89–3.92 (m, 1H), 3.84 (app d, <i>J</i> = 4.0 Hz, 2H), 3.56–3.71 (m, 2H), 3.02–3.09 (m, 1H), 2.91–2.99 (m, 1H), 2.72–2.87 (m, 1H), 2.52–2.69 (m, 3H), 2.11–2.26 (m, 2H), 1.94–1.95 (m, 1H), 1.77–1.80 (m, 1H), 1.58–1.69 (m, 1H), 1.53 (s, 4.5H), 1.46 (s, 4.5H). HRMS (NSI) <i>m</i>/<i>z</i> = 604.36452 (M + H); calcd for C<sub>38</sub>H<sub>45</sub>N<sub>5</sub>O<sub>2</sub> + H = 604.36460. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 604.2 (M + H), 302.6 (M/2 + H), <i>t</i> = 0.535 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 604.2 (M + H), 302.7 (M/2 + H), <i>t</i> = 4.604 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a white foam (106 mg, 0.210 mmol, 70% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.56–8.57 (m, 1H), 8.51 (d, <i>J</i> = 4.5 Hz, 1H), 7.63 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.43 (d, <i>J</i> = 8.0 Hz, 2H), 7.29–7.34 (m, 4H), 7.15–7.17 (m, 1H), 7.02–7.07 (m, 3H), 6.94–7.01 (m, 2H), 4.42 (d, <i>J</i> = 14.0 Hz, 1H), 4.10 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 10.0 Hz, 1H), 3.94 (dd, <i>J</i> = 15.0 Hz, <i>J</i> = 17.5 Hz, 2H), 3.92 (s, 2H), 3.84 (s, 2H), 3.68 (d, <i>J</i> = 14.5 Hz, 1H), 2.73–2.91 (m, 3H), 2.63–2.71 (m, 2H), 2.55 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.35–2.44 (m, 2H), 2.11–2.15 (m, 2H), 1.91–1.98 (m, 2H), 1.62–1.71 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.9, 159.0, 149.4, 146.9, 140.8, 138.6, 136.5, 135.8, 134.8, 134.2, 129.1, 128.5 (2C), 128.3 (2C), 126.5, 125.9, 125.5, 122.4, 122.0, 121.4, 62.2, 59.4, 58.0, 54.6, 53.4, 52.1, 48.7, 33.9, 29.7, 29.5, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 504.31269 (M + H); calcd for C<sub>33</sub>H<sub>37</sub>N<sub>5</sub> + H = 504.31217. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 504.2 (M + H), 252.6 (M/2 + H), <i>t</i> = 0.852 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 504.2 (M + H), 252.6 (M/2 + H), <i>t</i> = 3.286 min.</div></div><div id="sec4-9-21" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> (<i>S</i>)-<i>N</i>-(4-(((Pyridin-3-ylmethyl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>44b</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>41</b> and 3-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (179 mg, 0.296 mmol, 61% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.59 (br s, 1H), 8.52 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 8.43 (d, <i>J</i> = 9.5 Hz, 1H), 7.72 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.30–7.32 (m, 2H), 7.27 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 7.5 Hz, 1H), 7.22–7.25 (m, 3H), 7.04–7.05 (m, 2H), 6.78–7.00 (m, 3H), 4.65–4.78 (m, 1H), 4.45–4.52 (m, 1H), 3.86–4.09 (m, 2H), 3.82 (s, 2H), 3.58–3.80 (m, 4H), 2.71–3.04 (m, 3H), 2.53–2.70 (m, 3H), 2.11–2.24 (m, 1H), 1.95 (m, 1H), 1.65–1.80 (m, 3H), 1.53 (s, 4.5H), 1.46 (s, 4.5H). HRMS (NSI) <i>m</i>/<i>z</i> = 604.36444 (M + H); calcd for C<sub>38</sub>H<sub>45</sub>N<sub>5</sub>O<sub>2</sub> + H = 604.36460. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 604.2 (M + H), 302.6 (M/2 + H), <i>t</i> = 0.592 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 604.2(M + H), 302.6 (M/2 + H), <i>t</i> = 4.309 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a white foam (137 mg, 0.272 mmol, 92% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.57 (m, 1H), 8.50–8.52 (m, 2H), 7.67–7.70 (m, 1H), 7.44 (d, <i>J</i> = 7.5 Hz, 2H), 7.33 (d, <i>J</i> = 7.5 Hz, 1H), 7.24–7.29 (m, 3H), 7.02–7.08 (m, 3H), 6.92–7.01 (m, 2H), 4.39 (d, <i>J</i> = 14.0 Hz, 1H), 4.10 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 10.3 Hz, 1H), 3.94 (dd, <i>J</i> = 14.8 Hz, <i>J</i> = 18.8 Hz, 2H), 3.80 (s, 2H), 3.79 (s, 2H), 3.67 (d, <i>J</i> = 15.0 Hz, 1H), 2.90 (dd, <i>J</i> = 2.5 Hz, <i>J</i> = 13.0 Hz, 1H), 2.74–2.80 (m, 2H), 2.63–2.67 (m, 2H), 2.55 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 16.0 Hz, 1H), 2.43 (dd, <i>J</i> = 10.5 Hz, <i>J</i> = 13.0 Hz, 1H), 2.37 (dd, <i>J</i> = 11.0 Hz, <i>J</i> = 16.0 Hz, 1H), 2.12–2.16 (m, 1H), 1.91–1.99 (m, 3H), 1.62–1.71 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 149.8, 148.5, 146.9, 141.0, 138.4, 136.5, 135.9, 135.8, 134.7, 134.2, 129.1, 128.6 (2C), 128.1 (2C), 126.5, 125.9, 125.5, 123.5, 121.5, 62.3, 59.4, 58.1, 53.1, 52.1, 50.4, 48.7, 33.9, 29.6, 29.5, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 504.31292 (M + H); calcd for C<sub>33</sub>H<sub>37</sub>N<sub>5</sub> + H = 504.31217. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 504.2 (M + H), 252.6 (M/2 + H), <i>t</i> = 0.663 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 504.2 (M + H), 252.6 (M/2 + H), <i>t</i> = 2.495 min.</div></div><div id="sec4-9-22" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> (<i>S</i>)-<i>N</i>-(4-(((Pyridin-4-ylmethyl)amino)methyl)benzyl)-<i>N</i>-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine (<b>44c</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>41</b> and 4-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a white foam (192 mg, 0.318 mmol, 65% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.56–8.57 (m, 2H), 8.44 (d, <i>J</i> = 10.0 Hz, 1H), 7.31–7.32 (m, 4H), 7.22–7.26 (m, 3H), 7.04–7.05 (m, 2H), 6.78–7.00 (m, 3H), 4.65–4.78 (m, 1H), 4.46–4.52 (m, 1H), 3.87–4.09 (m, 2H), 3.83 (s, 2H), 3.56–3.79 (4H), 2.72–3.03 (m, 3H), 2.53–2.70 (m, 3H), 2.12–2.25 (m, 1H), 1.94 (m, 1H), 1.65–1.81 (m, 3H), 1.53 (s, 4.5H), 1.46 (s, 4.5H). HRMS (NSI) <i>m</i>/<i>z</i> = 604.36456 (M + H); calcd for C<sub>38</sub>H<sub>45</sub>N<sub>5</sub>O<sub>2</sub> + H = 604.36460. LC–MS (ESI-API) 75–95% MeOH in H<sub>2</sub>O, 5 min, <i>m</i>/<i>z</i> = 604.2 (M + H), 302.8 (M/2 + H), <i>t</i> = 0.553 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 604.2 (M + H), 302.6 (M/2 + H), <i>t</i> = 4.253 min. Deprotection was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a white foam (132 mg, 0.262 mmol, 82% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.54–8.55 (m, 2H), 8.52 (d, <i>J</i> = 4.5 Hz, 1H), 8.45 (d, <i>J</i> = 8.0 Hz, 2H), 7.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.27–7.29 (m, 4H), 6.99–7.08 (m, 3H), 6.93–7.00 (m, 2H), 4.38 (d, <i>J</i> = 14.0 Hz, 1H), 4.11 (dd, <i>J</i> = 6.8 Hz, <i>J</i> = 9.8 Hz, 1H), 3.94 (app t, <i>J</i> = 15.8 Hz, 2H), 3.80 (s, 2H), 3.79 (s, 2H), 3.66 (d, <i>J</i> = 15.0 Hz, 1H), 2.90 (dd, <i>J</i> = 2.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.74–2.80 (m, 1H), 2.62–2.68 (m, 2H), 2.55 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 16.0 Hz, 1H), 2.43 (dd, <i>J</i> = 11.0 Hz, <i>J</i> = 12.5 Hz, 1H), 2.37 (dd, <i>J</i> = 11.3 Hz, <i>J</i> = 15.8 Hz, 1H), 2.13–2.17 (m, 1H), 1.92–1.99 (m, 3H), 1.64–1.71 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 149.9 (2C), 149.5, 146.9, 141.1, 138.3, 136.5, 135.7, 134.7, 134.2, 129.1, 128.6 (2C), 128.1 (2C), 126.5, 125.9, 125.5, 123.1 (2C), 121.5, 62.4, 59.4, 58.1, 53.1, 52.1, 51.8, 48.7, 33.9, 29.5, 29.5, 22.2. HRMS (NSI) <i>m</i>/<i>z</i> = 504.31252 (M + H); calcd for C<sub>33</sub>H<sub>37</sub>N<sub>5</sub> + H = 504.31217. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 504.2 (M + H), 252.6 (M/2 + H), <i>t</i> = 0.636 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 504.2 (M + H), 252.7 (M/2 + H), <i>t</i> = 2.506 min.</div></div><div id="sec4-9-23" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> (<i>E</i>)-<i>N</i>1-((Tetrahydro-2<i>H</i>-pyran-4-yl)methyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>45</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>23</b> and aldehyde <b>10c</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (120 mg, 0.214 mmol, 40% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J</i> = 14.0 Hz, 1H), 7.24 (d, <i>J</i> = 7.0 Hz, 1H), 7.05–7.10 (m, 2H), 6.97 (m, 3H), 5.58–5.70 (m, 2H), 4.45–4.69 (m, 2H), 4.04–4.09 (m, 1H), 3.95–3.97 (m, 3H), 3.35–3.41 (m, 3H), 3.09–3.19 (m, 3H), 2.91–3.00 (m, 2H), 2.65–2.71 (m, 1H), 2.49–2.61 (m, 3H) 2.46 (d, <i>J</i> = 6.5 Hz, 2H), 1.91–1.98 (m, 2H), 1.53–1.77 (m, 6H), 1.49 (s, 9H), 1.28 (ddd, <i>J</i> = 4.5 Hz, <i>J</i> = 12.3 Hz, <i>J</i> = 24.0 Hz, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 561.37977 (M + H); calcd for C<sub>34</sub>H<sub>48</sub>N<sub>4</sub>O<sub>3</sub> + H = 561.37992. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 561.2 (M + H), 281.2 (M/2 + H), <i>t</i> = 0.793 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 561.2 (M + H), 281.2 (M/2 + H), <i>t</i> = 3.987 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (74.0 mg, 0.161 mmol, 75% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.46 (dd, <i>J</i> = 1.3 Hz, <i>J</i> = 4.8 Hz, 1H), 7.32 (m, 1H), 7.07–7.09 (m, 2H), 7.02–7.06 (m, 2H), 6.97–7.01 (m, 1H), 5.69–5.78 (m, 2H), 4.10 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.8 Hz, 1H), 4.01 (d, <i>J</i> = 10.5 Hz, 1H), 3.94 (dt, <i>J</i> = 2.0 Hz, <i>J</i> = 11.5 Hz, 2H), 3.82 (d, <i>J</i> = 15.0 Hz, 1H), 3.63 (dd, <i>J</i> = 5.3 Hz, <i>J</i> = 14.3 Hz, 1H), 3.32–3.38 (m, 3H), 3.22 (d, <i>J</i> = 4.5 Hz, 2H), 2.87 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 13.0 Hz, 1H), 2.71–2.80 (m, 2H), 2.65–2.68 (m, 1H), 2.60 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.47 (d, <i>J</i> = 7.0 Hz, 2H), 2.37–2.44 (m, 3H), 2.05–2.09 (m, 1H), 1.94–2.01 (m, 1H), 1.87–1.93 (m, 1H), 1.63–1.74 (m, 2H), 1.58–1.61 (m, 2H), 1.22–1.30 (m, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.7, 146.9, 136.6, 135.7, 134.8, 134.0, 131.9, 130.3, 129.2, 126.5, 126.0, 125.6, 121.5, 68.0 (2C), 61.3, 57.2, 56.6, 55.7, 52.1, 51.7, 48.7, 35.5, 33.9, 31.4 (2C), 29.5, 28.1, 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 461.32697 (M + H); calcd for C<sub>29</sub>H<sub>40</sub>N<sub>4</sub>O + H = 461.32749. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 461.2 (M + H), 231.2 (M/2 + H), <i>t</i> = 0.535 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 461.2 (M + H), 231.2 (M/2 + H), <i>t</i> = 1.198 min.</div></div><div id="sec4-9-24" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> (<i>E</i>)-<i>N</i>1-(4,4-Difluorocyclohexyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>46b</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>23</b> and ketone <b>12b</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (143 mg, 0.246 mmol, 51% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.39 (d, <i>J</i> = 13.5 Hz, 1H), 7.25 (d, <i>J</i> = 7.0 Hz, 1H), 7.06–7.10 (m, 2H), 6.98 (m, 3H), 5.58–5.70 (m, 2H), 4.46–4.70 (m, 2H), 4.07 (app t, <i>J</i> = 15.5 Hz, 1H), 3.96 (br s, 1H), 3.36–3.37 (m, 1H), 3.17 (d, <i>J</i> = 5.5 Hz, 2H), 3.12 (dd, <i>J</i> = 5.8 Hz, <i>J</i> = 14.3 Hz, 1H), 2.91–3.00 (m, 2H), 2.51–2.71 (m, 5H), 2.06–2.13 (m, 2H), 1.86–1.99 (m, 4H), 1.67–1.80 (m, 4H), 1.57–1.64 (m, 1H), 1.42–1.53 (m, 11H). HRMS (NSI) <i>m</i>/<i>z</i> = 581.36530 (M + H); calcd for C<sub>34</sub>H<sub>46</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> + H = 581.36616. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 581.2 (M + H), 291.2 (M/2 + H), <i>t</i> = 1.106 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 581.2 (M + H), 291.1 (M/2 + H), <i>t</i> = 4.471 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (116 mg, 0.241 mmol, 98% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.46 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 4.5 Hz, 1H), 7.32 (dd, <i>J</i> = 0.5 Hz, <i>J</i> = 7.5 Hz, 1H), 7.06–7.10 (m, 2H), 2.99 (m, 3H), 5.68–5.78 (m, 2H), 4.10 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.8 Hz, 1H), 4.01 (d, <i>J</i> = 15.0 Hz, 1H), 3.82 (d, <i>J</i> = 15.0 Hz, 1H), 3.62 (dd, <i>J</i> = 6.0 Hz, <i>J</i> = 14.0 Hz, 1H), 3.33 (dd, <i>J</i> = 5.3 Hz, <i>J</i> = 14.3 Hz, 1H), 3.24 (d, <i>J</i> = 5.5 Hz, 2H), 2.87 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 13.0 Hz, 1H), 2.71–2.80 (m, 2H), 2.70 (m, 1H), 2.58–2.65 (m, 2H), 2.38–2.44 (m, 2H), 1.92–2.13 (m, 5H), 1.86–1.91 (m, 3H), 1.65–1.79 (m, 3H), 1.42–1.49 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.6, 146.9, 136.6, 135.6, 134.7, 134.0, 131.9, 130.3, 129.2, 126.5, 126.0, 125.6, 123.4 (t, <i>J</i> = 239.4 Hz), 121.5, 61.2, 57.2, 56.5, 53.5, 52.1, 48.9, 48.6, 33.9, 31.8 (t, <i>J</i> = 24.4 Hz, 2C), 29.5, 28.9 (t, <i>J</i> = 2.5 Hz), 28.9 (t, <i>J</i> = 3.8 Hz), 27.9, 22.0. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>, TFA standard) δ −96.8 (app d, <i>J</i> = 233.1 Hz), −101.1 (app d, <i>J</i> = 206.8 Hz). HRMS (NSI) <i>m</i>/<i>z</i> = 481.31303 (M + H); calcd for C<sub>29</sub>H<sub>38</sub>F<sub>2</sub>N<sub>4</sub> + H = 481.31373. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 481.2 (M + H), 241.2 (M/2 + H), <i>t</i> = 0.591 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 481.2 (M + H), 241.2 (M/2 + H), <i>t</i> = 2.382 min.</div></div><div id="sec4-9-25" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> (<i>E</i>)-<i>N</i>1-(Tetrahydro-2<i>H</i>-pyran-4-yl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>46c</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>23</b> and ketone <b>12c</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (160 mg, 0.160 mmol, 61% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.38 (d, <i>J</i> = 13.5 Hz, 1H), 7.24 (d, <i>J</i> = 5.5 Hz, 1H), 7.05–7.09 (m, 2H), 6.97 (m, 3H), 5.59–5.70 (m, 2H), 4.45–4.69 (m, 2H), 4.07 (app t, <i>J</i> = 14.5 Hz, 1H), 3.95–3.97 (m, 3H), 3.34–3.39 (m, 3H), 3.20 (d, <i>J</i> = 4.5 Hz, 2H), 3.11 (dd, <i>J</i> = 5.3 Hz, <i>J</i> = 14.3 Hz, 1H), 2.91–3.00 (m, 2H), 2.50–2.68 (m, 5H), 1.91–1.98 (m, 2H), 1.70–1.82 (m, 4H), 1.57–1.64 (m, 1H), 1.45–1.54 (m, 9H), 1.36–1.41 (m, 2H). HRMS (NSI) <i>m</i>/<i>z</i> = 547.36397 (M + H); calcd for C<sub>33</sub>H<sub>46</sub>N<sub>4</sub>O<sub>3</sub> + H = 547.36427. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 547.2 (M + H), 274.2 (M/2 + H), <i>t</i> = 0.859 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 547.2 (M + H), 274.2 (M/2 + H), <i>t</i> = 4.085 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (126 mg, 0.282 mmol, 96% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.46 (dd, <i>J</i> = 1.3 Hz, <i>J</i> = 4.8 Hz, 1H), 7.32 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.06–7.10 (m, 2H), 6.98–7.05 (m, 3H), 5.69–5.79 (m, 2H), 4.10 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.8 Hz, 1H), 4.01 (d, <i>J</i> = 15.0 Hz, 1H), 3.92–3.97 (m, 2H), 3.81 (d, <i>J</i> = 15.0 Hz, 1H), 3.63 (dd, <i>J</i> = 5.3 Hz, <i>J</i> = 14.3 Hz, 1H), 3.31–3.38 (m, 3H), 3.27 (d, <i>J</i> = 5.0 Hz, 2H), 2.88 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 13.0 Hz, 1H), 2.58–2.80 (m, 6H), 2.38–2.44 (m, 2H), 2.04–2.09 (m, 1H), 1.94–2.01 (m, 1H), 1.87–1.93 (m, 1H), 1.79–1.82 (m, 2H), 1.65–1.74 (m, 1H), 1.34–1.42 (m, 2H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.6, 146.8, 136.5, 135.6, 134.6, 133.9, 131.7, 130.3, 129.1, 126.4, 125.9, 125.5, 121.4, 66.9, 66.8, 61.0, 57.1, 56.4, 53.3, 52.0, 48.6, 48.0, 33.8, 33.7 (2C), 29.4, 27.9, 21.9. HRMS (NSI) <i>m</i>/<i>z</i> = 447.31120 (M + H); calcd for C<sub>28</sub>H<sub>38</sub>N<sub>4</sub>O + H = 447.31184. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 447.2 (M + H), 224.2 (M/2 + H), <i>t</i> = 0.523 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 447.2 (M + H), 224.2 (M/2 + H), <i>t</i> = 1.126 min.</div></div><div id="sec4-9-26" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (<i>E</i>)-<i>N</i>1-(4,4-Dimethylcyclohexyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>46g</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>23</b> and ketone <b>12g</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (173 mg, 0.302 mmol, 63% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 4.39 (d, <i>J</i> = 14.5 Hz, 1H), 7.24 (d, <i>J</i> = 7.5 Hz, 1H), 7.05–7.10 (m, 2H), 6.97 (m, 3H), 5.58–5.67 (m, 2H), 4.44–4.69 (m, 2H), 4.07 (app t, <i>J</i> = 16.5 Hz, 1H), 3.97 (app t, <i>J</i> = 7.0 Hz, 1H), 3.34–3.41 (m, 1H), 3.18 (d, <i>J</i> = 5.0 Hz, 2H), 3.11 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 14.0 Hz, 1H), 2.91–3.00 (m, 2H), 2.65–2.72 (m, 1H), 2.48–2.62 (m, 3H), 2.35–2.39 (m, 1H), 1.92–1.98 (m, 2H), 1.58–1.77 (m, 5H), 1.50 (s, 9H), 1.36–1.39 (m, 2H), 1.15–1.29 (m, 4H), 0.89 (s, 3H), 0.89 (s, 3H). HRMS (NSI) <i>m</i>/<i>z</i> = 573.41600 (M + H); calcd for C<sub>36</sub>H<sub>52</sub>N<sub>4</sub>O<sub>2</sub> + H = 573.41630. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 573.2 (M + H), 287.2 (M/2 + H), <i>t</i> = 2.102 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 574.2 (M + H), 287.2 (M/2 + H), <i>t</i> = 5.200 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (27.0 mg, 0.057 mmol, 19% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 4.5 Hz, 1H), 7.31 (d, <i>J</i> = 7.0 Hz, 1H), 7.06–7.09 (m, 2H), 6.98–7.05 (m, 3H), 5.69–5.77 (m, 2H), 4.10 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.8 Hz, 1H), 4.00 (d, <i>J</i> = 15.0 Hz, 1H), 3.81 (d, <i>J</i> = 15.0 Hz, 1H), 3.59–3.63 (m, 1H), 3.28–3.32 (m, 1H), 3.21–3.25 (m, 2H), 2.88 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.70–2.79 (m, 2H), 2.64–2.67 (m, 1H), 2.59 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 16.0 Hz, 1H), 2.36–2.44 (m, 5H), 2.04–2.09 (m, 1H), 1.94–2.01 (m, 1H), 1.87–1.92 (m, 1H), 1.66–1.74 (m, 3H), 1.33–1.38 (m, 2H), 1.21–1.29 (m, 3H), 1.12–1.19 (m, 1H), 0.88 (s, 3H), 0.87 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 147.0, 136.7, 135.8, 134.8, 134.1, 131.6, 130.8, 129.2, 126.6, 126.0, 125.6, 121.6, 61.2, 57.2, 56.6, 53.6, 52.2, 48.8, 48.7, 38.0, 38.0, 33.9, 32.4, 30.3, 29.6, 29.4 (2C), 28.1, 24.8, 22.1. HRMS (NSI) <i>m</i>/<i>z</i> = 473.36329 (M + H); calcd for C<sub>31</sub>H<sub>44</sub>N<sub>4</sub> + H = 473.36387. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 473.2 (M + H), 237.2 (M/2 + H), <i>t</i> = 2.547 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 473.2 (M + H), 237.2 (M/2 + H), <i>t</i> = 4.437 min.</div></div><div id="sec4-9-27" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (<i>E</i>)-<i>N</i>1-(Pyridin-2-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>47a</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>23</b> and 2-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a yellow foam (161 mg, 0.291 mmol, 54% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.56 (dd, <i>J</i> = 0.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.38 (d, <i>J</i> = 12.5 Hz, 1H), 7.64 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 7.6 Hz, 1H), 7.24–7.29 (m, 2H), 7.16 (dd, <i>J</i> = 5.3 Hz, <i>J</i> = 6.8 Hz, 1H), 7.04–7.07 (m, 2H), 6.97 (m, 3H), 5.61–5.71 (m, 2H), 4.45–4.69 (m, 2H), 4.07 (app t, <i>J</i> = 16.5 Hz, 1H), 3.98 (m, 1H), 3.86 (s, 2H), 3.32–3.40 (m, 1H), 3.18–3.25 (m, 2H), 3.11 (dd, <i>J</i> = 5.5 Hz, <i>J</i> = 14.5 Hz, 1H), 2.91–3.02 (m, 2H), 2.51–2.72 (m, 4H), 1.92–2.00 (m, 3H), 1.74 (dd, <i>J</i> = 10.0 Hz, <i>J</i> = 21.0 Hz, 1H), 1.57–1.65 (m 1H), 1.49 (s, 9H). HRMS (NSI) <i>m</i>/<i>z</i> = 554.34870 (M + H); calcd for C<sub>34</sub>H<sub>43</sub>N<sub>5</sub>O<sub>2</sub> + H = 554.34895. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 554.2 (M + H), 277.6 (M/2 + H), <i>t</i> = 1.029 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 554.2 (M + H), 277.6 (M/2 + H), <i>t</i> = 4.339 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a yellow oil (130 mg, 0.287 mmol, 99% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.53–8.54 (m, 1H), 8.45–8.46 (m, 1H), 7.58–7.62 (m, 1H), 7.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.25–7.27 (m, 1H), 7.13–7.15 (m, 1H), 7.05–7.09 (m, 2H), 7.01–7.05 (m, 2H), 6.98–6.99 (m, 1H), 5.73–5.81 (m, 2H), 4.10 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 9.5 Hz, 1H), 4.00 (d, <i>J</i> = 15.5 Hz, 1H), 3.88 (s, 2H), 3.83 (d, <i>J</i> = 15.0 Hz, 1H), 3.68 (dd, <i>J</i> = 2.8 Hz, <i>J</i> = 15.8 Hz, 1H), 3.33–3.36 (m, 1H), 3.28–3.29 (m, 2H), 2.86 (dd, <i>J</i> = 3.0 Hz, <i>J</i> = 13.0 Hz, 1H), 2.58–2.79 (m, 5H), 2.37–2.43 (m, 2H), 2.05–2.09 (m, 1H), 1.87–1.99 (m, 2H), 1.65–1.73 (m, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 159.7, 158.6, 149.3, 146.8, 136.5, 136.4, 135.7, 134.7, 133.9, 132.0, 130.1, 129.1, 126.4, 125.9, 125.4, 122.4, 121.9, 121.4, 61.1, 57.2, 56.4, 54.6, 52.0, 51.0, 48.6, 33.8, 29.4, 28.1, 21.9. HRMS (NSI) <i>m</i>/<i>z</i> = 454.29750 (M + H); calcd for C<sub>29</sub>H<sub>35</sub>N<sub>5</sub> + H = 454.29652. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 454.2 (M + H), 227.6 (M/2 + H), <i>t</i> = 0.551 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 454.2 (M + H), 227.8 (M/2 + H), <i>t</i> = 2.148 min.</div></div><div id="sec4-9-28" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> (<i>E</i>)-<i>N</i>1-(Pyridin-3-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>47b</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>23</b> and 3-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a yellow foam (188 mg, 0.340 mmol, 63% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.54 (d, <i>J</i> = 1.5 Hz, 1H), 8.51 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.39 (d, <i>J</i> = 15.5 Hz, 1H), 7.67 (m, 1H), 7.24–7.26 (m, 2H), 7.03–7.06 (m, 2H), 6.97 (m, 3H), 5.60–5.70 (m, 2H), 4.46–4.70 (m, 2H), 4.09 (app t, <i>J</i> = 16.0 Hz, 1H), 3.97 (dd, <i>J</i> = 6.0 Hz, <i>J</i> = 8.0 Hz, 1H), 3.75 (s, 2H), 3.31–3.38 (m, 1H), 3.18 (d, <i>J</i> = 5.5 Hz, 2H), 3.11 (dd, <i>J</i> = 5.8 Hz, <i>J</i> = 14.3 Hz, 1H), 2.92–3.01 (m, 2H), 2.52–2.72 (m, 4H), 1.92–2.00 (m, 2H), 1.74 (dd, <i>J</i> = 10.0 Hz, <i>J</i> = 21.0 Hz, 1H), 1.58–1.66 (m, 2H), 1.48 (s, 9H). HRMS (NSI) <i>m</i>/<i>z</i> = 554.34895 (M + H); calcd for C<sub>34</sub>H<sub>43</sub>N<sub>5</sub>O<sub>2</sub> + H = 554.34895. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 554.2 (M + H), 277.6 (M/2 + H), <i>t</i> = 0.932 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 554.2 (M + H), 277.6 (M/2 + H), <i>t</i> = 4.144 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a yellow oil (138 mg, 0.304 mmol, 90% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.53 (d, <i>J</i> = 2.0 Hz, 1H), 8.49 (dd, <i>J</i> = 1.8 Hz, <i>J</i> = 4.8 Hz, 1H), 8.46 (d, <i>J</i> = 5.0 Hz, 1H), 7.64–7.66 (m, 1H), 7.31 (d, <i>J</i> = 8.0 Hz, 1H), 7.22 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 7.8 Hz, 1H), 7.06–7.09 (m, 2H), 7.01–7.05 (m, 2H), 6.98–6.99 (m, 1H), 5.70–5.80 (m, 2H), 4.10 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.8 Hz, 1H), 4.00 (d, <i>J</i> = 15.0 Hz, 1H), 3.82 (d, <i>J</i> = 15.0 Hz, 1H), 3.78 (s, 2H), 3.63–3.68 (m, 1H), 3.34 (dd, <i>J</i> = 4.8 Hz, <i>J</i> = 13.8 Hz, 1H), 3.25 (d, <i>J</i> = 5.0 Hz, 2H), 2.87 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 13.5 Hz, 1H), 2.58–2.79 (m, 5H), 2.37–2.43 (m, 2H), 2.05–2.09 (m, 1H), 1.87–2.00 (m, 2H), 1.65–1.73 (m, 1H) 1.34 (br s, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.6, 149.7, 148.5, 146.8, 136.5, 135.9, 135.7, 135.6, 134.7, 134.0, 132.3, 129.8, 129.1, 126.4, 125.9, 125.5, 123.4, 121.5, 61.1, 57.2, 56.4, 52.0, 50.8, 50.6, 48.6, 33.8, 29.4, 28.1, 21.9. HRMS (NSI) <i>m</i>/<i>z</i> = 454.29690 (M + H); calcd for C<sub>29</sub>H<sub>35</sub>N<sub>5</sub> + H = 454.29652. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 454.2 (M + H), 227.6 (M/2 + H), <i>t</i> = 0.534 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 454.2 (M + H), 227.6 (M/2 + H), <i>t</i> = 1.015 min.</div></div><div id="sec4-9-29" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> (<i>E</i>)-<i>N</i>1-(Pyridin-4-ylmethyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)but-2-ene-1,4-diamine (<b>47c</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>23</b> and 4-pyridinecarboxaldehyde. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a yellow foam (175 mg, 0.316 mmol, 59% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.54 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 2H), 8.38 (d, <i>J</i> = 14.5 Hz, 1H), 7.25 (m, 3H), 7.04–7.06 (m, 2H), 6.97 (m, 3H), 5.61–5.71 (m, 2H), 4.47–4.70 (m, 2H), 4.09 (app t, <i>J</i> = 15.8 Hz, 1H), 3.96–3.97 (m, 1H), 3.76 (s, 2H), 3.31–3.37 (m, 1H), 3.10–3.17 (m, 3H), 2.91–3.01 (m, 2H), 2.53–2.68 (m, 4H), 1.91–2.00 (m, 2H), 1.71–1.77 (m, 2H), 1.53–1.65 (m, 1H), 1.48 (s, 9H). HRMS (NSI) <i>m</i>/<i>z</i> = 554.34869 (M + H); calcd for C<sub>34</sub>H<sub>43</sub>N<sub>5</sub>O<sub>2</sub> + H = 554.34895. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 554.2 (M + H), 277.6 (M/2 + H), <i>t</i> = 0.861 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 554.2 (M + H), 277.6 (M/2 + H), <i>t</i> = 3.979 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with 100:10:1 DCM/MeOH/NH<sub>4</sub>OH to yield a yellow oil (137 mg, 0.302 mmol, 96% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.50–8.51 (m, 2H), 8.45 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.31 (d, <i>J</i> = 7.5 Hz, 1H), 7.22–7.23 (m, 2H), 7.07–7.10 (m, 2H), 7.01–7.06 (m, 2H), 6.98–6.99 (m, 1H), 5.70–5.80 (m, 2H), 4.10 (dd, <i>J</i> = 6.5 Hz, <i>J</i> = 9.5 Hz, 1H), 4.00 (d, <i>J</i> = 15.5 Hz, 1H), 3.82 (d, <i>J</i> = 15.0 Hz, 1H), 3.78 (s, 2H), 3.64 (dd, <i>J</i> = 5.8 Hz, <i>J</i> = 14.3 Hz, 1H), 3.34 (dd, <i>J</i> = 5.0 Hz, <i>J</i> = 14.0 Hz, 1H), 3.25 (d, <i>J</i> = 5.5 Hz, 2H), 2.87 (dd, <i>J</i> = 3.5 Hz, <i>J</i> = 13.0 Hz, 1H), 2.58–2.80 (m, 5H), 2.37–2.43 (m, 2H), 2.04–2.09 (m, 1H), 1.87–2.00 (m, 2H), 1.65–1.73 (m, 1H), 1.40 (br s, 1H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.6, 149.8 (2C), 149.4, 146.9, 136.6, 135.7, 134.7, 134.0, 132.4, 129.7, 129.1, 126.4, 125.9, 125.5, 123.0 (2C), 121.5, 61.2, 57.2, 56.5, 52.1, 51.9, 50.9, 48.7, 33.9, 29.5, 28.1, 21.9. HRMS (NSI) <i>m</i>/<i>z</i> = 454.29778 (M + H); calcd for C<sub>29</sub>H<sub>35</sub>N<sub>5</sub> + H = 454.29652. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 454.2 (M + H), 227.6 (M/2 + H), <i>t</i> = 0.528 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 454.2 (M + H), 227.8 (M/2 + H), <i>t</i> = 0.834 min.</div></div><div id="sec4-9-30" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 2,2-Dimethyl-<i>N</i>1-((tetrahydro-2<i>H</i>-pyran-4-yl)methyl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>48</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol D using amine <b>33</b> and aldehyde <b>10c</b>. Purified via column chromatography (CombiFlash, 24 g column, 30 mL/min), eluting with the following gradient to yield a clear oil (216 mg, 0.366 mmol, 73% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.35 (br s, 1H), 7.25 (d, <i>J</i> = 7.5 Hz, 1H), 7.08–7.11 (m, 2H), 7.04–7.05 (m, 1H), 6.95–6.97 (m, 2H), 4.38–4.68 (m, 2H), 3.88–4.08 (m, 4H), 3.37 (dt, <i>J</i> = 1.8 Hz, <i>J</i> = 11.8 Hz, 2H), 2.91–3.07 (m, 2H), 2.70–2.72 (m, 1H), 2.44–2.64 (m, 7H), 2.22–2.26 (m, 2H), 1.94–1.96 (m, 2H), 1.74–1.79 (m, 1H), 1.60–1.66 (m, 4H), 1.50 (s, 9H), 1.21–1.43 (m, 4H) 0.81 (s, 6H). HRMS (NSI) <i>m</i>/<i>z</i> = 591.42700 (M + H); calcd for C<sub>36</sub>H<sub>54</sub>N<sub>4</sub>O<sub>3</sub> + H = 591.42687. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 591.3 (M + H), 296.2 (M/2 + H), <i>t</i> = 0.895 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 591.2 (M + H), 296.2 (M/2 + H), <i>t</i> = 4.240 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a clear oil (133 mg, 0.271 mmol, 74% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.31–7.33 (m, 1H), 7.06–7.10 (m, 2H), 7.02–7.05 (m, 2H), 6.99–7.02 (m, 1H), 4.02–4.09 (m, 2H), 3.88–3.93 (m, 3H), 3.33 (ddt, <i>J</i> = 2.2 Hz, <i>J</i> = 3.7 Hz, <i>J</i> = 11.8 Hz, 2H), 3.10 (dt, <i>J</i> = 4.5 Hz, <i>J</i> = 12.3 Hz, 1H), 2.94 (dd, <i>J</i> = 3.3 Hz, <i>J</i> = 13.3 Hz, 1H), 2.58–2.81 (m, 5H), 2.45 (d, <i>J</i> = 6.5 Hz, 2H), 2.34–2.42 (m, 2H), 2.31 (d, <i>J</i> = 5.0 Hz, 2H), 2.04–2.08 (m, 1H), 1.96–2.02 (m, 1H), 1.87–1.94 (m, 1H), 1.69–1.76 (m, 1H), 1.59–1.68 (m, 4H), 1.42 (dt, <i>J</i> = 5.0 Hz, <i>J</i> = 12.5 Hz, 1H), 1.24 (ddd, <i>J</i> = 4.5 Hz, <i>J</i> = 11.8 Hz, <i>J</i> = 24.8 Hz, 2H), 0.87 (s, 3H), 0.87 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.8, 136.5, 135.7, 134.8, 133.9, 129.1, 126.5, 125.9, 125.5, 121.4, 68.0 (2C), 61.5, 60.6, 57.8, 57.2, 52.3, 50.0, 54.8, 39.8, 35.2, 33.9, 33.6, 31.4, 31.4, 29.5, 29.0, 26.1, 26.0, 21.9. HRMS (NSI) <i>m</i>/<i>z</i> = 491.37384 (M + H); calcd for C<sub>31</sub>H<sub>46</sub>N<sub>4</sub>O + H = 491.37444. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 491.2 (M + H), 246.2 (M/2 + H), <i>t</i> = 0.597 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 491.2 (M + H), 246.2 (M/2 + H), <i>t</i> = 2.390 min.</div></div><div id="sec4-9-31" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>1-(4,4-Difluorocyclohexyl)-2,2-dimethyl-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>49b</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>33</b> and ketone <b>12b</b>. Purified via column chromatography (CombiFlash, 24 g column, 35 mL/min), eluting with the following gradient to yield a clear oil (146 mg, 0.239 mmol, 60% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.36 (br s, 1H), 7.25–7.27 (m, 1H), 7.06–7.12 (m, 3H), 6.97–6.98 (m, 2H), 4.39–4.69 (m, 2H), 3.92–4.10 (m, 2H), 2.91–3.08 (m, 2H), 2.49–2.70 (m, 7H), 2.26 (m, 2H), 2.07–2.10 (m, 2H), 1.96 (br s, 2H), 1.58–1.79 (m, 6H), 1.42–1.54 (m, 12H), 1.25–1.30 (m, 2H), 0.81 (s, 6H). HRMS (NSI) <i>m</i>/<i>z</i> = 611.41292 (M + H); calcd for C<sub>36</sub>H<sub>52</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub> + H = 611.41311. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 612.2 (M + H), 306.2 (M/2 + H), <i>t</i> = 1.405 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 611.2 (M + H), 306.2 (M/2 + H), <i>t</i> = 4.764 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a slightly yellow foam (117 mg, 0.229 mmol, 96% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 4.5 Hz, 1H), 7.33 (d, <i>J</i> = 7.5 Hz, 1H), 7.07–7.11 (m, 2H), 6.99–7.06 (m, 3H), 4.03–4.09 (m, 2H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 2.94–3.02 (m, 2H), 2.72–2.81 (m, 2H), 2.69 (app t, <i>J</i> = 3.5 Hz, 1H), 2.60–2.66 (m, 3H), 2.50–2.54 (m, 1H), 2.39–2.45 (m, 1H), 2.27–2.37 (m, 3H), 1.96–2.10 (m, 5H), 1.87–1.94 (m, 1H), 1.78–1.83 (m, 2H), 1.68–1.77 (m, 3H), 1.61 (dt, <i>J</i> = 4.5 Hz, <i>J</i> = 12.5 Hz, 1H), 1.38–1.49 (m, 3H), 0.87 (s, 3H), 0.86 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.9, 136.6, 135.7, 134.8, 134.1, 129.2, 126.6, 126.0, 125.6, 123.7 (t, <i>J</i> = 246.3 Hz), 121.5, 61.6, 57.9, 57.9, 54.5, 52.4, 49.9, 48.8, 39.7, 33.9, 33.5, 31.6 (t, <i>J</i> = 23.8 Hz), 31.6 (t, <i>J</i> = 23.1 Hz), 29.5, 28.9–29.0 (m, 3C), 26.1, 26.0, 22.0. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>, TFA standard) δ −96.0 (app d, <i>J</i> = 236.9 Hz), −97.9 (app d, <i>J</i> = 218.1 Hz). HRMS (NSI) <i>m</i>/<i>z</i> = 511.36172 (M + H); calcd for C<sub>31</sub>H<sub>44</sub>F<sub>2</sub>N<sub>4</sub> + H = 511.36068. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 511.2 (M + H), 256.2 (M/2 + H), <i>t</i> = 0.709 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 511.2 (M + H), 256.2 (M/2 + H), <i>t</i> = 2.970 min.</div></div><div id="sec4-9-32" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2,2-Dimethyl-<i>N</i>1-(tetrahydro-2<i>H</i>-pyran-4-yl)-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>49c</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>23</b> and ketone <b>12c</b>. Purified via column chromatography (CombiFlash, 24 g column, 35 mL/min), eluting with the following gradient to yield a clear oil (125 mg, 0.217 mmol, 54% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.36 (br s, 1H), 7.25–7.27 (m, 1H), 7.06–7.12 (m, 3H), 6.96–7.00 (m, 2H), 4.39–4.68 (m, 2H), 3.94–4.09 (4H), 3.38 (app t, <i>J</i> = 11.5 Hz, 2H), 2.91–3.08 (m, 2H), 2.70–2.72 (m, 1H), 2.48–2.64 (m, 6H), 2.29 (m, 2H), 1.96 (m, 2H), 1.77 (m, 3H), 1.63–1.67 (m, 1H), 1.50 (s, 9H), 1.26–1.46 (m, 5H), 0.82 (s, 6H). HRMS (NSI) <i>m</i>/<i>z</i> = 577.41135 (M + H); calcd for C<sub>35</sub>H<sub>52</sub>N<sub>4</sub>O<sub>3</sub> + H = 577.41122. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 577.3 (M + H), 289.2 (M/2 + H), <i>t</i> = 1.049 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 577.3 (M + H), 289.2 (M/2 + H), <i>t</i> = 4.382 min. Deprotection was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a slightly yellow foam (100 mg, 0.210 mmol, 97% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.0 Hz, <i>J</i> = 4.5 Hz, 1H), 7.33 (dd, <i>J</i> = 0.5 Hz, <i>J</i> = 7.5 Hz, 1H), 7.07–7.09 (2H), 6.99–7.06 (m, 3H), 4.08 (dd, <i>J</i> = 6.3 Hz, <i>J</i> = 9.8 Hz, 1H), 4.04 (d, <i>J</i> = 15.0 Hz, 1H), 3.93 (dt, <i>J</i> = 3.5 Hz, <i>J</i> = 11.5 Hz, 2H), 3.89 (d, <i>J</i> = 15.0 Hz, 1H), 3.36 (tt, <i>J</i> = 2.0 Hz, <i>J</i> = 11.5 Hz, 2H), 2.95–3.06 (m, 2H), 2.71–2.82 (m, 2H), 2.69 (app t, <i>J</i> = 3.8 Hz, 1H), 2.49–2.66 (m, 4H), 2.39–2.47 (m, 1H), 2.32–2.38 (m, 3H), 2.04–2.09 (m, 1H), 1.96–2.02 (m, 1H), 1.87–1.95 (m, 1H), 1.67–1.79 (m, 3H), 1.62 (dt, <i>J</i> = 4.5 Hz, <i>J</i> = 12.5 Hz, 1H), 1.42 (dt, <i>J</i> = 5.0 Hz, <i>J</i> = 12.0 Hz, 1H), 1.30–1.38 (m, 2H), 0.87 (s, 3H), 0.86 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.8, 146.9, 136.6, 135.7, 134.8, 134.0, 129.2, 126.6, 126.0, 125.6, 121.5, 67.0 (2C), 61.6, 57.9, 57.0, 54.8, 52.4, 49.9, 48.8, 39.6, 34.0, 34.0, 33.9, 33.4, 29.6, 28.8, 26.1, 26.0, 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 477.35898 (M + H); calcd for C<sub>30</sub>H<sub>44</sub>N<sub>4</sub>O + H = 477.35879. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 477.2 (M + H), 239.2 (M/2 + H), <i>t</i> = 0.558 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 477.2 (M + H), 239.2 (M/2 + H), <i>t</i> = 2.310 min.</div></div><div id="sec4-9-33" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>1-(4,4-Dimethylcyclohexyl)-2,2-dimethyl-<i>N</i>4-(((<i>R</i>)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-<i>N</i>4-((<i>S</i>)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine (<b>49g</b>)</h4><div class="NLM_p last">Reductive amination was carried out according to general reductive amination protocol E using amine <b>23</b> and ketone <b>12g</b>. Purified via column chromatography (CombiFlash, 24 g column, 35 mL/min), eluting with the following gradient to yield a clear oil (133 mg, 0.221 mmol, 55% yield): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% DCM/MeOH/NH<sub>4</sub>OH in DCM. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.35 (br s, 1H), 7.25–7.27 (m, 1H), 7.06–7.11 (m, 3H), 6.95–6.98 (m, 2H), 4.38–4.68 (m, 2H), 3.90–4.09 (m, 2H), 2.92–3.09 (m, 2H), 2.71–2.73 (m, 1H), 2.57–2.64 (m, 3H), 2.46–2.50 (m, 2H), 2.22–2.28 (m, 3H), 1.95–1.96 (m, 2H), 1.75–1.79 (m, 1H), 1.63–1.65 (m, 3H), 1.50 (s, 9H), 1.36–1.46 (m, 3H), 1.15–1.33 (m, 6H), 0.90 (s, 3H), 0.90 (s, 3H), 0.78 (s, 6H). HRMS (NSI) <i>m</i>/<i>z</i> = 603.46280 (M + H); calcd for C<sub>38</sub>H<sub>58</sub>N<sub>4</sub>O<sub>2</sub> + H = 603.46325. LC–MS (ESI-API) 50–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 604.4 (M + H), 302.2 (M/2 + H), <i>t</i> = 2.457 min; 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 604.4 (M + H), 302.2 (M/2 + H), <i>t</i> = 5.593 min. BOC group removal was carried out according to the general deprotection protocol. Purified via column chromatography (CombiFlash, 12 g column, 25 mL/min), eluting with the following gradient to yield a slightly yellow foam (109 mg, 0.217 mmol, 98% yield, 90–95% purity): 0–3 min, 0% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 3–18 min, 0–100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH in DCM; 18–30 min, 100% 100:10:1 DCM/MeOH/NH<sub>4</sub>OH. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.45 (dd, <i>J</i> = 1.5 Hz, <i>J</i> = 4.5 Hz, 1H), 7.30–7.33 (m, 1H), 7.07–7.10 (m, 2H), 7.00–7.07 (m, 3H), 4.09 (dd, <i>J</i> = 6.0 Hz, <i>J</i> = 9.5 Hz, 1H), 4.04 (d, <i>J</i> = 15.0 Hz, 1H), 3.90 (d, <i>J</i> = 15.0 Hz, 1H), 2.94–3.02 (m, 3H), 2.73–2.81 (m, 2H), 2.69 (app t, <i>J</i> = 3.5 Hz, 1H), 2.59–2.66 (m, 3H), 2.32–2.47 (m, 4H), 2.21–2.31 (m, 1H), 2.04–2.09 (m, 1H), 1.96–2.02 (m, 1H), 1.87–1.95 (m, 1H), 1.68–1.76 (m, 1H), 1.58–1.66 (m, 3H), 1.39–1.45 (m, 1H), 1.35 (d, <i>J</i> = 12.5 Hz, 2H), 1.12–1.27 (m, 4H), 0.88 (s, 3H), 0.87 (s, 3H), 0.87 (s, 3H), 0.86 (s, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.9, 146.8, 136.5, 135.8, 134.9, 134.0, 129.2, 126.5, 125.9, 125.5, 121.4, 61.5, 58.1, 57.9, 57.8, 52.4, 49.8, 48.8, 39.7, 38.0, 33.9, 33.4 (2C), 32.3, 30.2, 29.5 (2C), 28.9, 26.1, 26.1, 25.0, 22.0. HRMS (NSI) <i>m</i>/<i>z</i> = 503.41093 (M + H); calcd for C<sub>33</sub>H<sub>50</sub>N<sub>4</sub> + H = 503.41082. LC–MS (ESI-API) 25–95% MeOH in H<sub>2</sub>O, 8 min, <i>m</i>/<i>z</i> = 503.3 (M + H), 252.2 (M/2 + H), <i>t</i> = 2.503 min; 10–95% MeOH in H<sub>2</sub>O, 10 min, <i>m</i>/<i>z</i> = 503.3 (M + H), 252.2 (M/2 + H), <i>t</i> = 4.340 min.</div></div></div><div id="sec4-10-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Biological Methods. CXCR4 and mAChR Calcium Flux Assays</h3><div class="NLM_p last">Exemplary compounds were tested for their ability to induce or inhibit Ca<sup>2+</sup> flux in CCRF-CEM cells. The experimental procedures, which follow, have been carried out with all compounds. Human T lymphoblast cells (CCRF-CEM) expressing endogenous CXCR4 and mAChR were grown in suspension culture and plated in clear bottom 384-well microplates (Greiner Bio-One catalog no. 789146) in assay buffer [Hanks’ buffered saline solution (Gibco catalog no. 14025-092) supplemented with 20 mM HEPES (Gibco catalog no. 15630-080) and 0.1% fatty-acid free BSA (Sigma catalog no. A9205)] at 40 000 cells per well. The cells were loaded with equal volume of Ca<sup>2+</sup> indicator dye (AAT Bioquest Inc., catalog no. 34601) for 30 min at 37 °C. The cells were then equilibrated to room temperature for 15 min before assay. Test compounds solubilized and serially diluted in DMSO were transferred to 384-well plates (Matrix catalog no. 4307). The serially diluted compounds were diluted to working concentrations with the same assay buffer to 0.5% DMSO. They were added to the cells by FDSS6000 (Hamamatsu) at final concentrations ranging from 25 000 nM to 0.423 nM. Activity of the compounds to induce Ca<sup>2+</sup> flux was monitored by FDSS in the “agonist mode” for 90 s. For “antagonist mode” assessment, the cells were subsequently incubated for 25 min at rt. SDF-1α (R&D System catalog no. 350-NS/CF) or acetylcholine was then added at a final concentration of 5 nM and 2000 nM, respectively, to stimulate the cells. Inhibition of SDF-1α and acetylcholine-induced Ca<sup>2+</sup> flux was monitored by FDSS6000 for 90 s. Activation data for test compounds over a range of concentrations were plotted as percentage activation of the standard agonist (100% = maximum response triggered by a saturating concentration of SDF-1α, i.e., 160 nM). After correcting for background, EC<sub>50</sub> values were determined. The EC<sub>50</sub> is defined as the concentration of test compound that produces 50% of the maximal response, and EC<sub>50</sub> values were quantified using the four-parameter logistic equation to fit the data. Inhibition data for test compounds over a range of concentrations were plotted as percentage inhibition of the standard agonist activity. The IC<sub>50</sub> is defined as the concentration of test compound that inhibits 50% of the maximal response, and IC<sub>50</sub> values were quantified using the four-parameter logistic equation to fit the data. None of the compounds tested demonstrated agonist activity in the Ca<sup>2+</sup> flux assay (EC<sub>50</sub> > 30 μM). In contrast, compounds demonstrated a range of potencies for inhibition of SDF-1α-induced Ca<sup>2+</sup> flux.</div></div><div id="sec4-10-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> PAMPA Assays</h3><div class="NLM_p last">Test compounds and controls were utilized as 10 mM stocks in 100% DMSO. Compounds were diluted 1:100 in pH 7.4 or pH 5.5 donor well buffer (pION catalog no. 110151) providing a 100 μM assay solution in 1% DMSO. Compound diluted in donor well buffer was transferred to a Whatman Unifilter plate and filtered prior to dispensing 200 μL into the donor well of the assay plate (pION catalog no. 110163). The PAMPA membrane was formed by pipetting 4 μL of the lipid solution (pION catalog no. 110169) onto the filter plate (VWR catalog no. 13503). The membrane was then covered with 200 μL of acceptor well buffer at pH 7.4 (pION catalog no. 110139). The PAMPA assay plate (donor side and acceptor side) was combined and allowed to incubate at rt for 4 h. The plate was then disassembled, and spectrophotometer plates (VWR catalog no. 655801) were filled (150 μL/well). The donor, acceptor, reference, and blank plates were read by the SpectraMax UV plate reader. Data were captured by the pION software which analyzed the spectra and generated Pc values.</div></div><div id="sec4-10-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> CYP450 Assays</h3><div class="NLM_p last">The CYP450 2D6 inhibition assay utilized microsomes from insect cells expressing human recombinant CYP450 2D6 enzyme, as well as the fluorogenic probe (AMMC, 3-[2-(<i>N</i>,<i>N</i>-diethyl-<i>N</i>-methylamino)ethyl]-7-methoxy-4-methylcoumarin) that produces fluorescent metabolite; both reagents were obtained from Thermo Fisher Scientific/Discovery Labware (Woburn, MA). Assays were performed in 1536-well microplates in a total volume of 5 μL. Automated liquid handling equipment (Thermo Multidrop Combi, LabCyte ECHO 550) was used in all steps of compound preparation and for assay reagent additions. Each compound was tested in duplicate at seven concentrations ranging from 1 nM to 20 μM; the final concentration of DMSO in reactions was 0.2%. Positive controls were included in each experiment/run. Test compounds (10 nL/well) were first preincubated at 37 °C for 30 min with 2.5 μL of prewarmed 2-fold-concentrated mixture of AMMC fluorogenic substrate (3 μM) and 12.5 nM rCYP450 2D6 enzyme in 100 mM potassium phosphate assay buffer, pH 7.4. At the end of preincubation, the reactions were initiated by the addition of 2.5 μL of prewarmed 2-fold-concentrated NADPH-regenerating system (16.2 nM NADP) in the same assay buffer. Assay plates were then incubated at 37 °C for 45 min. Following incubation, reactions were terminated by the addition of 3 μL of quench buffer (80% acetonitrile, 20% 0.5 M Tris-base). Fluorescence intensity was measured using the Envision fluorescence plate reader (PerkinElmer) at excitation and emission wavelengths of 405 and 460 nm, respectively, using a 430 nm cutoff filter. The end-point fluorescence readout was normalized to the fluorescence intensity of the reaction performed in the absence of the test substance (totals, 0% inhibition) and the mixture of reaction components in the presence of “inhibitor cocktail” (background, 100% inhibition). The IC<sub>50</sub> value for each compound was derived from the fitted 20-point curve using a four-parameter logistic regression model.</div></div><div id="sec4-10-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Metabolic Stability Assays</h3><div class="NLM_p last">The metabolic stability of each compound was assessed according to previously reported methods.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01420">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01420" class="ext-link">10.1021/acs.jmedchem.7b01420</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic methods used for the preparation of common intermediate <b>6</b>, including relevant compound characterization and X-ray crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_001.pdf">jm7b01420_si_001.pdf (1.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_002.csv">jm7b01420_si_002.csv (8.05 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01420" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis C. Liotta</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7736-7113" title="Orcid link">http://orcid.org/0000-0002-7736-7113</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e88c8481879c9c89a88d85879a91c68d8c9d"><span class="__cf_email__" data-cfemail="3a5e5653554e4e5b7a5f57554843145f5e4f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric J. Miller</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3659-0105" title="Orcid link">http://orcid.org/0000-0003-3659-0105</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edgars Jecs</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valarie M. Truax</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brooke M. Katzman</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yesim A. Tahirovic</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Wilson</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8344-5325" title="Orcid link">http://orcid.org/0000-0002-8344-5325</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katie M. Kuo</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle B. Kim</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huy H. Nguyen</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manohar T. Saindane</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huanyu Zhao</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tao Wang</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research & Development, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chi S. Sum</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research & Development, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary E. Cvijic</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research & Development, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gretchen M. Schroeder</span> - <span class="hlFld-Affiliation affiliation">Bristol-Myers
Squibb Research & Development, Princeton, New Jersey 08543, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence J. Wilson</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemistry, Emory University, 1515 Dickey Drive, Atlanta, Georgia 30322, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): D.C.L., L.J.W., E.J.M., E.J., H.H.N., Y.A.T., R.J.W., V.M.T., and M.B.K. are co-inventors on Emory-owned Intellectual Property that includes CXCR4 antagonists.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. John Bacsa, the Emory X-ray Crystallography Facility, and Thomas Pickel for X-ray structural analysis, as well as Dr. Fred Strobel, the Emory Mass Spectrometry Center, and Samantha Summer for high resolution mass spectrometry analysis. D.C.L. is the principle investigator on a research grant from Bristol-Myers Squibb Research & Development to Emory University. X-ray crystallographic studies were performed using a Rigaku SYNERGY diffractometer, which is supported by the National Science Foundation under Grant CHE-1626172.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i91" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i91"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i92" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i92"> Abbreviations Used</h2><tr><td class="NLM_term">CXCR4</td><td class="NLM_def"><p class="first last">CXC chemokine receptor 4</p></td></tr><tr><td class="NLM_term">CXCL12</td><td class="NLM_def"><p class="first last">CXC chemokine ligand 12</p></td></tr><tr><td class="NLM_term">SDF-1</td><td class="NLM_def"><p class="first last">stromal cell-derived factor 1</p></td></tr><tr><td class="NLM_term">AC</td><td class="NLM_def"><p class="first last">adenylyl cyclase</p></td></tr><tr><td class="NLM_term">PLC</td><td class="NLM_def"><p class="first last">phospholipase C</p></td></tr><tr><td class="NLM_term">HSC</td><td class="NLM_def"><p class="first last">hematopoietic stem cell</p></td></tr><tr><td class="NLM_term">FoxP3</td><td class="NLM_def"><p class="first last">forkhead box 3</p></td></tr><tr><td class="NLM_term">CD8</td><td class="NLM_def"><p class="first last">cluster of differentiation 8</p></td></tr><tr><td class="NLM_term">HCC</td><td class="NLM_def"><p class="first last">hepatocellular carcinoma</p></td></tr><tr><td class="NLM_term">PD-1</td><td class="NLM_def"><p class="first last">programmed cell death protein 1</p></td></tr><tr><td class="NLM_term">PD-L1</td><td class="NLM_def"><p class="first last">programmed death ligand 1</p></td></tr><tr><td class="NLM_term">STAB</td><td class="NLM_def"><p class="first last">sodium triacetoxyborohydride</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">mAChR</td><td class="NLM_def"><p class="first last">muscarinic acetylcholine receptor</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–tandem mass spectrometry.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 59 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Le, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iribarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. M.</span><span> </span><span class="NLM_article-title">Chemokines and Chemokine Receptors: Their Manifold Roles in Homeostasis and Disease</span> <span class="citation_source-journal">Cell. Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=16212895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvF2rs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=95-104&issue=2&author=Y.+Leauthor=Y.+Zhouauthor=P.+Iribarrenauthor=J.+M.+Wang&title=Chemokines+and+Chemokine+Receptors%3A+Their+Manifold+Roles+in+Homeostasis+and+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines and chemokine receptors: their manifold roles in homeostasis and disease</span></div><div class="casAuthors">Le, Yingying; Zhou, Ye; Iribarren, Pablo; Wang, Ji Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Chinese Society of Immunology</span>)
        </div><div class="casAbstract">A review.  Chemokines are a superfamily of small proteins that bind to G protein-coupled receptors on target cells and were originally discovered as mediators of directional migration of immune cells to sites of inflammation and injury.  In recent years, it has become clear that the function of chemokines extends well beyond the role in leukocyte chemotaxis.  They participate in organ development, angiogenesis/angiostasis, leukocyte trafficking and homing, tumorigenesis and metastasis, as well as in immune responses to microbial infection.  Therefore, chemokines and their receptors are important targets for modulation of host responses in pathophysiol. conditions and for therapeutic intervention of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg9DAAHw8Vl7Vg90H21EOLACvtfcHk0lgSLLNLSF76RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvF2rs7c%253D&md5=0361182e3797399ae6b2ea4a23627f5b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DIribarren%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DChemokines%2520and%2520Chemokine%2520Receptors%253A%2520Their%2520Manifold%2520Roles%2520in%2520Homeostasis%2520and%2520Disease%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2004%26volume%3D1%26issue%3D2%26spage%3D95%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Balkwill, F.</span><span> </span><span class="NLM_article-title">Cancer and the Chemokine Network</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span><span class="refDoi"> DOI: 10.1038/nrc1388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fnrc1388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=15229479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=540-550&issue=7&author=F.+Balkwill&title=Cancer+and+the+Chemokine+Network&doi=10.1038%2Fnrc1388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer and the chemokine network</span></div><div class="casAuthors">Balkwill, Fran</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">540-550</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A complex network of chemokines and their receptors influences the development of primary tumors and metastases.  New information about the biol. role of chemokines in these processes is providing insights into host-tumor interactions, such as the role of the leukocyte infiltrate, and into the mechanisms that det. the metastatic potential and site-specific spread of cancer cells.  Chemokine-receptor antagonists are showing promise in animal models of inflammation and autoimmune disease.  Could manipulating the local chemokine network have therapeutic benefits in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPYhFsIM97vbVg90H21EOLACvtfcHk0lg-qfrpV1FRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D&md5=a827ffe8e02074fed068557c4c8dec11</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc1388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1388%26sid%3Dliteratum%253Aachs%26aulast%3DBalkwill%26aufirst%3DF.%26atitle%3DCancer%2520and%2520the%2520Chemokine%2520Network%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26issue%3D7%26spage%3D540%26epage%3D550%26doi%3D10.1038%2Fnrc1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">The Structure and Function of G Protein-Coupled Receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span><span class="refDoi"> DOI: 10.1038/nature08144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fnature08144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19458711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFKmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=356-363&author=D.+M.+Rosenbaumauthor=S.+G.+F.+Rasmussenauthor=B.+K.+Kobilka&title=The+Structure+and+Function+of+G+Protein-Coupled+Receptors&doi=10.1038%2Fnature08144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The structure and function of G-protein-coupled receptors</span></div><div class="casAuthors">Rosenbaum, Daniel M.; Rasmussen, Soren G. F.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7245</span>),
    <span class="NLM_cas:pages">356-363</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) mediate most of the physiol. responses to hormones, neurotransmitters and environmental stimulants, and so have great potential as therapeutic targets for a broad spectrum of diseases.  They are also fascinating mols. from the perspective of membrane protein structure and biol.  Great progress has been made over the past 3 decades in understanding diverse GPCRs, from pharmacol. to functional characterization in vivo.  Recent high-resoln. structural studies have provided insights into the mol. mechanisms of GPCR activation and constitutive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyI06taQNjw7Vg90H21EOLACvtfcHk0lg-qfrpV1FRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFKmsLg%253D&md5=4d0271a5aacc58c4d255ddb7531ca8ed</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature08144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08144%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%2BF.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Structure%2520and%2520Function%2520of%2520G%2520Protein-Coupled%2520Receptors%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D356%26epage%3D363%26doi%3D10.1038%2Fnature08144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Giannone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malpeli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramarli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartoris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsurró, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krampera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tridente, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombatti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innamorati, G.</span><span> </span><span class="NLM_article-title">The Puzzling Uniqueness of the Heterotrimeric G<sub>15</sub> Protein and Its Potential Beyond Hematopoiesis</span> <span class="citation_source-journal">J. Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1677/JME-09-0134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1677%2FJME-09-0134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=20150327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=259-269&author=F.+Giannoneauthor=G.+Malpeliauthor=V.+Lisiauthor=S.+Grassoauthor=P.+Shuklaauthor=D.+Ramarliauthor=S.+Sartorisauthor=V.+Monsurr%C3%B3author=M.+Kramperaauthor=E.+Amatoauthor=G.+Tridenteauthor=M.+Colombattiauthor=M.+Parentiauthor=G.+Innamorati&title=The+Puzzling+Uniqueness+of+the+Heterotrimeric+G15+Protein+and+Its+Potential+Beyond+Hematopoiesis&doi=10.1677%2FJME-09-0134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis</span></div><div class="casAuthors">Giannone, Flavia; Malpeli, Giorgio; Lisi, Veronica; Grasso, Silvia; Shukla, Priyanka; Ramarli, Dunia; Sartoris, Silvia; Monsurro, Vladia; Krampera, Mauro; Amato, Eliana; Tridente, Giuseppe; Colombatti, Marco; Parenti, Marco; Innamorati, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5,6</span>),
    <span class="NLM_cas:pages">259-269</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">A review.  Heterotrimeric G proteins transduce the signals of the largest family of membrane receptors (G protein-coupled receptors, GPCRs) hence triggering the activation of a wide variety of physiol. responses.  G15 is a G protein characterized by a no. of functional peculiarities that make its signaling exceptional: (1) it can couple a variety of Gs-, Gi/o-, and Gq-linked receptors to phospholipase C activation; (2) relatively to other G proteins, it is poorly affected by β-arrestin-dependent desensitization, the general mechanism that regulates GPCR function and (3) at the protein level, its expression is only detected in highly specific cell types (hematopoietic and epithelial cells).  G15 α-subunit displays unique structural and biochem. properties, and is phylogenetically the most recent and divergent component of the Gαq/11 subfamily.  All these aspects shed a mysterious light on G15 biol. role, which remains substantially elusive.  Thus, far, G15 signaling has been analyzed in the context of hematopoiesis.  Here, we highlight observations supporting the view that G15 functions may extend further beyond the immune system.  In addn., we describe puzzling aspects of G15 signaling that offer a novel perspective in the understanding of its physiol. role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tGzO6j0g6LVg90H21EOLACvtfcHk0lg-qfrpV1FRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKnurg%253D&md5=3c213b20f5192c62a428c4ae423b2566</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1677%2FJME-09-0134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FJME-09-0134%26sid%3Dliteratum%253Aachs%26aulast%3DGiannone%26aufirst%3DF.%26aulast%3DMalpeli%26aufirst%3DG.%26aulast%3DLisi%26aufirst%3DV.%26aulast%3DGrasso%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DP.%26aulast%3DRamarli%26aufirst%3DD.%26aulast%3DSartoris%26aufirst%3DS.%26aulast%3DMonsurr%25C3%25B3%26aufirst%3DV.%26aulast%3DKrampera%26aufirst%3DM.%26aulast%3DAmato%26aufirst%3DE.%26aulast%3DTridente%26aufirst%3DG.%26aulast%3DColombatti%26aufirst%3DM.%26aulast%3DParenti%26aufirst%3DM.%26aulast%3DInnamorati%26aufirst%3DG.%26atitle%3DThe%2520Puzzling%2520Uniqueness%2520of%2520the%2520Heterotrimeric%2520G15%2520Protein%2520and%2520Its%2520Potential%2520Beyond%2520Hematopoiesis%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2010%26volume%3D44%26spage%3D259%26epage%3D269%26doi%3D10.1677%2FJME-09-0134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Teicher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">CXCL12 (SDF-1)/CXCR4 Pathway in Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2931</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1158%2F1078-0432.CCR-09-2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=20484021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2927-2931&issue=11&author=B.+A.+Teicherauthor=S.+P.+Fricker&title=CXCL12+%28SDF-1%29%2FCXCR4+Pathway+in+Cancer&doi=10.1158%2F1078-0432.CCR-09-2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12 (SDF-1)/CXCR4 Pathway in Cancer</span></div><div class="casAuthors">Teicher, Beverly A.; Fricker, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2927-2931</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Chemokines, small proinflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion.  The chemokine CXCL12 [stromal cell-derived factor-1 (SDF-1)] binds primarily to CXC receptor 4 (CXCR4; CD184).  The binding of CXCL12 to CXCR4 induces intracellular signaling through several divergent pathways initiating signals related to chemotaxis, cell survival and/or proliferation, increase in intracellular calcium, and gene transcription.  CXCR4 is expressed on multiple cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells, and cancer cells.  The CXCL12/CXCR4 axis is involved in tumor progression, angiogenesis, metastasis, and survival.  This pathway is a target for therapeutics that can block the CXCL12/CXCR4 interaction or inhibit downstream intracellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosuc1QGMW7LbVg90H21EOLACvtfcHk0lg-qfrpV1FRYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D&md5=ac1e120fac46488d6f8bb1fc7c6741c2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2329%26sid%3Dliteratum%253Aachs%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DCXCL12%2520%2528SDF-1%2529%252FCXCR4%2520Pathway%2520in%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26issue%3D11%26spage%3D2927%26epage%3D2931%26doi%3D10.1158%2F1078-0432.CCR-09-2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Wright, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, I. L.</span><span> </span><span class="NLM_article-title">Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1084/jem.20011284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1084%2Fjem.20011284" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2002&pages=1145-1154&issue=9&author=D.+E.+Wrightauthor=E.+P.+Bowmanauthor=A.+J.+Wagersauthor=E.+C.+Butcherauthor=I.+L.+Weissman&title=Hematopoietic+Stem+Cells+Are+Uniquely+Selective+in+Their+Migratory+Response+to+Chemokines&doi=10.1084%2Fjem.20011284"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1084%2Fjem.20011284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20011284%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DD.%2BE.%26aulast%3DBowman%26aufirst%3DE.%2BP.%26aulast%3DWagers%26aufirst%3DA.%2BJ.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DWeissman%26aufirst%3DI.%2BL.%26atitle%3DHematopoietic%2520Stem%2520Cells%2520Are%2520Uniquely%2520Selective%2520in%2520Their%2520Migratory%2520Response%2520to%2520Chemokines%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2002%26volume%3D195%26issue%3D9%26spage%3D1145%26epage%3D1154%26doi%3D10.1084%2Fjem.20011284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ratajczak, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuba-Surma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojakowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, J.</span><span> </span><span class="NLM_article-title">The Pleiotropic Effects of the SDF-1–CXCR4 Axis in Organogenesis, Regeneration and Tumorigenesis</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1924</span><span class="refDoi"> DOI: 10.1038/sj.leu.2404357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fsj.leu.2404357" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1915-1924&author=M.+Z.+Ratajczakauthor=E.+Zuba-Surmaauthor=M.+Kuciaauthor=R.+Recaauthor=W.+Wojakowskiauthor=J.+Ratajczak&title=The+Pleiotropic+Effects+of+the+SDF-1%E2%80%93CXCR4+Axis+in+Organogenesis%2C+Regeneration+and+Tumorigenesis&doi=10.1038%2Fsj.leu.2404357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2404357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2404357%26sid%3Dliteratum%253Aachs%26aulast%3DRatajczak%26aufirst%3DM.%2BZ.%26aulast%3DZuba-Surma%26aufirst%3DE.%26aulast%3DKucia%26aufirst%3DM.%26aulast%3DReca%26aufirst%3DR.%26aulast%3DWojakowski%26aufirst%3DW.%26aulast%3DRatajczak%26aufirst%3DJ.%26atitle%3DThe%2520Pleiotropic%2520Effects%2520of%2520the%2520SDF-1%25E2%2580%2593CXCR4%2520Axis%2520in%2520Organogenesis%252C%2520Regeneration%2520and%2520Tumorigenesis%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D1915%26epage%3D1924%26doi%3D10.1038%2Fsj.leu.2404357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghesani, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Impaired B-Lymphopoiesis, Myelopoiesis, and Derailed Cerebellar Neuron Migration in CXCR4- and SDF-1-Deficient Mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">9448</span><span class="NLM_x">–</span> <span class="NLM_lpage">9453</span><span class="refDoi"> DOI: 10.1073/pnas.95.16.9448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1073%2Fpnas.95.16.9448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=9689100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=9448-9453&author=Q.+Maauthor=D.+Jonesauthor=P.+R.+Borghesaniauthor=R.+A.+Segalauthor=T.+Nagasawaauthor=T.+Kishimotoauthor=R.+T.+Bronsonauthor=T.+A.+Springer&title=Impaired+B-Lymphopoiesis%2C+Myelopoiesis%2C+and+Derailed+Cerebellar+Neuron+Migration+in+CXCR4-+and+SDF-1-Deficient+Mice&doi=10.1073%2Fpnas.95.16.9448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice</span></div><div class="casAuthors">Ma, Qing; Jones, Dan; Borghesani, Paul R.; Segal, Rosalind A.; Nagasawa, Takashi; Kishimoto, Tadamitsu; Bronson, Roderick T.; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">9448-9453</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The chemokine stromal cell-derived factor 1, SDF-1, is an important regulator of leukocyte and hematopoietic precursor migration and pre-B cell proliferation.  The receptor for SDF-1, CXCR4, also functions as a coreceptor for T-tropic HIV-1 entry.  The authors find that mice deficient for CXCR4 die perinatally and display profound defects in the hematopoietic and nervous systems.  CXCR4-deficient mice have severely reduced B-lymphopoiesis, reduced myelopoiesis in fetal liver, and a virtual absence of myelopoiesis in bone marrow.  However, T-lymphopoiesis is unaffected.  Furthermore, the cerebellum develops abnormally with an irregular external granule cell layer, ectopically located Purkinje cells, and numerous chromophilic cell clumps of abnormally migrated granule cells within the cerebellar anlage.  Identical defects are obsd. in mice lacking SDF-1, suggesting a monogamous relation between CXCR4 and SDF-1.  This receptor-ligand selectivity is unusual among chemokines and their receptors, as is the function in migration of nonhematopoietic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ag_HDqKuUrVg90H21EOLACvtfcHk0lgRi8V2IHCpuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D&md5=8a71d69046ba28782c4cffdef33b77ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.16.9448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.16.9448%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DBorghesani%26aufirst%3DP.%2BR.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DImpaired%2520B-Lymphopoiesis%252C%2520Myelopoiesis%252C%2520and%2520Derailed%2520Cerebellar%2520Neuron%2520Migration%2520in%2520CXCR4-%2520and%2520SDF-1-Deficient%2520Mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D9448%26epage%3D9453%26doi%3D10.1073%2Fpnas.95.16.9448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kucia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysoczynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allendorf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, M. Z.</span><span> </span><span class="NLM_article-title">CXCR4-SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion</span> <span class="citation_source-journal">J. Mol. Histol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1023/B:HIJO.0000032355.66152.b8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1023%2FB%3AHIJO.0000032355.66152.b8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=233-245&author=M.+Kuciaauthor=K.+Jankowskiauthor=R.+Recaauthor=M.+Wysoczynskiauthor=L.+Banduraauthor=D.+J.+Allendorfauthor=J.+Zhangauthor=J.+Ratajczakauthor=M.+Z.+Ratajczak&title=CXCR4-SDF-1+Signalling%2C+Locomotion%2C+Chemotaxis+and+Adhesion&doi=10.1023%2FB%3AHIJO.0000032355.66152.b8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1023%2FB%3AHIJO.0000032355.66152.b8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AHIJO.0000032355.66152.b8%26sid%3Dliteratum%253Aachs%26aulast%3DKucia%26aufirst%3DM.%26aulast%3DJankowski%26aufirst%3DK.%26aulast%3DReca%26aufirst%3DR.%26aulast%3DWysoczynski%26aufirst%3DM.%26aulast%3DBandura%26aufirst%3DL.%26aulast%3DAllendorf%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRatajczak%26aufirst%3DJ.%26aulast%3DRatajczak%26aufirst%3DM.%2BZ.%26atitle%3DCXCR4-SDF-1%2520Signalling%252C%2520Locomotion%252C%2520Chemotaxis%2520and%2520Adhesion%26jtitle%3DJ.%2520Mol.%2520Histol.%26date%3D2003%26volume%3D35%26spage%3D233%26epage%3D245%26doi%3D10.1023%2FB%3AHIJO.0000032355.66152.b8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trkola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragic, T.</span><span> </span><span class="NLM_article-title">Co-Receptors for HIV-1 Entry</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.1016/S0952-7915(97)80110-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2FS0952-7915%2897%2980110-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=9287172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVyqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=551-562&issue=4&author=J.+P.+Mooreauthor=A.+Trkolaauthor=T.+Dragic&title=Co-Receptors+for+HIV-1+Entry&doi=10.1016%2FS0952-7915%2897%2980110-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Co-receptors for HIV-1 entry</span></div><div class="casAuthors">Moore, John P.; Trkola, Alexandra; Dragic, Tatjana</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">551-562</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review and discussion with 93 refs.  HIV-1 enters its target cells by fusion at the plasma membrane.  The primary cellular receptor for HIV is CD4, but this mol. is insufficient to permit viral fusion.  During 1996, the necessary entry co-factors (co-receptors or second receptors) were identified as being members of the seven-transmembrane-spanning receptor family fusin: CXCR4 for T-tropic strains and CCR5, principally, for M-tropic strains.  The co-receptor functions of these proteins are inhibited by their natural α- and β-chemokine ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvNiow88ydm7Vg90H21EOLACvtfcHk0lj2irBflRfk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVyqur0%253D&md5=d8805ccf35f191ea797470f08effd7a1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2897%2980110-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252897%252980110-0%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DTrkola%26aufirst%3DA.%26aulast%3DDragic%26aufirst%3DT.%26atitle%3DCo-Receptors%2520for%2520HIV-1%2520Entry%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1997%26volume%3D9%26issue%3D4%26spage%3D551%26epage%3D562%26doi%3D10.1016%2FS0952-7915%2897%2980110-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mishan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadiankia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahrami, A. R.</span><span> </span><span class="NLM_article-title">CXCR4 and CCR7: Two Eligible Targets in Targeted Cancer Therapy</span> <span class="citation_source-journal">Cell Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1002/cbin.10631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fcbin.10631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=27248053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlansbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2016&pages=955-967&author=M.+A.+Mishanauthor=N.+Ahmadiankiaauthor=A.+R.+Bahrami&title=CXCR4+and+CCR7%3A+Two+Eligible+Targets+in+Targeted+Cancer+Therapy&doi=10.1002%2Fcbin.10631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 and CCR7: Two eligible targets in targeted cancer therapy</span></div><div class="casAuthors">Mishan, Mohammad Amir; Ahmadiankia, Naghmeh; Bahrami, Ahmad Reza</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology International</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">955-967</span>CODEN:
                <span class="NLM_cas:coden">CBIIEV</span>;
        ISSN:<span class="NLM_cas:issn">1095-8355</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the most common cause of death in the world with high neg. emotional, economic, and social impacts.  Conventional therapeutic methods, including chemotherapy and radiotherapy, have not proven satisfactory and relapse is common in most cases.  Recent studies have focused on targeted therapy with more precise identification and targeted attacks to the cancer cells.  For this purpose, chemokine receptors are proper targets and among them, CXCR4 and CCR7, with a crucial role in cancer metastasis, are being considered as desired candidates for investigation.  In this review paper, the most important exptl. results are highlighted on the potential targeted therapies based on CXCR4 and CCR7 chemokine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJpWhGX9zQbVg90H21EOLACvtfcHk0lj2irBflRfk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlansbvF&md5=20b06bdd4810308ef0c73bd669e4c116</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fcbin.10631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbin.10631%26sid%3Dliteratum%253Aachs%26aulast%3DMishan%26aufirst%3DM.%2BA.%26aulast%3DAhmadiankia%26aufirst%3DN.%26aulast%3DBahrami%26aufirst%3DA.%2BR.%26atitle%3DCXCR4%2520and%2520CCR7%253A%2520Two%2520Eligible%2520Targets%2520in%2520Targeted%2520Cancer%2520Therapy%26jtitle%3DCell%2520Biol.%2520Int.%26date%3D2016%26volume%3D40%26spage%3D955%26epage%3D967%26doi%3D10.1002%2Fcbin.10631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Domanska, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruizinga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagengast, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmer-Bosscha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huls, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, E. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenkamp, A. M. E.</span><span> </span><span class="NLM_article-title">A Review on CXCR4/CXCL12 Axis in Oncology: No Place to Hide</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.1016/j.ejca.2012.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.ejca.2012.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=22683307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=219-230&author=U.+M.+Domanskaauthor=R.+C.+Kruizingaauthor=W.+B.+Nagengastauthor=H.+Timmer-Bosschaauthor=G.+Hulsauthor=E.+G.+E.+de+Vriesauthor=A.+M.+E.+Walenkamp&title=A+Review+on+CXCR4%2FCXCL12+Axis+in+Oncology%3A+No+Place+to+Hide&doi=10.1016%2Fj.ejca.2012.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A review on CXCR4/CXCL12 axis in oncology: No place to hide</span></div><div class="casAuthors">Domanska, Urszula M.; Kruizinga, Roeliene C.; Nagengast, Wouter B.; Timmer-Bosscha, Hetty; Huls, Gerwin; de Vries, Elisabeth G. E.; Walenkamp, Annemiek M. E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-230</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Classical chemotherapeutic anti-cancer treatments induce cell death through DNA damage by taking advantage of the proliferative behavior of cancer cells.  The more recent approach of targeted therapy (usually protein-targeted) has led to many treatments that are currently available or are under development, all of which are designed to strike at the crit. driving forces of cancer cells.  The interaction of the cancer cells with their microenvironment is one of these fundamental features of neoplasms that could be targeted in such cancer treatments.  Haematol. and solid tumor cells interact with their microenvironment through membrane chemokine receptors and their corresponding ligands, which are expressed in the tumor microenvironment.  Important representatives of this system are the chemokine ligand CXCL12 and its receptor chemokine receptor 4 (CXCR4).  This interaction can be disrupted by CXCR4 antagonists, and this concept is being used clin. to harvest haematopoietic stem/progenitor cells from bone marrow.  CXCR4 and CXCL12 also have roles in tumor growth and metastasis, and more recently their roles in cancer cell-tumor microenvironment interaction and angiogenesis have been studied.  Our review focuses on these roles and summarises strategies for treating cancer by disrupting this interaction with special emphasis on the CXCR4/CXCL12 axis.  Finally, we discuss ongoing clin. trials with several classes of CXCR4 inhibitors, and their potential additive value for patients with a (therapy resistant) malignancy by sensitizing cancer cells to conventional therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfeDVBrO4A3LVg90H21EOLACvtfcHk0lj2irBflRfk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWksro%253D&md5=d383282b39b7cc18c53cd81ccdc5a407</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2012.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2012.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DDomanska%26aufirst%3DU.%2BM.%26aulast%3DKruizinga%26aufirst%3DR.%2BC.%26aulast%3DNagengast%26aufirst%3DW.%2BB.%26aulast%3DTimmer-Bosscha%26aufirst%3DH.%26aulast%3DHuls%26aufirst%3DG.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%2BE.%26aulast%3DWalenkamp%26aufirst%3DA.%2BM.%2BE.%26atitle%3DA%2520Review%2520on%2520CXCR4%252FCXCL12%2520Axis%2520in%2520Oncology%253A%2520No%2520Place%2520to%2520Hide%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D219%26epage%3D230%26doi%3D10.1016%2Fj.ejca.2012.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Scala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascierto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castello, G.</span><span> </span><span class="NLM_article-title">Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1835</span><span class="NLM_x">–</span> <span class="NLM_lpage">1841</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1158%2F1078-0432.CCR-04-1887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=15756007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVKrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1835-1841&author=S.+Scalaauthor=A.+Ottaianoauthor=P.+A.+Asciertoauthor=M.+Cavalliauthor=E.+Simeoneauthor=P.+Giulianoauthor=M.+Napolitanoauthor=R.+Francoauthor=G.+Bottiauthor=G.+Castello&title=Expression+of+CXCR4+Predicts+Poor+Prognosis+in+Patients+with+Malignant+Melanoma&doi=10.1158%2F1078-0432.CCR-04-1887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma</span></div><div class="casAuthors">Scala, Stefania; Ottaiano, Alessandro; Ascierto, Paolo Antonio; Cavalli, Manuela; Simeone, Ester; Giuliano, Paola; Napolitano, Maria; Franco, Renato; Botti, Gerardo; Castello, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1835-1841</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CXCR4 receptor and its unique ligand, the CXCL12 chemokine, have been recently implicated in cancer metastasis.  Evidence about the role of CXCR4/CXCL12 axis has been reported in several cancers including melanoma.  Our goal was to investigate if CXCR4 expression has a prognostic value in malignant melanoma.  Immunohistochem. expression of CXCR4 was evaluated on 71 specimens of primary cutaneous melanoma with a Breslow tumor thickness of >1 mm after radical resection.  Assocns. between baseline patient features and tumors were analyzed by χ2 test.  The prognostic value of CXCR4 expression was evaluated by univariate and multivariate analyses adjusted by age, sex, Breslow tumor thickness, presence of ulceration, and sentinel lymph node metastases.  CXCR4 expression was detected in 31 of 71 (43.6%) primary cutaneous melanomas.  Membrane or cytoplasmic staining for CXCR4 protein was absent in 56% of the tumors.  The pos. cases were divided into three score classes according to their staining: low in 15 cases (21%), moderate in 10 (14%), and high in 6 (8%).  After a median follow-up of 38 mo, 26 patients progressed (16 of 26 expressed CXCR4) and 19 died (12 of 19 expressed CXCR4).  The CXCR4 expression on tumor cells was correlated with an unfavorable prognosis with a median disease-free and overall survival of 22 and 35 mo, resp.  The hazard ratios of relapse and death, compared with patients with CXCR4-neg. tumors, were 2.5 (95% confidence interval, 1.2-6.1) and 3.1 (95% confidence interval, 1.1-7.2), resp.  Median time-to-event (progression and survival) was not reached in patients with CXCR4-neg. tumors.  In the multivariate anal., CXCR4 expression, presence of ulceration, and sentinel lymph node status emerged as independent prognostic factors.  This article provides the first evidence that CXCR4 expression could be an independent and powerful prognostic marker in primary cutaneous malignant melanomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5rq8-aHeBKbVg90H21EOLACvtfcHk0lj2irBflRfk7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVKrs7k%253D&md5=2bf927225f53981fe02cbaa017a7de07</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1887%26sid%3Dliteratum%253Aachs%26aulast%3DScala%26aufirst%3DS.%26aulast%3DOttaiano%26aufirst%3DA.%26aulast%3DAscierto%26aufirst%3DP.%2BA.%26aulast%3DCavalli%26aufirst%3DM.%26aulast%3DSimeone%26aufirst%3DE.%26aulast%3DGiuliano%26aufirst%3DP.%26aulast%3DNapolitano%26aufirst%3DM.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DBotti%26aufirst%3DG.%26aulast%3DCastello%26aufirst%3DG.%26atitle%3DExpression%2520of%2520CXCR4%2520Predicts%2520Poor%2520Prognosis%2520in%2520Patients%2520with%2520Malignant%2520Melanoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D1835%26epage%3D1841%26doi%3D10.1158%2F1078-0432.CCR-04-1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Semaan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergheim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalff, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthaei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goltz, D.</span><span> </span><span class="NLM_article-title">CXCL12 Expression and PD-L1 Expression Serve as Prognostic Biomarkers in HCC and Are Induced by Hypoxia</span> <span class="citation_source-journal">Virchows Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">470</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1007/s00428-016-2051-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1007%2Fs00428-016-2051-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=27913861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKjtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2017&pages=185-196&author=A.+Semaanauthor=D.+Dietrichauthor=D.+Bergheimauthor=J.+Dietrichauthor=J.+C.+Kalffauthor=V.+Branchiauthor=H.+Matthaeiauthor=G.+Kristiansenauthor=H.-P.+Fischerauthor=D.+Goltz&title=CXCL12+Expression+and+PD-L1+Expression+Serve+as+Prognostic+Biomarkers+in+HCC+and+Are+Induced+by+Hypoxia&doi=10.1007%2Fs00428-016-2051-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia</span></div><div class="casAuthors">Semaan, Alexander; Dietrich, Dimo; Bergheim, Dominik; Dietrich, Joern; Kalff, Joerg C.; Branchi, Vittorio; Matthaei, Hanno; Kristiansen, Glen; Fischer, Hans-Peter; Goltz, Diane</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">470</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-196</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Anti-PD-1 treatment increases anti-tumor immune responses in animal models of hepatocellular carcinoma (HCC).  Sorafenib, the mainstay of treatment of HCC patients, however, leads to tumor hypoxia and thereby abrogates the efficacy of anti-PD-1 treatment.  This served as a rationale to implement CXCR4 inhibition as adjunct to sorafenib and anti-PD-1 treatment in murine HCC models.  We studied the relationship between tumor hypoxia, PD-L1 and CXCL12 expression in human HCC, aiming to test the rationale for triple therapy combining sorafenib, PD-1 immune checkpoint inhibitors and CXCR4 inhibitors.  Expression of CXCL12, PD-L1 and of surrogate markers for tumor hypoxia was evaluated at mRNA (mRNA) level in a cohort of HCC patients from The Cancer Genome Atlas and immunohistochem. in an independent cohort from the University Hospital of Bonn.  Retrospective survival analyses were conducted.  CXCL12 mRNA level significantly correlated with markers indicating tumor hypoxia in HCC (HIF1-α ρ = 0.104, p = 0.047).  PD-L1 expression was significantly increased in tumors with a high no. of tumor-infiltrating lymphocytes (ρ = 0.533, p < 0.001).  In Cox proportional hazard analyses, high PD-L1 expression and loss of nuclear CXCL12 expression showed significant prognostic value in terms of overall survival (hazard ratio (HR) = 3.35 [95%CI 1.33-8.46], p = 0.011 for PD-L1; HR = 2.64 [95%CI 1.18-5.88], p = 0.018 for CXCL12, resp.).  This study supports the rationale to combine CXCR4 inhibitors and PD-1 immune checkpoint inhibitors in patients with HCC, as sorafenib-induced tumor hypoxia leads to upregulation of PD-L1 and CXCL12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxOGOl9EmVI7Vg90H21EOLACvtfcHk0lhD2rWCrgdJzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKjtr3J&md5=455dd61016aa8c746319e5702aad0062</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00428-016-2051-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00428-016-2051-5%26sid%3Dliteratum%253Aachs%26aulast%3DSemaan%26aufirst%3DA.%26aulast%3DDietrich%26aufirst%3DD.%26aulast%3DBergheim%26aufirst%3DD.%26aulast%3DDietrich%26aufirst%3DJ.%26aulast%3DKalff%26aufirst%3DJ.%2BC.%26aulast%3DBranchi%26aufirst%3DV.%26aulast%3DMatthaei%26aufirst%3DH.%26aulast%3DKristiansen%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DH.-P.%26aulast%3DGoltz%26aufirst%3DD.%26atitle%3DCXCL12%2520Expression%2520and%2520PD-L1%2520Expression%2520Serve%2520as%2520Prognostic%2520Biomarkers%2520in%2520HCC%2520and%2520Are%2520Induced%2520by%2520Hypoxia%26jtitle%3DVirchows%2520Arch.%26date%3D2017%26volume%3D470%26spage%3D185%26epage%3D196%26doi%3D10.1007%2Fs00428-016-2051-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Sultan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcato, P.</span><span> </span><span class="NLM_article-title">Hide-and-Seek: The Interplay between Cancer Stem Cells and the Immune System</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1093/carcin/bgw115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1093%2Fcarcin%2Fbgw115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=107-118&issue=2&author=M.+Sultanauthor=K.+M.+Coyleauthor=D.+Vidovicauthor=M.+L.+Thomasauthor=S.+Gujarauthor=P.+Marcato&title=Hide-and-Seek%3A+The+Interplay+between+Cancer+Stem+Cells+and+the+Immune+System&doi=10.1093%2Fcarcin%2Fbgw115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgw115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgw115%26sid%3Dliteratum%253Aachs%26aulast%3DSultan%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DK.%2BM.%26aulast%3DVidovic%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DM.%2BL.%26aulast%3DGujar%26aufirst%3DS.%26aulast%3DMarcato%26aufirst%3DP.%26atitle%3DHide-and-Seek%253A%2520The%2520Interplay%2520between%2520Cancer%2520Stem%2520Cells%2520and%2520the%2520Immune%2520System%26jtitle%3DCarcinogenesis%26date%3D2017%26volume%3D38%26issue%3D2%26spage%3D107%26epage%3D118%26doi%3D10.1093%2Fcarcin%2Fbgw115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Righi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santosuosso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelblute, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collette, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingari, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dranoff, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poznansky, M. C.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5534</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1158%2F0008-5472.CAN-10-3143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=5522-5534&issue=16&author=E.+Righiauthor=S.+Kashiwagiauthor=J.+Yuanauthor=M.+Santosuossoauthor=P.+Leblancauthor=R.+Ingrahamauthor=B.+Forbesauthor=B.+Edelbluteauthor=B.+Colletteauthor=D.+Xingauthor=M.+Kowalskiauthor=M.+C.+Mingariauthor=F.+Vianelloauthor=M.+Birrerauthor=S.+Orsulicauthor=G.+Dranoffauthor=M.+C.+Poznansky&title=CXCL12%2FCXCR4+Blockade+Induces+Multimodal+Antitumor+Effects+That+Prolong+Survival+in+an+Immunocompetent+Mouse+Model+of+Ovarian+Cancer&doi=10.1158%2F0008-5472.CAN-10-3143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3143%26sid%3Dliteratum%253Aachs%26aulast%3DRighi%26aufirst%3DE.%26aulast%3DKashiwagi%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSantosuosso%26aufirst%3DM.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DIngraham%26aufirst%3DR.%26aulast%3DForbes%26aufirst%3DB.%26aulast%3DEdelblute%26aufirst%3DB.%26aulast%3DCollette%26aufirst%3DB.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DKowalski%26aufirst%3DM.%26aulast%3DMingari%26aufirst%3DM.%2BC.%26aulast%3DVianello%26aufirst%3DF.%26aulast%3DBirrer%26aufirst%3DM.%26aulast%3DOrsulic%26aufirst%3DS.%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DPoznansky%26aufirst%3DM.%2BC.%26atitle%3DCXCL12%252FCXCR4%2520Blockade%2520Induces%2520Multimodal%2520Antitumor%2520Effects%2520That%2520Prolong%2520Survival%2520in%2520an%2520Immunocompetent%2520Mouse%2520Model%2520of%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D16%26spage%3D5522%26epage%3D5534%26doi%3D10.1158%2F0008-5472.CAN-10-3143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Petit, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafii, S.</span><span> </span><span class="NLM_article-title">The SDF-1-CXCR4 Signaling Pathway: A Molecular Hub Modulating Neo-Angiogenesis</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/j.it.2007.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.it.2007.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=17560169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvV2gtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=299-307&issue=7&author=I.+Petitauthor=D.+Jinauthor=S.+Rafii&title=The+SDF-1-CXCR4+Signaling+Pathway%3A+A+Molecular+Hub+Modulating+Neo-Angiogenesis&doi=10.1016%2Fj.it.2007.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis</span></div><div class="casAuthors">Petit, Isabelle; Jin, David; Rafii, Shahin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">299-307</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pro-angiogenic bone marrow (BM) cells include subsets of hematopoietic cells that provide vascular support and endothelial progenitor cells (EPCs), which under certain permissive conditions could differentiate into functional vascular cells.  Recent evidence demonstrates that the chemokine stromal-cell derived factor-1 (SDF-1, also known as CXCL12) has a major role in the recruitment and retention of CXCR4+ BM cells to the neo-angiogenic niches supporting revascularization of ischemic tissue and tumor growth.  However, the precise mechanism by which activation of CXCR4 modulates neo-angiogenesis is not clear.  SDF-1 not only promotes revascularization by engaging with CXCR4 expressed on the vascular cells but also supports mobilization of pro-angiogenic CXCR4+VEGFR1+ hematopoietic cells, thereby accelerating revascularization of ischemic organs.  Here, we attempt to define the multiple functions of the SDF-1-CXCR4 signaling pathway in the regulation of neo-vascularization during acute ischemia and tumor growth.  In particular, we introduce the concept that, by modulating plasma SDF-1 levels, the CXCR4 antagonist AMD3100 acutely promotes, while chronic AMD3100 treatment inhibits, mobilization of pro-angiogenic cells.  We will also discuss strategies to modulate the mobilization of essential subsets of BM cells that participate in neo-angiogenesis, setting up the stage for enhancing revascularization or targeting tumor vessels by exploiting CXCR4 agonists and antagonists, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxzxqz-Sj0xbVg90H21EOLACvtfcHk0lhDnLOFRLfPAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvV2gtb0%253D&md5=f0e9a630059d267c7e69ec209319adf5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2007.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2007.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DPetit%26aufirst%3DI.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DRafii%26aufirst%3DS.%26atitle%3DThe%2520SDF-1-CXCR4%2520Signaling%2520Pathway%253A%2520A%2520Molecular%2520Hub%2520Modulating%2520Neo-Angiogenesis%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26issue%3D7%26spage%3D299%26epage%3D307%26doi%3D10.1016%2Fj.it.2007.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zlotnik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homey, B.</span><span> </span><span class="NLM_article-title">Homeostatic Chemokine Receptors and Organ-Specific Metastasis</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span><span class="refDoi"> DOI: 10.1038/nri3049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fnri3049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=21866172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOmsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=597-606&issue=9&author=A.+Zlotnikauthor=A.+M.+Burkhardtauthor=B.+Homey&title=Homeostatic+Chemokine+Receptors+and+Organ-Specific+Metastasis&doi=10.1038%2Fnri3049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Homeostatic chemokine receptors and organ-specific metastasis</span></div><div class="casAuthors">Zlotnik, Albert; Burkhardt, Amanda M.; Homey, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has been 10 years since the role of a chemokine receptor, CXCR4, in breast cancer metastasis was first documented.  Since then, the field of chemokines and cancer has grown significantly, so it is timely to review the progress, analyze the studies to date and identify future challenges facing this field.  Metastasis is the major factor that limits survival in most patients with cancer.  Therefore, understanding the mol. mechanisms that control the metastatic behavior of tumor cells is pivotal for treating cancer successfully.  Substantial exptl. and clin. evidence supports the conclusion that mol. mechanisms control organ-specific metastasis.  One of the most important mechanisms operating in metastasis involves homeostatic chemokines and their receptors.  Here, we review this field and propose a model of 'cellular highways' to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryoVfPLgvAELVg90H21EOLACvtfcHk0lhDnLOFRLfPAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOmsrbJ&md5=395fc0566f165340f1830a301192d803</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnri3049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3049%26sid%3Dliteratum%253Aachs%26aulast%3DZlotnik%26aufirst%3DA.%26aulast%3DBurkhardt%26aufirst%3DA.%2BM.%26aulast%3DHomey%26aufirst%3DB.%26atitle%3DHomeostatic%2520Chemokine%2520Receptors%2520and%2520Organ-Specific%2520Metastasis%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2011%26volume%3D11%26issue%3D9%26spage%3D597%26epage%3D606%26doi%3D10.1038%2Fnri3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kucia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miekus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanzeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojakowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowska-Wieczorek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, M. Z.</span><span> </span><span class="NLM_article-title">Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF-1-CXCR4 Axis</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1634/stemcells.2004-0342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1634%2Fstemcells.2004-0342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=879-894&author=M.+Kuciaauthor=R.+Recaauthor=K.+Miekusauthor=J.+Wanzeckauthor=W.+Wojakowskiauthor=A.+Janowska-Wieczorekauthor=J.+Ratajczakauthor=M.+Z.+Ratajczak&title=Trafficking+of+Normal+Stem+Cells+and+Metastasis+of+Cancer+Stem+Cells+Involve+Similar+Mechanisms%3A+Pivotal+Role+of+the+SDF-1-CXCR4+Axis&doi=10.1634%2Fstemcells.2004-0342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1634%2Fstemcells.2004-0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Fstemcells.2004-0342%26sid%3Dliteratum%253Aachs%26aulast%3DKucia%26aufirst%3DM.%26aulast%3DReca%26aufirst%3DR.%26aulast%3DMiekus%26aufirst%3DK.%26aulast%3DWanzeck%26aufirst%3DJ.%26aulast%3DWojakowski%26aufirst%3DW.%26aulast%3DJanowska-Wieczorek%26aufirst%3DA.%26aulast%3DRatajczak%26aufirst%3DJ.%26aulast%3DRatajczak%26aufirst%3DM.%2BZ.%26atitle%3DTrafficking%2520of%2520Normal%2520Stem%2520Cells%2520and%2520Metastasis%2520of%2520Cancer%2520Stem%2520Cells%2520Involve%2520Similar%2520Mechanisms%253A%2520Pivotal%2520Role%2520of%2520the%2520SDF-1-CXCR4%2520Axis%26jtitle%3DStem%2520Cells%26date%3D2005%26volume%3D23%26spage%3D879%26epage%3D894%26doi%3D10.1634%2Fstemcells.2004-0342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rubin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieran, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span> </span><span class="NLM_article-title">A Small-Molecule Antagonist of CXCR4 Inhibits Intracranial Growth of Primary Brain Tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">13513</span><span class="NLM_x">–</span> <span class="NLM_lpage">13518</span><span class="refDoi"> DOI: 10.1073/pnas.2235846100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1073%2Fpnas.2235846100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13513-13518&issue=23&author=J.+B.+Rubinauthor=A.+L.+Kungauthor=R.+S.+Kleinauthor=J.+A.+Chanauthor=Y.+Sunauthor=K.+Schmidtauthor=M.+W.+Kieranauthor=A.+D.+Lusterauthor=R.+A.+Segal&title=A+Small-Molecule+Antagonist+of+CXCR4+Inhibits+Intracranial+Growth+of+Primary+Brain+Tumors&doi=10.1073%2Fpnas.2235846100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2235846100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2235846100%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DA%2520Small-Molecule%2520Antagonist%2520of%2520CXCR4%2520Inhibits%2520Intracranial%2520Growth%2520of%2520Primary%2520Brain%2520Tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D23%26spage%3D13513%26epage%3D13518%26doi%3D10.1073%2Fpnas.2235846100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">de Nigris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napoli, C.</span><span> </span><span class="NLM_article-title">CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.2174/157489212801820039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.2174%2F157489212801820039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=251-264&issue=3&author=F.+de+Nigrisauthor=C.+Schianoauthor=T.+Infanteauthor=C.+Napoli&title=CXCR4+Inhibitors%3A+Tumor+Vasculature+and+Therapeutic+Challenges&doi=10.2174%2F157489212801820039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F157489212801820039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489212801820039%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BNigris%26aufirst%3DF.%26aulast%3DSchiano%26aufirst%3DC.%26aulast%3DInfante%26aufirst%3DT.%26aulast%3DNapoli%26aufirst%3DC.%26atitle%3DCXCR4%2520Inhibitors%253A%2520Tumor%2520Vasculature%2520and%2520Therapeutic%2520Challenges%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26issue%3D3%26spage%3D251%26epage%3D264%26doi%3D10.2174%2F157489212801820039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Uchida, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuribayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, Y.</span><span> </span><span class="NLM_article-title">Blockade of CXCR4 in Oral Squamous Cell Carcinoma Inhibits Lymph Node Metastases</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span><span class="refDoi"> DOI: 10.1016/j.ejca.2010.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.ejca.2010.09.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=452-459&author=D.+Uchidaauthor=T.+Onoueauthor=N.+Kuribayashiauthor=Y.+Tomizukaauthor=T.+Tamataniauthor=H.+Nagaiauthor=Y.+Miyamoto&title=Blockade+of+CXCR4+in+Oral+Squamous+Cell+Carcinoma+Inhibits+Lymph+Node+Metastases&doi=10.1016%2Fj.ejca.2010.09.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2010.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2010.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DD.%26aulast%3DOnoue%26aufirst%3DT.%26aulast%3DKuribayashi%26aufirst%3DN.%26aulast%3DTomizuka%26aufirst%3DY.%26aulast%3DTamatani%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DY.%26atitle%3DBlockade%2520of%2520CXCR4%2520in%2520Oral%2520Squamous%2520Cell%2520Carcinoma%2520Inhibits%2520Lymph%2520Node%2520Metastases%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D452%26epage%3D459%26doi%3D10.1016%2Fj.ejca.2010.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Domanska, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmer-Bosscha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagengast, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Munnink, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruizinga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananias, H. J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliphuis, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huls, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, E. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenkamp, A. M. E.</span><span> </span><span class="NLM_article-title">CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1593/neo.12324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1593%2Fneo.12324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=709-718&issue=8&author=U.+M.+Domanskaauthor=H.+Timmer-Bosschaauthor=W.+B.+Nagengastauthor=T.+H.+Oude+Munninkauthor=R.+C.+Kruizingaauthor=H.+J.+K.+Ananiasauthor=N.+M.+Kliphuisauthor=G.+Hulsauthor=E.+G.+E.+De+Vriesauthor=I.+J.+de+Jongauthor=A.+M.+E.+Walenkamp&title=CXCR4+Inhibition+with+AMD3100+Sensitizes+Prostate+Cancer+to+Docetaxel+Chemotherapy&doi=10.1593%2Fneo.12324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1593%2Fneo.12324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.12324%26sid%3Dliteratum%253Aachs%26aulast%3DDomanska%26aufirst%3DU.%2BM.%26aulast%3DTimmer-Bosscha%26aufirst%3DH.%26aulast%3DNagengast%26aufirst%3DW.%2BB.%26aulast%3DOude%2BMunnink%26aufirst%3DT.%2BH.%26aulast%3DKruizinga%26aufirst%3DR.%2BC.%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%2BK.%26aulast%3DKliphuis%26aufirst%3DN.%2BM.%26aulast%3DHuls%26aufirst%3DG.%26aulast%3DDe%2BVries%26aufirst%3DE.%2BG.%2BE.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26aulast%3DWalenkamp%26aufirst%3DA.%2BM.%2BE.%26atitle%3DCXCR4%2520Inhibition%2520with%2520AMD3100%2520Sensitizes%2520Prostate%2520Cancer%2520to%2520Docetaxel%2520Chemotherapy%26jtitle%3DNeoplasia%26date%3D2012%26volume%3D14%26issue%3D8%26spage%3D709%26epage%3D718%26doi%3D10.1593%2Fneo.12324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The AMD3100 Story: The Path to the Discovery of a Stem Cell Mobilizer (Mozobil)</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1664</span><span class="refDoi"> DOI: 10.1016/j.bcp.2008.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bcp.2008.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19161986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=1655-1664&author=E.+De+Clercq&title=The+AMD3100+Story%3A+The+Path+to+the+Discovery+of+a+Stem+Cell+Mobilizer+%28Mozobil%29&doi=10.1016%2Fj.bcp.2008.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1655-1664</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  AMD3100 was found to inhibit HIV-1 and HIV-2 within the 1-10 nM concn. range while not being toxic to the host cells at concns. up to 500 μM, thus achieving a selectivity index of approx. 100,000.  The target of action was initially thought to be the viral envelope glycoprotein gp120.  It appeared only to be the indirect target.  The direct target of action turned out to be the co-receptor CXCR4 used by T-lymphotropic HIV strains (now referred to as X4 strains) to enter the cells.  Initial (phase I) clin. trials undertaken with AMD3100, as a prelude to its development as a candidate anti-HIV drug for the treatment of AIDS, showed an unexpected side effect: an increase in the white blood cell counts.  Apparently, AMD3100 specifically increased CD34+ hematopoietic stem cell counts in the peripheral blood.  Stromal derived factor 1 (SDF-1), through its interaction with CXCR4, retains the stem cells in the bone marrow (a process referred to as homing), and AMD3100 specifically antagonizes this interaction.  AMD3100 in combination with granulocyte colony-stimulating factor (G-CSF) resulted in the collection of more progenitor cells than G-CSF alone.  At present, the major indication for clin. use of AMD3100 (Mozobil) is the mobilization of hematopoietic stem cells from the bone marrow into the circulating blood for transplantation in patients with hematol. malignancies such as non-Hodgkin's lymphoma or multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-vof1PYEX37Vg90H21EOLACvtfcHk0lgSIOVd64y2sA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSqsbc%253D&md5=19d5f76b85ef1c09e41a4d17ffbb2463</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2008.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2008.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520AMD3100%2520Story%253A%2520The%2520Path%2520to%2520the%2520Discovery%2520of%2520a%2520Stem%2520Cell%2520Mobilizer%2520%2528Mozobil%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D77%26spage%3D1655%26epage%3D1664%26doi%3D10.1016%2Fj.bcp.2008.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gupta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarisetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiyar, N.</span><span> </span><span class="NLM_article-title">Pharmacological Evidence for Complex and Multiple Site Interaction of CXCR4 with SDF-1α: Implications for Development of Selective CXCR4 Antagonists</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1016/S0165-2478(01)00228-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2FS0165-2478%2801%2900228-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2001&pages=29-34&author=S.+K.+Guptaauthor=K.+Pillarisettiauthor=R.+A.+Thomasauthor=N.+Aiyar&title=Pharmacological+Evidence+for+Complex+and+Multiple+Site+Interaction+of+CXCR4+with+SDF-1%CE%B1%3A+Implications+for+Development+of+Selective+CXCR4+Antagonists&doi=10.1016%2FS0165-2478%2801%2900228-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0165-2478%2801%2900228-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-2478%252801%252900228-0%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DPillarisetti%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DR.%2BA.%26aulast%3DAiyar%26aufirst%3DN.%26atitle%3DPharmacological%2520Evidence%2520for%2520Complex%2520and%2520Multiple%2520Site%2520Interaction%2520of%2520CXCR4%2520with%2520SDF-1%25CE%25B1%253A%2520Implications%2520for%2520Development%2520of%2520Selective%2520CXCR4%2520Antagonists%26jtitle%3DImmunol.%2520Lett.%26date%3D2001%26volume%3D78%26spage%3D29%26epage%3D34%26doi%3D10.1016%2FS0165-2478%2801%2900228-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Fricker, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darkes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grujic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span> </span><span class="NLM_article-title">Characterization of the Molecular Pharmacology of AMD3100: A Specific Antagonist of the G-Protein Coupled Chemokine Receptor, CXCR4</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span><span class="refDoi"> DOI: 10.1016/j.bcp.2006.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bcp.2006.05.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=588-596&author=S.+P.+Frickerauthor=V.+Anastassovauthor=J.+Coxauthor=M.+C.+Darkesauthor=O.+Grujicauthor=S.+R.+Idzanauthor=J.+Labrecqueauthor=G.+Lauauthor=R.+M.+Mosiauthor=K.+L.+Nelsonauthor=L.+Qinauthor=Z.+Santucciauthor=R.+S.+Y.+Wong&title=Characterization+of+the+Molecular+Pharmacology+of+AMD3100%3A+A+Specific+Antagonist+of+the+G-Protein+Coupled+Chemokine+Receptor%2C+CXCR4&doi=10.1016%2Fj.bcp.2006.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DS.%2BP.%26aulast%3DAnastassov%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DDarkes%26aufirst%3DM.%2BC.%26aulast%3DGrujic%26aufirst%3DO.%26aulast%3DIdzan%26aufirst%3DS.%2BR.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DG.%26aulast%3DMosi%26aufirst%3DR.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DSantucci%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520Molecular%2520Pharmacology%2520of%2520AMD3100%253A%2520A%2520Specific%2520Antagonist%2520of%2520the%2520G-Protein%2520Coupled%2520Chemokine%2520Receptor%252C%2520CXCR4%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D588%26epage%3D596%26doi%3D10.1016%2Fj.bcp.2006.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramjiawan, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unan, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. G.</span><span> </span><span class="NLM_article-title">CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1602</span><span class="refDoi"> DOI: 10.1002/hep.27665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fhep.27665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=25529917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=1591-1602&author=Y.+Chenauthor=R.+R.+Ramjiawanauthor=T.+Reibergerauthor=M.+R.+Ngauthor=T.+Hatoauthor=Y.+Huangauthor=H.+Ochiaiauthor=S.+Kitaharaauthor=E.+C.+Unanauthor=T.+P.+Reddyauthor=C.+Fanauthor=P.+Huangauthor=N.+Bardeesyauthor=A.+X.+Zhuauthor=R.+K.+Jainauthor=D.+G.+Duda&title=CXCR4+Inhibition+in+Tumor+Microenvironment+Facilitates+Anti-Programmed+Death+Receptor-1+Immunotherapy+in+Sorafenib-Treated+Hepatocellular+Carcinoma+in+Mice&doi=10.1002%2Fhep.27665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice</span></div><div class="casAuthors">Chen, Yunching; Ramjiawan, Rakesh R.; Reiberger, Thomas; Ng, Mei R.; Hato, Tai; Huang, Yuhui; Ochiai, Hiroki; Kitahara, Shuji; Unan, Elizabeth C.; Reddy, Tejaswini P.; Fan, Christopher; Huang, Peigen; Bardeesy, Nabeel; Zhu, Andrew X.; Jain, Rakesh K.; Duda, Dan G.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1591-1602</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Sorafenib, a broad tyrosine kinase inhibitor, is the only approved systemic therapy for advanced hepatocellular carcinoma (HCC) but provides limited survival benefits.  Recently, immunotherapy has emerged as a promising treatment strategy, but its role remains unclear in HCCs, which are assocd. with decreased cytotoxic CD8+ T-lymphocyte infiltration in both murine and human tumors.  Moreover, in mouse models after sorafenib treatment intratumoral hypoxia is increased and may fuel evasive resistance.  Using orthotopic HCC models, we now show that increased hypoxia after sorafenib treatment promotes immunosuppression, characterized by increased intratumoral expression of the immune checkpoint inhibitor programmed death ligand-1 and accumulation of T-regulatory cells and M2-type macrophages.  We also show that the recruitment of immunosuppressive cells is mediated in part by hypoxia-induced up-regulation of stromal cell-derived 1 alpha.  Inhibition of the stromal cell-derived 1 alpha receptor (C-X-C receptor type 4 or CXCR4) using AMD3100 prevented the polarization toward an immunosuppressive microenvironment after sorafenib treatment, inhibited tumor growth, reduced lung metastasis, and improved survival.  However, the combination of AMD3100 and sorafenib did not significantly change cytotoxic CD8+ T-lymphocyte infiltration into HCC tumors and did not modify their activation status.  In sep. expts., antibody blockade of the programmed death ligand-1 receptor programmed death receptor-1 (PD-1) showed antitumor effects in treatment-naive tumors in orthotopic (grafted and genetically engineered) models of HCC.  However, anti-PD-1 antibody treatment had addnl. antitumor activity only when combined with sorafenib and AMD3100 and not when combined with sorafenib alone.  Conclusion: Anti-PD-1 treatment can boost antitumor immune responses in HCC models; when used in combination with sorafenib, anti-PD-1 immunotherapy shows efficacy only with concomitant targeting of the hypoxic and immunosuppressive microenvironment with agents such as CXCR4 inhibitors. (Hepatol. 2015;61:1591-1602).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprDcrbDjodw7Vg90H21EOLACvtfcHk0liv3sMPR9EoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslWlsb8%253D&md5=4dcf1d6fadf34cc7a78c4af5703fdafb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhep.27665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27665%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRamjiawan%26aufirst%3DR.%2BR.%26aulast%3DReiberger%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DM.%2BR.%26aulast%3DHato%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DOchiai%26aufirst%3DH.%26aulast%3DKitahara%26aufirst%3DS.%26aulast%3DUnan%26aufirst%3DE.%2BC.%26aulast%3DReddy%26aufirst%3DT.%2BP.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DDuda%26aufirst%3DD.%2BG.%26atitle%3DCXCR4%2520Inhibition%2520in%2520Tumor%2520Microenvironment%2520Facilitates%2520Anti-Programmed%2520Death%2520Receptor-1%2520Immunotherapy%2520in%2520Sorafenib-Treated%2520Hepatocellular%2520Carcinoma%2520in%2520Mice%26jtitle%3DHepatology%26date%3D2015%26volume%3D61%26spage%3D1591%26epage%3D1602%26doi%3D10.1002%2Fhep.27665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Mosi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastassova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darkes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">The Molecular Pharmacology of AMD11070: An Orally Bioavailable CXCR4 HIV Entry Inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1016/j.bcp.2011.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bcp.2011.11.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=472-479&author=R.+M.+Mosiauthor=V.+Anastassovaauthor=J.+Coxauthor=M.+C.+Darkesauthor=S.+R.+Idzanauthor=J.+Labrecqueauthor=G.+Lauauthor=K.+L.+Nelsonauthor=K.+Patelauthor=Z.+Santucciauthor=R.+S.+Y.+Wongauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=D.+Huskensauthor=D.+Scholsauthor=S.+P.+Fricker&title=The+Molecular+Pharmacology+of+AMD11070%3A+An+Orally+Bioavailable+CXCR4+HIV+Entry+Inhibitor&doi=10.1016%2Fj.bcp.2011.11.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DMosi%26aufirst%3DR.%2BM.%26aulast%3DAnastassova%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DDarkes%26aufirst%3DM.%2BC.%26aulast%3DIdzan%26aufirst%3DS.%2BR.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DG.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DSantucci%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DHuskens%26aufirst%3DD.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DThe%2520Molecular%2520Pharmacology%2520of%2520AMD11070%253A%2520An%2520Orally%2520Bioavailable%2520CXCR4%2520HIV%2520Entry%2520Inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D472%26epage%3D479%26doi%3D10.1016%2Fj.bcp.2011.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nyunt, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macfarland, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, C. W.</span><span> </span><span class="NLM_article-title">Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e3181627566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1097%2FQAI.0b013e3181627566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=18362694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=559-565&issue=5&author=M.+M.+Nyuntauthor=S.+Beckerauthor=R.+T.+Macfarlandauthor=P.+Cheeauthor=R.+Scarboroughauthor=S.+Evertsauthor=G.+B.+Calandraauthor=C.+W.+Hendrix&title=Pharmacokinetic+Effect+of+AMD070%2C+an+Oral+CXCR4+Antagonist%2C+on+CYP3A4+and+CYP2D6+Substrates+Midazolam+and+Dextromethorphan+in+Healthy+Volunteers&doi=10.1097%2FQAI.0b013e3181627566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers</span></div><div class="casAuthors">Nyunt, Myaing M.; Becker, Stephen; MacFarland, Ron T.; Chee, Priscilla; Scarborough, Robert; Everts, Stephanie; Calandra, Gary B.; Hendrix, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">559-565</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Many antiretroviral drugs used in HIV care involve complex drug metab. by CYP3A4 and CYP2D6 enzymes, and drug interactions are problematic clin.  AMD070, a novel entry inhibitor, is an inhibitor of X4-tropic HIV virus.  In vitro data suggested that it is a CYP3A4 substrate and may inhibit CYP2D6 and CYP3A4.  Twelve healthy subjects were given a single oral dose of 5 mg of midazolam and 30 mg of dextromethorphan on day 1 and 9, and 200 mg of AMD070 twice daily on days 2 through 9 (inclusive).  Pharmacokinetic parameters of midazolam and dextromethorphan were assessed alone and in the presence of AMD070.  The mean AUC0-24 and Cmax of dextromethorphan increased 2.86-fold (2.20 to 5.10, 90% confidence interval [CI]) and 2.52-fold (1.99 to 4.24, 90% CI), resp., in the presence of AMD070.  Plasma AUC0-12 of midazolam increased 1.33-fold (1.15 to 1.61, 90% CI) without change in Cmax.  The half-life did not change for both drugs, but significant, parallel decrease in apparent oral clearance and vol. of distribution was obsd.  The data support an alteration in bioavailability due to an AMD070-mediated inhibition of presystemic metab., though an intestinal P-glycoprotein effect could also be contributing.  Interactions between AMD070 with CYP3A4 and, esp., 2D6 substrates of clin. importance in HIV care should be further explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcMlBnTo8oO7Vg90H21EOLACvtfcHk0liv3sMPR9EoGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D&md5=bfea110729b08f0c25d7219e971b209d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e3181627566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e3181627566%26sid%3Dliteratum%253Aachs%26aulast%3DNyunt%26aufirst%3DM.%2BM.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DMacfarland%26aufirst%3DR.%2BT.%26aulast%3DChee%26aufirst%3DP.%26aulast%3DScarborough%26aufirst%3DR.%26aulast%3DEverts%26aufirst%3DS.%26aulast%3DCalandra%26aufirst%3DG.%2BB.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DPharmacokinetic%2520Effect%2520of%2520AMD070%252C%2520an%2520Oral%2520CXCR4%2520Antagonist%252C%2520on%2520CYP3A4%2520and%2520CYP2D6%2520Substrates%2520Midazolam%2520and%2520Dextromethorphan%2520in%2520Healthy%2520Volunteers%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2008%26volume%3D47%26issue%3D5%26spage%3D559%26epage%3D565%26doi%3D10.1097%2FQAI.0b013e3181627566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Moyle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span> </span><span class="NLM_article-title">Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4-Tropic HIV Type 1</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1086/597097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1086%2F597097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19193109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=798-805&author=G.+Moyleauthor=E.+DeJesusauthor=M.+Boffitoauthor=R.+S.+Wongauthor=C.+Gibneyauthor=K.+Badelauthor=R.+MacFarlandauthor=G.+Calandraauthor=G.+Bridgerauthor=S.+Becker&title=Proof+of+Activity+with+AMD11070%2C+an+Orally+Bioavailable+Inhibitor+of+CXCR4-Tropic+HIV+Type+1&doi=10.1086%2F597097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1</span></div><div class="casAuthors">Moyle, Graeme; De Jesus, Edwin; Boffito, Marta; Wong, Rebecca S.; Gibney, Colleen; Badel, Karin; MacFarland, Ron; Calandra, Gary; Bridger, Gary; Becker, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">798-805</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: The X4 Antagonist Concept Trial investigates the safety and antiviral activity of AMD11070, a potent inhibitor of X4-tropic human immunodeficiency virus (HIV) in vitro in HIV-infected patients harboring X4-tropic virus.  Methods: Patients enrolled in the study had an X4 virus population ≥2000 relative luminescence units (rlu; by the Monogram Trofile Assay) and an HIV-1 RNA level ≥5000 copies/mL.  Patients received AMD11070 mono-therapy for 10 days.  Coreceptor tropism, plasma HIV-1 RNA level, and CD4 cell count were measured at study entry, on day 5, and on day 10.  Daily predose and serial samples on the last day of treatment were obtained for detn. of plasma AMD11070 concn.  Results: Ten patients were given AMD11070 monotherapy (200 mg to 8 patients and 100 mg to 2 patients) twice daily for 10 days.  The median baseline CD4 cell count was 160 cells/mm3, and the median HIV-1 RNA level was 91,447 copies/mL.  Four of 9 evaluable patients achieved a redn. in X4 virus population of ≥1 - log10 rlu.  The median change in X4 virus population at the end of treatment was -0.22 log10 rlu (range, -1.90 to 0.23 log10 rlu).  Three of 4 patients who responded to therapy showed a tropism shift from dual- or mixed-tropic viruses to exclusively R5 virus by day 10.  There were no drug-related serious adverse events, adverse events of greater than grade 2, or lab. abnormalities.  Conclusion: These results demonstrate the activity of AMD11070, the first oral CXCR4 antagonist, against X4-tropic HIV-1.  The drug was well tolerated, with no serious safety concerns.  AMD11070 is on clin. hold because of histol. changes to the liver obsd. in long-term animal studies; addnl. preclin. safety assessments are pending.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiMCeVyzm_ZLVg90H21EOLACvtfcHk0ljnqciRjnCJ_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D&md5=e6406e781295be3e9a05e7d142048010</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1086%2F597097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F597097%26sid%3Dliteratum%253Aachs%26aulast%3DMoyle%26aufirst%3DG.%26aulast%3DDeJesus%26aufirst%3DE.%26aulast%3DBoffito%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DR.%2BS.%26aulast%3DGibney%26aufirst%3DC.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DMacFarland%26aufirst%3DR.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DS.%26atitle%3DProof%2520of%2520Activity%2520with%2520AMD11070%252C%2520an%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520CXCR4-Tropic%2520HIV%2520Type%25201%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D48%26spage%3D798%26epage%3D805%26doi%3D10.1086%2F597097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Skerlj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skupinska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fluri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Novel CXCR4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bmcl.2010.11.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=262-266&author=R.+Skerljauthor=G.+Bridgerauthor=E.+McEachernauthor=C.+Harwigauthor=C.+Smithauthor=T.+Wilsonauthor=D.+Vealeauthor=H.+Yeeauthor=J.+Crawfordauthor=K.+Skupinskaauthor=R.+Wauthyauthor=W.+Yangauthor=Y.+Zhuauthor=D.+Boguckiauthor=M.+Di+Fluriauthor=J.+Langilleauthor=D.+Huskensauthor=E.+De+Clercqauthor=D.+Schols&title=Synthesis+and+SAR+of+Novel+CXCR4+Antagonists+That+Are+Potent+Inhibitors+of+T-Tropic+%28X4%29+HIV-1+Replication&doi=10.1016%2Fj.bmcl.2010.11.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DMcEachern%26aufirst%3DE.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DVeale%26aufirst%3DD.%26aulast%3DYee%26aufirst%3DH.%26aulast%3DCrawford%26aufirst%3DJ.%26aulast%3DSkupinska%26aufirst%3DK.%26aulast%3DWauthy%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DDi%2BFluri%26aufirst%3DM.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DHuskens%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Novel%2520CXCR4%2520Antagonists%2520That%2520Are%2520Potent%2520Inhibitors%2520of%2520T-Tropic%2520%2528X4%2529%2520HIV-1%2520Replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D262%26epage%3D266%26doi%3D10.1016%2Fj.bmcl.2010.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Discovery of Novel Small Molecule Orally Bioavailable C-X-C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3376</span><span class="NLM_x">–</span> <span class="NLM_lpage">3388</span><span class="refDoi"> DOI: 10.1021/jm100073m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100073m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3376-3388&issue=8&author=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=A.+Kallerauthor=E.+J.+McEachernauthor=J.+B.+Crawfordauthor=Y.+Zhouauthor=B.+Atsmaauthor=J.+Langilleauthor=S.+Nanauthor=D.+Vealeauthor=T.+Wilsonauthor=C.+Harwigauthor=S.+Hatseauthor=K.+Princenauthor=E.+De+Clercqauthor=D.+Schols&title=Discovery+of+Novel+Small+Molecule+Orally+Bioavailable+C-X-C+Chemokine+Receptor+4+Antagonists+That+Are+Potent+Inhibitors+of+T-Tropic+%28X4%29+HIV-1+Replication&doi=10.1021%2Fjm100073m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm100073m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100073m%26sid%3Dliteratum%253Aachs%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DKaller%26aufirst%3DA.%26aulast%3DMcEachern%26aufirst%3DE.%2BJ.%26aulast%3DCrawford%26aufirst%3DJ.%2BB.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DAtsma%26aufirst%3DB.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DNan%26aufirst%3DS.%26aulast%3DVeale%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Novel%2520Small%2520Molecule%2520Orally%2520Bioavailable%2520C-X-C%2520Chemokine%2520Receptor%25204%2520Antagonists%2520That%2520Are%2520Potent%2520Inhibitors%2520of%2520T-Tropic%2520%2528X4%2529%2520HIV-1%2520Replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D8%26spage%3D3376%26epage%3D3388%26doi%3D10.1021%2Fjm100073m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Aurora Richardson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Novel Isoquinoline CXCR4 Antagonists with Potent Anti-HIV Activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3026</span><span class="NLM_x">–</span> <span class="NLM_lpage">3030</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bmcl.2010.03.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=20443225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3026-3030&author=J.+F.+Millerauthor=K.+S.+Gudmundssonauthor=L.+D%E2%80%99Aurora+Richardsonauthor=S.+Jenkinsonauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelan&title=Synthesis+and+SAR+of+Novel+Isoquinoline+CXCR4+Antagonists+with+Potent+Anti-HIV+Activity&doi=10.1016%2Fj.bmcl.2010.03.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity</span></div><div class="casAuthors">Miller, John F.; Gudmundsson, Kristjan S.; Richardson, Leah D'Aurora; Jenkinson, Stephen; Spaltenstein, Andrew; Thomson, Michael; Wheelan, Pat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3026-3030</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using AMD070, I, as a starting point for structural modification, a novel series of isoquinoline CXCR4 antagonists was developed, e.g., II.  A structure-activity scan of alternate lower heterocycles led to the 3-isoquinolinyl moiety as an attractive replacement for benzimidazole.  Side chain optimization in the isoquinoline series led to a no. of compds. with low nanomolar anti-HIV activities and promising rat PK properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKb6n6z51MXbVg90H21EOLACvtfcHk0liIjgKKOyWFhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D&md5=4b929a2e6843cb3b8ea5fbb9eba4a865</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.118%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DD%25E2%2580%2599Aurora%2BRichardson%26aufirst%3DL.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Novel%2520Isoquinoline%2520CXCR4%2520Antagonists%2520with%2520Potent%2520Anti-HIV%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3026%26epage%3D3030%26doi%3D10.1016%2Fj.bmcl.2010.03.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danehower, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K.</span><span> </span><span class="NLM_article-title">Blockade of X4-Tropic HIV-1 Cellular Entry by GSK812397, a Potent Noncompetitive CXCR4 Receptor Antagonist</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span><span class="refDoi"> DOI: 10.1128/AAC.01293-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1128%2FAAC.01293-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19949058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=817-824&issue=2&author=S.+Jenkinsonauthor=M.+Thomsonauthor=D.+McCoyauthor=M.+Edelsteinauthor=S.+Danehowerauthor=W.+Lawrenceauthor=P.+Wheelanauthor=A.+Spaltensteinauthor=K.+Gudmundsson&title=Blockade+of+X4-Tropic+HIV-1+Cellular+Entry+by+GSK812397%2C+a+Potent+Noncompetitive+CXCR4+Receptor+Antagonist&doi=10.1128%2FAAC.01293-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist</span></div><div class="casAuthors">Jenkinson, Stephen; Thomson, Michael; McCoy, David; Edelstein, Mark; Danehower, Susan; Lawrence, Wendell; Wheelan, Pat; Spaltenstein, Andrew; Gudmundsson, Kristjan</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">817-824</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GSK812397 is a potent entry inhibitor of X4-tropic strains of HIV-1, as demonstrated in multiple in vitro cellular assays (e.g., in peripheral blood mononuclear cells [PBMCs] and a viral human osteosarcoma [HOS] assay, mean 50% inhibitory concns. [IC50s] ± std. errors of the means were 4.60 ± 1.23 nM and 1.50 ± 0.21 nM, resp.).  The primary in vitro potency of GSK812397 was not significantly altered by the addn. of serum proteins (2.55 [±0.12]-fold shift in the presence of human serum albumin and α-acid glycoprotein in the PBMC assay).  Pharmacol. characterization of GSK812397 in cell-based functional assays revealed it to be a noncompetitive antagonist of the CXCR4 receptor, with GSK812397 producing a concn.-dependent decrease in both an SDF-1-mediated chemotaxis and intracellular calcium release (IC50s were 0.34 ± 0.01 nM and 2.41 ± 0.50 nM, resp.).  With respect to the antiviral activity of GSK812397, it was effective against a broad range of X4- and X4R5-utilizing clin. isolates.  The potency and efficacy of GSK812397 were dependent on the individual isolate, with complete inhibition of infection obsd. with 24 of 30 isolates.  GSK812397 did not show any detectable in vitro cytotoxicity and was highly selective for CXCR4, as detd. using a wide range of receptors, enzymes, and transporters.  Moreover, GSK812397 demonstrated acceptable pharmacokinetic properties and bioavailability across species.  The data demonstrate that GSK812397 has antiviral activity against a broad range of X4-utilizing strains of HIV-1 via a noncompetitive antagonism of the CXCR4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQcIVYziyq1bVg90H21EOLACvtfcHk0liIjgKKOyWFhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFSiu7k%253D&md5=8aab7a9bb97e53d62268402b0e81e602</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.01293-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01293-09%26sid%3Dliteratum%253Aachs%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DMcCoy%26aufirst%3DD.%26aulast%3DEdelstein%26aufirst%3DM.%26aulast%3DDanehower%26aufirst%3DS.%26aulast%3DLawrence%26aufirst%3DW.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DGudmundsson%26aufirst%3DK.%26atitle%3DBlockade%2520of%2520X4-Tropic%2520HIV-1%2520Cellular%2520Entry%2520by%2520GSK812397%252C%2520a%2520Potent%2520Noncompetitive%2520CXCR4%2520Receptor%2520Antagonist%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26issue%3D2%26spage%3D817%26epage%3D824%26doi%3D10.1128%2FAAC.01293-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7915</span><span class="NLM_x">–</span> <span class="NLM_lpage">7920</span><span class="refDoi"> DOI: 10.1021/jm801065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7915-7920&author=G.+Thomaauthor=M.+B.+Streiffauthor=J.+Kovarikauthor=F.+Glickmanauthor=T.+Wagnerauthor=C.+Beerliauthor=H.-G.+Zerwes&title=Orally+Bioavailable+Isothioureas+Block+Function+of+the+Chemokine+Receptor+CXCR4+In+Vitro+and+In+Vivo&doi=10.1021%2Fjm801065q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm801065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801065q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DStreiff%26aufirst%3DM.%2BB.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DGlickman%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DOrally%2520Bioavailable%2520Isothioureas%2520Block%2520Function%2520of%2520the%2520Chemokine%2520Receptor%2520CXCR4%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7915%26epage%3D7920%26doi%3D10.1021%2Fjm801065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itotani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Study of CXCR4 Antagonists Bearing the Cyclic Pentapeptide Scaffold: Identification of the New Pharmacophore</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4374</span><span class="NLM_x">–</span> <span class="NLM_lpage">4377</span><span class="refDoi"> DOI: 10.1039/b812029c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1039%2Fb812029c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=4374-4377&author=T.+Tanakaauthor=H.+Tsutsumiauthor=W.+Nomuraauthor=Y.+Tanabeauthor=N.+Ohashiauthor=A.+Esakaauthor=C.+Ochiaiauthor=J.+Satoauthor=K.+Itotaniauthor=T.+Murakamiauthor=K.+Ohbaauthor=N.+Yamamotoauthor=N.+Fujiiauthor=H.+Tamamura&title=Structure-Activity+Relationship+Study+of+CXCR4+Antagonists+Bearing+the+Cyclic+Pentapeptide+Scaffold%3A+Identification+of+the+New+Pharmacophore&doi=10.1039%2Fb812029c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2Fb812029c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb812029c%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTsutsumi%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DW.%26aulast%3DTanabe%26aufirst%3DY.%26aulast%3DOhashi%26aufirst%3DN.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DOchiai%26aufirst%3DC.%26aulast%3DSato%26aufirst%3DJ.%26aulast%3DItotani%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DTamamura%26aufirst%3DH.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520of%2520CXCR4%2520Antagonists%2520Bearing%2520the%2520Cyclic%2520Pentapeptide%2520Scaffold%253A%2520Identification%2520of%2520the%2520New%2520Pharmacophore%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D4374%26epage%3D4377%26doi%3D10.1039%2Fb812029c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of CXCR4</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.7150/thno.5376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.7150%2Fthno.5376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=23382786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=47-75&issue=1&author=B.+Debnathauthor=S.+Xuauthor=F.+Grandeauthor=A.+Garofaloauthor=N.+Neamati&title=Small+Molecule+Inhibitors+of+CXCR4&doi=10.7150%2Fthno.5376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of CXCR4</span></div><div class="casAuthors">Debnath, Bikash; Xu, Shili; Grande, Fedora; Garofalo, Antonio; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-75</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  CXCR4 is a G-protein-coupled receptor involved in a no. of physiol. processes in the hematopoietic and immune systems.  The SDF-1/CXCR4 axis is significantly assocd. with several diseases, such as HIV, cancer, WHIM syndrome, rheumatoid arthritis, pulmonary fibrosis and lupus.  For example, CXCR4 is one of the major co-receptors for HIV entry into target cells, while in cancer it plays an important role in tumor cell metastasis.  Several promising CXCR4 antagonists have been developed to block SDF-1/CXCR4 interactions that are currently under different stages of development.  The first in class CXCR4 antagonist, plerixafor, was approved by the FDA in 2008 for the mobilization of hematopoietic stem cells and several other drugs are currently in clin. trials for cancer, HIV and WHIM syndrome.  While the long-term safety data for the first generation CXCR4 antagonists are not yet available, several new compds. are under preclin. development in an attempt to provide safer and more efficient treatment options for HIV and cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8UIj2_rKgk7Vg90H21EOLACvtfcHk0liQqg1-HeTdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7w%253D&md5=f38ef176046dfe51f7160988d4e71245</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.7150%2Fthno.5376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.5376%26sid%3Dliteratum%253Aachs%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520CXCR4%26jtitle%3DTheranostics%26date%3D2013%26volume%3D3%26issue%3D1%26spage%3D47%26epage%3D75%26doi%3D10.7150%2Fthno.5376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of Novel <i>N</i>-Aryl Piperazine CXCR4 Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bmcl.2015.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4950-4955&author=H.+Zhaoauthor=A.+R.+Prosserauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+Novel+N-Aryl+Piperazine+CXCR4+Antagonists&doi=10.1016%2Fj.bmcl.2015.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520Novel%2520N-Aryl%2520Piperazine%2520CXCR4%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4950%26epage%3D4955%26doi%3D10.1016%2Fj.bmcl.2015.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+Tetrahydroisoquinoline-Based+CXCR4+Antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0liQqg1-HeTdeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520Tetrahydroisoquinoline-Based%2520CXCR4%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><div class="note"><p class="first last">Mono-2-pyridylmethyl analog <b>8a</b> was alternatively prepared according to the following:</p></div><span class="NLM_contrib-group">Truax, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mono-2-pyridylmethyl+analog+8a+was+alternatively+prepared+according+to+the+following%3ATruax%2C+V.+T.%3B+Zhao%2C+H.%3B+Katzman%2C+B.+M.%3B+Prosser%2C+A.+R.%3B+Alcaraz%2C+A.+A.%3B+Saindane%2C+M.+T.%3B+Howard%2C+R.+B.%3B+Culver%2C+D.%3B+Arrendale%2C+R.+F.%3B+Gruddanti%2C+P.+R.%3B+Evers%2C+T.+J.%3B+Natchus%2C+M.+G.%3B+Snyder%2C+J.+P.%3B+Liotta%2C+D.+C.%3B+Wilson%2C+L.+J.ACS+Med.+Chem.+Lett.+2013%2C+4%2C+1025%E2%80%931030+10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BT.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Kumpaty, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehr, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span> </span><span class="NLM_article-title">Selective Access to Secondary Amines by a Highly Controlled Reductive Mono-<i>N</i>-Alkylation of Primary Amines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2210</span><span class="refDoi"> DOI: 10.1055/s-2003-41066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1055%2Fs-2003-41066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=2206-2210&author=H.+J.+Kumpatyauthor=S.+Bhattacharyyaauthor=E.+W.+Rehrauthor=A.+M.+Gonzalez&title=Selective+Access+to+Secondary+Amines+by+a+Highly+Controlled+Reductive+Mono-N-Alkylation+of+Primary+Amines&doi=10.1055%2Fs-2003-41066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-41066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-41066%26sid%3Dliteratum%253Aachs%26aulast%3DKumpaty%26aufirst%3DH.%2BJ.%26aulast%3DBhattacharyya%26aufirst%3DS.%26aulast%3DRehr%26aufirst%3DE.%2BW.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26atitle%3DSelective%2520Access%2520to%2520Secondary%2520Amines%2520by%2520a%2520Highly%2520Controlled%2520Reductive%2520Mono-N-Alkylation%2520of%2520Primary%2520Amines%26jtitle%3DSynthesis%26date%3D2003%26volume%3D14%26spage%3D2206%26epage%3D2210%26doi%3D10.1055%2Fs-2003-41066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper-Catalyzed Regioselective Ortho C-H Cyanation of Vinylarenes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8677</span><span class="NLM_x">–</span> <span class="NLM_lpage">8681</span><span class="refDoi"> DOI: 10.1002/anie.201402449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fanie.201402449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslWlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=8677-8681&author=Y.+Yangauthor=S.+L.+Buchwald&title=Copper-Catalyzed+Regioselective+Ortho+C-H+Cyanation+of+Vinylarenes&doi=10.1002%2Fanie.201402449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Catalyzed Regioselective ortho C-H Cyanation of Vinylarenes</span></div><div class="casAuthors">Yang, Yang; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8677-8681</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A copper-based catalytic technique for the regioselective ortho C-H cyanation of vinylarenes has been developed.  This method provides an effective means for the selective functionalization of vinylarene derivs.  A copper-catalyzed cyanative dearomatization mechanism is proposed to account for the regiochem. course of this reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHYHmtMawKB7Vg90H21EOLACvtfcHk0liR3ADt5dsH-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslWlu74%253D&md5=4da19476270dfa443e48e0dc6e3e0129</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402449%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper-Catalyzed%2520Regioselective%2520Ortho%2520C-H%2520Cyanation%2520of%2520Vinylarenes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D8677%26epage%3D8681%26doi%3D10.1002%2Fanie.201402449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Adlington, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, G. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Proposed Active Site Binding Analysis of Monocyclic 2-Azetidinone Inhibitors of Prostate Specific Antigen</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span><span class="refDoi"> DOI: 10.1021/jm000145g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000145g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1491-1508&issue=10&author=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=G.+W.+Beckerauthor=B.+Chenauthor=L.+Chengauthor=S.+L.+Cooperauthor=R.+B.+Hermannauthor=T.+J.+Howeauthor=W.+McCoullauthor=A.+M.+McNultyauthor=B.+L.+Neubauerauthor=G.+J.+Pritchard&title=Design%2C+Synthesis%2C+and+Proposed+Active+Site+Binding+Analysis+of+Monocyclic+2-Azetidinone+Inhibitors+of+Prostate+Specific+Antigen&doi=10.1021%2Fjm000145g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm000145g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000145g%26sid%3Dliteratum%253Aachs%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DBecker%26aufirst%3DG.%2BW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DS.%2BL.%26aulast%3DHermann%26aufirst%3DR.%2BB.%26aulast%3DHowe%26aufirst%3DT.%2BJ.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DNeubauer%26aufirst%3DB.%2BL.%26aulast%3DPritchard%26aufirst%3DG.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Proposed%2520Active%2520Site%2520Binding%2520Analysis%2520of%2520Monocyclic%25202-Azetidinone%2520Inhibitors%2520of%2520Prostate%2520Specific%2520Antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D10%26spage%3D1491%26epage%3D1508%26doi%3D10.1021%2Fjm000145g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">Readily Accessible 12-I-5′ Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4155</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span><span class="refDoi"> DOI: 10.1021/jo00170a070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00170a070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=4155-4156&author=D.+B.+Dessauthor=J.+C.+Martin&title=Readily+Accessible+12-I-5%E2%80%B2+Oxidant+for+the+Conversion+of+Primary+and+Secondary+Alcohols+to+Aldehydes+and+Ketones&doi=10.1021%2Fjo00170a070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo00170a070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00170a070%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DReadily%2520Accessible%252012-I-5%25E2%2580%25B2%2520Oxidant%2520for%2520the%2520Conversion%2520of%2520Primary%2520and%2520Secondary%2520Alcohols%2520to%2520Aldehydes%2520and%2520Ketones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26spage%3D4155%26epage%3D4156%26doi%3D10.1021%2Fjo00170a070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Evaluation of Fluorine-Containing D<sub>3</sub> Dopamine Receptor Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1021/jm101323b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1555-1564&author=Z.+Tuauthor=S.+Liauthor=J.+Cuiauthor=J.+Xuauthor=M.+Taylorauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+Pharmacological+Evaluation+of+Fluorine-Containing+D3+Dopamine+Receptor+Ligands&doi=10.1021%2Fjm101323b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands</span></div><div class="casAuthors">Tu, Zhu-De; Li, Shi-Hong; Cui, Jin-Quan; Xu, Jin-Bin; Taylor, Michelle; Ho, David; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1555-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of fluorine-contg. N-(2-methoxyphenyl)piperazine and N-(2-fluoroethoxy)piperazine analogs, e. g. I, were synthesized, and their affinities for human dopamine D2, D3, and D4 receptors were detd.  Radioligand binding studies identified five compds., 18a, 20a, 20c, 20e, and 21e, which bind with high affinity at D3 (Ki = 0.17-5 nM) and moderate to high selectivity for D3 vs D2 receptors (ranging from ∼25- to 163-fold).  These compds. were also evaluated for intrinsic activity at D2 and D3 receptors using a forskolin-dependent adenylyl cyclase assay.  This panel of compds. exhibits varying receptor subtype binding selectivity and intrinsic activity at D2 vs D3 receptors.  These compds. may be useful for behavioral pharmacol. studies on the role of D2-like dopamine receptors in neuropsychiatric and neurol. disorders.  Furthermore, compd. 20e, which has the highest binding affinity and selectivity for the D3 receptor (Ki = 0.17 nM for D3, 163-fold selectivity for D3 vs D2 receptors), represents a candidate fluorine-18 radiotracer for in vivo PET imaging studies on the regulation of D3 receptor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_lRIZaeiUnbVg90H21EOLACvtfcHk0ljj39XEXm1zyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D&md5=138e7cf0e434cd726af353d75f99b0f6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm101323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101323b%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Fluorine-Containing%2520D3%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1555%26epage%3D1564%26doi%3D10.1021%2Fjm101323b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gierasch, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdine, G. L.</span><span> </span><span class="NLM_article-title">Extensively Stereodiversified Scaffolds for Use in Diversity-Oriented Library Synthesis</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1021/ol027116f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol027116f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=621-624&issue=5&author=T.+M.+Gieraschauthor=Z.+Shiauthor=G.+L.+Verdine&title=Extensively+Stereodiversified+Scaffolds+for+Use+in+Diversity-Oriented+Library+Synthesis&doi=10.1021%2Fol027116f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol027116f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol027116f%26sid%3Dliteratum%253Aachs%26aulast%3DGierasch%26aufirst%3DT.%2BM.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26atitle%3DExtensively%2520Stereodiversified%2520Scaffolds%2520for%2520Use%2520in%2520Diversity-Oriented%2520Library%2520Synthesis%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26issue%3D5%26spage%3D621%26epage%3D624%26doi%3D10.1021%2Fol027116f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Mitsunobu, O.</span><span> </span><span class="NLM_article-title">The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">1981</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1055/s-1981-29317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1055%2Fs-1981-29317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1981&publication_year=1981&pages=1-28&author=O.+Mitsunobu&title=The+Use+of+Diethyl+Azodicarboxylate+and+Triphenylphosphine+in+Synthesis+and+Transformation+of+Natural+Products&doi=10.1055%2Fs-1981-29317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29317%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26atitle%3DThe%2520Use%2520of%2520Diethyl%2520Azodicarboxylate%2520and%2520Triphenylphosphine%2520in%2520Synthesis%2520and%2520Transformation%2520of%2520Natural%2520Products%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1981%26spage%3D1%26epage%3D28%26doi%3D10.1055%2Fs-1981-29317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Coleman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. J.</span><span> </span><span class="NLM_article-title">Synthesis of the Aziridino[1,2-a]pyrrolidine Substructure of the Antitumor Agents Azinomycin A and B</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5813</span><span class="NLM_x">–</span> <span class="NLM_lpage">5815</span><span class="refDoi"> DOI: 10.1021/jo00048a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00048a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=5813-5815&author=R.+S.+Colemanauthor=A.+J.+Carpenter&title=Synthesis+of+the+Aziridino%5B1%2C2-a%5Dpyrrolidine+Substructure+of+the+Antitumor+Agents+Azinomycin+A+and+B&doi=10.1021%2Fjo00048a006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjo00048a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00048a006%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BS.%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520of%2520the%2520Aziridino%255B1%252C2-a%255Dpyrrolidine%2520Substructure%2520of%2520the%2520Antitumor%2520Agents%2520Azinomycin%2520A%2520and%2520B%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D5813%26epage%3D5815%26doi%3D10.1021%2Fjo00048a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Cooper, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker-Milburn, K. I.</span><span> </span><span class="NLM_article-title">A Palladium(II)-Catalyzed C-H Activation Cascade Sequence for Polyheterocycle Formation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6496</span><span class="NLM_x">–</span> <span class="NLM_lpage">6500</span><span class="refDoi"> DOI: 10.1002/anie.201501037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fanie.201501037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFyrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=6496-6500&author=S.+P.+Cooperauthor=K.+I.+Booker-Milburn&title=A+Palladium%28II%29-Catalyzed+C-H+Activation+Cascade+Sequence+for+Polyheterocycle+Formation&doi=10.1002%2Fanie.201501037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A Palladium(II)-Catalyzed C-H Activation Cascade Sequence for Polyheterocycle Formation</span></div><div class="casAuthors">Cooper, Stephen P.; Booker-Milburn, Kevin I.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6496-6500</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Polyheterocycles are found in many natural products and are useful moieties in functional materials and drug design.  As part of a program towards the synthesis of Stemona alkaloids, a novel palladium(II)-catalyzed C-H activation strategy for the construction of such systems has been developed.  Starting from simple 1,3-dienyl-substituted heterocycles, a large range of polycyclic systems contg. pyrrole, indole, furan and thiophene moieties can be synthesized in a single step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ9U8j4fHmqbVg90H21EOLACvtfcHk0ljU3rVfQZq7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFyrsb0%253D&md5=74a54e2a9c238761fa34476562d6e5cc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fanie.201501037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201501037%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DS.%2BP.%26aulast%3DBooker-Milburn%26aufirst%3DK.%2BI.%26atitle%3DA%2520Palladium%2528II%2529-Catalyzed%2520C-H%2520Activation%2520Cascade%2520Sequence%2520for%2520Polyheterocycle%2520Formation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D6496%26epage%3D6500%26doi%3D10.1002%2Fanie.201501037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Parikh, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doering, W. E.</span><span> </span><span class="NLM_article-title">Sulfur Trioxide in the Oxidation of Alcohols by Dimethyl Sulfoxide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5507</span><span class="refDoi"> DOI: 10.1021/ja00997a067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00997a067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADyaF1cXjtV2q" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1967&pages=5505-5507&issue=21&author=J.+R.+Parikhauthor=W.+E.+Doering&title=Sulfur+Trioxide+in+the+Oxidation+of+Alcohols+by+Dimethyl+Sulfoxide&doi=10.1021%2Fja00997a067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide</span></div><div class="casAuthors">Parikh, Jekishan R.; Doering, William v. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5505-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A soln. of pyridine-SO3 complex in Me2SO is used to oxidize p-nitrobenzyl alc., l-menthol, and many steroidal alcs. to the corresponding aldehydes and ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ2qbwXRJMT7Vg90H21EOLACvtfcHk0ljU3rVfQZq7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXjtV2q&md5=fa83f740ef49cb695547ae90c1ae291a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fja00997a067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00997a067%26sid%3Dliteratum%253Aachs%26aulast%3DParikh%26aufirst%3DJ.%2BR.%26aulast%3DDoering%26aufirst%3DW.%2BE.%26atitle%3DSulfur%2520Trioxide%2520in%2520the%2520Oxidation%2520of%2520Alcohols%2520by%2520Dimethyl%2520Sulfoxide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1967%26volume%3D89%26issue%3D21%26spage%3D5505%26epage%3D5507%26doi%3D10.1021%2Fja00997a067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Moffett, R. B.</span><span> </span><span class="NLM_article-title">5,5-Dimethyl-2-Pyrrolidone</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.15227/orgsyn.032.0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.15227%2Forgsyn.032.0059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1952&pages=59-60&author=R.+B.+Moffett&title=5%2C5-Dimethyl-2-Pyrrolidone&doi=10.15227%2Forgsyn.032.0059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.032.0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.032.0059%26sid%3Dliteratum%253Aachs%26aulast%3DMoffett%26aufirst%3DR.%2BB.%26atitle%3D5%252C5-Dimethyl-2-Pyrrolidone%26jtitle%3DOrg.%2520Synth.%26date%3D1952%26volume%3D32%26spage%3D59%26epage%3D60%26doi%3D10.15227%2Forgsyn.032.0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Evaluation of SDF-1/CXCR4-Induced Ca<sup>2+</sup> Signaling by Fluorometric Imaging Plate Reader (FLIPR) and Flow Cytometry</span> <span class="citation_source-journal">Cytometry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">51A</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1002/cyto.a.10008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fcyto.a.10008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Siu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51A&publication_year=2003&pages=35-45&author=K.+Princenauthor=S.+Hatseauthor=K.+Vermeireauthor=E.+De+Clercqauthor=D.+Schols&title=Evaluation+of+SDF-1%2FCXCR4-Induced+Ca2%2B+Signaling+by+Fluorometric+Imaging+Plate+Reader+%28FLIPR%29+and+Flow+Cytometry&doi=10.1002%2Fcyto.a.10008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry</span></div><div class="casAuthors">Princen, Katrien; Hatse, Sigrid; Vermeire, Kurt; De Clercq, Erik; Schols, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry, Part A</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51A</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-45</span>CODEN:
                <span class="NLM_cas:coden">CPAYAV</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Background: The chemokine receptors CXCR4 and CCR5 are the main coreceptors for human immunodeficiency virus (HIV) 1 to enter its target cells.  The antiviral activity of their natural ligands (stromal cell-derived factor 1 [SDF-1], regulated on activation normal T-cell expressed and secreted, (RANTES) and macrophage inflammatory proteins 1α and 1β, MIP-1α and MIP-1β) and the finding that individuals deficient in CCR5 are relatively resistant to HIV infection led to the concept that chemokine receptor antagonists can play an important role in anti-HIV therapy.  AMD3100, the prototype compd. of the bicyclams, is one of the most potent and selective CXCR4 antagonists described to date.  The search for new chemokine receptor antagonists involves the evaluation of compds. for their ability to block the specific chemokine-induced transient intracellular Ca2+ flux.  We evaluated two cell-based-fluorescent methods with the use of the Fluorometric Imaging Plate Reader (FLIPR) system and a flow cytometric assay to measure the SDF-1-induced intracellular Ca2+ mobilization via CXCR4.  Both assay systems were compared for their sensitivity, advantages, and system-dependent limitations.  Methods: CXCR4+ lymphocytic and monocytic cell lines commonly used in labs. studying acquired immunodeficiency syndrome and freshly isolated peripheral blood mononuclear cells (PBMCs) were loaded with the Ca2+ indicator Fluo-3.  After washing, the cells were pre-incubated with the CXCR4 antagonist AMD3100.  Then the increase in intracellular Ca2+ concn. after stimulation with SDF-1 was examd. by the FLIPR and the flow cytometer, which monitored the change in green fluorescence intensity of Ca2+-bound Fluo-3.  Surface CXCR4 expression was also detd. flow cytometrically.  Results: In all five CXCR4+ cell lines, SDF-1 elicited a transient increase in intracellular Ca2+ concn.  For each cell line, the magnitude of response was related to the level of CXCR4 expression: the cells with the highest CXCR4 level showed the strongest Ca2+ response.  AMD3100 effected a dose-dependent inhibition of the SDF-1-induced Ca2+ flux in all cell lines examd.  The FLIPR was more sensitive than the flow cytometer in detecting minor Ca2+ responses.  In freshly isolated PBMCs, the Ca2+ response was due solely to the stimulation of monocytes and granulocytes, whereas the lymphocyte population, although expressing CXCR4, did not respond at all.  This phenomenon could be obsd. with the flow cytometer and not with the FLIPR.  Conclusions: The FLIPR system is a most adequate to monitor intracellular Ca2+ mobilization and to evaluate chemokine receptor antagonists.  However, flow cytometry and its multiparameter anal. allow addnl. characterization of the cells involved in the chemokine receptor-mediated signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGE06CEHIiELVg90H21EOLACvtfcHk0ljU3rVfQZq7ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Siu7w%253D&md5=a6156389b91539519ad45a6f2c3699a2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcyto.a.10008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcyto.a.10008%26sid%3Dliteratum%253Aachs%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DVermeire%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DEvaluation%2520of%2520SDF-1%252FCXCR4-Induced%2520Ca2%252B%2520Signaling%2520by%2520Fluorometric%2520Imaging%2520Plate%2520Reader%2520%2528FLIPR%2529%2520and%2520Flow%2520Cytometry%26jtitle%3DCytometry%26date%3D2003%26volume%3D51A%26spage%3D35%26epage%3D45%26doi%3D10.1002%2Fcyto.a.10008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, K.-K.</span><span> </span><span class="NLM_article-title">A Comparative Study of Artificial Membrane Permeability Assay for High Throughput Profiling of Drug Absorption Potential</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/S0223-5234(02)01360-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2FS0223-5234%2802%2901360-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=12008054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=399-407&author=C.+Zhuauthor=L.+Jiangauthor=T.-M.+Chenauthor=K.-K.+Hwang&title=A+Comparative+Study+of+Artificial+Membrane+Permeability+Assay+for+High+Throughput+Profiling+of+Drug+Absorption+Potential&doi=10.1016%2FS0223-5234%2802%2901360-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential</span></div><div class="casAuthors">Zhu, Chengyue; Jiang, Lan; Chen, Teng-Man; Hwang, Kin-Kai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Artificial membrane permeability measurement is a potentially high throughput and low cost alternative for in vitro assessment of drug absorption potential.  It will be an ideal screening/profiling tool in the lead generation program of drug discovery research if it is proven to be generally applicable for classifying drug absorption potential and is advantageous over other in vitro or in silico methods.  This study provides an in-depth evaluation of the method in close comparison to Caco-2, Log D, Log P, polar surface area (PSA), and quant. structure-property relationship (QSPR) predictions using a large and diverse compd. set.  It showed that the accuracy of using artificial membrane permeability in assessing drug absorption is comparable to Caco-2, but significantly better than Log P, Log D, PSA, and QSPR predictions.  This study also explored the artificial membrane compn. by adopting a hydrophilic filter membrane for artificial membrane (lecithin-dodecane) support.  The use of hydrophilic filter membrane increased the rate of permeation significantly and reduced the transport time to 2 h or less as compared with over 10 h when a hydrophobic filter membrane is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnV2XGwbLMnLVg90H21EOLACvtfcHk0lgifSmXV6FBVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D&md5=4bfab862f5872f6abf0d0d18f5b5e28f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2802%2901360-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252802%252901360-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.-M.%26aulast%3DHwang%26aufirst%3DK.-K.%26atitle%3DA%2520Comparative%2520Study%2520of%2520Artificial%2520Membrane%2520Permeability%2520Assay%2520for%2520High%2520Throughput%2520Profiling%2520of%2520Drug%2520Absorption%2520Potential%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26spage%3D399%26epage%3D407%26doi%3D10.1016%2FS0223-5234%2802%2901360-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Donato, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castell, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Lechon, M.</span><span> </span><span class="NLM_article-title">Fluorescence-Based Assays for Screening Nine Cytochrome P450 (CYP450) Activities in Intact Cells Expressing Individual Human P450 Enzymes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1124/dmd.32.7.699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1124%2Fdmd.32.7.699" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=699-706&issue=7&author=M.+T.+Donatoauthor=N.+Jimenezauthor=J.+V.+Castellauthor=M.+Gomez-Lechon&title=Fluorescence-Based+Assays+for+Screening+Nine+Cytochrome+P450+%28CYP450%29+Activities+in+Intact+Cells+Expressing+Individual+Human+P450+Enzymes&doi=10.1124%2Fdmd.32.7.699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.7.699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.7.699%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DM.%2BT.%26aulast%3DJimenez%26aufirst%3DN.%26aulast%3DCastell%26aufirst%3DJ.%2BV.%26aulast%3DGomez-Lechon%26aufirst%3DM.%26atitle%3DFluorescence-Based%2520Assays%2520for%2520Screening%2520Nine%2520Cytochrome%2520P450%2520%2528CYP450%2529%2520Activities%2520in%2520Intact%2520Cells%2520Expressing%2520Individual%2520Human%2520P450%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26issue%3D7%26spage%3D699%26epage%3D706%26doi%3D10.1124%2Fdmd.32.7.699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadjura, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesenberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S. B.</span><span> </span><span class="NLM_article-title">Utilization of <i>in vitro</i> Caco-2 Permeability and Liver Microsomal Half-Life Screens in Discovering BMS-488043, a Novel HIV-1 Attachment Inhibitor with Improved Pharmacokinetic Properties</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2135</span><span class="NLM_x">–</span> <span class="NLM_lpage">2152</span><span class="refDoi"> DOI: 10.1002/jps.21948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fjps.21948" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=2135-2152&issue=4&author=Z.+Yangauthor=L.+M.+Zadjuraauthor=A.+M.+Marinoauthor=C.+J.+D%E2%80%99Arienzoauthor=J.+Malinowskiauthor=C.+Gesenbergauthor=P.-F.+Linauthor=R.+J.+Colonnoauthor=T.+Wangauthor=J.+F.+Kadowauthor=N.+A.+Meanwellauthor=S.+B.+Hansel&title=Utilization+of+in+vitro+Caco-2+Permeability+and+Liver+Microsomal+Half-Life+Screens+in+Discovering+BMS-488043%2C+a+Novel+HIV-1+Attachment+Inhibitor+with+Improved+Pharmacokinetic+Properties&doi=10.1002%2Fjps.21948"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fjps.21948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21948%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZadjura%26aufirst%3DL.%2BM.%26aulast%3DMarino%26aufirst%3DA.%2BM.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DMalinowski%26aufirst%3DJ.%26aulast%3DGesenberg%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DP.-F.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHansel%26aufirst%3DS.%2BB.%26atitle%3DUtilization%2520of%2520in%2520vitro%2520Caco-2%2520Permeability%2520and%2520Liver%2520Microsomal%2520Half-Life%2520Screens%2520in%2520Discovering%2520BMS-488043%252C%2520a%2520Novel%2520HIV-1%2520Attachment%2520Inhibitor%2520with%2520Improved%2520Pharmacokinetic%2520Properties%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26issue%3D4%26spage%3D2135%26epage%3D2152%26doi%3D10.1002%2Fjps.21948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Storz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müsken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häussler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Validation of PqsD as an Anti-Biofilm Target in Pseudomonas Aeruginosa by Development of Small-Molecule Inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">16143</span><span class="NLM_x">–</span> <span class="NLM_lpage">16146</span><span class="refDoi"> DOI: 10.1021/ja3072397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3072397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=16143-16146&author=M.+P.+Storzauthor=C.+K.+Maurerauthor=C.+Zimmerauthor=N.+Wagnerauthor=C.+Brengelauthor=J.+C.+de+Jongauthor=S.+Lucasauthor=M.+M%C3%BCskenauthor=S.+H%C3%A4usslerauthor=A.+Steinbachauthor=R.+W.+Hartmann&title=Validation+of+PqsD+as+an+Anti-Biofilm+Target+in+Pseudomonas+Aeruginosa+by+Development+of+Small-Molecule+Inhibitors&doi=10.1021%2Fja3072397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja3072397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3072397%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DM.%2BP.%26aulast%3DMaurer%26aufirst%3DC.%2BK.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DN.%26aulast%3DBrengel%26aufirst%3DC.%26aulast%3Dde%2BJong%26aufirst%3DJ.%2BC.%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DM%25C3%25BCsken%26aufirst%3DM.%26aulast%3DH%25C3%25A4ussler%26aufirst%3DS.%26aulast%3DSteinbach%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DValidation%2520of%2520PqsD%2520as%2520an%2520Anti-Biofilm%2520Target%2520in%2520Pseudomonas%2520Aeruginosa%2520by%2520Development%2520of%2520Small-Molecule%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D16143%26epage%3D16146%26doi%3D10.1021%2Fja3072397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">O’Hagan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skibiński, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M. Z.</span><span> </span><span class="NLM_article-title">Influence of the Difluoromethylene Group (CF<sub>2</sub>) on the Conformation and Properties of Selected Organic Compounds</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1595</span><span class="refDoi"> DOI: 10.1351/PAC-CON-11-09-26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1351%2FPAC-CON-11-09-26" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1587-1595&issue=7&author=D.+O%E2%80%99Haganauthor=Y.+Wangauthor=M.+Skibi%C5%84skiauthor=A.+M.+Z.+Slawin&title=Influence+of+the+Difluoromethylene+Group+%28CF2%29+on+the+Conformation+and+Properties+of+Selected+Organic+Compounds&doi=10.1351%2FPAC-CON-11-09-26"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1351%2FPAC-CON-11-09-26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252FPAC-CON-11-09-26%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSkibi%25C5%2584ski%26aufirst%3DM.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%2BZ.%26atitle%3DInfluence%2520of%2520the%2520Difluoromethylene%2520Group%2520%2528CF2%2529%2520on%2520the%2520Conformation%2520and%2520Properties%2520of%2520Selected%2520Organic%2520Compounds%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2012%26volume%3D84%26issue%3D7%26spage%3D1587%26epage%3D1595%26doi%3D10.1351%2FPAC-CON-11-09-26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Huchet, Q. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">9041</span><span class="NLM_x">–</span> <span class="NLM_lpage">9060</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGmsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9041-9060&author=Q.+A.+Huchetauthor=B.+Kuhnauthor=B.+Wagnerauthor=N.+A.+Kratochwilauthor=H.+Fischerauthor=M.+Kansyauthor=D.+Zimmerliauthor=E.+M.+Carreiraauthor=K.+Muller&title=Fluorination+Patterning%3A+A+Study+of+Structural+Motifs+That+Impact+Physicochemical+Properties+of+Relevance+to+Drug+Discovery&doi=10.1021%2Facs.jmedchem.5b01455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery</span></div><div class="casAuthors">Huchet, Quentin A.; Kuhn, Bernd; Wagner, Bjorn; Kratochwil, Nicole A.; Fischer, Holger; Kansy, Manfred; Zimmerli, Daniel; Carreira, Erick M.; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9041-9060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a collection of 3-substituted indole derivs. incorporating partially fluorinated Pr and Bu groups is described along with an in-depth study of the effects of various fluorination patterns on their properties, such as lipophilicity, aq. soly., and metabolic stability.  The exptl. observations confirm predictions of a marked lipophilicity decrease imparted by a vic-difluoro unit when compared to the gem-difluoro counterparts.  The data involving the comparison of the two substitution patterns is expected to benefit mol. design in medicinal chem. and, more broadly, in life as well as materials sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49KCeC1WDm7Vg90H21EOLACvtfcHk0lgephsZ1npZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGmsrzM&md5=20d7a36b75501c02570744857c82f325</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01455%26sid%3Dliteratum%253Aachs%26aulast%3DHuchet%26aufirst%3DQ.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKratochwil%26aufirst%3DN.%2BA.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DFluorination%2520Patterning%253A%2520A%2520Study%2520of%2520Structural%2520Motifs%2520That%2520Impact%2520Physicochemical%2520Properties%2520of%2520Relevance%2520to%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9041%26epage%3D9060%26doi%3D10.1021%2Facs.jmedchem.5b01455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Kieltyka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baglieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shou, W. Z.</span><span> </span><span class="NLM_article-title">A High-Throughput Bioanalytical Platform Using Automated Infusion for Tandem Mass Spectrometric Method Optimization and Its Application in a Metabolic Stability Screen</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1579</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span><span class="refDoi"> DOI: 10.1002/rcm.4037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Frcm.4037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19399765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1579-1591&issue=11&author=K.+Kieltykaauthor=J.+Zhangauthor=S.+Liauthor=M.+Vathauthor=C.+Baglieriauthor=C.+Ferraroauthor=T.+A.+Zvyagaauthor=D.+M.+Drexlerauthor=H.+N.+Wellerauthor=W.+Z.+Shou&title=A+High-Throughput+Bioanalytical+Platform+Using+Automated+Infusion+for+Tandem+Mass+Spectrometric+Method+Optimization+and+Its+Application+in+a+Metabolic+Stability+Screen&doi=10.1002%2Frcm.4037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen</span></div><div class="casAuthors">Kieltyka, Kasia; Zhang, Jun; Li, Shu; Vath, Marianne; Baglieri, Chris; Ferraro, Cheryl; Zvyaga, Tatyana A.; Drexler, Dieter M.; Weller, Harold N.; Shou, Wilson Z.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1579-1591</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Liq. chromatog./tandem mass spectrometry (LC/MS/MS) is the bioanal. method of choice to support plate-based, in vitro early ADME (Absorption, Distribution, Metab. and Excretion) screens such as metabolic stability (Metstab) assessment.  MS/MS method optimization has historically been the bottleneck in this environment, where samples from thousands of discrete compds. are analyzed on a monthly basis, mainly due to the lack of a high-quality com. available platform to handle the necessary MS/MS method optimization steps for sample anal. by selected reaction monitoring (SRM) on triple quadrupole mass spectrometers.  To address this challenge, we recently developed a highly automated bioanal. platform by successfully integrating QuickQuan 2.0, a unique high-throughput soln. featuring MS/MS method optimization by automated infusion, with a customized inhouse software tool in support of a Metstab screen.  In this platform, a dual-column setup running parallel chromatog. was also implemented to reduce the bioanal. cycle time for LC/MS/MS sample anal.  A set of 45 validation compds. was used to demonstrate the speed, quality and reproducibility of MS/MS method optimization, sample anal., and data processing using this automated platform.  Metstab results for the validation compds. in microsomes from multiple species (human, rat, mouse) showed good consistency within each batch, and also between batches conducted on different days.  We have achieved and maintained a monthly throughput of 1300 compd. assays representing 500 discrete compds. per instrument per mo on this platform, and it has been used to generate metabolic stability data for more than 25 000 compds. to date with an overall success rate of more than 95%.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8W1PNTqYnALVg90H21EOLACvtfcHk0lgephsZ1npZ5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D&md5=57977322942dc41955c1d9cf015e5b05</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Frcm.4037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4037%26sid%3Dliteratum%253Aachs%26aulast%3DKieltyka%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DVath%26aufirst%3DM.%26aulast%3DBaglieri%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DC.%26aulast%3DZvyaga%26aufirst%3DT.%2BA.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DWeller%26aufirst%3DH.%2BN.%26aulast%3DShou%26aufirst%3DW.%2BZ.%26atitle%3DA%2520High-Throughput%2520Bioanalytical%2520Platform%2520Using%2520Automated%2520Infusion%2520for%2520Tandem%2520Mass%2520Spectrometric%2520Method%2520Optimization%2520and%2520Its%2520Application%2520in%2520a%2520Metabolic%2520Stability%2520Screen%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2009%26volume%3D23%26issue%3D11%26spage%3D1579%26epage%3D1591%26doi%3D10.1002%2Frcm.4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 14 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhonghua Qu, Feng Zhang, Guo-Jun Deng, <span class="NLM_string-name hlFld-ContribAuthor">Huawen Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselectivity Control in the Oxidative Formal [3 + 2] Annulations of Ketoxime Acetates and Tetrohydroisoquinolines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (20)
                                     , 8239-8243. <a href="https://doi.org/10.1021/acs.orglett.9b02978" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02978</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02978&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02978%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRegioselectivity%252BControl%252Bin%252Bthe%252BOxidative%252BFormal%252B%25255B3%252B%25252B%252B2%25255D%252BAnnulations%252Bof%252BKetoxime%252BAcetates%252Band%252BTetrohydroisoquinolines%26aulast%3DQu%26aufirst%3DZhonghua%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21082019%26date%3D03102019%26volume%3D21%26issue%3D20%26spage%3D8239%26epage%3D8243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 88-127. <a href="https://doi.org/10.1021/acs.jmedchem.8b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulation%252Bof%252BClass%252BA%252BGPCRs%25253A%252BTargets%25252C%252BAgents%25252C%252Band%252BEmerging%252BConcepts%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02062018%26date%3D28082018%26date%3D14082018%26volume%3D62%26issue%3D1%26spage%3D88%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yesim
A. Tahirovic, Valarie M. Truax, Robert J. Wilson, Edgars Jecs, Huy H. Nguyen, Eric J. Miller, Michelle B. Kim, Katie M. Kuo, Tao Wang, Chi S. Sum, Mary E. Cvijic, Gretchen M. Schroeder, Lawrence J. Wilson, <span class="NLM_string-name hlFld-ContribAuthor">Dennis C. Liotta</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-Alkyl Piperazine Side Chain Based CXCR4 Antagonists with Improved Drug-like Properties. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (5)
                                     , 446-451. <a href="https://doi.org/10.1021/acsmedchemlett.8b00030" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00030%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BN-Alkyl%252BPiperazine%252BSide%252BChain%252BBased%252BCXCR4%252BAntagonists%252Bwith%252BImproved%252BDrug-like%252BProperties%26aulast%3DTahirovic%26aufirst%3DYesim%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D19012018%26date%3D09042018%26date%3D12042018%26date%3D09042018%26volume%3D9%26issue%3D5%26spage%3D446%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Faheem</span>, <span class="hlFld-ContribAuthor ">Banoth  Karan Kumar</span>, <span class="hlFld-ContribAuthor ">Kondapalli  Venkata Gowri Chandra Sekhar</span>, <span class="hlFld-ContribAuthor ">Subhash  Chander</span>, <span class="hlFld-ContribAuthor ">Selvaraj  Kunjiappan</span>, <span class="hlFld-ContribAuthor ">Sankaranarayanan  Murugesan</span>. </span><span class="cited-content_cbyCitation_article-title">1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2021,</strong> <em>5 </em>, 1-30. <a href="https://doi.org/10.1080/17460441.2021.1916464" title="DOI URL">https://doi.org/10.1080/17460441.2021.1916464</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2021.1916464&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2021.1916464%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3D1%25252C2%25252C3%25252C4-Tetrahydroisoquinoline%252B%252528THIQ%252529%252Bas%252Bprivileged%252Bscaffold%252Bfor%252Banticancer%252Bde%252Bnovo%252Bdrug%252Bdesign%26aulast%3DFaheem%26date%3D2021%26date%3D2021%26volume%3D5%26spage%3D1%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jen-Shin  Song</span>, <span class="hlFld-ContribAuthor ">Chih-Chun  Chang</span>, <span class="hlFld-ContribAuthor ">Chien-Huang  Wu</span>, <span class="hlFld-ContribAuthor ">Trinh Kieu  Dinh</span>, <span class="hlFld-ContribAuthor ">Jiing-Jyh  Jan</span>, <span class="hlFld-ContribAuthor ">Kuan-Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Ming-Chen  Chou</span>, <span class="hlFld-ContribAuthor ">Ting-Yun  Shiue</span>, <span class="hlFld-ContribAuthor ">Kai-Chia  Yeh</span>, <span class="hlFld-ContribAuthor ">Yi-Yu  Ke</span>, <span class="hlFld-ContribAuthor ">Teng-Kuang  Yeh</span>, <span class="hlFld-ContribAuthor ">Yen-Nhi Ngoc  Ta</span>, <span class="hlFld-ContribAuthor ">Chia-Jui  Lee</span>, <span class="hlFld-ContribAuthor ">Jing-Kai  Huang</span>, <span class="hlFld-ContribAuthor ">Yun-Chieh  Sung</span>, <span class="hlFld-ContribAuthor ">Kak-Shan  Shia</span>, <span class="hlFld-ContribAuthor ">Yunching  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2021,</strong> <em>118 </em>
                                    (13)
                                     , e2015433118. <a href="https://doi.org/10.1073/pnas.2015433118" title="DOI URL">https://doi.org/10.1073/pnas.2015433118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.2015433118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.2015433118%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DA%252Bhighly%252Bselective%252Band%252Bpotent%252BCXCR4%252Bantagonist%252Bfor%252Bhepatocellular%252Bcarcinoma%252Btreatment%26aulast%3DSong%26aufirst%3DJen-Shin%26date%3D2021%26date%3D2021%26volume%3D118%26issue%3D13%26spage%3De2015433118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giorgio  Facchetti</span>, <span class="hlFld-ContribAuthor ">Michael S.  Christodoulou</span>, <span class="hlFld-ContribAuthor ">Lina Barragán  Mendoza</span>, <span class="hlFld-ContribAuthor ">Federico  Cusinato</span>, <span class="hlFld-ContribAuthor ">Lisa  Dalla Via</span>, <span class="hlFld-ContribAuthor ">Isabella  Rimoldi</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Properties of New Chiral 2-Methyl-5,6,7,8-tetrahydroquinolin-8-amine-based Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (23)
                                     , 5561. <a href="https://doi.org/10.3390/molecules25235561" title="DOI URL">https://doi.org/10.3390/molecules25235561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25235561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25235561%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DBiological%252BProperties%252Bof%252BNew%252BChiral%252B2-Methyl-5%25252C6%25252C7%25252C8-tetrahydroquinolin-8-amine-based%252BCompounds%26aulast%3DFacchetti%26aufirst%3DGiorgio%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D23%26spage%3D5561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandra  Hernández-Ibáñez</span>, <span class="hlFld-ContribAuthor ">Olga  Soares do Rego Barros</span>, <span class="hlFld-ContribAuthor ">Alejandro  Lahosa</span>, <span class="hlFld-ContribAuthor ">María Jesús  García-Muñoz</span>, <span class="hlFld-ContribAuthor ">Meriem  Benlahrech</span>, <span class="hlFld-ContribAuthor ">Cherif  Behloul</span>, <span class="hlFld-ContribAuthor ">Francisco  Foubelo</span>, <span class="hlFld-ContribAuthor ">Miguel  Yus</span>. </span><span class="cited-content_cbyCitation_article-title">Stereoselective synthesis of 5-(1-aminoalkyl)-2-pyrrolidones and 1,7-diazaspiro[4.5]decane-2,8-diones from chiral N-tert-butanesulfinyl imines and ethyl 4-nitrobutanoate. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (3)
                                     , 130842. <a href="https://doi.org/10.1016/j.tet.2019.130842" title="DOI URL">https://doi.org/10.1016/j.tet.2019.130842</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2019.130842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2019.130842%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DStereoselective%252Bsynthesis%252Bof%252B5-%2525281-aminoalkyl%252529-2-pyrrolidones%252Band%252B1%25252C7-diazaspiro%25255B4.5%25255Ddecane-2%25252C8-diones%252Bfrom%252Bchiral%252BN-tert-butanesulfinyl%252Bimines%252Band%252Bethyl%252B4-nitrobutanoate%26aulast%3DHern%25C3%25A1ndez-Ib%25C3%25A1%25C3%25B1ez%26aufirst%3DSandra%26date%3D2020%26volume%3D76%26issue%3D3%26spage%3D130842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ilze  Adlere</span>, <span class="hlFld-ContribAuthor ">Birgit  Caspar</span>, <span class="hlFld-ContribAuthor ">Marta  Arimont</span>, <span class="hlFld-ContribAuthor ">Sebastian  Dekkers</span>, <span class="hlFld-ContribAuthor ">Kirsten  Visser</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Stuijt</span>, <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>, <span class="hlFld-ContribAuthor ">Michael  Stocks</span>, <span class="hlFld-ContribAuthor ">Barrie  Kellam</span>, <span class="hlFld-ContribAuthor ">Stephen  Briddon</span>, <span class="hlFld-ContribAuthor ">Maikel  Wijtmans</span>, <span class="hlFld-ContribAuthor ">Iwan  de Esch</span>, <span class="hlFld-ContribAuthor ">Stephen  Hill</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>. </span><span class="cited-content_cbyCitation_article-title">Modulators of CXCR4 and CXCR7/ACKR3 Function. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2019,</strong> <em>96 </em>
                                    (6)
                                     , 737-752. <a href="https://doi.org/10.1124/mol.119.117663" title="DOI URL">https://doi.org/10.1124/mol.119.117663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.117663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.117663%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DModulators%252Bof%252BCXCR4%252Band%252BCXCR7%25252FACKR3%252BFunction%26aulast%3DAdlere%26aufirst%3DIlze%26date%3D2019%26date%3D2019%26volume%3D96%26issue%3D6%26spage%3D737%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khomson  Suttisintong</span>, <span class="hlFld-ContribAuthor ">Narongpol  Kaewchangwat</span>, <span class="hlFld-ContribAuthor ">Eknarin  Thanayupong</span>, <span class="hlFld-ContribAuthor ">Chakkrapan  Nerungsi</span>, <span class="hlFld-ContribAuthor ">Onsiri  Srikun</span>, <span class="hlFld-ContribAuthor ">Pornpan  Pungpo</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (18)
                                     , 1599-1620. <a href="https://doi.org/10.2174/1568026619666190712204050" title="DOI URL">https://doi.org/10.2174/1568026619666190712204050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190712204050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190712204050%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BHIV-1%252BEntry%252BInhibitors%25253A%252BFrom%252BSmall%252BMolecules%252Bto%252BPotent%252BAnti-HIV%252BAgents%26aulast%3DSuttisintong%26aufirst%3DKhomson%26date%3D2019%26volume%3D19%26issue%3D18%26spage%3D1599%26epage%3D1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuyun  Ju</span>, <span class="hlFld-ContribAuthor ">Mingxin  Qian</span>, <span class="hlFld-ContribAuthor ">Gang  Xu</span>, <span class="hlFld-ContribAuthor ">Lirong  Yang</span>, <span class="hlFld-ContribAuthor ">Jianping  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoenzymatic Approach to (
              S
              )‐1,2,3,4‐Tetrahydroisoquinoline Carboxylic Acids Employing D‐Amino Acid Oxidase. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2019,</strong> <em>361 </em>
                                    (13)
                                     , 3191-3199. <a href="https://doi.org/10.1002/adsc.201900178" title="DOI URL">https://doi.org/10.1002/adsc.201900178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201900178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201900178%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DChemoenzymatic%252BApproach%252Bto%252B%252528%252BS%252B%252529%2525E2%252580%2525901%25252C2%25252C3%25252C4%2525E2%252580%252590Tetrahydroisoquinoline%252BCarboxylic%252BAcids%252BEmploying%252BD%2525E2%252580%252590Amino%252BAcid%252BOxidase%26aulast%3DJu%26aufirst%3DShuyun%26date%3D2019%26date%3D2019%26volume%3D361%26issue%3D13%26spage%3D3191%26epage%3D3199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahereh  Mostashari-Rad</span>, <span class="hlFld-ContribAuthor ">Roya  Arian</span>, <span class="hlFld-ContribAuthor ">Houri  Sadri</span>, <span class="hlFld-ContribAuthor ">Alireza  Mehridehnavi</span>, <span class="hlFld-ContribAuthor ">Marzieh  Mokhtari</span>, <span class="hlFld-ContribAuthor ">Fahimeh  Ghasemi</span>, <span class="hlFld-ContribAuthor ">Afshin  Fassihi</span>. </span><span class="cited-content_cbyCitation_article-title">Study of CXCR4 chemokine receptor inhibitors using QSPR and molecular docking methodologies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Theoretical and Computational Chemistry</span><span> <strong>2019,</strong> <em>18 </em>
                                    (04)
                                     , 1950018. <a href="https://doi.org/10.1142/S0219633619500184" title="DOI URL">https://doi.org/10.1142/S0219633619500184</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1142/S0219633619500184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1142%2FS0219633619500184%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Theoretical%2520and%2520Computational%2520Chemistry%26atitle%3DStudy%252Bof%252BCXCR4%252Bchemokine%252Breceptor%252Binhibitors%252Busing%252BQSPR%252Band%252Bmolecular%252Bdocking%252Bmethodologies%26aulast%3DMostashari-Rad%26aufirst%3DTahereh%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D04%26spage%3D1950018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I.  Adlere</span>, <span class="hlFld-ContribAuthor ">S.  Sun</span>, <span class="hlFld-ContribAuthor ">A.  Zarca</span>, <span class="hlFld-ContribAuthor ">L.  Roumen</span>, <span class="hlFld-ContribAuthor ">M.  Gozelle</span>, <span class="hlFld-ContribAuthor ">C. Perpiñá  Viciano</span>, <span class="hlFld-ContribAuthor ">B.  Caspar</span>, <span class="hlFld-ContribAuthor ">M.  Arimont</span>, <span class="hlFld-ContribAuthor ">J.P.  Bebelman</span>, <span class="hlFld-ContribAuthor ">S.J.  Briddon</span>, <span class="hlFld-ContribAuthor ">C.  Hoffmann</span>, <span class="hlFld-ContribAuthor ">S.J.  Hill</span>, <span class="hlFld-ContribAuthor ">M.J.  Smit</span>, <span class="hlFld-ContribAuthor ">H.F.  Vischer</span>, <span class="hlFld-ContribAuthor ">M.  Wijtmans</span>, <span class="hlFld-ContribAuthor ">C.  de Graaf</span>, <span class="hlFld-ContribAuthor ">I.J.P.  de Esch</span>, <span class="hlFld-ContribAuthor ">R.  Leurs</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>162 </em>, 631-649. <a href="https://doi.org/10.1016/j.ejmech.2018.10.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bexploration%252Band%252Bpharmacological%252Bevaluation%252Bof%252BN-substituted%252Bpiperidin-4-yl-methanamine%252BCXCR4%252Bchemokine%252Breceptor%252Bantagonists%26aulast%3DAdlere%26aufirst%3DI.%26date%3D2019%26volume%3D162%26spage%3D631%26epage%3D649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahereh  Mostashari Rad</span>, <span class="hlFld-ContribAuthor ">Lotfollah  Saghaie</span>, <span class="hlFld-ContribAuthor ">Afshin  Fassihi</span>. </span><span class="cited-content_cbyCitation_article-title">HIV-1 Entry Inhibitors: A Review of Experimental and Computational Studies. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2018,</strong> <em>15 </em>
                                    (10)
                                     , e1800159. <a href="https://doi.org/10.1002/cbdv.201800159" title="DOI URL">https://doi.org/10.1002/cbdv.201800159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800159%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DHIV-1%252BEntry%252BInhibitors%25253A%252BA%252BReview%252Bof%252BExperimental%252Band%252BComputational%252BStudies%26aulast%3DMostashari%2BRad%26aufirst%3DTahereh%26date%3D2018%26date%3D2018%26volume%3D15%26issue%3D10%26spage%3De1800159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potential CXCR4 mechanisms of action against cancer progression. Reproduced from  <cite>European Journal of Cancer</cite> (<a href="https://www.sciencedirect.com/science/journal/09598049" class="extLink">https://www.sciencedirect.com/science/journal/09598049</a>), Vol. <em>49</em>, <contrib-group>Domanska, U. M.; Kruizinga, R. C.; Nagengast, W. B.; Timmer-Bosscha, H.; Huls, G.; de Vries, E. G. E.; Walenkamp, A. M. E.</contrib-group>, A Review on CXCR4/CXCL12 Axis in Oncology: No Place to Hide, pp 219–230, Copyright <span class="NLM_year">2013</span>,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> with permission from Elsevier.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Non-peptide small molecule CXCR4 antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Design principles of TIQ-15 analogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Arylmethyl Functionalization of the Butylamine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) C<sub>5</sub>H<sub>5</sub>NCHO or PhCHO, Na(OAc)<sub>3</sub>BH, DCM, rt, 24 h, 26–68% yield; (b) TFA, DCM, rt, 24 h, 67–88% yield; (c) C<sub>5</sub>H<sub>5</sub>NCHO, Na(OAc)<sub>3</sub>BH, DCM, rt, 5 h; (d) BOC<sub>2</sub>O, DMAP, DIPEA, DCM, rt, 6 h, 78–79% yield over 2 steps; (e) TFA, DCM, rt, 24 h, 14–24% yield; (f) PhCHO, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 44% yield; (g) TFA, DCM, rt, 24 h, 20% yield.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Saturated Cyclic Functionalization of the Butylamine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 27–62% yield; (b) TFA, DCM, rt, 24 h, 42–98% yield; (c) <b>12</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 40–55% yield; (d) TFA, DCM, rt, 24 h, 19–98% yield.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Benzylic Amine Side Chain Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-cyanobenzaldehyde, Na(OAc)<sub>3</sub>BH, DCM, rt, 4 h, 64% yield; (b) NiCl<sub>2</sub>-(H<sub>2</sub>O)<sub>6</sub>, NaBH<sub>4</sub>, BOC<sub>2</sub>O, NH(CH<sub>2</sub>CH<sub>2</sub>NH<sub>2</sub>)<sub>2</sub>, MeOH, 0 °C to rt, 96 h, 26% yield; (c) TFA, DCM, rt, 24 h, 62% yield; (d) BH<sub>3</sub>-Me<sub>2</sub>S, DCM, rt, 24 h, 49–74% yield; (e) Dess–Martin periodinane, DCM, rt, 2.5 h; (f) <b>14</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 51–55% yield over 2 steps; (g) TFA, DCM, rt, 24 h, 49–65% yield.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Allylic Amine Side Chain Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>20</b>, KI, DIPEA, MeCN, 50 °C, 72 h, 69% yield; (b) TFA, DCM, rt, 24 h, 59% yield; (c) <b>22</b>, KI, DIPEA, 50 °C, 24 h, 51% yield; (d) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 24 h, 76% yield; (e) TFA, DCM, rt, 24 h, 25% yield.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <i>gem</i>-Dimethylbutylamine Side Chain Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HSC<sub>8</sub>H<sub>17</sub>, Me<sub>3</sub>Al, DCM, 0 °C to rt, 12 h, 66% yield; (b) PPh<sub>3</sub>, DIAD, phthalimide, THF, rt, 2.5 h, 93% yield; (c) PdCl<sub>2</sub>, Et<sub>3</sub>SiH, Et<sub>3</sub>N, DCM, rt, 20 min, 86% yield; (d) <b>27</b>, Na(OAc)<sub>3</sub>BH, DCE, rt, 1 h, 99% yield; (e) <b>29</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, Na(OAc)<sub>3</sub>BH, DCM, rt, 12 h, 56% yield; (f) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 12 h; (g) TFA, DCM, rt, 24 h, 85% over 2 steps; (h) TBSCl, imidazole, DMF, 0 °C to rt, 1 h, 67% yield; (i) PPh<sub>3</sub>, DIAD, phthalimide, THF, rt, 36 h; (j) HCl (aq), THF, rt, 2 h, 84% yield over 2 steps; (k) SO<sub>3</sub>-C<sub>5</sub>H<sub>5</sub>N, Et<sub>3</sub>N, DCM, DMSO, 0 °C, 3 h, 77% yield; (l) <b>14</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCE, rt, 12 h, 81% yield; (m) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 24 h; (n) TFA, DCM, rt, 24 h, 91% yield over 2 steps; (o) Raney Ni, H<sub>2</sub>, EtOH, rt, 18 h, 88% yield; (p) BOC<sub>2</sub>O, DMAP, Et<sub>3</sub>N, DCM, 18 h, 40 °C, 82% yield; (q) DIBALH, Et<sub>2</sub>O, −78 °C to rt, 6 h, 71% yield; (r) <b>14</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 60 h, 30% yield; (s) TFA, DCM, rt, 24 h, 36% yield.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Preparation of the <i>para</i>-Benzylic Amine Side Chain Scaffold<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>39</b>, Et<sub>3</sub>N, THF, rt, 24 h; (b) Dess–Martin periodinane, DCM, rt, 3 h; (c) <b>14</b>, Na(OAc)<sub>3</sub>BH, DCM, rt, 24 h, 65% yield over 3 steps; (d) NH<sub>2</sub>-NH<sub>2</sub> (aq), MeOH, rt, 24 h, 55% yield.</p></p></figure><figure data-id="sch7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Functionalization of the <i>para</i>-Benzylic Amine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10c</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 37% yield; (b) TFA, DCM, rt, 24 h, 88% yield; (c) <b>12b</b>, <b>12c</b>, or <b>12g</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 59–84% yield; (d) TFA, DCM, rt, 24 h, 71–87% yield; (e) C<sub>5</sub>H<sub>5</sub>NCHO, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 61–65% yield; (f) TFA, DCM, rt, 24 h, 70–92% yield.</p></p></figure><figure data-id="sch8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Functionalization of the <i>trans</i>-Allylic Amine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10c</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 40% yield; (b) TFA, DCM, rt, 24 h, 75% yield; (c) <b>12b</b>, <b>12c</b>, or <b>12g</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 51–63% yield; (d) TFA, DCM, rt, 24 h, 19–98% yield; (e) C<sub>5</sub>H<sub>5</sub>NCHO, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 54–63% yield; (f) TFA, DCM, rt, 24 h, 70–92% yield.</p></p></figure><figure data-id="sch9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Functionalization of the 3,3-Dimethylbutylamine Side Chain<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>10c</b>, Ti(O<i>i</i>Pr)<sub>4</sub>, NaBH<sub>4</sub>, DCM, MeOH, rt, 4 h, 73% yield; (b) TFA, DCM, rt, 24 h, 74% yield; (c) <b>12b</b>, <b>12c</b>, or <b>12g</b>, Na(OAc)<sub>3</sub>BH, AcOH, DCM, rt, 24 h, 54–60% yield; (d) TFA, DCM, rt, 24 h, 96–98% yield.</p></p></figure><figure data-id="fig4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/medium/jm-2017-01420m_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Activity profile summary of TIQ-15 analogs with improved ADMET properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-3/acs.jmedchem.7b01420/20180201/images/large/jm-2017-01420m_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01420&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i93">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16562" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16562" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 59 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Le, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iribarren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J. M.</span><span> </span><span class="NLM_article-title">Chemokines and Chemokine Receptors: Their Manifold Roles in Homeostasis and Disease</span> <span class="citation_source-journal">Cell. Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=16212895" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvF2rs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2004&pages=95-104&issue=2&author=Y.+Leauthor=Y.+Zhouauthor=P.+Iribarrenauthor=J.+M.+Wang&title=Chemokines+and+Chemokine+Receptors%3A+Their+Manifold+Roles+in+Homeostasis+and+Disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chemokines and chemokine receptors: their manifold roles in homeostasis and disease</span></div><div class="casAuthors">Le, Yingying; Zhou, Ye; Iribarren, Pablo; Wang, Ji Ming</div><div class="citationInfo"><span class="NLM_cas:title">Cellular & Molecular Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">95-104</span>CODEN:
                <span class="NLM_cas:coden">CMIEAO</span>;
        ISSN:<span class="NLM_cas:issn">1672-7681</span>.
    
            (<span class="NLM_cas:orgname">Chinese Society of Immunology</span>)
        </div><div class="casAbstract">A review.  Chemokines are a superfamily of small proteins that bind to G protein-coupled receptors on target cells and were originally discovered as mediators of directional migration of immune cells to sites of inflammation and injury.  In recent years, it has become clear that the function of chemokines extends well beyond the role in leukocyte chemotaxis.  They participate in organ development, angiogenesis/angiostasis, leukocyte trafficking and homing, tumorigenesis and metastasis, as well as in immune responses to microbial infection.  Therefore, chemokines and their receptors are important targets for modulation of host responses in pathophysiol. conditions and for therapeutic intervention of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpg9DAAHw8Vl7Vg90H21EOLACvtfcHk0ljwUYPkj-ZZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvF2rs7c%253D&md5=0361182e3797399ae6b2ea4a23627f5b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLe%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DIribarren%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%2BM.%26atitle%3DChemokines%2520and%2520Chemokine%2520Receptors%253A%2520Their%2520Manifold%2520Roles%2520in%2520Homeostasis%2520and%2520Disease%26jtitle%3DCell.%2520Mol.%2520Immunol.%26date%3D2004%26volume%3D1%26issue%3D2%26spage%3D95%26epage%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Balkwill, F.</span><span> </span><span class="NLM_article-title">Cancer and the Chemokine Network</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">540</span><span class="NLM_x">–</span> <span class="NLM_lpage">550</span><span class="refDoi"> DOI: 10.1038/nrc1388</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fnrc1388" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=15229479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2004&pages=540-550&issue=7&author=F.+Balkwill&title=Cancer+and+the+Chemokine+Network&doi=10.1038%2Fnrc1388"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer and the chemokine network</span></div><div class="casAuthors">Balkwill, Fran</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">540-550</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A complex network of chemokines and their receptors influences the development of primary tumors and metastases.  New information about the biol. role of chemokines in these processes is providing insights into host-tumor interactions, such as the role of the leukocyte infiltrate, and into the mechanisms that det. the metastatic potential and site-specific spread of cancer cells.  Chemokine-receptor antagonists are showing promise in animal models of inflammation and autoimmune disease.  Could manipulating the local chemokine network have therapeutic benefits in malignant disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPYhFsIM97vbVg90H21EOLACvtfcHk0ljwUYPkj-ZZYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Oktrs%253D&md5=a827ffe8e02074fed068557c4c8dec11</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrc1388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1388%26sid%3Dliteratum%253Aachs%26aulast%3DBalkwill%26aufirst%3DF.%26atitle%3DCancer%2520and%2520the%2520Chemokine%2520Network%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2004%26volume%3D4%26issue%3D7%26spage%3D540%26epage%3D550%26doi%3D10.1038%2Fnrc1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rosenbaum, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, S. G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobilka, B. K.</span><span> </span><span class="NLM_article-title">The Structure and Function of G Protein-Coupled Receptors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">459</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">363</span><span class="refDoi"> DOI: 10.1038/nature08144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fnature08144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19458711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFKmsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=459&publication_year=2009&pages=356-363&author=D.+M.+Rosenbaumauthor=S.+G.+F.+Rasmussenauthor=B.+K.+Kobilka&title=The+Structure+and+Function+of+G+Protein-Coupled+Receptors&doi=10.1038%2Fnature08144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The structure and function of G-protein-coupled receptors</span></div><div class="casAuthors">Rosenbaum, Daniel M.; Rasmussen, Soren G. F.; Kobilka, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">459</span>
        (<span class="NLM_cas:issue">7245</span>),
    <span class="NLM_cas:pages">356-363</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) mediate most of the physiol. responses to hormones, neurotransmitters and environmental stimulants, and so have great potential as therapeutic targets for a broad spectrum of diseases.  They are also fascinating mols. from the perspective of membrane protein structure and biol.  Great progress has been made over the past 3 decades in understanding diverse GPCRs, from pharmacol. to functional characterization in vivo.  Recent high-resoln. structural studies have provided insights into the mol. mechanisms of GPCR activation and constitutive activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyI06taQNjw7Vg90H21EOLACvtfcHk0lhWJGNNxmtWbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFKmsLg%253D&md5=4d0271a5aacc58c4d255ddb7531ca8ed</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature08144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08144%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbaum%26aufirst%3DD.%2BM.%26aulast%3DRasmussen%26aufirst%3DS.%2BG.%2BF.%26aulast%3DKobilka%26aufirst%3DB.%2BK.%26atitle%3DThe%2520Structure%2520and%2520Function%2520of%2520G%2520Protein-Coupled%2520Receptors%26jtitle%3DNature%26date%3D2009%26volume%3D459%26spage%3D356%26epage%3D363%26doi%3D10.1038%2Fnature08144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Giannone, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malpeli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lisi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shukla, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramarli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartoris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monsurró, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krampera, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tridente, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombatti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Innamorati, G.</span><span> </span><span class="NLM_article-title">The Puzzling Uniqueness of the Heterotrimeric G<sub>15</sub> Protein and Its Potential Beyond Hematopoiesis</span> <span class="citation_source-journal">J. Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span><span class="refDoi"> DOI: 10.1677/JME-09-0134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1677%2FJME-09-0134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=20150327" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntlKnurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2010&pages=259-269&author=F.+Giannoneauthor=G.+Malpeliauthor=V.+Lisiauthor=S.+Grassoauthor=P.+Shuklaauthor=D.+Ramarliauthor=S.+Sartorisauthor=V.+Monsurr%C3%B3author=M.+Kramperaauthor=E.+Amatoauthor=G.+Tridenteauthor=M.+Colombattiauthor=M.+Parentiauthor=G.+Innamorati&title=The+Puzzling+Uniqueness+of+the+Heterotrimeric+G15+Protein+and+Its+Potential+Beyond+Hematopoiesis&doi=10.1677%2FJME-09-0134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The puzzling uniqueness of the heterotrimeric G15 protein and its potential beyond hematopoiesis</span></div><div class="casAuthors">Giannone, Flavia; Malpeli, Giorgio; Lisi, Veronica; Grasso, Silvia; Shukla, Priyanka; Ramarli, Dunia; Sartoris, Silvia; Monsurro, Vladia; Krampera, Mauro; Amato, Eliana; Tridente, Giuseppe; Colombatti, Marco; Parenti, Marco; Innamorati, Giulio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5,6</span>),
    <span class="NLM_cas:pages">259-269</span>CODEN:
                <span class="NLM_cas:coden">JMLEEI</span>;
        ISSN:<span class="NLM_cas:issn">0952-5041</span>.
    
            (<span class="NLM_cas:orgname">Society for Endocrinology</span>)
        </div><div class="casAbstract">A review.  Heterotrimeric G proteins transduce the signals of the largest family of membrane receptors (G protein-coupled receptors, GPCRs) hence triggering the activation of a wide variety of physiol. responses.  G15 is a G protein characterized by a no. of functional peculiarities that make its signaling exceptional: (1) it can couple a variety of Gs-, Gi/o-, and Gq-linked receptors to phospholipase C activation; (2) relatively to other G proteins, it is poorly affected by β-arrestin-dependent desensitization, the general mechanism that regulates GPCR function and (3) at the protein level, its expression is only detected in highly specific cell types (hematopoietic and epithelial cells).  G15 α-subunit displays unique structural and biochem. properties, and is phylogenetically the most recent and divergent component of the Gαq/11 subfamily.  All these aspects shed a mysterious light on G15 biol. role, which remains substantially elusive.  Thus, far, G15 signaling has been analyzed in the context of hematopoiesis.  Here, we highlight observations supporting the view that G15 functions may extend further beyond the immune system.  In addn., we describe puzzling aspects of G15 signaling that offer a novel perspective in the understanding of its physiol. role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tGzO6j0g6LVg90H21EOLACvtfcHk0lhWJGNNxmtWbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntlKnurg%253D&md5=3c213b20f5192c62a428c4ae423b2566</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1677%2FJME-09-0134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1677%252FJME-09-0134%26sid%3Dliteratum%253Aachs%26aulast%3DGiannone%26aufirst%3DF.%26aulast%3DMalpeli%26aufirst%3DG.%26aulast%3DLisi%26aufirst%3DV.%26aulast%3DGrasso%26aufirst%3DS.%26aulast%3DShukla%26aufirst%3DP.%26aulast%3DRamarli%26aufirst%3DD.%26aulast%3DSartoris%26aufirst%3DS.%26aulast%3DMonsurr%25C3%25B3%26aufirst%3DV.%26aulast%3DKrampera%26aufirst%3DM.%26aulast%3DAmato%26aufirst%3DE.%26aulast%3DTridente%26aufirst%3DG.%26aulast%3DColombatti%26aufirst%3DM.%26aulast%3DParenti%26aufirst%3DM.%26aulast%3DInnamorati%26aufirst%3DG.%26atitle%3DThe%2520Puzzling%2520Uniqueness%2520of%2520the%2520Heterotrimeric%2520G15%2520Protein%2520and%2520Its%2520Potential%2520Beyond%2520Hematopoiesis%26jtitle%3DJ.%2520Mol.%2520Endocrinol.%26date%3D2010%26volume%3D44%26spage%3D259%26epage%3D269%26doi%3D10.1677%2FJME-09-0134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Teicher, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">CXCL12 (SDF-1)/CXCR4 Pathway in Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2927</span><span class="NLM_x">–</span> <span class="NLM_lpage">2931</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-2329</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1158%2F1078-0432.CCR-09-2329" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=20484021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2927-2931&issue=11&author=B.+A.+Teicherauthor=S.+P.+Fricker&title=CXCL12+%28SDF-1%29%2FCXCR4+Pathway+in+Cancer&doi=10.1158%2F1078-0432.CCR-09-2329"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12 (SDF-1)/CXCR4 Pathway in Cancer</span></div><div class="casAuthors">Teicher, Beverly A.; Fricker, Simon P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2927-2931</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Chemokines, small proinflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion.  The chemokine CXCL12 [stromal cell-derived factor-1 (SDF-1)] binds primarily to CXC receptor 4 (CXCR4; CD184).  The binding of CXCL12 to CXCR4 induces intracellular signaling through several divergent pathways initiating signals related to chemotaxis, cell survival and/or proliferation, increase in intracellular calcium, and gene transcription.  CXCR4 is expressed on multiple cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells, and cancer cells.  The CXCL12/CXCR4 axis is involved in tumor progression, angiogenesis, metastasis, and survival.  This pathway is a target for therapeutics that can block the CXCL12/CXCR4 interaction or inhibit downstream intracellular signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosuc1QGMW7LbVg90H21EOLACvtfcHk0lhWJGNNxmtWbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXms1Ojs7o%253D&md5=ac1e120fac46488d6f8bb1fc7c6741c2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2329%26sid%3Dliteratum%253Aachs%26aulast%3DTeicher%26aufirst%3DB.%2BA.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DCXCL12%2520%2528SDF-1%2529%252FCXCR4%2520Pathway%2520in%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26issue%3D11%26spage%3D2927%26epage%3D2931%26doi%3D10.1158%2F1078-0432.CCR-09-2329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Wright, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowman, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weissman, I. L.</span><span> </span><span class="NLM_article-title">Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">195</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1145</span><span class="NLM_x">–</span> <span class="NLM_lpage">1154</span><span class="refDoi"> DOI: 10.1084/jem.20011284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1084%2Fjem.20011284" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2002&pages=1145-1154&issue=9&author=D.+E.+Wrightauthor=E.+P.+Bowmanauthor=A.+J.+Wagersauthor=E.+C.+Butcherauthor=I.+L.+Weissman&title=Hematopoietic+Stem+Cells+Are+Uniquely+Selective+in+Their+Migratory+Response+to+Chemokines&doi=10.1084%2Fjem.20011284"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1084%2Fjem.20011284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20011284%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DD.%2BE.%26aulast%3DBowman%26aufirst%3DE.%2BP.%26aulast%3DWagers%26aufirst%3DA.%2BJ.%26aulast%3DButcher%26aufirst%3DE.%2BC.%26aulast%3DWeissman%26aufirst%3DI.%2BL.%26atitle%3DHematopoietic%2520Stem%2520Cells%2520Are%2520Uniquely%2520Selective%2520in%2520Their%2520Migratory%2520Response%2520to%2520Chemokines%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2002%26volume%3D195%26issue%3D9%26spage%3D1145%26epage%3D1154%26doi%3D10.1084%2Fjem.20011284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ratajczak, M. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuba-Surma, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojakowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, J.</span><span> </span><span class="NLM_article-title">The Pleiotropic Effects of the SDF-1–CXCR4 Axis in Organogenesis, Regeneration and Tumorigenesis</span> <span class="citation_source-journal">Leukemia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1915</span><span class="NLM_x">–</span> <span class="NLM_lpage">1924</span><span class="refDoi"> DOI: 10.1038/sj.leu.2404357</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fsj.leu.2404357" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=1915-1924&author=M.+Z.+Ratajczakauthor=E.+Zuba-Surmaauthor=M.+Kuciaauthor=R.+Recaauthor=W.+Wojakowskiauthor=J.+Ratajczak&title=The+Pleiotropic+Effects+of+the+SDF-1%E2%80%93CXCR4+Axis+in+Organogenesis%2C+Regeneration+and+Tumorigenesis&doi=10.1038%2Fsj.leu.2404357"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2404357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2404357%26sid%3Dliteratum%253Aachs%26aulast%3DRatajczak%26aufirst%3DM.%2BZ.%26aulast%3DZuba-Surma%26aufirst%3DE.%26aulast%3DKucia%26aufirst%3DM.%26aulast%3DReca%26aufirst%3DR.%26aulast%3DWojakowski%26aufirst%3DW.%26aulast%3DRatajczak%26aufirst%3DJ.%26atitle%3DThe%2520Pleiotropic%2520Effects%2520of%2520the%2520SDF-1%25E2%2580%2593CXCR4%2520Axis%2520in%2520Organogenesis%252C%2520Regeneration%2520and%2520Tumorigenesis%26jtitle%3DLeukemia%26date%3D2006%26volume%3D20%26spage%3D1915%26epage%3D1924%26doi%3D10.1038%2Fsj.leu.2404357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Ma, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghesani, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagasawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bronson, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, T. A.</span><span> </span><span class="NLM_article-title">Impaired B-Lymphopoiesis, Myelopoiesis, and Derailed Cerebellar Neuron Migration in CXCR4- and SDF-1-Deficient Mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">9448</span><span class="NLM_x">–</span> <span class="NLM_lpage">9453</span><span class="refDoi"> DOI: 10.1073/pnas.95.16.9448</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1073%2Fpnas.95.16.9448" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=9689100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=9448-9453&author=Q.+Maauthor=D.+Jonesauthor=P.+R.+Borghesaniauthor=R.+A.+Segalauthor=T.+Nagasawaauthor=T.+Kishimotoauthor=R.+T.+Bronsonauthor=T.+A.+Springer&title=Impaired+B-Lymphopoiesis%2C+Myelopoiesis%2C+and+Derailed+Cerebellar+Neuron+Migration+in+CXCR4-+and+SDF-1-Deficient+Mice&doi=10.1073%2Fpnas.95.16.9448"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice</span></div><div class="casAuthors">Ma, Qing; Jones, Dan; Borghesani, Paul R.; Segal, Rosalind A.; Nagasawa, Takashi; Kishimoto, Tadamitsu; Bronson, Roderick T.; Springer, Timothy A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">9448-9453</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The chemokine stromal cell-derived factor 1, SDF-1, is an important regulator of leukocyte and hematopoietic precursor migration and pre-B cell proliferation.  The receptor for SDF-1, CXCR4, also functions as a coreceptor for T-tropic HIV-1 entry.  The authors find that mice deficient for CXCR4 die perinatally and display profound defects in the hematopoietic and nervous systems.  CXCR4-deficient mice have severely reduced B-lymphopoiesis, reduced myelopoiesis in fetal liver, and a virtual absence of myelopoiesis in bone marrow.  However, T-lymphopoiesis is unaffected.  Furthermore, the cerebellum develops abnormally with an irregular external granule cell layer, ectopically located Purkinje cells, and numerous chromophilic cell clumps of abnormally migrated granule cells within the cerebellar anlage.  Identical defects are obsd. in mice lacking SDF-1, suggesting a monogamous relation between CXCR4 and SDF-1.  This receptor-ligand selectivity is unusual among chemokines and their receptors, as is the function in migration of nonhematopoietic cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1ag_HDqKuUrVg90H21EOLACvtfcHk0liU0ZFFyNvRgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltlCls74%253D&md5=8a71d69046ba28782c4cffdef33b77ed</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1073%2Fpnas.95.16.9448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.95.16.9448%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DQ.%26aulast%3DJones%26aufirst%3DD.%26aulast%3DBorghesani%26aufirst%3DP.%2BR.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DSpringer%26aufirst%3DT.%2BA.%26atitle%3DImpaired%2520B-Lymphopoiesis%252C%2520Myelopoiesis%252C%2520and%2520Derailed%2520Cerebellar%2520Neuron%2520Migration%2520in%2520CXCR4-%2520and%2520SDF-1-Deficient%2520Mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D9448%26epage%3D9453%26doi%3D10.1073%2Fpnas.95.16.9448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kucia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jankowski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wysoczynski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allendorf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, M. Z.</span><span> </span><span class="NLM_article-title">CXCR4-SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion</span> <span class="citation_source-journal">J. Mol. Histol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1023/B:HIJO.0000032355.66152.b8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1023%2FB%3AHIJO.0000032355.66152.b8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=233-245&author=M.+Kuciaauthor=K.+Jankowskiauthor=R.+Recaauthor=M.+Wysoczynskiauthor=L.+Banduraauthor=D.+J.+Allendorfauthor=J.+Zhangauthor=J.+Ratajczakauthor=M.+Z.+Ratajczak&title=CXCR4-SDF-1+Signalling%2C+Locomotion%2C+Chemotaxis+and+Adhesion&doi=10.1023%2FB%3AHIJO.0000032355.66152.b8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1023%2FB%3AHIJO.0000032355.66152.b8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FB%253AHIJO.0000032355.66152.b8%26sid%3Dliteratum%253Aachs%26aulast%3DKucia%26aufirst%3DM.%26aulast%3DJankowski%26aufirst%3DK.%26aulast%3DReca%26aufirst%3DR.%26aulast%3DWysoczynski%26aufirst%3DM.%26aulast%3DBandura%26aufirst%3DL.%26aulast%3DAllendorf%26aufirst%3DD.%2BJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DRatajczak%26aufirst%3DJ.%26aulast%3DRatajczak%26aufirst%3DM.%2BZ.%26atitle%3DCXCR4-SDF-1%2520Signalling%252C%2520Locomotion%252C%2520Chemotaxis%2520and%2520Adhesion%26jtitle%3DJ.%2520Mol.%2520Histol.%26date%3D2003%26volume%3D35%26spage%3D233%26epage%3D245%26doi%3D10.1023%2FB%3AHIJO.0000032355.66152.b8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Moore, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trkola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragic, T.</span><span> </span><span class="NLM_article-title">Co-Receptors for HIV-1 Entry</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span><span class="refDoi"> DOI: 10.1016/S0952-7915(97)80110-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2FS0952-7915%2897%2980110-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=9287172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVyqur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=551-562&issue=4&author=J.+P.+Mooreauthor=A.+Trkolaauthor=T.+Dragic&title=Co-Receptors+for+HIV-1+Entry&doi=10.1016%2FS0952-7915%2897%2980110-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Co-receptors for HIV-1 entry</span></div><div class="casAuthors">Moore, John P.; Trkola, Alexandra; Dragic, Tatjana</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">551-562</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review and discussion with 93 refs.  HIV-1 enters its target cells by fusion at the plasma membrane.  The primary cellular receptor for HIV is CD4, but this mol. is insufficient to permit viral fusion.  During 1996, the necessary entry co-factors (co-receptors or second receptors) were identified as being members of the seven-transmembrane-spanning receptor family fusin: CXCR4 for T-tropic strains and CCR5, principally, for M-tropic strains.  The co-receptor functions of these proteins are inhibited by their natural α- and β-chemokine ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvNiow88ydm7Vg90H21EOLACvtfcHk0lhKd8R4MH-eYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVyqur0%253D&md5=d8805ccf35f191ea797470f08effd7a1</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2897%2980110-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252897%252980110-0%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DJ.%2BP.%26aulast%3DTrkola%26aufirst%3DA.%26aulast%3DDragic%26aufirst%3DT.%26atitle%3DCo-Receptors%2520for%2520HIV-1%2520Entry%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1997%26volume%3D9%26issue%3D4%26spage%3D551%26epage%3D562%26doi%3D10.1016%2FS0952-7915%2897%2980110-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mishan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadiankia, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahrami, A. R.</span><span> </span><span class="NLM_article-title">CXCR4 and CCR7: Two Eligible Targets in Targeted Cancer Therapy</span> <span class="citation_source-journal">Cell Biol. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">967</span><span class="refDoi"> DOI: 10.1002/cbin.10631</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fcbin.10631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=27248053" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlansbvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2016&pages=955-967&author=M.+A.+Mishanauthor=N.+Ahmadiankiaauthor=A.+R.+Bahrami&title=CXCR4+and+CCR7%3A+Two+Eligible+Targets+in+Targeted+Cancer+Therapy&doi=10.1002%2Fcbin.10631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 and CCR7: Two eligible targets in targeted cancer therapy</span></div><div class="casAuthors">Mishan, Mohammad Amir; Ahmadiankia, Naghmeh; Bahrami, Ahmad Reza</div><div class="citationInfo"><span class="NLM_cas:title">Cell Biology International</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">955-967</span>CODEN:
                <span class="NLM_cas:coden">CBIIEV</span>;
        ISSN:<span class="NLM_cas:issn">1095-8355</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cancer is one of the most common cause of death in the world with high neg. emotional, economic, and social impacts.  Conventional therapeutic methods, including chemotherapy and radiotherapy, have not proven satisfactory and relapse is common in most cases.  Recent studies have focused on targeted therapy with more precise identification and targeted attacks to the cancer cells.  For this purpose, chemokine receptors are proper targets and among them, CXCR4 and CCR7, with a crucial role in cancer metastasis, are being considered as desired candidates for investigation.  In this review paper, the most important exptl. results are highlighted on the potential targeted therapies based on CXCR4 and CCR7 chemokine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMJpWhGX9zQbVg90H21EOLACvtfcHk0lhKd8R4MH-eYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlansbvF&md5=20b06bdd4810308ef0c73bd669e4c116</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fcbin.10631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbin.10631%26sid%3Dliteratum%253Aachs%26aulast%3DMishan%26aufirst%3DM.%2BA.%26aulast%3DAhmadiankia%26aufirst%3DN.%26aulast%3DBahrami%26aufirst%3DA.%2BR.%26atitle%3DCXCR4%2520and%2520CCR7%253A%2520Two%2520Eligible%2520Targets%2520in%2520Targeted%2520Cancer%2520Therapy%26jtitle%3DCell%2520Biol.%2520Int.%26date%3D2016%26volume%3D40%26spage%3D955%26epage%3D967%26doi%3D10.1002%2Fcbin.10631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Domanska, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruizinga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagengast, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmer-Bosscha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huls, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Vries, E. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenkamp, A. M. E.</span><span> </span><span class="NLM_article-title">A Review on CXCR4/CXCL12 Axis in Oncology: No Place to Hide</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span><span class="refDoi"> DOI: 10.1016/j.ejca.2012.05.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.ejca.2012.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=22683307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWksro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2013&pages=219-230&author=U.+M.+Domanskaauthor=R.+C.+Kruizingaauthor=W.+B.+Nagengastauthor=H.+Timmer-Bosschaauthor=G.+Hulsauthor=E.+G.+E.+de+Vriesauthor=A.+M.+E.+Walenkamp&title=A+Review+on+CXCR4%2FCXCL12+Axis+in+Oncology%3A+No+Place+to+Hide&doi=10.1016%2Fj.ejca.2012.05.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">A review on CXCR4/CXCL12 axis in oncology: No place to hide</span></div><div class="casAuthors">Domanska, Urszula M.; Kruizinga, Roeliene C.; Nagengast, Wouter B.; Timmer-Bosscha, Hetty; Huls, Gerwin; de Vries, Elisabeth G. E.; Walenkamp, Annemiek M. E.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Cancer</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-230</span>CODEN:
                <span class="NLM_cas:coden">EJCAEL</span>;
        ISSN:<span class="NLM_cas:issn">0959-8049</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Classical chemotherapeutic anti-cancer treatments induce cell death through DNA damage by taking advantage of the proliferative behavior of cancer cells.  The more recent approach of targeted therapy (usually protein-targeted) has led to many treatments that are currently available or are under development, all of which are designed to strike at the crit. driving forces of cancer cells.  The interaction of the cancer cells with their microenvironment is one of these fundamental features of neoplasms that could be targeted in such cancer treatments.  Haematol. and solid tumor cells interact with their microenvironment through membrane chemokine receptors and their corresponding ligands, which are expressed in the tumor microenvironment.  Important representatives of this system are the chemokine ligand CXCL12 and its receptor chemokine receptor 4 (CXCR4).  This interaction can be disrupted by CXCR4 antagonists, and this concept is being used clin. to harvest haematopoietic stem/progenitor cells from bone marrow.  CXCR4 and CXCL12 also have roles in tumor growth and metastasis, and more recently their roles in cancer cell-tumor microenvironment interaction and angiogenesis have been studied.  Our review focuses on these roles and summarises strategies for treating cancer by disrupting this interaction with special emphasis on the CXCR4/CXCL12 axis.  Finally, we discuss ongoing clin. trials with several classes of CXCR4 inhibitors, and their potential additive value for patients with a (therapy resistant) malignancy by sensitizing cancer cells to conventional therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfeDVBrO4A3LVg90H21EOLACvtfcHk0lhKd8R4MH-eYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWksro%253D&md5=d383282b39b7cc18c53cd81ccdc5a407</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2012.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2012.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DDomanska%26aufirst%3DU.%2BM.%26aulast%3DKruizinga%26aufirst%3DR.%2BC.%26aulast%3DNagengast%26aufirst%3DW.%2BB.%26aulast%3DTimmer-Bosscha%26aufirst%3DH.%26aulast%3DHuls%26aufirst%3DG.%26aulast%3Dde%2BVries%26aufirst%3DE.%2BG.%2BE.%26aulast%3DWalenkamp%26aufirst%3DA.%2BM.%2BE.%26atitle%3DA%2520Review%2520on%2520CXCR4%252FCXCL12%2520Axis%2520in%2520Oncology%253A%2520No%2520Place%2520to%2520Hide%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2013%26volume%3D49%26spage%3D219%26epage%3D230%26doi%3D10.1016%2Fj.ejca.2012.05.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Scala, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottaiano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascierto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavalli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeone, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giuliano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napolitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castello, G.</span><span> </span><span class="NLM_article-title">Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1835</span><span class="NLM_x">–</span> <span class="NLM_lpage">1841</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1158%2F1078-0432.CCR-04-1887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=15756007" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitVKrs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=1835-1841&author=S.+Scalaauthor=A.+Ottaianoauthor=P.+A.+Asciertoauthor=M.+Cavalliauthor=E.+Simeoneauthor=P.+Giulianoauthor=M.+Napolitanoauthor=R.+Francoauthor=G.+Bottiauthor=G.+Castello&title=Expression+of+CXCR4+Predicts+Poor+Prognosis+in+Patients+with+Malignant+Melanoma&doi=10.1158%2F1078-0432.CCR-04-1887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma</span></div><div class="casAuthors">Scala, Stefania; Ottaiano, Alessandro; Ascierto, Paolo Antonio; Cavalli, Manuela; Simeone, Ester; Giuliano, Paola; Napolitano, Maria; Franco, Renato; Botti, Gerardo; Castello, Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1835-1841</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">CXCR4 receptor and its unique ligand, the CXCL12 chemokine, have been recently implicated in cancer metastasis.  Evidence about the role of CXCR4/CXCL12 axis has been reported in several cancers including melanoma.  Our goal was to investigate if CXCR4 expression has a prognostic value in malignant melanoma.  Immunohistochem. expression of CXCR4 was evaluated on 71 specimens of primary cutaneous melanoma with a Breslow tumor thickness of >1 mm after radical resection.  Assocns. between baseline patient features and tumors were analyzed by χ2 test.  The prognostic value of CXCR4 expression was evaluated by univariate and multivariate analyses adjusted by age, sex, Breslow tumor thickness, presence of ulceration, and sentinel lymph node metastases.  CXCR4 expression was detected in 31 of 71 (43.6%) primary cutaneous melanomas.  Membrane or cytoplasmic staining for CXCR4 protein was absent in 56% of the tumors.  The pos. cases were divided into three score classes according to their staining: low in 15 cases (21%), moderate in 10 (14%), and high in 6 (8%).  After a median follow-up of 38 mo, 26 patients progressed (16 of 26 expressed CXCR4) and 19 died (12 of 19 expressed CXCR4).  The CXCR4 expression on tumor cells was correlated with an unfavorable prognosis with a median disease-free and overall survival of 22 and 35 mo, resp.  The hazard ratios of relapse and death, compared with patients with CXCR4-neg. tumors, were 2.5 (95% confidence interval, 1.2-6.1) and 3.1 (95% confidence interval, 1.1-7.2), resp.  Median time-to-event (progression and survival) was not reached in patients with CXCR4-neg. tumors.  In the multivariate anal., CXCR4 expression, presence of ulceration, and sentinel lymph node status emerged as independent prognostic factors.  This article provides the first evidence that CXCR4 expression could be an independent and powerful prognostic marker in primary cutaneous malignant melanomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5rq8-aHeBKbVg90H21EOLACvtfcHk0lhoeE7c3kPGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitVKrs7k%253D&md5=2bf927225f53981fe02cbaa017a7de07</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1887%26sid%3Dliteratum%253Aachs%26aulast%3DScala%26aufirst%3DS.%26aulast%3DOttaiano%26aufirst%3DA.%26aulast%3DAscierto%26aufirst%3DP.%2BA.%26aulast%3DCavalli%26aufirst%3DM.%26aulast%3DSimeone%26aufirst%3DE.%26aulast%3DGiuliano%26aufirst%3DP.%26aulast%3DNapolitano%26aufirst%3DM.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DBotti%26aufirst%3DG.%26aulast%3DCastello%26aufirst%3DG.%26atitle%3DExpression%2520of%2520CXCR4%2520Predicts%2520Poor%2520Prognosis%2520in%2520Patients%2520with%2520Malignant%2520Melanoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D1835%26epage%3D1841%26doi%3D10.1158%2F1078-0432.CCR-04-1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Semaan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergheim, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietrich, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalff, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branchi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthaei, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goltz, D.</span><span> </span><span class="NLM_article-title">CXCL12 Expression and PD-L1 Expression Serve as Prognostic Biomarkers in HCC and Are Induced by Hypoxia</span> <span class="citation_source-journal">Virchows Arch.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">470</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span><span class="refDoi"> DOI: 10.1007/s00428-016-2051-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1007%2Fs00428-016-2051-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=27913861" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKjtr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=470&publication_year=2017&pages=185-196&author=A.+Semaanauthor=D.+Dietrichauthor=D.+Bergheimauthor=J.+Dietrichauthor=J.+C.+Kalffauthor=V.+Branchiauthor=H.+Matthaeiauthor=G.+Kristiansenauthor=H.-P.+Fischerauthor=D.+Goltz&title=CXCL12+Expression+and+PD-L1+Expression+Serve+as+Prognostic+Biomarkers+in+HCC+and+Are+Induced+by+Hypoxia&doi=10.1007%2Fs00428-016-2051-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia</span></div><div class="casAuthors">Semaan, Alexander; Dietrich, Dimo; Bergheim, Dominik; Dietrich, Joern; Kalff, Joerg C.; Branchi, Vittorio; Matthaei, Hanno; Kristiansen, Glen; Fischer, Hans-Peter; Goltz, Diane</div><div class="citationInfo"><span class="NLM_cas:title">Virchows Archiv</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">470</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-196</span>CODEN:
                <span class="NLM_cas:coden">VARCEM</span>;
        ISSN:<span class="NLM_cas:issn">0945-6317</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Anti-PD-1 treatment increases anti-tumor immune responses in animal models of hepatocellular carcinoma (HCC).  Sorafenib, the mainstay of treatment of HCC patients, however, leads to tumor hypoxia and thereby abrogates the efficacy of anti-PD-1 treatment.  This served as a rationale to implement CXCR4 inhibition as adjunct to sorafenib and anti-PD-1 treatment in murine HCC models.  We studied the relationship between tumor hypoxia, PD-L1 and CXCL12 expression in human HCC, aiming to test the rationale for triple therapy combining sorafenib, PD-1 immune checkpoint inhibitors and CXCR4 inhibitors.  Expression of CXCL12, PD-L1 and of surrogate markers for tumor hypoxia was evaluated at mRNA (mRNA) level in a cohort of HCC patients from The Cancer Genome Atlas and immunohistochem. in an independent cohort from the University Hospital of Bonn.  Retrospective survival analyses were conducted.  CXCL12 mRNA level significantly correlated with markers indicating tumor hypoxia in HCC (HIF1-α ρ = 0.104, p = 0.047).  PD-L1 expression was significantly increased in tumors with a high no. of tumor-infiltrating lymphocytes (ρ = 0.533, p < 0.001).  In Cox proportional hazard analyses, high PD-L1 expression and loss of nuclear CXCL12 expression showed significant prognostic value in terms of overall survival (hazard ratio (HR) = 3.35 [95%CI 1.33-8.46], p = 0.011 for PD-L1; HR = 2.64 [95%CI 1.18-5.88], p = 0.018 for CXCL12, resp.).  This study supports the rationale to combine CXCR4 inhibitors and PD-1 immune checkpoint inhibitors in patients with HCC, as sorafenib-induced tumor hypoxia leads to upregulation of PD-L1 and CXCL12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxOGOl9EmVI7Vg90H21EOLACvtfcHk0lhoeE7c3kPGXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKjtr3J&md5=455dd61016aa8c746319e5702aad0062</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00428-016-2051-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00428-016-2051-5%26sid%3Dliteratum%253Aachs%26aulast%3DSemaan%26aufirst%3DA.%26aulast%3DDietrich%26aufirst%3DD.%26aulast%3DBergheim%26aufirst%3DD.%26aulast%3DDietrich%26aufirst%3DJ.%26aulast%3DKalff%26aufirst%3DJ.%2BC.%26aulast%3DBranchi%26aufirst%3DV.%26aulast%3DMatthaei%26aufirst%3DH.%26aulast%3DKristiansen%26aufirst%3DG.%26aulast%3DFischer%26aufirst%3DH.-P.%26aulast%3DGoltz%26aufirst%3DD.%26atitle%3DCXCL12%2520Expression%2520and%2520PD-L1%2520Expression%2520Serve%2520as%2520Prognostic%2520Biomarkers%2520in%2520HCC%2520and%2520Are%2520Induced%2520by%2520Hypoxia%26jtitle%3DVirchows%2520Arch.%26date%3D2017%26volume%3D470%26spage%3D185%26epage%3D196%26doi%3D10.1007%2Fs00428-016-2051-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Sultan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidovic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gujar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcato, P.</span><span> </span><span class="NLM_article-title">Hide-and-Seek: The Interplay between Cancer Stem Cells and the Immune System</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">107</span><span class="NLM_x">–</span> <span class="NLM_lpage">118</span><span class="refDoi"> DOI: 10.1093/carcin/bgw115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1093%2Fcarcin%2Fbgw115" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2017&pages=107-118&issue=2&author=M.+Sultanauthor=K.+M.+Coyleauthor=D.+Vidovicauthor=M.+L.+Thomasauthor=S.+Gujarauthor=P.+Marcato&title=Hide-and-Seek%3A+The+Interplay+between+Cancer+Stem+Cells+and+the+Immune+System&doi=10.1093%2Fcarcin%2Fbgw115"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgw115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgw115%26sid%3Dliteratum%253Aachs%26aulast%3DSultan%26aufirst%3DM.%26aulast%3DCoyle%26aufirst%3DK.%2BM.%26aulast%3DVidovic%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DM.%2BL.%26aulast%3DGujar%26aufirst%3DS.%26aulast%3DMarcato%26aufirst%3DP.%26atitle%3DHide-and-Seek%253A%2520The%2520Interplay%2520between%2520Cancer%2520Stem%2520Cells%2520and%2520the%2520Immune%2520System%26jtitle%3DCarcinogenesis%26date%3D2017%26volume%3D38%26issue%3D2%26spage%3D107%26epage%3D118%26doi%3D10.1093%2Fcarcin%2Fbgw115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Righi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashiwagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santosuosso, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingraham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelblute, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collette, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingari, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birrer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsulic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dranoff, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poznansky, M. C.</span><span> </span><span class="NLM_article-title">CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">5522</span><span class="NLM_x">–</span> <span class="NLM_lpage">5534</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-3143</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1158%2F0008-5472.CAN-10-3143" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2011&pages=5522-5534&issue=16&author=E.+Righiauthor=S.+Kashiwagiauthor=J.+Yuanauthor=M.+Santosuossoauthor=P.+Leblancauthor=R.+Ingrahamauthor=B.+Forbesauthor=B.+Edelbluteauthor=B.+Colletteauthor=D.+Xingauthor=M.+Kowalskiauthor=M.+C.+Mingariauthor=F.+Vianelloauthor=M.+Birrerauthor=S.+Orsulicauthor=G.+Dranoffauthor=M.+C.+Poznansky&title=CXCL12%2FCXCR4+Blockade+Induces+Multimodal+Antitumor+Effects+That+Prolong+Survival+in+an+Immunocompetent+Mouse+Model+of+Ovarian+Cancer&doi=10.1158%2F0008-5472.CAN-10-3143"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-3143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-3143%26sid%3Dliteratum%253Aachs%26aulast%3DRighi%26aufirst%3DE.%26aulast%3DKashiwagi%26aufirst%3DS.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DSantosuosso%26aufirst%3DM.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DIngraham%26aufirst%3DR.%26aulast%3DForbes%26aufirst%3DB.%26aulast%3DEdelblute%26aufirst%3DB.%26aulast%3DCollette%26aufirst%3DB.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DKowalski%26aufirst%3DM.%26aulast%3DMingari%26aufirst%3DM.%2BC.%26aulast%3DVianello%26aufirst%3DF.%26aulast%3DBirrer%26aufirst%3DM.%26aulast%3DOrsulic%26aufirst%3DS.%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DPoznansky%26aufirst%3DM.%2BC.%26atitle%3DCXCL12%252FCXCR4%2520Blockade%2520Induces%2520Multimodal%2520Antitumor%2520Effects%2520That%2520Prolong%2520Survival%2520in%2520an%2520Immunocompetent%2520Mouse%2520Model%2520of%2520Ovarian%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2011%26volume%3D71%26issue%3D16%26spage%3D5522%26epage%3D5534%26doi%3D10.1158%2F0008-5472.CAN-10-3143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Petit, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafii, S.</span><span> </span><span class="NLM_article-title">The SDF-1-CXCR4 Signaling Pathway: A Molecular Hub Modulating Neo-Angiogenesis</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">299</span><span class="NLM_x">–</span> <span class="NLM_lpage">307</span><span class="refDoi"> DOI: 10.1016/j.it.2007.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.it.2007.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=17560169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmvV2gtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=299-307&issue=7&author=I.+Petitauthor=D.+Jinauthor=S.+Rafii&title=The+SDF-1-CXCR4+Signaling+Pathway%3A+A+Molecular+Hub+Modulating+Neo-Angiogenesis&doi=10.1016%2Fj.it.2007.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis</span></div><div class="casAuthors">Petit, Isabelle; Jin, David; Rafii, Shahin</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">299-307</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pro-angiogenic bone marrow (BM) cells include subsets of hematopoietic cells that provide vascular support and endothelial progenitor cells (EPCs), which under certain permissive conditions could differentiate into functional vascular cells.  Recent evidence demonstrates that the chemokine stromal-cell derived factor-1 (SDF-1, also known as CXCL12) has a major role in the recruitment and retention of CXCR4+ BM cells to the neo-angiogenic niches supporting revascularization of ischemic tissue and tumor growth.  However, the precise mechanism by which activation of CXCR4 modulates neo-angiogenesis is not clear.  SDF-1 not only promotes revascularization by engaging with CXCR4 expressed on the vascular cells but also supports mobilization of pro-angiogenic CXCR4+VEGFR1+ hematopoietic cells, thereby accelerating revascularization of ischemic organs.  Here, we attempt to define the multiple functions of the SDF-1-CXCR4 signaling pathway in the regulation of neo-vascularization during acute ischemia and tumor growth.  In particular, we introduce the concept that, by modulating plasma SDF-1 levels, the CXCR4 antagonist AMD3100 acutely promotes, while chronic AMD3100 treatment inhibits, mobilization of pro-angiogenic cells.  We will also discuss strategies to modulate the mobilization of essential subsets of BM cells that participate in neo-angiogenesis, setting up the stage for enhancing revascularization or targeting tumor vessels by exploiting CXCR4 agonists and antagonists, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxzxqz-Sj0xbVg90H21EOLACvtfcHk0li9lqLIcusthg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmvV2gtb0%253D&md5=f0e9a630059d267c7e69ec209319adf5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2007.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2007.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DPetit%26aufirst%3DI.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DRafii%26aufirst%3DS.%26atitle%3DThe%2520SDF-1-CXCR4%2520Signaling%2520Pathway%253A%2520A%2520Molecular%2520Hub%2520Modulating%2520Neo-Angiogenesis%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26issue%3D7%26spage%3D299%26epage%3D307%26doi%3D10.1016%2Fj.it.2007.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zlotnik, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homey, B.</span><span> </span><span class="NLM_article-title">Homeostatic Chemokine Receptors and Organ-Specific Metastasis</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">597</span><span class="NLM_x">–</span> <span class="NLM_lpage">606</span><span class="refDoi"> DOI: 10.1038/nri3049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1038%2Fnri3049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=21866172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVOmsrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2011&pages=597-606&issue=9&author=A.+Zlotnikauthor=A.+M.+Burkhardtauthor=B.+Homey&title=Homeostatic+Chemokine+Receptors+and+Organ-Specific+Metastasis&doi=10.1038%2Fnri3049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Homeostatic chemokine receptors and organ-specific metastasis</span></div><div class="casAuthors">Zlotnik, Albert; Burkhardt, Amanda M.; Homey, Bernhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">597-606</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  It has been 10 years since the role of a chemokine receptor, CXCR4, in breast cancer metastasis was first documented.  Since then, the field of chemokines and cancer has grown significantly, so it is timely to review the progress, analyze the studies to date and identify future challenges facing this field.  Metastasis is the major factor that limits survival in most patients with cancer.  Therefore, understanding the mol. mechanisms that control the metastatic behavior of tumor cells is pivotal for treating cancer successfully.  Substantial exptl. and clin. evidence supports the conclusion that mol. mechanisms control organ-specific metastasis.  One of the most important mechanisms operating in metastasis involves homeostatic chemokines and their receptors.  Here, we review this field and propose a model of 'cellular highways' to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryoVfPLgvAELVg90H21EOLACvtfcHk0li9lqLIcusthg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVOmsrbJ&md5=395fc0566f165340f1830a301192d803</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnri3049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3049%26sid%3Dliteratum%253Aachs%26aulast%3DZlotnik%26aufirst%3DA.%26aulast%3DBurkhardt%26aufirst%3DA.%2BM.%26aulast%3DHomey%26aufirst%3DB.%26atitle%3DHomeostatic%2520Chemokine%2520Receptors%2520and%2520Organ-Specific%2520Metastasis%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2011%26volume%3D11%26issue%3D9%26spage%3D597%26epage%3D606%26doi%3D10.1038%2Fnri3049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kucia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miekus, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wanzeck, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wojakowski, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janowska-Wieczorek, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratajczak, M. Z.</span><span> </span><span class="NLM_article-title">Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF-1-CXCR4 Axis</span> <span class="citation_source-journal">Stem Cells</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">879</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1634/stemcells.2004-0342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1634%2Fstemcells.2004-0342" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=879-894&author=M.+Kuciaauthor=R.+Recaauthor=K.+Miekusauthor=J.+Wanzeckauthor=W.+Wojakowskiauthor=A.+Janowska-Wieczorekauthor=J.+Ratajczakauthor=M.+Z.+Ratajczak&title=Trafficking+of+Normal+Stem+Cells+and+Metastasis+of+Cancer+Stem+Cells+Involve+Similar+Mechanisms%3A+Pivotal+Role+of+the+SDF-1-CXCR4+Axis&doi=10.1634%2Fstemcells.2004-0342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1634%2Fstemcells.2004-0342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1634%252Fstemcells.2004-0342%26sid%3Dliteratum%253Aachs%26aulast%3DKucia%26aufirst%3DM.%26aulast%3DReca%26aufirst%3DR.%26aulast%3DMiekus%26aufirst%3DK.%26aulast%3DWanzeck%26aufirst%3DJ.%26aulast%3DWojakowski%26aufirst%3DW.%26aulast%3DJanowska-Wieczorek%26aufirst%3DA.%26aulast%3DRatajczak%26aufirst%3DJ.%26aulast%3DRatajczak%26aufirst%3DM.%2BZ.%26atitle%3DTrafficking%2520of%2520Normal%2520Stem%2520Cells%2520and%2520Metastasis%2520of%2520Cancer%2520Stem%2520Cells%2520Involve%2520Similar%2520Mechanisms%253A%2520Pivotal%2520Role%2520of%2520the%2520SDF-1-CXCR4%2520Axis%26jtitle%3DStem%2520Cells%26date%3D2005%26volume%3D23%26spage%3D879%26epage%3D894%26doi%3D10.1634%2Fstemcells.2004-0342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rubin, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieran, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, R. A.</span><span> </span><span class="NLM_article-title">A Small-Molecule Antagonist of CXCR4 Inhibits Intracranial Growth of Primary Brain Tumors</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">13513</span><span class="NLM_x">–</span> <span class="NLM_lpage">13518</span><span class="refDoi"> DOI: 10.1073/pnas.2235846100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1073%2Fpnas.2235846100" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=13513-13518&issue=23&author=J.+B.+Rubinauthor=A.+L.+Kungauthor=R.+S.+Kleinauthor=J.+A.+Chanauthor=Y.+Sunauthor=K.+Schmidtauthor=M.+W.+Kieranauthor=A.+D.+Lusterauthor=R.+A.+Segal&title=A+Small-Molecule+Antagonist+of+CXCR4+Inhibits+Intracranial+Growth+of+Primary+Brain+Tumors&doi=10.1073%2Fpnas.2235846100"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2235846100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2235846100%26sid%3Dliteratum%253Aachs%26aulast%3DRubin%26aufirst%3DJ.%2BB.%26aulast%3DKung%26aufirst%3DA.%2BL.%26aulast%3DKlein%26aufirst%3DR.%2BS.%26aulast%3DChan%26aufirst%3DJ.%2BA.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DKieran%26aufirst%3DM.%2BW.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DSegal%26aufirst%3DR.%2BA.%26atitle%3DA%2520Small-Molecule%2520Antagonist%2520of%2520CXCR4%2520Inhibits%2520Intracranial%2520Growth%2520of%2520Primary%2520Brain%2520Tumors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26issue%3D23%26spage%3D13513%26epage%3D13518%26doi%3D10.1073%2Fpnas.2235846100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">de Nigris, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Infante, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napoli, C.</span><span> </span><span class="NLM_article-title">CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span><span class="refDoi"> DOI: 10.2174/157489212801820039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.2174%2F157489212801820039" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=251-264&issue=3&author=F.+de+Nigrisauthor=C.+Schianoauthor=T.+Infanteauthor=C.+Napoli&title=CXCR4+Inhibitors%3A+Tumor+Vasculature+and+Therapeutic+Challenges&doi=10.2174%2F157489212801820039"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F157489212801820039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F157489212801820039%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BNigris%26aufirst%3DF.%26aulast%3DSchiano%26aufirst%3DC.%26aulast%3DInfante%26aufirst%3DT.%26aulast%3DNapoli%26aufirst%3DC.%26atitle%3DCXCR4%2520Inhibitors%253A%2520Tumor%2520Vasculature%2520and%2520Therapeutic%2520Challenges%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2012%26volume%3D7%26issue%3D3%26spage%3D251%26epage%3D264%26doi%3D10.2174%2F157489212801820039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Uchida, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuribayashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomizuka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamatani, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, Y.</span><span> </span><span class="NLM_article-title">Blockade of CXCR4 in Oral Squamous Cell Carcinoma Inhibits Lymph Node Metastases</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">452</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span><span class="refDoi"> DOI: 10.1016/j.ejca.2010.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.ejca.2010.09.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=452-459&author=D.+Uchidaauthor=T.+Onoueauthor=N.+Kuribayashiauthor=Y.+Tomizukaauthor=T.+Tamataniauthor=H.+Nagaiauthor=Y.+Miyamoto&title=Blockade+of+CXCR4+in+Oral+Squamous+Cell+Carcinoma+Inhibits+Lymph+Node+Metastases&doi=10.1016%2Fj.ejca.2010.09.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2010.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2010.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DUchida%26aufirst%3DD.%26aulast%3DOnoue%26aufirst%3DT.%26aulast%3DKuribayashi%26aufirst%3DN.%26aulast%3DTomizuka%26aufirst%3DY.%26aulast%3DTamatani%26aufirst%3DT.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DMiyamoto%26aufirst%3DY.%26atitle%3DBlockade%2520of%2520CXCR4%2520in%2520Oral%2520Squamous%2520Cell%2520Carcinoma%2520Inhibits%2520Lymph%2520Node%2520Metastases%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D452%26epage%3D459%26doi%3D10.1016%2Fj.ejca.2010.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Domanska, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmer-Bosscha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagengast, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oude Munnink, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruizinga, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ananias, H. J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kliphuis, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huls, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, E. G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walenkamp, A. M. E.</span><span> </span><span class="NLM_article-title">CXCR4 Inhibition with AMD3100 Sensitizes Prostate Cancer to Docetaxel Chemotherapy</span> <span class="citation_source-journal">Neoplasia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">718</span><span class="refDoi"> DOI: 10.1593/neo.12324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1593%2Fneo.12324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=709-718&issue=8&author=U.+M.+Domanskaauthor=H.+Timmer-Bosschaauthor=W.+B.+Nagengastauthor=T.+H.+Oude+Munninkauthor=R.+C.+Kruizingaauthor=H.+J.+K.+Ananiasauthor=N.+M.+Kliphuisauthor=G.+Hulsauthor=E.+G.+E.+De+Vriesauthor=I.+J.+de+Jongauthor=A.+M.+E.+Walenkamp&title=CXCR4+Inhibition+with+AMD3100+Sensitizes+Prostate+Cancer+to+Docetaxel+Chemotherapy&doi=10.1593%2Fneo.12324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1593%2Fneo.12324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.12324%26sid%3Dliteratum%253Aachs%26aulast%3DDomanska%26aufirst%3DU.%2BM.%26aulast%3DTimmer-Bosscha%26aufirst%3DH.%26aulast%3DNagengast%26aufirst%3DW.%2BB.%26aulast%3DOude%2BMunnink%26aufirst%3DT.%2BH.%26aulast%3DKruizinga%26aufirst%3DR.%2BC.%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%2BK.%26aulast%3DKliphuis%26aufirst%3DN.%2BM.%26aulast%3DHuls%26aufirst%3DG.%26aulast%3DDe%2BVries%26aufirst%3DE.%2BG.%2BE.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26aulast%3DWalenkamp%26aufirst%3DA.%2BM.%2BE.%26atitle%3DCXCR4%2520Inhibition%2520with%2520AMD3100%2520Sensitizes%2520Prostate%2520Cancer%2520to%2520Docetaxel%2520Chemotherapy%26jtitle%3DNeoplasia%26date%3D2012%26volume%3D14%26issue%3D8%26spage%3D709%26epage%3D718%26doi%3D10.1593%2Fneo.12324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">De Clercq, E.</span><span> </span><span class="NLM_article-title">The AMD3100 Story: The Path to the Discovery of a Stem Cell Mobilizer (Mozobil)</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1655</span><span class="NLM_x">–</span> <span class="NLM_lpage">1664</span><span class="refDoi"> DOI: 10.1016/j.bcp.2008.12.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bcp.2008.12.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19161986" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkvVSqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=1655-1664&author=E.+De+Clercq&title=The+AMD3100+Story%3A+The+Path+to+the+Discovery+of+a+Stem+Cell+Mobilizer+%28Mozobil%29&doi=10.1016%2Fj.bcp.2008.12.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1655-1664</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  AMD3100 was found to inhibit HIV-1 and HIV-2 within the 1-10 nM concn. range while not being toxic to the host cells at concns. up to 500 μM, thus achieving a selectivity index of approx. 100,000.  The target of action was initially thought to be the viral envelope glycoprotein gp120.  It appeared only to be the indirect target.  The direct target of action turned out to be the co-receptor CXCR4 used by T-lymphotropic HIV strains (now referred to as X4 strains) to enter the cells.  Initial (phase I) clin. trials undertaken with AMD3100, as a prelude to its development as a candidate anti-HIV drug for the treatment of AIDS, showed an unexpected side effect: an increase in the white blood cell counts.  Apparently, AMD3100 specifically increased CD34+ hematopoietic stem cell counts in the peripheral blood.  Stromal derived factor 1 (SDF-1), through its interaction with CXCR4, retains the stem cells in the bone marrow (a process referred to as homing), and AMD3100 specifically antagonizes this interaction.  AMD3100 in combination with granulocyte colony-stimulating factor (G-CSF) resulted in the collection of more progenitor cells than G-CSF alone.  At present, the major indication for clin. use of AMD3100 (Mozobil) is the mobilization of hematopoietic stem cells from the bone marrow into the circulating blood for transplantation in patients with hematol. malignancies such as non-Hodgkin's lymphoma or multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-vof1PYEX37Vg90H21EOLACvtfcHk0lg-dy8v6r3jkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkvVSqsbc%253D&md5=19d5f76b85ef1c09e41a4d17ffbb2463</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2008.12.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2008.12.014%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520AMD3100%2520Story%253A%2520The%2520Path%2520to%2520the%2520Discovery%2520of%2520a%2520Stem%2520Cell%2520Mobilizer%2520%2528Mozobil%2529%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D77%26spage%3D1655%26epage%3D1664%26doi%3D10.1016%2Fj.bcp.2008.12.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gupta, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillarisetti, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiyar, N.</span><span> </span><span class="NLM_article-title">Pharmacological Evidence for Complex and Multiple Site Interaction of CXCR4 with SDF-1α: Implications for Development of Selective CXCR4 Antagonists</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span><span class="refDoi"> DOI: 10.1016/S0165-2478(01)00228-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2FS0165-2478%2801%2900228-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2001&pages=29-34&author=S.+K.+Guptaauthor=K.+Pillarisettiauthor=R.+A.+Thomasauthor=N.+Aiyar&title=Pharmacological+Evidence+for+Complex+and+Multiple+Site+Interaction+of+CXCR4+with+SDF-1%CE%B1%3A+Implications+for+Development+of+Selective+CXCR4+Antagonists&doi=10.1016%2FS0165-2478%2801%2900228-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2FS0165-2478%2801%2900228-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-2478%252801%252900228-0%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DS.%2BK.%26aulast%3DPillarisetti%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DR.%2BA.%26aulast%3DAiyar%26aufirst%3DN.%26atitle%3DPharmacological%2520Evidence%2520for%2520Complex%2520and%2520Multiple%2520Site%2520Interaction%2520of%2520CXCR4%2520with%2520SDF-1%25CE%25B1%253A%2520Implications%2520for%2520Development%2520of%2520Selective%2520CXCR4%2520Antagonists%26jtitle%3DImmunol.%2520Lett.%26date%3D2001%26volume%3D78%26spage%3D29%26epage%3D34%26doi%3D10.1016%2FS0165-2478%2801%2900228-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Fricker, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastassov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darkes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grujic, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span> </span><span class="NLM_article-title">Characterization of the Molecular Pharmacology of AMD3100: A Specific Antagonist of the G-Protein Coupled Chemokine Receptor, CXCR4</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">588</span><span class="NLM_x">–</span> <span class="NLM_lpage">596</span><span class="refDoi"> DOI: 10.1016/j.bcp.2006.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bcp.2006.05.010" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=588-596&author=S.+P.+Frickerauthor=V.+Anastassovauthor=J.+Coxauthor=M.+C.+Darkesauthor=O.+Grujicauthor=S.+R.+Idzanauthor=J.+Labrecqueauthor=G.+Lauauthor=R.+M.+Mosiauthor=K.+L.+Nelsonauthor=L.+Qinauthor=Z.+Santucciauthor=R.+S.+Y.+Wong&title=Characterization+of+the+Molecular+Pharmacology+of+AMD3100%3A+A+Specific+Antagonist+of+the+G-Protein+Coupled+Chemokine+Receptor%2C+CXCR4&doi=10.1016%2Fj.bcp.2006.05.010"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2006.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2006.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DFricker%26aufirst%3DS.%2BP.%26aulast%3DAnastassov%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DDarkes%26aufirst%3DM.%2BC.%26aulast%3DGrujic%26aufirst%3DO.%26aulast%3DIdzan%26aufirst%3DS.%2BR.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DG.%26aulast%3DMosi%26aufirst%3DR.%2BM.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DSantucci%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26atitle%3DCharacterization%2520of%2520the%2520Molecular%2520Pharmacology%2520of%2520AMD3100%253A%2520A%2520Specific%2520Antagonist%2520of%2520the%2520G-Protein%2520Coupled%2520Chemokine%2520Receptor%252C%2520CXCR4%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2006%26volume%3D72%26spage%3D588%26epage%3D596%26doi%3D10.1016%2Fj.bcp.2006.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramjiawan, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiberger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unan, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardeesy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duda, D. G.</span><span> </span><span class="NLM_article-title">CXCR4 Inhibition in Tumor Microenvironment Facilitates Anti-Programmed Death Receptor-1 Immunotherapy in Sorafenib-Treated Hepatocellular Carcinoma in Mice</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1591</span><span class="NLM_x">–</span> <span class="NLM_lpage">1602</span><span class="refDoi"> DOI: 10.1002/hep.27665</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fhep.27665" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=25529917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslWlsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2015&pages=1591-1602&author=Y.+Chenauthor=R.+R.+Ramjiawanauthor=T.+Reibergerauthor=M.+R.+Ngauthor=T.+Hatoauthor=Y.+Huangauthor=H.+Ochiaiauthor=S.+Kitaharaauthor=E.+C.+Unanauthor=T.+P.+Reddyauthor=C.+Fanauthor=P.+Huangauthor=N.+Bardeesyauthor=A.+X.+Zhuauthor=R.+K.+Jainauthor=D.+G.+Duda&title=CXCR4+Inhibition+in+Tumor+Microenvironment+Facilitates+Anti-Programmed+Death+Receptor-1+Immunotherapy+in+Sorafenib-Treated+Hepatocellular+Carcinoma+in+Mice&doi=10.1002%2Fhep.27665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice</span></div><div class="casAuthors">Chen, Yunching; Ramjiawan, Rakesh R.; Reiberger, Thomas; Ng, Mei R.; Hato, Tai; Huang, Yuhui; Ochiai, Hiroki; Kitahara, Shuji; Unan, Elizabeth C.; Reddy, Tejaswini P.; Fan, Christopher; Huang, Peigen; Bardeesy, Nabeel; Zhu, Andrew X.; Jain, Rakesh K.; Duda, Dan G.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1591-1602</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Sorafenib, a broad tyrosine kinase inhibitor, is the only approved systemic therapy for advanced hepatocellular carcinoma (HCC) but provides limited survival benefits.  Recently, immunotherapy has emerged as a promising treatment strategy, but its role remains unclear in HCCs, which are assocd. with decreased cytotoxic CD8+ T-lymphocyte infiltration in both murine and human tumors.  Moreover, in mouse models after sorafenib treatment intratumoral hypoxia is increased and may fuel evasive resistance.  Using orthotopic HCC models, we now show that increased hypoxia after sorafenib treatment promotes immunosuppression, characterized by increased intratumoral expression of the immune checkpoint inhibitor programmed death ligand-1 and accumulation of T-regulatory cells and M2-type macrophages.  We also show that the recruitment of immunosuppressive cells is mediated in part by hypoxia-induced up-regulation of stromal cell-derived 1 alpha.  Inhibition of the stromal cell-derived 1 alpha receptor (C-X-C receptor type 4 or CXCR4) using AMD3100 prevented the polarization toward an immunosuppressive microenvironment after sorafenib treatment, inhibited tumor growth, reduced lung metastasis, and improved survival.  However, the combination of AMD3100 and sorafenib did not significantly change cytotoxic CD8+ T-lymphocyte infiltration into HCC tumors and did not modify their activation status.  In sep. expts., antibody blockade of the programmed death ligand-1 receptor programmed death receptor-1 (PD-1) showed antitumor effects in treatment-naive tumors in orthotopic (grafted and genetically engineered) models of HCC.  However, anti-PD-1 antibody treatment had addnl. antitumor activity only when combined with sorafenib and AMD3100 and not when combined with sorafenib alone.  Conclusion: Anti-PD-1 treatment can boost antitumor immune responses in HCC models; when used in combination with sorafenib, anti-PD-1 immunotherapy shows efficacy only with concomitant targeting of the hypoxic and immunosuppressive microenvironment with agents such as CXCR4 inhibitors. (Hepatol. 2015;61:1591-1602).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprDcrbDjodw7Vg90H21EOLACvtfcHk0lhjA6_zWLmd1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslWlsb8%253D&md5=4dcf1d6fadf34cc7a78c4af5703fdafb</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1002%2Fhep.27665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.27665%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRamjiawan%26aufirst%3DR.%2BR.%26aulast%3DReiberger%26aufirst%3DT.%26aulast%3DNg%26aufirst%3DM.%2BR.%26aulast%3DHato%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DOchiai%26aufirst%3DH.%26aulast%3DKitahara%26aufirst%3DS.%26aulast%3DUnan%26aufirst%3DE.%2BC.%26aulast%3DReddy%26aufirst%3DT.%2BP.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DBardeesy%26aufirst%3DN.%26aulast%3DZhu%26aufirst%3DA.%2BX.%26aulast%3DJain%26aufirst%3DR.%2BK.%26aulast%3DDuda%26aufirst%3DD.%2BG.%26atitle%3DCXCR4%2520Inhibition%2520in%2520Tumor%2520Microenvironment%2520Facilitates%2520Anti-Programmed%2520Death%2520Receptor-1%2520Immunotherapy%2520in%2520Sorafenib-Treated%2520Hepatocellular%2520Carcinoma%2520in%2520Mice%26jtitle%3DHepatology%26date%3D2015%26volume%3D61%26spage%3D1591%26epage%3D1602%26doi%3D10.1002%2Fhep.27665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Mosi, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anastassova, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darkes, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idzan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labrecque, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santucci, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, S. P.</span><span> </span><span class="NLM_article-title">The Molecular Pharmacology of AMD11070: An Orally Bioavailable CXCR4 HIV Entry Inhibitor</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">472</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1016/j.bcp.2011.11.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bcp.2011.11.020" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=472-479&author=R.+M.+Mosiauthor=V.+Anastassovaauthor=J.+Coxauthor=M.+C.+Darkesauthor=S.+R.+Idzanauthor=J.+Labrecqueauthor=G.+Lauauthor=K.+L.+Nelsonauthor=K.+Patelauthor=Z.+Santucciauthor=R.+S.+Y.+Wongauthor=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=D.+Huskensauthor=D.+Scholsauthor=S.+P.+Fricker&title=The+Molecular+Pharmacology+of+AMD11070%3A+An+Orally+Bioavailable+CXCR4+HIV+Entry+Inhibitor&doi=10.1016%2Fj.bcp.2011.11.020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.11.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.11.020%26sid%3Dliteratum%253Aachs%26aulast%3DMosi%26aufirst%3DR.%2BM.%26aulast%3DAnastassova%26aufirst%3DV.%26aulast%3DCox%26aufirst%3DJ.%26aulast%3DDarkes%26aufirst%3DM.%2BC.%26aulast%3DIdzan%26aufirst%3DS.%2BR.%26aulast%3DLabrecque%26aufirst%3DJ.%26aulast%3DLau%26aufirst%3DG.%26aulast%3DNelson%26aufirst%3DK.%2BL.%26aulast%3DPatel%26aufirst%3DK.%26aulast%3DSantucci%26aufirst%3DZ.%26aulast%3DWong%26aufirst%3DR.%2BS.%2BY.%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DHuskens%26aufirst%3DD.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DFricker%26aufirst%3DS.%2BP.%26atitle%3DThe%2520Molecular%2520Pharmacology%2520of%2520AMD11070%253A%2520An%2520Orally%2520Bioavailable%2520CXCR4%2520HIV%2520Entry%2520Inhibitor%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D472%26epage%3D479%26doi%3D10.1016%2Fj.bcp.2011.11.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nyunt, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macfarland, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarborough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everts, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, C. W.</span><span> </span><span class="NLM_article-title">Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers</span> <span class="citation_source-journal">JAIDS, J. Acquired Immune Defic. Syndr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">565</span><span class="refDoi"> DOI: 10.1097/QAI.0b013e3181627566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1097%2FQAI.0b013e3181627566" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=18362694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=559-565&issue=5&author=M.+M.+Nyuntauthor=S.+Beckerauthor=R.+T.+Macfarlandauthor=P.+Cheeauthor=R.+Scarboroughauthor=S.+Evertsauthor=G.+B.+Calandraauthor=C.+W.+Hendrix&title=Pharmacokinetic+Effect+of+AMD070%2C+an+Oral+CXCR4+Antagonist%2C+on+CYP3A4+and+CYP2D6+Substrates+Midazolam+and+Dextromethorphan+in+Healthy+Volunteers&doi=10.1097%2FQAI.0b013e3181627566"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic Effect of AMD070, an Oral CXCR4 Antagonist, on CYP3A4 and CYP2D6 Substrates Midazolam and Dextromethorphan in Healthy Volunteers</span></div><div class="casAuthors">Nyunt, Myaing M.; Becker, Stephen; MacFarland, Ron T.; Chee, Priscilla; Scarborough, Robert; Everts, Stephanie; Calandra, Gary B.; Hendrix, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">JAIDS, Journal of Acquired Immune Deficiency Syndromes</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">559-565</span>CODEN:
                <span class="NLM_cas:coden">JJASFJ</span>;
        ISSN:<span class="NLM_cas:issn">1525-4135</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Many antiretroviral drugs used in HIV care involve complex drug metab. by CYP3A4 and CYP2D6 enzymes, and drug interactions are problematic clin.  AMD070, a novel entry inhibitor, is an inhibitor of X4-tropic HIV virus.  In vitro data suggested that it is a CYP3A4 substrate and may inhibit CYP2D6 and CYP3A4.  Twelve healthy subjects were given a single oral dose of 5 mg of midazolam and 30 mg of dextromethorphan on day 1 and 9, and 200 mg of AMD070 twice daily on days 2 through 9 (inclusive).  Pharmacokinetic parameters of midazolam and dextromethorphan were assessed alone and in the presence of AMD070.  The mean AUC0-24 and Cmax of dextromethorphan increased 2.86-fold (2.20 to 5.10, 90% confidence interval [CI]) and 2.52-fold (1.99 to 4.24, 90% CI), resp., in the presence of AMD070.  Plasma AUC0-12 of midazolam increased 1.33-fold (1.15 to 1.61, 90% CI) without change in Cmax.  The half-life did not change for both drugs, but significant, parallel decrease in apparent oral clearance and vol. of distribution was obsd.  The data support an alteration in bioavailability due to an AMD070-mediated inhibition of presystemic metab., though an intestinal P-glycoprotein effect could also be contributing.  Interactions between AMD070 with CYP3A4 and, esp., 2D6 substrates of clin. importance in HIV care should be further explored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcMlBnTo8oO7Vg90H21EOLACvtfcHk0ljS3ddZU1Zf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjs1Gqt7s%253D&md5=bfea110729b08f0c25d7219e971b209d</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1097%2FQAI.0b013e3181627566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAI.0b013e3181627566%26sid%3Dliteratum%253Aachs%26aulast%3DNyunt%26aufirst%3DM.%2BM.%26aulast%3DBecker%26aufirst%3DS.%26aulast%3DMacfarland%26aufirst%3DR.%2BT.%26aulast%3DChee%26aufirst%3DP.%26aulast%3DScarborough%26aufirst%3DR.%26aulast%3DEverts%26aufirst%3DS.%26aulast%3DCalandra%26aufirst%3DG.%2BB.%26aulast%3DHendrix%26aufirst%3DC.%2BW.%26atitle%3DPharmacokinetic%2520Effect%2520of%2520AMD070%252C%2520an%2520Oral%2520CXCR4%2520Antagonist%252C%2520on%2520CYP3A4%2520and%2520CYP2D6%2520Substrates%2520Midazolam%2520and%2520Dextromethorphan%2520in%2520Healthy%2520Volunteers%26jtitle%3DJAIDS%252C%2520J.%2520Acquired%2520Immune%2520Defic.%2520Syndr.%26date%3D2008%26volume%3D47%26issue%3D5%26spage%3D559%26epage%3D565%26doi%3D10.1097%2FQAI.0b013e3181627566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Moyle, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boffito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibney, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFarland, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calandra, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S.</span><span> </span><span class="NLM_article-title">Proof of Activity with AMD11070, an Orally Bioavailable Inhibitor of CXCR4-Tropic HIV Type 1</span> <span class="citation_source-journal">Clin. Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">798</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span><span class="refDoi"> DOI: 10.1086/597097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1086%2F597097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19193109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=798-805&author=G.+Moyleauthor=E.+DeJesusauthor=M.+Boffitoauthor=R.+S.+Wongauthor=C.+Gibneyauthor=K.+Badelauthor=R.+MacFarlandauthor=G.+Calandraauthor=G.+Bridgerauthor=S.+Becker&title=Proof+of+Activity+with+AMD11070%2C+an+Orally+Bioavailable+Inhibitor+of+CXCR4-Tropic+HIV+Type+1&doi=10.1086%2F597097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1</span></div><div class="casAuthors">Moyle, Graeme; De Jesus, Edwin; Boffito, Marta; Wong, Rebecca S.; Gibney, Colleen; Badel, Karin; MacFarland, Ron; Calandra, Gary; Bridger, Gary; Becker, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Infectious Diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">798-805</span>CODEN:
                <span class="NLM_cas:coden">CIDIEL</span>;
        ISSN:<span class="NLM_cas:issn">1058-4838</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Background: The X4 Antagonist Concept Trial investigates the safety and antiviral activity of AMD11070, a potent inhibitor of X4-tropic human immunodeficiency virus (HIV) in vitro in HIV-infected patients harboring X4-tropic virus.  Methods: Patients enrolled in the study had an X4 virus population ≥2000 relative luminescence units (rlu; by the Monogram Trofile Assay) and an HIV-1 RNA level ≥5000 copies/mL.  Patients received AMD11070 mono-therapy for 10 days.  Coreceptor tropism, plasma HIV-1 RNA level, and CD4 cell count were measured at study entry, on day 5, and on day 10.  Daily predose and serial samples on the last day of treatment were obtained for detn. of plasma AMD11070 concn.  Results: Ten patients were given AMD11070 monotherapy (200 mg to 8 patients and 100 mg to 2 patients) twice daily for 10 days.  The median baseline CD4 cell count was 160 cells/mm3, and the median HIV-1 RNA level was 91,447 copies/mL.  Four of 9 evaluable patients achieved a redn. in X4 virus population of ≥1 - log10 rlu.  The median change in X4 virus population at the end of treatment was -0.22 log10 rlu (range, -1.90 to 0.23 log10 rlu).  Three of 4 patients who responded to therapy showed a tropism shift from dual- or mixed-tropic viruses to exclusively R5 virus by day 10.  There were no drug-related serious adverse events, adverse events of greater than grade 2, or lab. abnormalities.  Conclusion: These results demonstrate the activity of AMD11070, the first oral CXCR4 antagonist, against X4-tropic HIV-1.  The drug was well tolerated, with no serious safety concerns.  AMD11070 is on clin. hold because of histol. changes to the liver obsd. in long-term animal studies; addnl. preclin. safety assessments are pending.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiMCeVyzm_ZLVg90H21EOLACvtfcHk0ljS3ddZU1Zf1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVyrsbY%253D&md5=e6406e781295be3e9a05e7d142048010</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1086%2F597097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F597097%26sid%3Dliteratum%253Aachs%26aulast%3DMoyle%26aufirst%3DG.%26aulast%3DDeJesus%26aufirst%3DE.%26aulast%3DBoffito%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DR.%2BS.%26aulast%3DGibney%26aufirst%3DC.%26aulast%3DBadel%26aufirst%3DK.%26aulast%3DMacFarland%26aufirst%3DR.%26aulast%3DCalandra%26aufirst%3DG.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DBecker%26aufirst%3DS.%26atitle%3DProof%2520of%2520Activity%2520with%2520AMD11070%252C%2520an%2520Orally%2520Bioavailable%2520Inhibitor%2520of%2520CXCR4-Tropic%2520HIV%2520Type%25201%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D48%26spage%3D798%26epage%3D805%26doi%3D10.1086%2F597097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Skerlj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skupinska, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wauthy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogucki, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Fluri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskens, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Novel CXCR4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.11.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bmcl.2010.11.023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=262-266&author=R.+Skerljauthor=G.+Bridgerauthor=E.+McEachernauthor=C.+Harwigauthor=C.+Smithauthor=T.+Wilsonauthor=D.+Vealeauthor=H.+Yeeauthor=J.+Crawfordauthor=K.+Skupinskaauthor=R.+Wauthyauthor=W.+Yangauthor=Y.+Zhuauthor=D.+Boguckiauthor=M.+Di+Fluriauthor=J.+Langilleauthor=D.+Huskensauthor=E.+De+Clercqauthor=D.+Schols&title=Synthesis+and+SAR+of+Novel+CXCR4+Antagonists+That+Are+Potent+Inhibitors+of+T-Tropic+%28X4%29+HIV-1+Replication&doi=10.1016%2Fj.bmcl.2010.11.023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.11.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.11.023%26sid%3Dliteratum%253Aachs%26aulast%3DSkerlj%26aufirst%3DR.%26aulast%3DBridger%26aufirst%3DG.%26aulast%3DMcEachern%26aufirst%3DE.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DVeale%26aufirst%3DD.%26aulast%3DYee%26aufirst%3DH.%26aulast%3DCrawford%26aufirst%3DJ.%26aulast%3DSkupinska%26aufirst%3DK.%26aulast%3DWauthy%26aufirst%3DR.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DBogucki%26aufirst%3DD.%26aulast%3DDi%2BFluri%26aufirst%3DM.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DHuskens%26aufirst%3DD.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Novel%2520CXCR4%2520Antagonists%2520That%2520Are%2520Potent%2520Inhibitors%2520of%2520T-Tropic%2520%2528X4%2529%2520HIV-1%2520Replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D262%26epage%3D266%26doi%3D10.1016%2Fj.bmcl.2010.11.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Skerlj, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridger, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atsma, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langille, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veale, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harwig, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Discovery of Novel Small Molecule Orally Bioavailable C-X-C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">3376</span><span class="NLM_x">–</span> <span class="NLM_lpage">3388</span><span class="refDoi"> DOI: 10.1021/jm100073m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm100073m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3376-3388&issue=8&author=R.+T.+Skerljauthor=G.+J.+Bridgerauthor=A.+Kallerauthor=E.+J.+McEachernauthor=J.+B.+Crawfordauthor=Y.+Zhouauthor=B.+Atsmaauthor=J.+Langilleauthor=S.+Nanauthor=D.+Vealeauthor=T.+Wilsonauthor=C.+Harwigauthor=S.+Hatseauthor=K.+Princenauthor=E.+De+Clercqauthor=D.+Schols&title=Discovery+of+Novel+Small+Molecule+Orally+Bioavailable+C-X-C+Chemokine+Receptor+4+Antagonists+That+Are+Potent+Inhibitors+of+T-Tropic+%28X4%29+HIV-1+Replication&doi=10.1021%2Fjm100073m"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm100073m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100073m%26sid%3Dliteratum%253Aachs%26aulast%3DSkerlj%26aufirst%3DR.%2BT.%26aulast%3DBridger%26aufirst%3DG.%2BJ.%26aulast%3DKaller%26aufirst%3DA.%26aulast%3DMcEachern%26aufirst%3DE.%2BJ.%26aulast%3DCrawford%26aufirst%3DJ.%2BB.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DAtsma%26aufirst%3DB.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DNan%26aufirst%3DS.%26aulast%3DVeale%26aufirst%3DD.%26aulast%3DWilson%26aufirst%3DT.%26aulast%3DHarwig%26aufirst%3DC.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520Novel%2520Small%2520Molecule%2520Orally%2520Bioavailable%2520C-X-C%2520Chemokine%2520Receptor%25204%2520Antagonists%2520That%2520Are%2520Potent%2520Inhibitors%2520of%2520T-Tropic%2520%2528X4%2529%2520HIV-1%2520Replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D8%26spage%3D3376%26epage%3D3388%26doi%3D10.1021%2Fjm100073m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Miller, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Aurora Richardson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Novel Isoquinoline CXCR4 Antagonists with Potent Anti-HIV Activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3026</span><span class="NLM_x">–</span> <span class="NLM_lpage">3030</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.03.118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bmcl.2010.03.118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=20443225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3026-3030&author=J.+F.+Millerauthor=K.+S.+Gudmundssonauthor=L.+D%E2%80%99Aurora+Richardsonauthor=S.+Jenkinsonauthor=A.+Spaltensteinauthor=M.+Thomsonauthor=P.+Wheelan&title=Synthesis+and+SAR+of+Novel+Isoquinoline+CXCR4+Antagonists+with+Potent+Anti-HIV+Activity&doi=10.1016%2Fj.bmcl.2010.03.118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity</span></div><div class="casAuthors">Miller, John F.; Gudmundsson, Kristjan S.; Richardson, Leah D'Aurora; Jenkinson, Stephen; Spaltenstein, Andrew; Thomson, Michael; Wheelan, Pat</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3026-3030</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Using AMD070, I, as a starting point for structural modification, a novel series of isoquinoline CXCR4 antagonists was developed, e.g., II.  A structure-activity scan of alternate lower heterocycles led to the 3-isoquinolinyl moiety as an attractive replacement for benzimidazole.  Side chain optimization in the isoquinoline series led to a no. of compds. with low nanomolar anti-HIV activities and promising rat PK properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKb6n6z51MXbVg90H21EOLACvtfcHk0liVEJ8KHqfrcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGnsr8%253D&md5=4b929a2e6843cb3b8ea5fbb9eba4a865</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.03.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.03.118%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DJ.%2BF.%26aulast%3DGudmundsson%26aufirst%3DK.%2BS.%26aulast%3DD%25E2%2580%2599Aurora%2BRichardson%26aufirst%3DL.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DWheelan%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Novel%2520Isoquinoline%2520CXCR4%2520Antagonists%2520with%2520Potent%2520Anti-HIV%2520Activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3026%26epage%3D3030%26doi%3D10.1016%2Fj.bmcl.2010.03.118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Jenkinson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edelstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danehower, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheelan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spaltenstein, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudmundsson, K.</span><span> </span><span class="NLM_article-title">Blockade of X4-Tropic HIV-1 Cellular Entry by GSK812397, a Potent Noncompetitive CXCR4 Receptor Antagonist</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span><span class="refDoi"> DOI: 10.1128/AAC.01293-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1128%2FAAC.01293-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19949058" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=817-824&issue=2&author=S.+Jenkinsonauthor=M.+Thomsonauthor=D.+McCoyauthor=M.+Edelsteinauthor=S.+Danehowerauthor=W.+Lawrenceauthor=P.+Wheelanauthor=A.+Spaltensteinauthor=K.+Gudmundsson&title=Blockade+of+X4-Tropic+HIV-1+Cellular+Entry+by+GSK812397%2C+a+Potent+Noncompetitive+CXCR4+Receptor+Antagonist&doi=10.1128%2FAAC.01293-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist</span></div><div class="casAuthors">Jenkinson, Stephen; Thomson, Michael; McCoy, David; Edelstein, Mark; Danehower, Susan; Lawrence, Wendell; Wheelan, Pat; Spaltenstein, Andrew; Gudmundsson, Kristjan</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">817-824</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">GSK812397 is a potent entry inhibitor of X4-tropic strains of HIV-1, as demonstrated in multiple in vitro cellular assays (e.g., in peripheral blood mononuclear cells [PBMCs] and a viral human osteosarcoma [HOS] assay, mean 50% inhibitory concns. [IC50s] ± std. errors of the means were 4.60 ± 1.23 nM and 1.50 ± 0.21 nM, resp.).  The primary in vitro potency of GSK812397 was not significantly altered by the addn. of serum proteins (2.55 [±0.12]-fold shift in the presence of human serum albumin and α-acid glycoprotein in the PBMC assay).  Pharmacol. characterization of GSK812397 in cell-based functional assays revealed it to be a noncompetitive antagonist of the CXCR4 receptor, with GSK812397 producing a concn.-dependent decrease in both an SDF-1-mediated chemotaxis and intracellular calcium release (IC50s were 0.34 ± 0.01 nM and 2.41 ± 0.50 nM, resp.).  With respect to the antiviral activity of GSK812397, it was effective against a broad range of X4- and X4R5-utilizing clin. isolates.  The potency and efficacy of GSK812397 were dependent on the individual isolate, with complete inhibition of infection obsd. with 24 of 30 isolates.  GSK812397 did not show any detectable in vitro cytotoxicity and was highly selective for CXCR4, as detd. using a wide range of receptors, enzymes, and transporters.  Moreover, GSK812397 demonstrated acceptable pharmacokinetic properties and bioavailability across species.  The data demonstrate that GSK812397 has antiviral activity against a broad range of X4-utilizing strains of HIV-1 via a noncompetitive antagonism of the CXCR4 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQcIVYziyq1bVg90H21EOLACvtfcHk0liVEJ8KHqfrcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFSiu7k%253D&md5=8aab7a9bb97e53d62268402b0e81e602</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1128%2FAAC.01293-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01293-09%26sid%3Dliteratum%253Aachs%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DThomson%26aufirst%3DM.%26aulast%3DMcCoy%26aufirst%3DD.%26aulast%3DEdelstein%26aufirst%3DM.%26aulast%3DDanehower%26aufirst%3DS.%26aulast%3DLawrence%26aufirst%3DW.%26aulast%3DWheelan%26aufirst%3DP.%26aulast%3DSpaltenstein%26aufirst%3DA.%26aulast%3DGudmundsson%26aufirst%3DK.%26atitle%3DBlockade%2520of%2520X4-Tropic%2520HIV-1%2520Cellular%2520Entry%2520by%2520GSK812397%252C%2520a%2520Potent%2520Noncompetitive%2520CXCR4%2520Receptor%2520Antagonist%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26issue%3D2%26spage%3D817%26epage%3D824%26doi%3D10.1128%2FAAC.01293-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Streiff, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovarik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glickman, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beerli, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Orally Bioavailable Isothioureas Block Function of the Chemokine Receptor CXCR4 In Vitro and In Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7915</span><span class="NLM_x">–</span> <span class="NLM_lpage">7920</span><span class="refDoi"> DOI: 10.1021/jm801065q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801065q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7915-7920&author=G.+Thomaauthor=M.+B.+Streiffauthor=J.+Kovarikauthor=F.+Glickmanauthor=T.+Wagnerauthor=C.+Beerliauthor=H.-G.+Zerwes&title=Orally+Bioavailable+Isothioureas+Block+Function+of+the+Chemokine+Receptor+CXCR4+In+Vitro+and+In+Vivo&doi=10.1021%2Fjm801065q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm801065q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801065q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DStreiff%26aufirst%3DM.%2BB.%26aulast%3DKovarik%26aufirst%3DJ.%26aulast%3DGlickman%26aufirst%3DF.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DBeerli%26aufirst%3DC.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DOrally%2520Bioavailable%2520Isothioureas%2520Block%2520Function%2520of%2520the%2520Chemokine%2520Receptor%2520CXCR4%2520In%2520Vitro%2520and%2520In%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7915%26epage%3D7920%26doi%3D10.1021%2Fjm801065q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsutsumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanabe, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochiai, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itotani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamamura, H.</span><span> </span><span class="NLM_article-title">Structure-Activity Relationship Study of CXCR4 Antagonists Bearing the Cyclic Pentapeptide Scaffold: Identification of the New Pharmacophore</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">4374</span><span class="NLM_x">–</span> <span class="NLM_lpage">4377</span><span class="refDoi"> DOI: 10.1039/b812029c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1039%2Fb812029c" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=4374-4377&author=T.+Tanakaauthor=H.+Tsutsumiauthor=W.+Nomuraauthor=Y.+Tanabeauthor=N.+Ohashiauthor=A.+Esakaauthor=C.+Ochiaiauthor=J.+Satoauthor=K.+Itotaniauthor=T.+Murakamiauthor=K.+Ohbaauthor=N.+Yamamotoauthor=N.+Fujiiauthor=H.+Tamamura&title=Structure-Activity+Relationship+Study+of+CXCR4+Antagonists+Bearing+the+Cyclic+Pentapeptide+Scaffold%3A+Identification+of+the+New+Pharmacophore&doi=10.1039%2Fb812029c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1039%2Fb812029c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb812029c%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DTsutsumi%26aufirst%3DH.%26aulast%3DNomura%26aufirst%3DW.%26aulast%3DTanabe%26aufirst%3DY.%26aulast%3DOhashi%26aufirst%3DN.%26aulast%3DEsaka%26aufirst%3DA.%26aulast%3DOchiai%26aufirst%3DC.%26aulast%3DSato%26aufirst%3DJ.%26aulast%3DItotani%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DT.%26aulast%3DOhba%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DFujii%26aufirst%3DN.%26aulast%3DTamamura%26aufirst%3DH.%26atitle%3DStructure-Activity%2520Relationship%2520Study%2520of%2520CXCR4%2520Antagonists%2520Bearing%2520the%2520Cyclic%2520Pentapeptide%2520Scaffold%253A%2520Identification%2520of%2520the%2520New%2520Pharmacophore%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D4374%26epage%3D4377%26doi%3D10.1039%2Fb812029c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Debnath, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grande, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Small Molecule Inhibitors of CXCR4</span> <span class="citation_source-journal">Theranostics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">75</span><span class="refDoi"> DOI: 10.7150/thno.5376</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.7150%2Fthno.5376" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=23382786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=47-75&issue=1&author=B.+Debnathauthor=S.+Xuauthor=F.+Grandeauthor=A.+Garofaloauthor=N.+Neamati&title=Small+Molecule+Inhibitors+of+CXCR4&doi=10.7150%2Fthno.5376"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of CXCR4</span></div><div class="casAuthors">Debnath, Bikash; Xu, Shili; Grande, Fedora; Garofalo, Antonio; Neamati, Nouri</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-75</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">A review.  CXCR4 is a G-protein-coupled receptor involved in a no. of physiol. processes in the hematopoietic and immune systems.  The SDF-1/CXCR4 axis is significantly assocd. with several diseases, such as HIV, cancer, WHIM syndrome, rheumatoid arthritis, pulmonary fibrosis and lupus.  For example, CXCR4 is one of the major co-receptors for HIV entry into target cells, while in cancer it plays an important role in tumor cell metastasis.  Several promising CXCR4 antagonists have been developed to block SDF-1/CXCR4 interactions that are currently under different stages of development.  The first in class CXCR4 antagonist, plerixafor, was approved by the FDA in 2008 for the mobilization of hematopoietic stem cells and several other drugs are currently in clin. trials for cancer, HIV and WHIM syndrome.  While the long-term safety data for the first generation CXCR4 antagonists are not yet available, several new compds. are under preclin. development in an attempt to provide safer and more efficient treatment options for HIV and cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8UIj2_rKgk7Vg90H21EOLACvtfcHk0lg1G_kWJlW15g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7w%253D&md5=f38ef176046dfe51f7160988d4e71245</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.7150%2Fthno.5376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.5376%26sid%3Dliteratum%253Aachs%26aulast%3DDebnath%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DGrande%26aufirst%3DF.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DSmall%2520Molecule%2520Inhibitors%2520of%2520CXCR4%26jtitle%3DTheranostics%26date%3D2013%26volume%3D3%26issue%3D1%26spage%3D47%26epage%3D75%26doi%3D10.7150%2Fthno.5376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of Novel <i>N</i>-Aryl Piperazine CXCR4 Antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4950</span><span class="NLM_x">–</span> <span class="NLM_lpage">4955</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2Fj.bmcl.2015.04.036" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4950-4955&author=H.+Zhaoauthor=A.+R.+Prosserauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+Novel+N-Aryl+Piperazine+CXCR4+Antagonists&doi=10.1016%2Fj.bmcl.2015.04.036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520Novel%2520N-Aryl%2520Piperazine%2520CXCR4%2520Antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4950%26epage%3D4955%26doi%3D10.1016%2Fj.bmcl.2015.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Truax, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span><span> </span><span class="NLM_article-title">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1025-1030&author=V.+M.+Truaxauthor=H.+Zhaoauthor=B.+M.+Katzmanauthor=A.+R.+Prosserauthor=A.+A.+Alcarazauthor=M.+T.+Saindaneauthor=R.+B.+Howardauthor=D.+Culverauthor=R.+F.+Arrendaleauthor=P.+R.+Gruddantiauthor=T.+J.+Eversauthor=M.+G.+Natchusauthor=J.+P.+Snyderauthor=D.+C.+Liottaauthor=L.+J.+Wilson&title=Discovery+of+Tetrahydroisoquinoline-Based+CXCR4+Antagonists&doi=10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tetrahydroisoquinoline-Based CXCR4 Antagonists</span></div><div class="casAuthors">Truax, Valarie M.; Zhao, Huanyu; Katzman, Brooke M.; Prosser, Anthony R.; Alcaraz, Ana A.; Saindane, Manohar T.; Howard, Randy B.; Culver, Deborah; Arrendale, Richard F.; Gruddanti, Prahbakar R.; Evers, Taylor J.; Natchus, Michael G.; Snyder, James P.; Liotta, Dennis C.; Wilson, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1025-1030</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A de novo hit-to-lead effort involving the redesign of benzimidazole-contg. antagonists of the CXCR4 receptor resulted in the discovery of a novel series of 1,2,3,4-tetrahydroisoquinoline (TIQ) analogs.  In general, this series of compds. show good potencies (3-650 nM) in assays involving CXCR4 function, including both inhibition of attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells and inhibition of calcium release in Chem-1 cells.  Series profiling permitted the identification of TIQ-(R)-stereoisomer I as a potent and selective CXCR4 antagonist lead candidate with a promising in vitro profile.  The drug-like properties of I were detd. in ADME in vitro studies, revealing low metabolic liability potential.  Further in vivo evaluations included pharmacokinetic expts. in rats and mice, where I was shown to have oral bioavailability (F = 63%) and resulted in the mobilization of white blood cells (WBCs) in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEHgfxHZaoI7Vg90H21EOLACvtfcHk0lh11s06dnR4WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSisL3O&md5=aaea8e1f85d3898d1c33b20c0fca64c9</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26atitle%3DDiscovery%2520of%2520Tetrahydroisoquinoline-Based%2520CXCR4%2520Antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><div class="note"><p class="first last">Mono-2-pyridylmethyl analog <b>8a</b> was alternatively prepared according to the following:</p></div><span class="NLM_contrib-group">Truax, V. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzman, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosser, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcaraz, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saindane, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrendale, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruddanti, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natchus, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liotta, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L. J.</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1025</span><span class="NLM_x">–</span> <span class="NLM_lpage">1030</span><span class="refDoi"> DOI: 10.1021/ml400183q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400183q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mono-2-pyridylmethyl+analog+8a+was+alternatively+prepared+according+to+the+following%3ATruax%2C+V.+T.%3B+Zhao%2C+H.%3B+Katzman%2C+B.+M.%3B+Prosser%2C+A.+R.%3B+Alcaraz%2C+A.+A.%3B+Saindane%2C+M.+T.%3B+Howard%2C+R.+B.%3B+Culver%2C+D.%3B+Arrendale%2C+R.+F.%3B+Gruddanti%2C+P.+R.%3B+Evers%2C+T.+J.%3B+Natchus%2C+M.+G.%3B+Snyder%2C+J.+P.%3B+Liotta%2C+D.+C.%3B+Wilson%2C+L.+J.ACS+Med.+Chem.+Lett.+2013%2C+4%2C+1025%E2%80%931030+10.1021%2Fml400183q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fml400183q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400183q%26sid%3Dliteratum%253Aachs%26aulast%3DTruax%26aufirst%3DV.%2BT.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DProsser%26aufirst%3DA.%2BR.%26aulast%3DAlcaraz%26aufirst%3DA.%2BA.%26aulast%3DSaindane%26aufirst%3DM.%2BT.%26aulast%3DHoward%26aufirst%3DR.%2BB.%26aulast%3DCulver%26aufirst%3DD.%26aulast%3DArrendale%26aufirst%3DR.%2BF.%26aulast%3DGruddanti%26aufirst%3DP.%2BR.%26aulast%3DEvers%26aufirst%3DT.%2BJ.%26aulast%3DNatchus%26aufirst%3DM.%2BG.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DWilson%26aufirst%3DL.%2BJ.%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1025%26epage%3D1030%26doi%3D10.1021%2Fml400183q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Kumpaty, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rehr, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span> </span><span class="NLM_article-title">Selective Access to Secondary Amines by a Highly Controlled Reductive Mono-<i>N</i>-Alkylation of Primary Amines</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2206</span><span class="NLM_x">–</span> <span class="NLM_lpage">2210</span><span class="refDoi"> DOI: 10.1055/s-2003-41066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1055%2Fs-2003-41066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=2206-2210&author=H.+J.+Kumpatyauthor=S.+Bhattacharyyaauthor=E.+W.+Rehrauthor=A.+M.+Gonzalez&title=Selective+Access+to+Secondary+Amines+by+a+Highly+Controlled+Reductive+Mono-N-Alkylation+of+Primary+Amines&doi=10.1055%2Fs-2003-41066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1055%2Fs-2003-41066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2003-41066%26sid%3Dliteratum%253Aachs%26aulast%3DKumpaty%26aufirst%3DH.%2BJ.%26aulast%3DBhattacharyya%26aufirst%3DS.%26aulast%3DRehr%26aufirst%3DE.%2BW.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26atitle%3DSelective%2520Access%2520to%2520Secondary%2520Amines%2520by%2520a%2520Highly%2520Controlled%2520Reductive%2520Mono-N-Alkylation%2520of%2520Primary%2520Amines%26jtitle%3DSynthesis%26date%3D2003%26volume%3D14%26spage%3D2206%26epage%3D2210%26doi%3D10.1055%2Fs-2003-41066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper-Catalyzed Regioselective Ortho C-H Cyanation of Vinylarenes</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8677</span><span class="NLM_x">–</span> <span class="NLM_lpage">8681</span><span class="refDoi"> DOI: 10.1002/anie.201402449</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fanie.201402449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnslWlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2014&pages=8677-8681&author=Y.+Yangauthor=S.+L.+Buchwald&title=Copper-Catalyzed+Regioselective+Ortho+C-H+Cyanation+of+Vinylarenes&doi=10.1002%2Fanie.201402449"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Copper-Catalyzed Regioselective ortho C-H Cyanation of Vinylarenes</span></div><div class="casAuthors">Yang, Yang; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">8677-8681</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A copper-based catalytic technique for the regioselective ortho C-H cyanation of vinylarenes has been developed.  This method provides an effective means for the selective functionalization of vinylarene derivs.  A copper-catalyzed cyanative dearomatization mechanism is proposed to account for the regiochem. course of this reaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHYHmtMawKB7Vg90H21EOLACvtfcHk0lh11s06dnR4WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnslWlu74%253D&md5=4da19476270dfa443e48e0dc6e3e0129</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1002%2Fanie.201402449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201402449%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper-Catalyzed%2520Regioselective%2520Ortho%2520C-H%2520Cyanation%2520of%2520Vinylarenes%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2014%26volume%3D53%26spage%3D8677%26epage%3D8681%26doi%3D10.1002%2Fanie.201402449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Adlington, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermann, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howe, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, G. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Proposed Active Site Binding Analysis of Monocyclic 2-Azetidinone Inhibitors of Prostate Specific Antigen</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1491</span><span class="NLM_x">–</span> <span class="NLM_lpage">1508</span><span class="refDoi"> DOI: 10.1021/jm000145g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000145g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1491-1508&issue=10&author=R.+M.+Adlingtonauthor=J.+E.+Baldwinauthor=G.+W.+Beckerauthor=B.+Chenauthor=L.+Chengauthor=S.+L.+Cooperauthor=R.+B.+Hermannauthor=T.+J.+Howeauthor=W.+McCoullauthor=A.+M.+McNultyauthor=B.+L.+Neubauerauthor=G.+J.+Pritchard&title=Design%2C+Synthesis%2C+and+Proposed+Active+Site+Binding+Analysis+of+Monocyclic+2-Azetidinone+Inhibitors+of+Prostate+Specific+Antigen&doi=10.1021%2Fjm000145g"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm000145g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000145g%26sid%3Dliteratum%253Aachs%26aulast%3DAdlington%26aufirst%3DR.%2BM.%26aulast%3DBaldwin%26aufirst%3DJ.%2BE.%26aulast%3DBecker%26aufirst%3DG.%2BW.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DCooper%26aufirst%3DS.%2BL.%26aulast%3DHermann%26aufirst%3DR.%2BB.%26aulast%3DHowe%26aufirst%3DT.%2BJ.%26aulast%3DMcCoull%26aufirst%3DW.%26aulast%3DMcNulty%26aufirst%3DA.%2BM.%26aulast%3DNeubauer%26aufirst%3DB.%2BL.%26aulast%3DPritchard%26aufirst%3DG.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Proposed%2520Active%2520Site%2520Binding%2520Analysis%2520of%2520Monocyclic%25202-Azetidinone%2520Inhibitors%2520of%2520Prostate%2520Specific%2520Antigen%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26issue%3D10%26spage%3D1491%26epage%3D1508%26doi%3D10.1021%2Fjm000145g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Dess, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J. C.</span><span> </span><span class="NLM_article-title">Readily Accessible 12-I-5′ Oxidant for the Conversion of Primary and Secondary Alcohols to Aldehydes and Ketones</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4155</span><span class="NLM_x">–</span> <span class="NLM_lpage">4156</span><span class="refDoi"> DOI: 10.1021/jo00170a070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00170a070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=4155-4156&author=D.+B.+Dessauthor=J.+C.+Martin&title=Readily+Accessible+12-I-5%E2%80%B2+Oxidant+for+the+Conversion+of+Primary+and+Secondary+Alcohols+to+Aldehydes+and+Ketones&doi=10.1021%2Fjo00170a070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjo00170a070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00170a070%26sid%3Dliteratum%253Aachs%26aulast%3DDess%26aufirst%3DD.%2BB.%26aulast%3DMartin%26aufirst%3DJ.%2BC.%26atitle%3DReadily%2520Accessible%252012-I-5%25E2%2580%25B2%2520Oxidant%2520for%2520the%2520Conversion%2520of%2520Primary%2520and%2520Secondary%2520Alcohols%2520to%2520Aldehydes%2520and%2520Ketones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26spage%3D4155%26epage%3D4156%26doi%3D10.1021%2Fjo00170a070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Tu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luedtke, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">Synthesis and Pharmacological Evaluation of Fluorine-Containing D<sub>3</sub> Dopamine Receptor Ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span><span class="refDoi"> DOI: 10.1021/jm101323b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101323b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1555-1564&author=Z.+Tuauthor=S.+Liauthor=J.+Cuiauthor=J.+Xuauthor=M.+Taylorauthor=D.+Hoauthor=R.+R.+Luedtkeauthor=R.+H.+Mach&title=Synthesis+and+Pharmacological+Evaluation+of+Fluorine-Containing+D3+Dopamine+Receptor+Ligands&doi=10.1021%2Fjm101323b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Pharmacological Evaluation of Fluorine-Containing D3 Dopamine Receptor Ligands</span></div><div class="casAuthors">Tu, Zhu-De; Li, Shi-Hong; Cui, Jin-Quan; Xu, Jin-Bin; Taylor, Michelle; Ho, David; Luedtke, Robert R.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1555-1564</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of fluorine-contg. N-(2-methoxyphenyl)piperazine and N-(2-fluoroethoxy)piperazine analogs, e. g. I, were synthesized, and their affinities for human dopamine D2, D3, and D4 receptors were detd.  Radioligand binding studies identified five compds., 18a, 20a, 20c, 20e, and 21e, which bind with high affinity at D3 (Ki = 0.17-5 nM) and moderate to high selectivity for D3 vs D2 receptors (ranging from ∼25- to 163-fold).  These compds. were also evaluated for intrinsic activity at D2 and D3 receptors using a forskolin-dependent adenylyl cyclase assay.  This panel of compds. exhibits varying receptor subtype binding selectivity and intrinsic activity at D2 vs D3 receptors.  These compds. may be useful for behavioral pharmacol. studies on the role of D2-like dopamine receptors in neuropsychiatric and neurol. disorders.  Furthermore, compd. 20e, which has the highest binding affinity and selectivity for the D3 receptor (Ki = 0.17 nM for D3, 163-fold selectivity for D3 vs D2 receptors), represents a candidate fluorine-18 radiotracer for in vivo PET imaging studies on the regulation of D3 receptor expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_lRIZaeiUnbVg90H21EOLACvtfcHk0lj-KDg9K0kfpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFWntrY%253D&md5=138e7cf0e434cd726af353d75f99b0f6</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm101323b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101323b%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHo%26aufirst%3DD.%26aulast%3DLuedtke%26aufirst%3DR.%2BR.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520Pharmacological%2520Evaluation%2520of%2520Fluorine-Containing%2520D3%2520Dopamine%2520Receptor%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1555%26epage%3D1564%26doi%3D10.1021%2Fjm101323b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gierasch, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdine, G. L.</span><span> </span><span class="NLM_article-title">Extensively Stereodiversified Scaffolds for Use in Diversity-Oriented Library Synthesis</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span><span class="refDoi"> DOI: 10.1021/ol027116f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol027116f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=621-624&issue=5&author=T.+M.+Gieraschauthor=Z.+Shiauthor=G.+L.+Verdine&title=Extensively+Stereodiversified+Scaffolds+for+Use+in+Diversity-Oriented+Library+Synthesis&doi=10.1021%2Fol027116f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fol027116f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol027116f%26sid%3Dliteratum%253Aachs%26aulast%3DGierasch%26aufirst%3DT.%2BM.%26aulast%3DShi%26aufirst%3DZ.%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26atitle%3DExtensively%2520Stereodiversified%2520Scaffolds%2520for%2520Use%2520in%2520Diversity-Oriented%2520Library%2520Synthesis%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26issue%3D5%26spage%3D621%26epage%3D624%26doi%3D10.1021%2Fol027116f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Mitsunobu, O.</span><span> </span><span class="NLM_article-title">The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1981</span><span class="NLM_x">, </span> <span class="NLM_volume">1981</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1055/s-1981-29317</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1055%2Fs-1981-29317" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1981&publication_year=1981&pages=1-28&author=O.+Mitsunobu&title=The+Use+of+Diethyl+Azodicarboxylate+and+Triphenylphosphine+in+Synthesis+and+Transformation+of+Natural+Products&doi=10.1055%2Fs-1981-29317"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1055%2Fs-1981-29317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1981-29317%26sid%3Dliteratum%253Aachs%26aulast%3DMitsunobu%26aufirst%3DO.%26atitle%3DThe%2520Use%2520of%2520Diethyl%2520Azodicarboxylate%2520and%2520Triphenylphosphine%2520in%2520Synthesis%2520and%2520Transformation%2520of%2520Natural%2520Products%26jtitle%3DSynthesis%26date%3D1981%26volume%3D1981%26spage%3D1%26epage%3D28%26doi%3D10.1055%2Fs-1981-29317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Coleman, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. J.</span><span> </span><span class="NLM_article-title">Synthesis of the Aziridino[1,2-a]pyrrolidine Substructure of the Antitumor Agents Azinomycin A and B</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">5813</span><span class="NLM_x">–</span> <span class="NLM_lpage">5815</span><span class="refDoi"> DOI: 10.1021/jo00048a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00048a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=5813-5815&author=R.+S.+Colemanauthor=A.+J.+Carpenter&title=Synthesis+of+the+Aziridino%5B1%2C2-a%5Dpyrrolidine+Substructure+of+the+Antitumor+Agents+Azinomycin+A+and+B&doi=10.1021%2Fjo00048a006"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjo00048a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00048a006%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DR.%2BS.%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26atitle%3DSynthesis%2520of%2520the%2520Aziridino%255B1%252C2-a%255Dpyrrolidine%2520Substructure%2520of%2520the%2520Antitumor%2520Agents%2520Azinomycin%2520A%2520and%2520B%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D5813%26epage%3D5815%26doi%3D10.1021%2Fjo00048a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Cooper, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Booker-Milburn, K. I.</span><span> </span><span class="NLM_article-title">A Palladium(II)-Catalyzed C-H Activation Cascade Sequence for Polyheterocycle Formation</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6496</span><span class="NLM_x">–</span> <span class="NLM_lpage">6500</span><span class="refDoi"> DOI: 10.1002/anie.201501037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fanie.201501037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsFyrsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=6496-6500&author=S.+P.+Cooperauthor=K.+I.+Booker-Milburn&title=A+Palladium%28II%29-Catalyzed+C-H+Activation+Cascade+Sequence+for+Polyheterocycle+Formation&doi=10.1002%2Fanie.201501037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A Palladium(II)-Catalyzed C-H Activation Cascade Sequence for Polyheterocycle Formation</span></div><div class="casAuthors">Cooper, Stephen P.; Booker-Milburn, Kevin I.</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6496-6500</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Polyheterocycles are found in many natural products and are useful moieties in functional materials and drug design.  As part of a program towards the synthesis of Stemona alkaloids, a novel palladium(II)-catalyzed C-H activation strategy for the construction of such systems has been developed.  Starting from simple 1,3-dienyl-substituted heterocycles, a large range of polycyclic systems contg. pyrrole, indole, furan and thiophene moieties can be synthesized in a single step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ9U8j4fHmqbVg90H21EOLACvtfcHk0lhfEUX6C8Dkog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsFyrsb0%253D&md5=74a54e2a9c238761fa34476562d6e5cc</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1002%2Fanie.201501037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201501037%26sid%3Dliteratum%253Aachs%26aulast%3DCooper%26aufirst%3DS.%2BP.%26aulast%3DBooker-Milburn%26aufirst%3DK.%2BI.%26atitle%3DA%2520Palladium%2528II%2529-Catalyzed%2520C-H%2520Activation%2520Cascade%2520Sequence%2520for%2520Polyheterocycle%2520Formation%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D6496%26epage%3D6500%26doi%3D10.1002%2Fanie.201501037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Parikh, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doering, W. E.</span><span> </span><span class="NLM_article-title">Sulfur Trioxide in the Oxidation of Alcohols by Dimethyl Sulfoxide</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">5505</span><span class="NLM_x">–</span> <span class="NLM_lpage">5507</span><span class="refDoi"> DOI: 10.1021/ja00997a067</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00997a067" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADyaF1cXjtV2q" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1967&pages=5505-5507&issue=21&author=J.+R.+Parikhauthor=W.+E.+Doering&title=Sulfur+Trioxide+in+the+Oxidation+of+Alcohols+by+Dimethyl+Sulfoxide&doi=10.1021%2Fja00997a067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfur trioxide in the oxidation of alcohols by dimethyl sulfoxide</span></div><div class="casAuthors">Parikh, Jekishan R.; Doering, William v. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5505-7</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">A soln. of pyridine-SO3 complex in Me2SO is used to oxidize p-nitrobenzyl alc., l-menthol, and many steroidal alcs. to the corresponding aldehydes and ketones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ2qbwXRJMT7Vg90H21EOLACvtfcHk0lhfEUX6C8Dkog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF1cXjtV2q&md5=fa83f740ef49cb695547ae90c1ae291a</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fja00997a067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00997a067%26sid%3Dliteratum%253Aachs%26aulast%3DParikh%26aufirst%3DJ.%2BR.%26aulast%3DDoering%26aufirst%3DW.%2BE.%26atitle%3DSulfur%2520Trioxide%2520in%2520the%2520Oxidation%2520of%2520Alcohols%2520by%2520Dimethyl%2520Sulfoxide%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1967%26volume%3D89%26issue%3D21%26spage%3D5505%26epage%3D5507%26doi%3D10.1021%2Fja00997a067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Moffett, R. B.</span><span> </span><span class="NLM_article-title">5,5-Dimethyl-2-Pyrrolidone</span> <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">60</span><span class="refDoi"> DOI: 10.15227/orgsyn.032.0059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.15227%2Forgsyn.032.0059" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1952&pages=59-60&author=R.+B.+Moffett&title=5%2C5-Dimethyl-2-Pyrrolidone&doi=10.15227%2Forgsyn.032.0059"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.15227%2Forgsyn.032.0059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15227%252Forgsyn.032.0059%26sid%3Dliteratum%253Aachs%26aulast%3DMoffett%26aufirst%3DR.%2BB.%26atitle%3D5%252C5-Dimethyl-2-Pyrrolidone%26jtitle%3DOrg.%2520Synth.%26date%3D1952%26volume%3D32%26spage%3D59%26epage%3D60%26doi%3D10.15227%2Forgsyn.032.0059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Princen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Clercq, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schols, D.</span><span> </span><span class="NLM_article-title">Evaluation of SDF-1/CXCR4-Induced Ca<sup>2+</sup> Signaling by Fluorometric Imaging Plate Reader (FLIPR) and Flow Cytometry</span> <span class="citation_source-journal">Cytometry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">51A</span><span class="NLM_x">, </span> <span class="NLM_fpage">35</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span><span class="refDoi"> DOI: 10.1002/cyto.a.10008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fcyto.a.10008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD3sXht1Siu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51A&publication_year=2003&pages=35-45&author=K.+Princenauthor=S.+Hatseauthor=K.+Vermeireauthor=E.+De+Clercqauthor=D.+Schols&title=Evaluation+of+SDF-1%2FCXCR4-Induced+Ca2%2B+Signaling+by+Fluorometric+Imaging+Plate+Reader+%28FLIPR%29+and+Flow+Cytometry&doi=10.1002%2Fcyto.a.10008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of SDF-1/CXCR4-induced Ca2+ signaling by fluorometric imaging plate reader (FLIPR) and flow cytometry</span></div><div class="casAuthors">Princen, Katrien; Hatse, Sigrid; Vermeire, Kurt; De Clercq, Erik; Schols, Dominique</div><div class="citationInfo"><span class="NLM_cas:title">Cytometry, Part A</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">51A</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-45</span>CODEN:
                <span class="NLM_cas:coden">CPAYAV</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Background: The chemokine receptors CXCR4 and CCR5 are the main coreceptors for human immunodeficiency virus (HIV) 1 to enter its target cells.  The antiviral activity of their natural ligands (stromal cell-derived factor 1 [SDF-1], regulated on activation normal T-cell expressed and secreted, (RANTES) and macrophage inflammatory proteins 1α and 1β, MIP-1α and MIP-1β) and the finding that individuals deficient in CCR5 are relatively resistant to HIV infection led to the concept that chemokine receptor antagonists can play an important role in anti-HIV therapy.  AMD3100, the prototype compd. of the bicyclams, is one of the most potent and selective CXCR4 antagonists described to date.  The search for new chemokine receptor antagonists involves the evaluation of compds. for their ability to block the specific chemokine-induced transient intracellular Ca2+ flux.  We evaluated two cell-based-fluorescent methods with the use of the Fluorometric Imaging Plate Reader (FLIPR) system and a flow cytometric assay to measure the SDF-1-induced intracellular Ca2+ mobilization via CXCR4.  Both assay systems were compared for their sensitivity, advantages, and system-dependent limitations.  Methods: CXCR4+ lymphocytic and monocytic cell lines commonly used in labs. studying acquired immunodeficiency syndrome and freshly isolated peripheral blood mononuclear cells (PBMCs) were loaded with the Ca2+ indicator Fluo-3.  After washing, the cells were pre-incubated with the CXCR4 antagonist AMD3100.  Then the increase in intracellular Ca2+ concn. after stimulation with SDF-1 was examd. by the FLIPR and the flow cytometer, which monitored the change in green fluorescence intensity of Ca2+-bound Fluo-3.  Surface CXCR4 expression was also detd. flow cytometrically.  Results: In all five CXCR4+ cell lines, SDF-1 elicited a transient increase in intracellular Ca2+ concn.  For each cell line, the magnitude of response was related to the level of CXCR4 expression: the cells with the highest CXCR4 level showed the strongest Ca2+ response.  AMD3100 effected a dose-dependent inhibition of the SDF-1-induced Ca2+ flux in all cell lines examd.  The FLIPR was more sensitive than the flow cytometer in detecting minor Ca2+ responses.  In freshly isolated PBMCs, the Ca2+ response was due solely to the stimulation of monocytes and granulocytes, whereas the lymphocyte population, although expressing CXCR4, did not respond at all.  This phenomenon could be obsd. with the flow cytometer and not with the FLIPR.  Conclusions: The FLIPR system is a most adequate to monitor intracellular Ca2+ mobilization and to evaluate chemokine receptor antagonists.  However, flow cytometry and its multiparameter anal. allow addnl. characterization of the cells involved in the chemokine receptor-mediated signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGE06CEHIiELVg90H21EOLACvtfcHk0lhfEUX6C8Dkog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXht1Siu7w%253D&md5=a6156389b91539519ad45a6f2c3699a2</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1002%2Fcyto.a.10008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcyto.a.10008%26sid%3Dliteratum%253Aachs%26aulast%3DPrincen%26aufirst%3DK.%26aulast%3DHatse%26aufirst%3DS.%26aulast%3DVermeire%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DSchols%26aufirst%3DD.%26atitle%3DEvaluation%2520of%2520SDF-1%252FCXCR4-Induced%2520Ca2%252B%2520Signaling%2520by%2520Fluorometric%2520Imaging%2520Plate%2520Reader%2520%2528FLIPR%2529%2520and%2520Flow%2520Cytometry%26jtitle%3DCytometry%26date%3D2003%26volume%3D51A%26spage%3D35%26epage%3D45%26doi%3D10.1002%2Fcyto.a.10008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, K.-K.</span><span> </span><span class="NLM_article-title">A Comparative Study of Artificial Membrane Permeability Assay for High Throughput Profiling of Drug Absorption Potential</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span><span class="refDoi"> DOI: 10.1016/S0223-5234(02)01360-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1016%2FS0223-5234%2802%2901360-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=12008054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2002&pages=399-407&author=C.+Zhuauthor=L.+Jiangauthor=T.-M.+Chenauthor=K.-K.+Hwang&title=A+Comparative+Study+of+Artificial+Membrane+Permeability+Assay+for+High+Throughput+Profiling+of+Drug+Absorption+Potential&doi=10.1016%2FS0223-5234%2802%2901360-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential</span></div><div class="casAuthors">Zhu, Chengyue; Jiang, Lan; Chen, Teng-Man; Hwang, Kin-Kai</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">399-407</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Artificial membrane permeability measurement is a potentially high throughput and low cost alternative for in vitro assessment of drug absorption potential.  It will be an ideal screening/profiling tool in the lead generation program of drug discovery research if it is proven to be generally applicable for classifying drug absorption potential and is advantageous over other in vitro or in silico methods.  This study provides an in-depth evaluation of the method in close comparison to Caco-2, Log D, Log P, polar surface area (PSA), and quant. structure-property relationship (QSPR) predictions using a large and diverse compd. set.  It showed that the accuracy of using artificial membrane permeability in assessing drug absorption is comparable to Caco-2, but significantly better than Log P, Log D, PSA, and QSPR predictions.  This study also explored the artificial membrane compn. by adopting a hydrophilic filter membrane for artificial membrane (lecithin-dodecane) support.  The use of hydrophilic filter membrane increased the rate of permeation significantly and reduced the transport time to 2 h or less as compared with over 10 h when a hydrophobic filter membrane is used.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnV2XGwbLMnLVg90H21EOLACvtfcHk0lhMJIOYcgLoMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlKksLY%253D&md5=4bfab862f5872f6abf0d0d18f5b5e28f</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2802%2901360-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252802%252901360-0%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DT.-M.%26aulast%3DHwang%26aufirst%3DK.-K.%26atitle%3DA%2520Comparative%2520Study%2520of%2520Artificial%2520Membrane%2520Permeability%2520Assay%2520for%2520High%2520Throughput%2520Profiling%2520of%2520Drug%2520Absorption%2520Potential%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2002%26volume%3D37%26spage%3D399%26epage%3D407%26doi%3D10.1016%2FS0223-5234%2802%2901360-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Donato, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castell, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Lechon, M.</span><span> </span><span class="NLM_article-title">Fluorescence-Based Assays for Screening Nine Cytochrome P450 (CYP450) Activities in Intact Cells Expressing Individual Human P450 Enzymes</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">699</span><span class="NLM_x">–</span> <span class="NLM_lpage">706</span><span class="refDoi"> DOI: 10.1124/dmd.32.7.699</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1124%2Fdmd.32.7.699" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2004&pages=699-706&issue=7&author=M.+T.+Donatoauthor=N.+Jimenezauthor=J.+V.+Castellauthor=M.+Gomez-Lechon&title=Fluorescence-Based+Assays+for+Screening+Nine+Cytochrome+P450+%28CYP450%29+Activities+in+Intact+Cells+Expressing+Individual+Human+P450+Enzymes&doi=10.1124%2Fdmd.32.7.699"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1124%2Fdmd.32.7.699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.32.7.699%26sid%3Dliteratum%253Aachs%26aulast%3DDonato%26aufirst%3DM.%2BT.%26aulast%3DJimenez%26aufirst%3DN.%26aulast%3DCastell%26aufirst%3DJ.%2BV.%26aulast%3DGomez-Lechon%26aufirst%3DM.%26atitle%3DFluorescence-Based%2520Assays%2520for%2520Screening%2520Nine%2520Cytochrome%2520P450%2520%2528CYP450%2529%2520Activities%2520in%2520Intact%2520Cells%2520Expressing%2520Individual%2520Human%2520P450%2520Enzymes%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2004%26volume%3D32%26issue%3D7%26spage%3D699%26epage%3D706%26doi%3D10.1124%2Fdmd.32.7.699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadjura, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arienzo, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malinowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesenberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, P.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonno, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadow, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meanwell, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansel, S. B.</span><span> </span><span class="NLM_article-title">Utilization of <i>in vitro</i> Caco-2 Permeability and Liver Microsomal Half-Life Screens in Discovering BMS-488043, a Novel HIV-1 Attachment Inhibitor with Improved Pharmacokinetic Properties</span> <span class="citation_source-journal">J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">2135</span><span class="NLM_x">–</span> <span class="NLM_lpage">2152</span><span class="refDoi"> DOI: 10.1002/jps.21948</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Fjps.21948" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=2135-2152&issue=4&author=Z.+Yangauthor=L.+M.+Zadjuraauthor=A.+M.+Marinoauthor=C.+J.+D%E2%80%99Arienzoauthor=J.+Malinowskiauthor=C.+Gesenbergauthor=P.-F.+Linauthor=R.+J.+Colonnoauthor=T.+Wangauthor=J.+F.+Kadowauthor=N.+A.+Meanwellauthor=S.+B.+Hansel&title=Utilization+of+in+vitro+Caco-2+Permeability+and+Liver+Microsomal+Half-Life+Screens+in+Discovering+BMS-488043%2C+a+Novel+HIV-1+Attachment+Inhibitor+with+Improved+Pharmacokinetic+Properties&doi=10.1002%2Fjps.21948"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fjps.21948&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.21948%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DZadjura%26aufirst%3DL.%2BM.%26aulast%3DMarino%26aufirst%3DA.%2BM.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DMalinowski%26aufirst%3DJ.%26aulast%3DGesenberg%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DP.-F.%26aulast%3DColonno%26aufirst%3DR.%2BJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DHansel%26aufirst%3DS.%2BB.%26atitle%3DUtilization%2520of%2520in%2520vitro%2520Caco-2%2520Permeability%2520and%2520Liver%2520Microsomal%2520Half-Life%2520Screens%2520in%2520Discovering%2520BMS-488043%252C%2520a%2520Novel%2520HIV-1%2520Attachment%2520Inhibitor%2520with%2520Improved%2520Pharmacokinetic%2520Properties%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26issue%3D4%26spage%3D2135%26epage%3D2152%26doi%3D10.1002%2Fjps.21948" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Storz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brengel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Jong, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müsken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Häussler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, R. W.</span><span> </span><span class="NLM_article-title">Validation of PqsD as an Anti-Biofilm Target in Pseudomonas Aeruginosa by Development of Small-Molecule Inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">16143</span><span class="NLM_x">–</span> <span class="NLM_lpage">16146</span><span class="refDoi"> DOI: 10.1021/ja3072397</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja3072397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2012&pages=16143-16146&author=M.+P.+Storzauthor=C.+K.+Maurerauthor=C.+Zimmerauthor=N.+Wagnerauthor=C.+Brengelauthor=J.+C.+de+Jongauthor=S.+Lucasauthor=M.+M%C3%BCskenauthor=S.+H%C3%A4usslerauthor=A.+Steinbachauthor=R.+W.+Hartmann&title=Validation+of+PqsD+as+an+Anti-Biofilm+Target+in+Pseudomonas+Aeruginosa+by+Development+of+Small-Molecule+Inhibitors&doi=10.1021%2Fja3072397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fja3072397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja3072397%26sid%3Dliteratum%253Aachs%26aulast%3DStorz%26aufirst%3DM.%2BP.%26aulast%3DMaurer%26aufirst%3DC.%2BK.%26aulast%3DZimmer%26aufirst%3DC.%26aulast%3DWagner%26aufirst%3DN.%26aulast%3DBrengel%26aufirst%3DC.%26aulast%3Dde%2BJong%26aufirst%3DJ.%2BC.%26aulast%3DLucas%26aufirst%3DS.%26aulast%3DM%25C3%25BCsken%26aufirst%3DM.%26aulast%3DH%25C3%25A4ussler%26aufirst%3DS.%26aulast%3DSteinbach%26aufirst%3DA.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26atitle%3DValidation%2520of%2520PqsD%2520as%2520an%2520Anti-Biofilm%2520Target%2520in%2520Pseudomonas%2520Aeruginosa%2520by%2520Development%2520of%2520Small-Molecule%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2012%26volume%3D134%26spage%3D16143%26epage%3D16146%26doi%3D10.1021%2Fja3072397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">O’Hagan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skibiński, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slawin, A. M. Z.</span><span> </span><span class="NLM_article-title">Influence of the Difluoromethylene Group (CF<sub>2</sub>) on the Conformation and Properties of Selected Organic Compounds</span> <span class="citation_source-journal">Pure Appl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1595</span><span class="refDoi"> DOI: 10.1351/PAC-CON-11-09-26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1351%2FPAC-CON-11-09-26" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2012&pages=1587-1595&issue=7&author=D.+O%E2%80%99Haganauthor=Y.+Wangauthor=M.+Skibi%C5%84skiauthor=A.+M.+Z.+Slawin&title=Influence+of+the+Difluoromethylene+Group+%28CF2%29+on+the+Conformation+and+Properties+of+Selected+Organic+Compounds&doi=10.1351%2FPAC-CON-11-09-26"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1351%2FPAC-CON-11-09-26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1351%252FPAC-CON-11-09-26%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSkibi%25C5%2584ski%26aufirst%3DM.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%2BZ.%26atitle%3DInfluence%2520of%2520the%2520Difluoromethylene%2520Group%2520%2528CF2%2529%2520on%2520the%2520Conformation%2520and%2520Properties%2520of%2520Selected%2520Organic%2520Compounds%26jtitle%3DPure%2520Appl.%2520Chem.%26date%3D2012%26volume%3D84%26issue%3D7%26spage%3D1587%26epage%3D1595%26doi%3D10.1351%2FPAC-CON-11-09-26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Huchet, Q. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carreira, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span> </span><span class="NLM_article-title">Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">9041</span><span class="NLM_x">–</span> <span class="NLM_lpage">9060</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01455</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01455" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGmsrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9041-9060&author=Q.+A.+Huchetauthor=B.+Kuhnauthor=B.+Wagnerauthor=N.+A.+Kratochwilauthor=H.+Fischerauthor=M.+Kansyauthor=D.+Zimmerliauthor=E.+M.+Carreiraauthor=K.+Muller&title=Fluorination+Patterning%3A+A+Study+of+Structural+Motifs+That+Impact+Physicochemical+Properties+of+Relevance+to+Drug+Discovery&doi=10.1021%2Facs.jmedchem.5b01455"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorination Patterning: A Study of Structural Motifs That Impact Physicochemical Properties of Relevance to Drug Discovery</span></div><div class="casAuthors">Huchet, Quentin A.; Kuhn, Bernd; Wagner, Bjorn; Kratochwil, Nicole A.; Fischer, Holger; Kansy, Manfred; Zimmerli, Daniel; Carreira, Erick M.; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9041-9060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a collection of 3-substituted indole derivs. incorporating partially fluorinated Pr and Bu groups is described along with an in-depth study of the effects of various fluorination patterns on their properties, such as lipophilicity, aq. soly., and metabolic stability.  The exptl. observations confirm predictions of a marked lipophilicity decrease imparted by a vic-difluoro unit when compared to the gem-difluoro counterparts.  The data involving the comparison of the two substitution patterns is expected to benefit mol. design in medicinal chem. and, more broadly, in life as well as materials sciences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp49KCeC1WDm7Vg90H21EOLACvtfcHk0lgeKL0h5O4ZBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGmsrzM&md5=20d7a36b75501c02570744857c82f325</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01455%26sid%3Dliteratum%253Aachs%26aulast%3DHuchet%26aufirst%3DQ.%2BA.%26aulast%3DKuhn%26aufirst%3DB.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKratochwil%26aufirst%3DN.%2BA.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DCarreira%26aufirst%3DE.%2BM.%26aulast%3DMuller%26aufirst%3DK.%26atitle%3DFluorination%2520Patterning%253A%2520A%2520Study%2520of%2520Structural%2520Motifs%2520That%2520Impact%2520Physicochemical%2520Properties%2520of%2520Relevance%2520to%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9041%26epage%3D9060%26doi%3D10.1021%2Facs.jmedchem.5b01455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Kieltyka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baglieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraro, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zvyaga, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drexler, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shou, W. Z.</span><span> </span><span class="NLM_article-title">A High-Throughput Bioanalytical Platform Using Automated Infusion for Tandem Mass Spectrometric Method Optimization and Its Application in a Metabolic Stability Screen</span> <span class="citation_source-journal">Rapid Commun. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1579</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span><span class="refDoi"> DOI: 10.1002/rcm.4037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=10.1002%2Frcm.4037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=19399765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2009&pages=1579-1591&issue=11&author=K.+Kieltykaauthor=J.+Zhangauthor=S.+Liauthor=M.+Vathauthor=C.+Baglieriauthor=C.+Ferraroauthor=T.+A.+Zvyagaauthor=D.+M.+Drexlerauthor=H.+N.+Wellerauthor=W.+Z.+Shou&title=A+High-Throughput+Bioanalytical+Platform+Using+Automated+Infusion+for+Tandem+Mass+Spectrometric+Method+Optimization+and+Its+Application+in+a+Metabolic+Stability+Screen&doi=10.1002%2Frcm.4037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">A high-throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen</span></div><div class="casAuthors">Kieltyka, Kasia; Zhang, Jun; Li, Shu; Vath, Marianne; Baglieri, Chris; Ferraro, Cheryl; Zvyaga, Tatyana A.; Drexler, Dieter M.; Weller, Harold N.; Shou, Wilson Z.</div><div class="citationInfo"><span class="NLM_cas:title">Rapid Communications in Mass Spectrometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1579-1591</span>CODEN:
                <span class="NLM_cas:coden">RCMSEF</span>;
        ISSN:<span class="NLM_cas:issn">0951-4198</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Liq. chromatog./tandem mass spectrometry (LC/MS/MS) is the bioanal. method of choice to support plate-based, in vitro early ADME (Absorption, Distribution, Metab. and Excretion) screens such as metabolic stability (Metstab) assessment.  MS/MS method optimization has historically been the bottleneck in this environment, where samples from thousands of discrete compds. are analyzed on a monthly basis, mainly due to the lack of a high-quality com. available platform to handle the necessary MS/MS method optimization steps for sample anal. by selected reaction monitoring (SRM) on triple quadrupole mass spectrometers.  To address this challenge, we recently developed a highly automated bioanal. platform by successfully integrating QuickQuan 2.0, a unique high-throughput soln. featuring MS/MS method optimization by automated infusion, with a customized inhouse software tool in support of a Metstab screen.  In this platform, a dual-column setup running parallel chromatog. was also implemented to reduce the bioanal. cycle time for LC/MS/MS sample anal.  A set of 45 validation compds. was used to demonstrate the speed, quality and reproducibility of MS/MS method optimization, sample anal., and data processing using this automated platform.  Metstab results for the validation compds. in microsomes from multiple species (human, rat, mouse) showed good consistency within each batch, and also between batches conducted on different days.  We have achieved and maintained a monthly throughput of 1300 compd. assays representing 500 discrete compds. per instrument per mo on this platform, and it has been used to generate metabolic stability data for more than 25 000 compds. to date with an overall success rate of more than 95%.  Copyright © 2009 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8W1PNTqYnALVg90H21EOLACvtfcHk0lgeKL0h5O4ZBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtVKmt70%253D&md5=57977322942dc41955c1d9cf015e5b05</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1002%2Frcm.4037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Frcm.4037%26sid%3Dliteratum%253Aachs%26aulast%3DKieltyka%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DVath%26aufirst%3DM.%26aulast%3DBaglieri%26aufirst%3DC.%26aulast%3DFerraro%26aufirst%3DC.%26aulast%3DZvyaga%26aufirst%3DT.%2BA.%26aulast%3DDrexler%26aufirst%3DD.%2BM.%26aulast%3DWeller%26aufirst%3DH.%2BN.%26aulast%3DShou%26aufirst%3DW.%2BZ.%26atitle%3DA%2520High-Throughput%2520Bioanalytical%2520Platform%2520Using%2520Automated%2520Infusion%2520for%2520Tandem%2520Mass%2520Spectrometric%2520Method%2520Optimization%2520and%2520Its%2520Application%2520in%2520a%2520Metabolic%2520Stability%2520Screen%26jtitle%3DRapid%2520Commun.%2520Mass%2520Spectrom.%26date%3D2009%26volume%3D23%26issue%3D11%26spage%3D1579%26epage%3D1591%26doi%3D10.1002%2Frcm.4037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i88"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01420">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_51757"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01420">10.1021/acs.jmedchem.7b01420</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic methods used for the preparation of common intermediate <b>6</b>, including relevant compound characterization and X-ray crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_001.pdf">jm7b01420_si_001.pdf (1.46 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01420/suppl_file/jm7b01420_si_002.csv">jm7b01420_si_002.csv (8.05 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01420&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-3%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01420%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01420" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992898d8d63d24","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
